BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 043278
(752 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 207 bits (527), Expect = 2e-53, Method: Compositional matrix adjust.
Identities = 119/297 (40%), Positives = 175/297 (58%), Gaps = 5/297 (1%)
Query: 416 ELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQG-IVEFK 474
+LK F + + A++NFS N LG GGFG VYKG+LAD VA+KRL QG ++F+
Sbjct: 24 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQ 83
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFI 533
EV +I+ H NL+RL G + ERLLVY +M N S+ L L+W KR
Sbjct: 84 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 143
Query: 534 IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR 593
I G ++GL YLH + ++IHRD+KA+NILLD++ + DFG+A++ + +
Sbjct: 144 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA- 202
Query: 594 IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQK--NHTRHHPDRPLNLIGYAWQ 651
+ GT G+++PEY +G S KTDVF +GV++LE+++GQ+ + R D + L+ +
Sbjct: 203 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 262
Query: 652 LLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETM 708
LL + K L+D L+ EV + I V LLC Q M+RP M EVV ML+ + +
Sbjct: 263 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 319
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 203 bits (517), Expect = 3e-52, Method: Compositional matrix adjust.
Identities = 117/297 (39%), Positives = 173/297 (58%), Gaps = 5/297 (1%)
Query: 416 ELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQG-IVEFK 474
+LK F + + A++NF N LG GGFG VYKG+LAD VA+KRL QG ++F+
Sbjct: 16 QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQ 75
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFI 533
EV +I+ H NL+RL G + ERLLVY +M N S+ L L+W KR
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 534 IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR 593
I G ++GL YLH + ++IHRD+KA+NILLD++ + DFG+A++ + +
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA- 194
Query: 594 IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQK--NHTRHHPDRPLNLIGYAWQ 651
+ G G+++PEY +G S KTDVF +GV++LE+++GQ+ + R D + L+ +
Sbjct: 195 VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 652 LLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETM 708
LL + K L+D L+ EV + I V LLC Q M+RP M EVV ML+ + +
Sbjct: 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 156 bits (395), Expect = 3e-38, Method: Compositional matrix adjust.
Identities = 107/298 (35%), Positives = 158/298 (53%), Gaps = 17/298 (5%)
Query: 420 FDFQTIAAAANNFSTT------NKLGEGGFGPVYKGKLADEQEVAIKRLSR----SSGQG 469
F F + NNF NK+GEGGFG VYKG + + VA+K+L+ ++ +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 470 IVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE 529
+F E++++AK QH NLV LLG S G++ LVY +MPN SL L L+W
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 530 KRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589
R I +G + G+ +LH+ IHRD+K++NILLD+ KISDFG+AR E
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYA 649
RIVGT YM+PE A+ G ++ K+D++SFGV++LEI++G H + L L
Sbjct: 191 MXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPA-VDEHREPQLLLDIKE 248
Query: 650 WQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707
+ + ID + S + V V C+ ++ RP + +V +LQ T
Sbjct: 249 EIEDEEKTIEDYIDKKMNDADSTS-VEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 156 bits (395), Expect = 4e-38, Method: Compositional matrix adjust.
Identities = 107/298 (35%), Positives = 158/298 (53%), Gaps = 17/298 (5%)
Query: 420 FDFQTIAAAANNFSTT------NKLGEGGFGPVYKGKLADEQEVAIKRLSR----SSGQG 469
F F + NNF NK+GEGGFG VYKG + + VA+K+L+ ++ +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 470 IVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE 529
+F E++++AK QH NLV LLG S G++ LVY +MPN SL L L+W
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 530 KRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589
R I +G + G+ +LH+ IHRD+K++NILLD+ KISDFG+AR E
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYA 649
RIVGT YM+PE A+ G ++ K+D++SFGV++LEI++G H + L L
Sbjct: 191 MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPA-VDEHREPQLLLDIKE 248
Query: 650 WQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707
+ + ID + S + V V C+ ++ RP + +V +LQ T
Sbjct: 249 EIEDEEKTIEDYIDKKMNDADSTS-VEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 156 bits (394), Expect = 4e-38, Method: Compositional matrix adjust.
Identities = 107/298 (35%), Positives = 158/298 (53%), Gaps = 17/298 (5%)
Query: 420 FDFQTIAAAANNFSTT------NKLGEGGFGPVYKGKLADEQEVAIKRLSR----SSGQG 469
F F + NNF NK+GEGGFG VYKG + + VA+K+L+ ++ +
Sbjct: 9 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 67
Query: 470 IVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE 529
+F E++++AK QH NLV LLG S G++ LVY +MPN SL L L+W
Sbjct: 68 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 127
Query: 530 KRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589
R I +G + G+ +LH+ IHRD+K++NILLD+ KISDFG+AR E
Sbjct: 128 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 184
Query: 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYA 649
RIVGT YM+PE A+ G ++ K+D++SFGV++LEI++G H + L L
Sbjct: 185 MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPA-VDEHREPQLLLDIKE 242
Query: 650 WQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707
+ + ID + S + V V C+ ++ RP + +V +LQ T
Sbjct: 243 EIEDEEKTIEDYIDKKMNDADSTS-VEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 299
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 155 bits (393), Expect = 6e-38, Method: Compositional matrix adjust.
Identities = 95/281 (33%), Positives = 161/281 (57%), Gaps = 4/281 (1%)
Query: 425 IAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ 484
+ A NNF +G G FG VYKG L D +VA+KR + S QGI EF+ E+ ++ +
Sbjct: 34 LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQGLL 543
H +LV L+G E +L+Y++M N +L L+ S + ++WE+R I G ++GL
Sbjct: 94 HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLH 153
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
YLH + +IHRD+K+ NILLD+ PKI+DFG+++ + + GT GY+ P
Sbjct: 154 YLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDP 210
Query: 604 EYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663
EY + G ++ K+DV+SFGV++ E++ + + P +NL +A + ++G+ +++D
Sbjct: 211 EYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270
Query: 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
P+L + + + C+ + DRP+M +V+ L+
Sbjct: 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 154 bits (389), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 96/282 (34%), Positives = 164/282 (58%), Gaps = 6/282 (2%)
Query: 425 IAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ 484
+ A NNF +G G FG VYKG L D +VA+KR + S QGI EF+ E+ ++ +
Sbjct: 34 LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQGLL 543
H +LV L+G E +L+Y++M N +L L+ S + ++WE+R I G ++GL
Sbjct: 94 HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLH 153
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI-FEVNESEANTKRIVGTYGYMS 602
YLH + +IHRD+K+ NILLD+ PKI+DFG+++ E+ ++ + GT GY+
Sbjct: 154 YLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXV-VKGTLGYID 209
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662
PEY + G ++ K+DV+SFGV++ E++ + + P +NL +A + ++G+ +++
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV 269
Query: 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
DP+L + + + C+ + DRP+M +V+ L+
Sbjct: 270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 149 bits (377), Expect = 4e-36, Method: Compositional matrix adjust.
Identities = 105/298 (35%), Positives = 153/298 (51%), Gaps = 17/298 (5%)
Query: 420 FDFQTIAAAANNFSTT------NKLGEGGFGPVYKGKLADEQEVAIKRLSR----SSGQG 469
F F + NNF NK GEGGFG VYKG + + VA+K+L+ ++ +
Sbjct: 6 FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 64
Query: 470 IVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE 529
+F E+++ AK QH NLV LLG S G++ LVY + PN SL L L+W
Sbjct: 65 KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 530 KRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589
R I +G + G+ +LH+ IHRD+K++NILLD+ KISDFG+AR E
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYA 649
RIVGT Y +PE A+ G ++ K+D++SFGV++LEI++G H + L L
Sbjct: 182 XXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPA-VDEHREPQLLLDIKE 239
Query: 650 WQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707
+ + ID S + V V C+ ++ RP + +V +LQ T
Sbjct: 240 EIEDEEKTIEDYIDKKXNDADSTS-VEAXYSVASQCLHEKKNKRPDIKKVQQLLQEXT 296
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 107 bits (266), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 86/272 (31%), Positives = 136/272 (50%), Gaps = 24/272 (8%)
Query: 435 TNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGC 494
+LG G FG V+ G +VA+K L + S F E L+ +LQH LVRL
Sbjct: 26 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAV 84
Query: 495 SLHGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRV 553
E ++ E+M N SL DF SG K +N K + I++G+ ++ + +
Sbjct: 85 VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---Y 138
Query: 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI 613
IHRDL+A+NIL+ D ++ KI+DFG+AR+ E NE A + +PE G +I
Sbjct: 139 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTAPEAINYGTFTI 197
Query: 614 KTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSAN 673
K+DV+SFG+L+ EIV+ H P + + + +G ++ P P
Sbjct: 198 KSDVWSFGILLTEIVT--------HGRIPYPGMTNPEVIQNLERGYRMVRPD-NCPEELY 248
Query: 674 EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
++MR LC +++ DRPT + +L++
Sbjct: 249 QLMR------LCWKERPEDRPTFDYLRSVLED 274
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 107 bits (266), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 86/272 (31%), Positives = 136/272 (50%), Gaps = 24/272 (8%)
Query: 435 TNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGC 494
+LG G FG V+ G +VA+K L + S F E L+ +LQH LVRL
Sbjct: 20 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAV 78
Query: 495 SLHGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRV 553
E ++ E+M N SL DF SG K +N K + I++G+ ++ + +
Sbjct: 79 VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---Y 132
Query: 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI 613
IHRDL+A+NIL+ D ++ KI+DFG+AR+ E NE A + +PE G +I
Sbjct: 133 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTFTI 191
Query: 614 KTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSAN 673
K+DV+SFG+L+ EIV+ H P + + + +G ++ P P
Sbjct: 192 KSDVWSFGILLTEIVT--------HGRIPYPGMTNPEVIQNLERGYRMVRPD-NCPEELY 242
Query: 674 EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
++MR LC +++ DRPT + +L++
Sbjct: 243 QLMR------LCWKERPEDRPTFDYLRSVLED 268
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 106 bits (265), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 86/272 (31%), Positives = 136/272 (50%), Gaps = 24/272 (8%)
Query: 435 TNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGC 494
+LG G FG V+ G +VA+K L + S F E L+ +LQH LVRL
Sbjct: 24 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAV 82
Query: 495 SLHGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRV 553
E ++ E+M N SL DF SG K +N K + I++G+ ++ + +
Sbjct: 83 VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---Y 136
Query: 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI 613
IHRDL+A+NIL+ D ++ KI+DFG+AR+ E NE A + +PE G +I
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTFTI 195
Query: 614 KTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSAN 673
K+DV+SFG+L+ EIV+ H P + + + +G ++ P P
Sbjct: 196 KSDVWSFGILLTEIVT--------HGRIPYPGMTNPEVIQNLERGYRMVRPD-NCPEELY 246
Query: 674 EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
++MR LC +++ DRPT + +L++
Sbjct: 247 QLMR------LCWKERPEDRPTFDYLRSVLED 272
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 106 bits (265), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 86/272 (31%), Positives = 136/272 (50%), Gaps = 24/272 (8%)
Query: 435 TNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGC 494
+LG G FG V+ G +VA+K L + S F E L+ +LQH LVRL
Sbjct: 27 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAV 85
Query: 495 SLHGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRV 553
E ++ E+M N SL DF SG K +N K + I++G+ ++ + +
Sbjct: 86 VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---Y 139
Query: 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI 613
IHRDL+A+NIL+ D ++ KI+DFG+AR+ E NE A + +PE G +I
Sbjct: 140 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTFTI 198
Query: 614 KTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSAN 673
K+DV+SFG+L+ EIV+ H P + + + +G ++ P P
Sbjct: 199 KSDVWSFGILLTEIVT--------HGRIPYPGMTNPEVIQNLERGYRMVRPD-NCPEELY 249
Query: 674 EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
++MR LC +++ DRPT + +L++
Sbjct: 250 QLMR------LCWKERPEDRPTFDYLRSVLED 275
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 106 bits (265), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 86/272 (31%), Positives = 136/272 (50%), Gaps = 24/272 (8%)
Query: 435 TNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGC 494
+LG G FG V+ G +VA+K L + S F E L+ +LQH LVRL
Sbjct: 19 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAV 77
Query: 495 SLHGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRV 553
E ++ E+M N SL DF SG K +N K + I++G+ ++ + +
Sbjct: 78 VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---Y 131
Query: 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI 613
IHRDL+A+NIL+ D ++ KI+DFG+AR+ E NE A + +PE G +I
Sbjct: 132 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTFTI 190
Query: 614 KTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSAN 673
K+DV+SFG+L+ EIV+ H P + + + +G ++ P P
Sbjct: 191 KSDVWSFGILLTEIVT--------HGRIPYPGMTNPEVIQNLERGYRMVRPD-NCPEELY 241
Query: 674 EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
++MR LC +++ DRPT + +L++
Sbjct: 242 QLMR------LCWKERPEDRPTFDYLRSVLED 267
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 106 bits (265), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 86/272 (31%), Positives = 136/272 (50%), Gaps = 24/272 (8%)
Query: 435 TNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGC 494
+LG G FG V+ G +VA+K L + S F E L+ +LQH LVRL
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAV 76
Query: 495 SLHGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRV 553
E ++ E+M N SL DF SG K +N K + I++G+ ++ + +
Sbjct: 77 VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---Y 130
Query: 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI 613
IHRDL+A+NIL+ D ++ KI+DFG+AR+ E NE A + +PE G +I
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTFTI 189
Query: 614 KTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSAN 673
K+DV+SFG+L+ EIV+ H P + + + +G ++ P P
Sbjct: 190 KSDVWSFGILLTEIVT--------HGRIPYPGMTNPEVIQNLERGYRMVRPD-NCPEELY 240
Query: 674 EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
++MR LC +++ DRPT + +L++
Sbjct: 241 QLMR------LCWKERPEDRPTFDYLRSVLED 266
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 106 bits (265), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 89/278 (32%), Positives = 138/278 (49%), Gaps = 36/278 (12%)
Query: 435 TNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGC 494
+LG G FG V+ G +VA+K L + S F E L+ +LQH LVRL
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAV 76
Query: 495 SLHGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRV 553
E ++ E+M N SL DF SG K +N K + I++G+ ++ + +
Sbjct: 77 VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---Y 130
Query: 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI 613
IHRDL+A+NIL+ D ++ KI+DFG+AR+ E NE A + +PE G +I
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTFTI 189
Query: 614 KTDVFSFGVLVLEIVSGQKNHTR------HHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667
K+DV+SFG+L+ EIV+ H R +P+ NL +G ++ P
Sbjct: 190 KSDVWSFGILLTEIVT----HGRIPYPGMTNPEVIQNL----------ERGYRMVRPD-N 234
Query: 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
P ++MR LC +++ DRPT + +L++
Sbjct: 235 CPEELYQLMR------LCWKERPEDRPTFDYLRSVLED 266
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 106 bits (265), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 89/278 (32%), Positives = 138/278 (49%), Gaps = 36/278 (12%)
Query: 435 TNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGC 494
+LG G FG V+ G +VA+K L + S F E L+ +LQH LVRL
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAV 76
Query: 495 SLHGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRV 553
E ++ E+M N SL DF SG K +N K + I++G+ ++ + +
Sbjct: 77 VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---Y 130
Query: 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI 613
IHRDL+A+NIL+ D ++ KI+DFG+AR+ E NE A + +PE G +I
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTFTI 189
Query: 614 KTDVFSFGVLVLEIVSGQKNHTR------HHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667
K+DV+SFG+L+ EIV+ H R +P+ NL +G ++ P
Sbjct: 190 KSDVWSFGILLTEIVT----HGRIPYPGMTNPEVIQNL----------ERGYRMVRPD-N 234
Query: 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
P ++MR LC +++ DRPT + +L++
Sbjct: 235 CPEELYQLMR------LCWKERPEDRPTFDYLRSVLED 266
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 106 bits (265), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 86/272 (31%), Positives = 136/272 (50%), Gaps = 24/272 (8%)
Query: 435 TNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGC 494
+LG G FG V+ G +VA+K L + S F E L+ +LQH LVRL
Sbjct: 28 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAV 86
Query: 495 SLHGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRV 553
E ++ E+M N SL DF SG K +N K + I++G+ ++ + +
Sbjct: 87 VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---Y 140
Query: 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI 613
IHRDL+A+NIL+ D ++ KI+DFG+AR+ E NE A + +PE G +I
Sbjct: 141 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTFTI 199
Query: 614 KTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSAN 673
K+DV+SFG+L+ EIV+ H P + + + +G ++ P P
Sbjct: 200 KSDVWSFGILLTEIVT--------HGRIPYPGMTNPEVIQNLERGYRMVRPD-NCPEELY 250
Query: 674 EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
++MR LC +++ DRPT + +L++
Sbjct: 251 QLMR------LCWKERPEDRPTFDYLRSVLED 276
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 106 bits (264), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 86/272 (31%), Positives = 136/272 (50%), Gaps = 24/272 (8%)
Query: 435 TNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGC 494
+LG G FG V+ G +VA+K L + S F E L+ +LQH LVRL
Sbjct: 23 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAV 81
Query: 495 SLHGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRV 553
E ++ E+M N SL DF SG K +N K + I++G+ ++ + +
Sbjct: 82 VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---Y 135
Query: 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI 613
IHRDL+A+NIL+ D ++ KI+DFG+AR+ E NE A + +PE G +I
Sbjct: 136 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTFTI 194
Query: 614 KTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSAN 673
K+DV+SFG+L+ EIV+ H P + + + +G ++ P P
Sbjct: 195 KSDVWSFGILLTEIVT--------HGRIPYPGMTNPEVIQNLERGYRMVRPD-NCPEELY 245
Query: 674 EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
++MR LC +++ DRPT + +L++
Sbjct: 246 QLMR------LCWKERPEDRPTFDYLRSVLED 271
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 106 bits (264), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 86/272 (31%), Positives = 136/272 (50%), Gaps = 24/272 (8%)
Query: 435 TNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGC 494
+LG G FG V+ G +VA+K L + S F E L+ +LQH LVRL
Sbjct: 24 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAV 82
Query: 495 SLHGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRV 553
E ++ E+M N SL DF SG K +N K + I++G+ ++ + +
Sbjct: 83 VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---Y 136
Query: 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI 613
IHRDL+A+NIL+ D ++ KI+DFG+AR+ E NE A + +PE G +I
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTFTI 195
Query: 614 KTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSAN 673
K+DV+SFG+L+ EIV+ H P + + + +G ++ P P
Sbjct: 196 KSDVWSFGILLTEIVT--------HGRIPYPGMTNPEVIQNLERGYRMVRPD-NCPEELY 246
Query: 674 EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
++MR LC +++ DRPT + +L++
Sbjct: 247 QLMR------LCWKERPEDRPTFDYLRSVLED 272
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 105 bits (261), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 86/272 (31%), Positives = 136/272 (50%), Gaps = 24/272 (8%)
Query: 435 TNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGC 494
+LG G FG V+ G +VA+K L + S F E L+ +LQH LVRL
Sbjct: 13 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAV 71
Query: 495 SLHGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRV 553
E ++ E+M N SL DF SG K +N K + I++G+ ++ + +
Sbjct: 72 VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---Y 125
Query: 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI 613
IHRDL+A+NIL+ D ++ KI+DFG+AR+ E NE A + +PE G +I
Sbjct: 126 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTFTI 184
Query: 614 KTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSAN 673
K+DV+SFG+L+ EIV+ H P + + + +G ++ P P
Sbjct: 185 KSDVWSFGILLTEIVT--------HGRIPYPGMTNPEVIQNLERGYRMVRPD-NCPEELY 235
Query: 674 EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
++MR LC +++ DRPT + +L++
Sbjct: 236 QLMR------LCWKERPEDRPTFDYLRSVLED 261
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 105 bits (261), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 86/273 (31%), Positives = 135/273 (49%), Gaps = 25/273 (9%)
Query: 435 TNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGC 494
+LG G FG V+ G + +VA+K L + + F E L+ LQH LVRL
Sbjct: 18 VKRLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAV 76
Query: 495 SLHGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRV 553
E ++ E+M SL DF + G K +L K I++G+ Y+ R
Sbjct: 77 VTREEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNY 131
Query: 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI 613
IHRDL+A+N+L+ + + KI+DFG+AR+ E NE A + +PE G +I
Sbjct: 132 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI-KWTAPEAINFGCFTI 190
Query: 614 KTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ-PCSA 672
K+DV+SFG+L+ EIV+ K +P R + A LS G + P +E P
Sbjct: 191 KSDVWSFGILLYEIVTYGKI---PYPGRTNADVMTA---LSQGYRM----PRVENCPDEL 240
Query: 673 NEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
++M+ +C +++A +RPT + +L +
Sbjct: 241 YDIMK------MCWKEKAEERPTFDYLQSVLDD 267
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 104 bits (260), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 87/273 (31%), Positives = 135/273 (49%), Gaps = 25/273 (9%)
Query: 435 TNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGC 494
KLG G FG V+ G + +VA+K L + + F E L+ LQH LVRL
Sbjct: 17 VKKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAV 75
Query: 495 SLHGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRV 553
E ++ EFM SL DF + G K +L K I++G+ Y+ R
Sbjct: 76 VTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNY 130
Query: 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI 613
IHRDL+A+N+L+ + + KI+DFG+AR+ E NE A + +PE G +I
Sbjct: 131 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI-KWTAPEAINFGCFTI 189
Query: 614 KTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ-PCSA 672
K++V+SFG+L+ EIV+ K +P R + A LS G + P +E P
Sbjct: 190 KSNVWSFGILLYEIVTYGK---IPYPGRTNADVMSA---LSQGYRM----PRMENCPDEL 239
Query: 673 NEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
++M+ +C +++A +RPT + +L +
Sbjct: 240 YDIMK------MCWKEKAEERPTFDYLQSVLDD 266
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 104 bits (259), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 68/246 (27%), Positives = 126/246 (51%), Gaps = 6/246 (2%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNL 488
+ + K+G G FG V++ + +VA+K L + + EF EV ++ +L+H N+
Sbjct: 38 DLNIKEKIGAGSFGTVHRAEWHG-SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
V +G +V E++ SL L SG + L+ +R + +++G+ YLH
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS 608
+ ++HRDLK+ N+L+D K K+ DFG++R+ +K GT +M+PE
Sbjct: 157 NP-PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA--SXFLXSKXAAGTPEWMAPEVLRD 213
Query: 609 GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668
+ K+DV+SFGV++ E+ + Q+ +P + + +G+ + L + L ++ +
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIE 273
Query: 669 PCSANE 674
C NE
Sbjct: 274 GCWTNE 279
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 103 bits (258), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 67/246 (27%), Positives = 128/246 (52%), Gaps = 6/246 (2%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNL 488
+ + K+G G FG V++ + +VA+K L + + EF EV ++ +L+H N+
Sbjct: 38 DLNIKEKIGAGSFGTVHRAEWHG-SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
V +G +V E++ SL L SG + L+ +R + +++G+ YLH
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS 608
+ ++HR+LK+ N+L+D K K+ DFG++R+ + ++K GT +M+PE
Sbjct: 157 NP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA--STFLSSKSAAGTPEWMAPEVLRD 213
Query: 609 GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668
+ K+DV+SFGV++ E+ + Q+ +P + + +G+ + L + L ++ +
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIE 273
Query: 669 PCSANE 674
C NE
Sbjct: 274 GCWTNE 279
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 103 bits (256), Expect = 4e-22, Method: Compositional matrix adjust.
Identities = 85/272 (31%), Positives = 136/272 (50%), Gaps = 24/272 (8%)
Query: 435 TNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGC 494
+LG G FG V+ G +VA+K L + S F E L+ +LQH LVRL
Sbjct: 14 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 72
Query: 495 SLHGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRV 553
E ++ E+M N SL DF SG K +N K + I++G+ ++ + +
Sbjct: 73 VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---Y 126
Query: 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI 613
IHR+L+A+NIL+ D ++ KI+DFG+AR+ E NE A + +PE G +I
Sbjct: 127 IHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTFTI 185
Query: 614 KTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSAN 673
K+DV+SFG+L+ EIV+ H P + + + +G ++ P P
Sbjct: 186 KSDVWSFGILLTEIVT--------HGRIPYPGMTNPEVIQNLERGYRMVRPD-NCPEELY 236
Query: 674 EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
++MR LC +++ DRPT + +L++
Sbjct: 237 QLMR------LCWKERPEDRPTFDYLRSVLED 262
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 102 bits (255), Expect = 6e-22, Method: Compositional matrix adjust.
Identities = 100/329 (30%), Positives = 157/329 (47%), Gaps = 63/329 (19%)
Query: 438 LGEGGFGPVYKGKLADEQE-----VAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRL 491
LG G FG VYKG E E VAIK L+ ++G + VEF +E ++A + H +LVRL
Sbjct: 23 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 492 LGCSLHGEERLLVYEFMPNKSLDFFLF----NSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
LG L +L V + MP+ L ++ N G + +LNW + I++G++YL +
Sbjct: 83 LGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 135
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
R++HRDL A N+L+ + KI+DFG+AR+ E +E E N +M+ E
Sbjct: 136 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 192
Query: 608 SGIVSIKTDVFSFGVLVLEIVS-GQKNH----TRHHPDRPLNLIGYAWQLLSDGKGLELI 662
+ ++DV+S+GV + E+++ G K + TR PD LL G+
Sbjct: 193 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD-----------LLEKGE----- 236
Query: 663 DPSLEQP--CSANEVMRCIHVGLLCVQDQAMDRPTMPEV--------------VCMLQNE 706
L QP C+ + M V + C A RP E+ + + ++
Sbjct: 237 --RLPQPPICTIDVYM----VMVKCWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGDD 290
Query: 707 TMPLPPPKQPAFFINANADDQVPEVPDNE 735
M LP P FF N ++ + ++ D E
Sbjct: 291 RMKLPSPNDSKFFQNLLDEEDLEDMMDAE 319
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 101 bits (251), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 77/218 (35%), Positives = 120/218 (55%), Gaps = 25/218 (11%)
Query: 438 LGEGGFGPVYKGKLADEQE-----VAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRL 491
LG G FG VYKG E E VAIK L+ ++G + VEF +E ++A + H +LVRL
Sbjct: 46 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 492 LGCSLHGEERLLVYEFMPNKSLDFFLF----NSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
LG L +L V + MP+ L ++ N G + +LNW + I++G++YL +
Sbjct: 106 LGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 158
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
R++HRDL A N+L+ + KI+DFG+AR+ E +E E N +M+ E
Sbjct: 159 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 215
Query: 608 SGIVSIKTDVFSFGVLVLEIVS-GQKNH----TRHHPD 640
+ ++DV+S+GV + E+++ G K + TR PD
Sbjct: 216 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD 253
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 100 bits (250), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 84/272 (30%), Positives = 134/272 (49%), Gaps = 24/272 (8%)
Query: 435 TNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGC 494
+LG G G V+ G +VA+K L + S F E L+ +LQH LVRL
Sbjct: 18 VERLGAGQAGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 495 SLHGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRV 553
E ++ E+M N SL DF SG K +N K + I++G+ ++ + +
Sbjct: 77 VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---Y 130
Query: 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI 613
IHRDL+A+NIL+ D ++ KI+DFG+AR+ E E A + +PE G +I
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPI-KWTAPEAINYGTFTI 189
Query: 614 KTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSAN 673
K+DV+SFG+L+ EIV+ H P + + + +G ++ P P
Sbjct: 190 KSDVWSFGILLTEIVT--------HGRIPYPGMTNPEVIQNLERGYRMVRPD-NCPEELY 240
Query: 674 EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
++MR LC +++ DRPT + +L++
Sbjct: 241 QLMR------LCWKERPEDRPTFDYLRSVLED 266
>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With
Staurosporine
Length = 283
Score = 98.6 bits (244), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 78/287 (27%), Positives = 133/287 (46%), Gaps = 22/287 (7%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+ +LG G FG V+ G +VAIK L + F E +++ KL+H LV+
Sbjct: 10 SLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTL-KPGTMSPESFLEEAQIMKKLKHDKLVQ 68
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
L + E +V E+M SL FL G L + ++ G+ Y+ R
Sbjct: 69 LYAV-VSEEPIYIVTEYMNKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIE---R 123
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGI 610
+ IHRDL+++NIL+ + + KI+DFG+AR+ E NE A + +PE A+ G
Sbjct: 124 MNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGR 182
Query: 611 VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPC 670
+IK+DV+SFG+L+ E+V+ + + +++ + LE ++ PC
Sbjct: 183 FTIKSDVWSFGILLTELVTKGR---------------VPYPGMNNREVLEQVERGYRMPC 227
Query: 671 SANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLPPPKQPA 717
+ + + + C + +RPT + L++ P QP
Sbjct: 228 PQDCPISLHELMIHCWKKDPEERPTFEYLQSFLEDYFTATEPQYQPG 274
>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor
Length = 535
Score = 98.2 bits (243), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 79/283 (27%), Positives = 134/283 (47%), Gaps = 26/283 (9%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
KLG+G FG V+ G VAIK L + F E +++ KL+H LV+L +
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 331
Query: 497 HGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
E +V E+M SL DF +G+ L + + I+ G+ Y+ R+ +H
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 386
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKT 615
RDL+A+NIL+ + + K++DFG+AR+ E NE A + +PE A+ G +IK+
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 445
Query: 616 DVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEV 675
DV+SFG+L+ E+ + + + + + + L+ ++ PC E
Sbjct: 446 DVWSFGILLTELTTKGR---------------VPYPGMVNREVLDQVERGYRMPCPP-EC 489
Query: 676 MRCIH-VGLLCVQDQAMDRPTMPEVVCMLQNETMPLPPPKQPA 717
+H + C + + +RPT + L++ P QP
Sbjct: 490 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQPG 532
>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:s768a Triple Mutant
Length = 373
Score = 98.2 bits (243), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 83/287 (28%), Positives = 137/287 (47%), Gaps = 38/287 (13%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLA----DEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
A N S +G G FG V G+L E VAIK L + + +F E ++ +
Sbjct: 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE------G 537
H N++RL G + ++V E+M N SLD FL RK+ + +F +I+ G
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKH----DAQFTVIQLVGMLRG 155
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT 597
I+ G+ YL S + +HRDL A NIL++ + K+SDFG+AR+ E + A T R
Sbjct: 156 IASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKI 212
Query: 598 -YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG 656
+ SPE + +DV+S+G+++ E++S + +RP W+ +S+
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS--------YGERPY------WE-MSNQ 257
Query: 657 KGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
++ +D P + + L C Q +RP ++V +L
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304
>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src
pdb|2SRC|A Chain A, Crystal Structure Of Human Tyrosine-protein Kinase C-src,
In Complex With Amp-pnp
Length = 452
Score = 97.8 bits (242), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 80/283 (28%), Positives = 133/283 (46%), Gaps = 26/283 (9%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
KLG+G FG V+ G VAIK L + F E +++ KL+H LV+L +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 248
Query: 497 HGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
E +V E+M SL DF +G+ L + + I+ G+ Y+ R+ +H
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKT 615
RDL+A+NIL+ + + K++DFG+AR+ E NE A + +PE A+ G +IK+
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIKS 362
Query: 616 DVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEV 675
DV+SFG+L+ E+ + + +R + L+ ++ PC E
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREV---------------LDQVERGYRMPCPP-EC 406
Query: 676 MRCIH-VGLLCVQDQAMDRPTMPEVVCMLQNETMPLPPPKQPA 717
+H + C + + +RPT + L++ P QP
Sbjct: 407 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQPG 449
>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An
Inhibitor
Length = 452
Score = 97.4 bits (241), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 80/283 (28%), Positives = 133/283 (46%), Gaps = 26/283 (9%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
KLG+G FG V+ G VAIK L + F E +++ KL+H LV+L +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 248
Query: 497 HGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
E +V E+M SL DF +G+ L + + I+ G+ Y+ R+ +H
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKT 615
RDL+A+NIL+ + + K++DFG+AR+ E NE A + +PE A+ G +IK+
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIKS 362
Query: 616 DVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEV 675
DV+SFG+L+ E+ + + +R + L+ ++ PC E
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREV---------------LDQVERGYRMPCPP-EC 406
Query: 676 MRCIH-VGLLCVQDQAMDRPTMPEVVCMLQNETMPLPPPKQPA 717
+H + C + + +RPT + L++ P QP
Sbjct: 407 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 449
>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly
Mutant) In Complex With N6-Benzyl Adp
Length = 452
Score = 97.4 bits (241), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 80/283 (28%), Positives = 133/283 (46%), Gaps = 26/283 (9%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
KLG+G FG V+ G VAIK L + F E +++ KL+H LV+L +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 248
Query: 497 HGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
E +V E+M SL DF +G+ L + + I+ G+ Y+ R+ +H
Sbjct: 249 SEEPIYIVGEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKT 615
RDL+A+NIL+ + + K++DFG+AR+ E NE A + +PE A+ G +IK+
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 362
Query: 616 DVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEV 675
DV+SFG+L+ E+ + + +R + L+ ++ PC E
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREV---------------LDQVERGYRMPCPP-EC 406
Query: 676 MRCIH-VGLLCVQDQAMDRPTMPEVVCMLQNETMPLPPPKQPA 717
+H + C + + +RPT + L++ P QP
Sbjct: 407 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQPG 449
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 97.1 bits (240), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 80/276 (28%), Positives = 136/276 (49%), Gaps = 32/276 (11%)
Query: 438 LGEGGFGPVYKGKLA----DEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLVRLL 492
+G G FG V +G+L E VAIK L + + EF +E ++ + +H N++RL
Sbjct: 22 IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFL-FNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRL 551
G + +++ EFM N +LD FL N G+ V+ + ++ GI+ G+ YL + S
Sbjct: 82 GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGIASGMRYLAEMS-- 136
Query: 552 RVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG---TYGYMSPEYAMS 608
+HRDL A NIL++ + K+SDFG++R E N S+ +G + +PE
Sbjct: 137 -YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAF 195
Query: 609 GIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667
+ +D +S+G+++ E++S G++ + +N I ++L P +
Sbjct: 196 RKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRL----------PPPPD 245
Query: 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
P S +++M L C Q RP P+VV L
Sbjct: 246 CPTSLHQLM------LDCWQKDRNARPRFPQVVSAL 275
>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound
Structure
Length = 344
Score = 97.1 bits (240), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 82/287 (28%), Positives = 137/287 (47%), Gaps = 38/287 (13%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLA----DEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
A N S +G G FG V G+L E VAIK L + + +F E ++ +
Sbjct: 15 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 74
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE------G 537
H N++RL G + ++V E+M N SLD FL RK+ + +F +I+ G
Sbjct: 75 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKH----DAQFTVIQLVGMLRG 126
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT 597
I+ G+ YL S + +HRDL A NIL++ + K+SDFG++R+ E + A T R
Sbjct: 127 IASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 183
Query: 598 -YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG 656
+ SPE + +DV+S+G+++ E++S + +RP W+ +S+
Sbjct: 184 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS--------YGERPY------WE-MSNQ 228
Query: 657 KGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
++ +D P + + L C Q +RP ++V +L
Sbjct: 229 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275
>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane
Region
pdb|2QO2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Apo Structure
pdb|2QO9|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Phosphorylated, Amp-pnp Bound
Length = 373
Score = 97.1 bits (240), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 82/287 (28%), Positives = 137/287 (47%), Gaps = 38/287 (13%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLA----DEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
A N S +G G FG V G+L E VAIK L + + +F E ++ +
Sbjct: 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE------G 537
H N++RL G + ++V E+M N SLD FL RK+ + +F +I+ G
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKH----DAQFTVIQLVGMLRG 155
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT 597
I+ G+ YL S + +HRDL A NIL++ + K+SDFG++R+ E + A T R
Sbjct: 156 IASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 598 -YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG 656
+ SPE + +DV+S+G+++ E++S + +RP W+ +S+
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS--------YGERPY------WE-MSNQ 257
Query: 657 KGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
++ +D P + + L C Q +RP ++V +L
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304
>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant
Length = 373
Score = 97.1 bits (240), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 82/287 (28%), Positives = 137/287 (47%), Gaps = 38/287 (13%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLA----DEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
A N S +G G FG V G+L E VAIK L + + +F E ++ +
Sbjct: 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE------G 537
H N++RL G + ++V E+M N SLD FL RK+ + +F +I+ G
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKH----DAQFTVIQLVGMLRG 155
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT 597
I+ G+ YL S + +HRDL A NIL++ + K+SDFG++R+ E + A T R
Sbjct: 156 IASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 598 -YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG 656
+ SPE + +DV+S+G+++ E++S + +RP W+ +S+
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS--------YGERPY------WE-MSNQ 257
Query: 657 KGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
++ +D P + + L C Q +RP ++V +L
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304
>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant
Length = 373
Score = 97.1 bits (240), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 82/287 (28%), Positives = 137/287 (47%), Gaps = 38/287 (13%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLA----DEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
A N S +G G FG V G+L E VAIK L + + +F E ++ +
Sbjct: 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE------G 537
H N++RL G + ++V E+M N SLD FL RK+ + +F +I+ G
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKH----DAQFTVIQLVGMLRG 155
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT 597
I+ G+ YL S + +HRDL A NIL++ + K+SDFG++R+ E + A T R
Sbjct: 156 IASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 598 -YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG 656
+ SPE + +DV+S+G+++ E++S + +RP W+ +S+
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS--------YGERPY------WE-MSNQ 257
Query: 657 KGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
++ +D P + + L C Q +RP ++V +L
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304
>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnye[ptyr]iw
pdb|3FY2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnyefiw
Length = 371
Score = 97.1 bits (240), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 82/287 (28%), Positives = 137/287 (47%), Gaps = 38/287 (13%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLA----DEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
A N S +G G FG V G+L E VAIK L + + +F E ++ +
Sbjct: 42 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 101
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE------G 537
H N++RL G + ++V E+M N SLD FL RK+ + +F +I+ G
Sbjct: 102 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKH----DAQFTVIQLVGMLRG 153
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT 597
I+ G+ YL S + +HRDL A NIL++ + K+SDFG++R+ E + A T R
Sbjct: 154 IASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 210
Query: 598 -YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG 656
+ SPE + +DV+S+G+++ E++S + +RP W+ +S+
Sbjct: 211 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS--------YGERPY------WE-MSNQ 255
Query: 657 KGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
++ +D P + + L C Q +RP ++V +L
Sbjct: 256 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 302
>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor
Awl-Ii- 38.3
pdb|4G2F|A Chain A, Human Epha3 Kinase Domain In Complex With Compound 7
pdb|4GK2|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 66
pdb|4GK3|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 87
pdb|4GK4|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 90
Length = 361
Score = 97.1 bits (240), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 82/287 (28%), Positives = 137/287 (47%), Gaps = 38/287 (13%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLA----DEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
A N S +G G FG V G+L E VAIK L + + +F E ++ +
Sbjct: 32 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 91
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE------G 537
H N++RL G + ++V E+M N SLD FL RK+ + +F +I+ G
Sbjct: 92 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKH----DAQFTVIQLVGMLRG 143
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT 597
I+ G+ YL S + +HRDL A NIL++ + K+SDFG++R+ E + A T R
Sbjct: 144 IASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 200
Query: 598 -YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG 656
+ SPE + +DV+S+G+++ E++S + +RP W+ +S+
Sbjct: 201 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS--------YGERPY------WE-MSNQ 245
Query: 657 KGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
++ +D P + + L C Q +RP ++V +L
Sbjct: 246 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 292
>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f
Double Mutant
Length = 373
Score = 96.7 bits (239), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 82/287 (28%), Positives = 137/287 (47%), Gaps = 38/287 (13%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLA----DEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
A N S +G G FG V G+L E VAIK L + + +F E ++ +
Sbjct: 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE------G 537
H N++RL G + ++V E+M N SLD FL RK+ + +F +I+ G
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKH----DAQFTVIQLVGMLRG 155
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT 597
I+ G+ YL S + +HRDL A NIL++ + K+SDFG++R+ E + A T R
Sbjct: 156 IASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 598 -YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG 656
+ SPE + +DV+S+G+++ E++S + +RP W+ +S+
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS--------YGERPY------WE-MSNQ 257
Query: 657 KGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
++ +D P + + L C Q +RP ++V +L
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304
>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742f Triple Mutant
Length = 373
Score = 96.7 bits (239), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 82/287 (28%), Positives = 137/287 (47%), Gaps = 38/287 (13%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLA----DEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
A N S +G G FG V G+L E VAIK L + + +F E ++ +
Sbjct: 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE------G 537
H N++RL G + ++V E+M N SLD FL RK+ + +F +I+ G
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKH----DAQFTVIQLVGMLRG 155
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT 597
I+ G+ YL S + +HRDL A NIL++ + K+SDFG++R+ E + A T R
Sbjct: 156 IASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 598 -YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG 656
+ SPE + +DV+S+G+++ E++S + +RP W+ +S+
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS--------YGERPY------WE-MSNQ 257
Query: 657 KGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
++ +D P + + L C Q +RP ++V +L
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 96.7 bits (239), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 72/278 (25%), Positives = 138/278 (49%), Gaps = 22/278 (7%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+ ++G G FG VYKGK + V + ++ + Q + FKNEV ++ K +H N++
Sbjct: 13 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 72
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
+G S + +V ++ SL L S K +K I ++G+ YLH S
Sbjct: 73 FMGYSTK-PQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKS- 128
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM--- 607
+IHRDLK++NI L + KI DFG+A + +++ G+ +M+PE
Sbjct: 129 --IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 186
Query: 608 SGIVSIKTDVFSFGVLVLEIVSGQKNHTR-HHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
S S ++DV++FG+++ E+++GQ ++ ++ D+ + ++G + P L
Sbjct: 187 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRG-----------SLSPDL 235
Query: 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
+ +N R + C++ + +RP+ P ++ ++
Sbjct: 236 SK-VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 272
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 96.7 bits (239), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 72/210 (34%), Positives = 109/210 (51%), Gaps = 29/210 (13%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLS--RSSGQGIVEFKNEVRLIAKLQHTNLVRLLGC 494
+G GGFG VY+ + DE V R Q I + E +L A L+H N++ L G
Sbjct: 15 IGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV 74
Query: 495 SLHGEERLLVYEFMPNKSLDFFLFNSGRKN----VLNWEKRFIIIEGISQGLLYLHKYSR 550
L LV EF L+ L SG++ ++NW + I++G+ YLH +
Sbjct: 75 CLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQ------IARGMNYLHDEAI 126
Query: 551 LRVIHRDLKASNILLDDKMNP--------KISDFGMARIFEVNESEANTK-RIVGTYGYM 601
+ +IHRDLK+SNIL+ K+ KI+DFG+AR E TK G Y +M
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSAAGAYAWM 181
Query: 602 SPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+PE + + S +DV+S+GVL+ E+++G+
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGE 211
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 96.7 bits (239), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 80/276 (28%), Positives = 136/276 (49%), Gaps = 32/276 (11%)
Query: 438 LGEGGFGPVYKGKLA----DEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLVRLL 492
+G G FG V +G+L E VAIK L + + EF +E ++ + +H N++RL
Sbjct: 24 IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFL-FNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRL 551
G + +++ EFM N +LD FL N G+ V+ + ++ GI+ G+ YL + S
Sbjct: 84 GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGIASGMRYLAEMS-- 138
Query: 552 RVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG---TYGYMSPEYAMS 608
+HRDL A NIL++ + K+SDFG++R E N S+ +G + +PE
Sbjct: 139 -YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAF 197
Query: 609 GIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667
+ +D +S+G+++ E++S G++ + +N I ++L P +
Sbjct: 198 RKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRL----------PPPPD 247
Query: 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
P S +++M L C Q RP P+VV L
Sbjct: 248 CPTSLHQLM------LDCWQKDRNARPRFPQVVSAL 277
>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596:y602:s768g Triple Mutant
Length = 373
Score = 96.7 bits (239), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 82/287 (28%), Positives = 136/287 (47%), Gaps = 38/287 (13%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLA----DEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
A N S +G G FG V G+L E VAIK L + + +F E ++ +
Sbjct: 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE------G 537
H N++RL G + ++V E+M N SLD FL RK+ + +F +I+ G
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKH----DAQFTVIQLVGMLRG 155
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT 597
I+ G+ YL S + +HRDL A NIL++ + K+SDFG+ R+ E + A T R
Sbjct: 156 IASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI 212
Query: 598 -YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG 656
+ SPE + +DV+S+G+++ E++S + +RP W+ +S+
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS--------YGERPY------WE-MSNQ 257
Query: 657 KGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
++ +D P + + L C Q +RP ++V +L
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304
>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
pdb|1YI6|B Chain B, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
Length = 276
Score = 96.3 bits (238), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 66/194 (34%), Positives = 105/194 (54%), Gaps = 9/194 (4%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
KLG+G FG V+ G VAIK L + F E +++ KL+H LV+L +
Sbjct: 15 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 72
Query: 497 HGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
E +V E+M SL DF +G+ L + + I+ G+ Y+ R+ +H
Sbjct: 73 SEEPIXIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 127
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKT 615
RDL+A+NIL+ + + K++DFG+AR+ E NE A + +PE A+ G +IK+
Sbjct: 128 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGRFTIKS 186
Query: 616 DVFSFGVLVLEIVS 629
DV+SFG+L+ E+ +
Sbjct: 187 DVWSFGILLTELTT 200
>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDF|B Chain B, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDJ|A Chain A, Src Kinase In Complex With Inhibitor Ap23464
Length = 279
Score = 95.5 bits (236), Expect = 9e-20, Method: Compositional matrix adjust.
Identities = 66/194 (34%), Positives = 105/194 (54%), Gaps = 9/194 (4%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
KLG+G FG V+ G VAIK L + F E +++ KL+H LV+L +
Sbjct: 18 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 75
Query: 497 HGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
E +V E+M SL DF +G+ L + + I+ G+ Y+ R+ +H
Sbjct: 76 SEEPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 130
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKT 615
RDL+A+NIL+ + + K++DFG+AR+ E NE A + +PE A+ G +IK+
Sbjct: 131 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 189
Query: 616 DVFSFGVLVLEIVS 629
DV+SFG+L+ E+ +
Sbjct: 190 DVWSFGILLTELTT 203
>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742a Triple Mutant
Length = 373
Score = 95.5 bits (236), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 82/287 (28%), Positives = 136/287 (47%), Gaps = 38/287 (13%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLA----DEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
A N S +G G FG V G+L E VAIK L + + +F E ++ +
Sbjct: 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE------G 537
H N++RL G + ++V E M N SLD FL RK+ + +F +I+ G
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL----RKH----DAQFTVIQLVGMLRG 155
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT 597
I+ G+ YL S + +HRDL A NIL++ + K+SDFG++R+ E + A T R
Sbjct: 156 IASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 598 -YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG 656
+ SPE + +DV+S+G+++ E++S + +RP W+ +S+
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS--------YGERPY------WE-MSNQ 257
Query: 657 KGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
++ +D P + + L C Q +RP ++V +L
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304
>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Amp-Pnp Bound
pdb|2QOQ|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Base, Amp-Pnp
Bound Structure
Length = 373
Score = 95.1 bits (235), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 82/287 (28%), Positives = 136/287 (47%), Gaps = 38/287 (13%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLA----DEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
A N S +G G FG V G+L E VAIK L + + +F E ++ +
Sbjct: 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE------G 537
H N++RL G + ++V E M N SLD FL RK+ + +F +I+ G
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL----RKH----DAQFTVIQLVGMLRG 155
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT 597
I+ G+ YL S + +HRDL A NIL++ + K+SDFG++R+ E + A T R
Sbjct: 156 IASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 598 -YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG 656
+ SPE + +DV+S+G+++ E++S + +RP W+ +S+
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS--------YGERPY------WE-MSNQ 257
Query: 657 KGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
++ +D P + + L C Q +RP ++V +L
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304
>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|B Chain B, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|C Chain C, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|D Chain D, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
Length = 286
Score = 95.1 bits (235), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 66/194 (34%), Positives = 104/194 (53%), Gaps = 9/194 (4%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
KLG+G FG V+ G VAIK L + F E +++ KL+H LV+L +
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 497 HGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
E +V E+M SL DF G+ L + + I+ G+ Y+ R+ +H
Sbjct: 83 SEEPIYIVIEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKT 615
RDL+A+NIL+ + + K++DFG+AR+ E NE A + +PE A+ G +IK+
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGRFTIKS 196
Query: 616 DVFSFGVLVLEIVS 629
DV+SFG+L+ E+ +
Sbjct: 197 DVWSFGILLTELTT 210
>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure
Length = 344
Score = 95.1 bits (235), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 82/287 (28%), Positives = 136/287 (47%), Gaps = 38/287 (13%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLA----DEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
A N S +G G FG V G+L E VAIK L + + +F E ++ +
Sbjct: 15 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 74
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE------G 537
H N++RL G + ++V E M N SLD FL RK+ + +F +I+ G
Sbjct: 75 DHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL----RKH----DAQFTVIQLVGMLRG 126
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT 597
I+ G+ YL S + +HRDL A NIL++ + K+SDFG++R+ E + A T R
Sbjct: 127 IASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 183
Query: 598 -YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG 656
+ SPE + +DV+S+G+++ E++S + +RP W+ +S+
Sbjct: 184 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS--------YGERPY------WE-MSNQ 228
Query: 657 KGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
++ +D P + + L C Q +RP ++V +L
Sbjct: 229 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 95.1 bits (235), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 72/278 (25%), Positives = 137/278 (49%), Gaps = 22/278 (7%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+ ++G G FG VYKGK + V + ++ + Q + FKNEV ++ K +H N++
Sbjct: 25 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 84
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
+G S + +V ++ SL L S K +K I ++G+ YLH S
Sbjct: 85 FMGYST-APQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKS- 140
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM--- 607
+IHRDLK++NI L + KI DFG+A +++ G+ +M+PE
Sbjct: 141 --IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 608 SGIVSIKTDVFSFGVLVLEIVSGQKNHTR-HHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
S S ++DV++FG+++ E+++GQ ++ ++ D+ + ++G + P L
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRG-----------SLSPDL 247
Query: 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
+ +N R + C++ + +RP+ P ++ ++
Sbjct: 248 SK-VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284
>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Human Insulin Receptor
Length = 306
Score = 94.7 bits (234), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 87/294 (29%), Positives = 139/294 (47%), Gaps = 40/294 (13%)
Query: 437 KLGEGGFGPVYKGKLAD------EQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLV 489
+LG+G FG VY+G D E VA+K ++ S+ + +EF NE ++ ++V
Sbjct: 24 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLF--------NSGRKNVLNWEKRFIIIEGISQG 541
RLLG G+ L+V E M + L +L N GR E + E I+ G
Sbjct: 84 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE-IADG 142
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEANTKRIVGTYGY 600
+ YL+ + +HRDL A N ++ KI DFGM R I+E + K ++ +
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-W 198
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLE 660
M+PE G+ + +D++SFGV++ EI S L +Q LS+ + L+
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVLK 243
Query: 661 LIDPS--LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLPP 712
+ L+QP + E R + +C Q RPT E+V +L+++ P P
Sbjct: 244 FVMDGGYLDQPDNCPE--RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 295
>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
pdb|1YOL|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
Length = 283
Score = 94.7 bits (234), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 66/194 (34%), Positives = 105/194 (54%), Gaps = 9/194 (4%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
KLG+G FG V+ G VAIK L + F E +++ KL+H LV+L +
Sbjct: 22 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 79
Query: 497 HGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
E +V E+M SL DF +G+ L + + I+ G+ Y+ R+ +H
Sbjct: 80 SEEPIYIVTEYMNKGSLLDFLKGETGK--YLRLPQLVDMSAQIASGMAYVE---RMNYVH 134
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKT 615
RDL+A+NIL+ + + K++DFG+AR+ E NE A + +PE A+ G +IK+
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 193
Query: 616 DVFSFGVLVLEIVS 629
DV+SFG+L+ E+ +
Sbjct: 194 DVWSFGILLTELTT 207
>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase
Length = 453
Score = 94.7 bits (234), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 79/283 (27%), Positives = 130/283 (45%), Gaps = 26/283 (9%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
KLG+G FG V+ G VAIK L + F E +++ KL+H LV+L +
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGNMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 249
Query: 497 HGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
E +V E+M SL DF G+ L + + I+ G+ Y+ R+ +H
Sbjct: 250 SEEPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 304
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKT 615
RDL+A+NIL+ + + K++DFG+ R+ E NE A + +PE A+ G +IK+
Sbjct: 305 RDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 363
Query: 616 DVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEV 675
DV+SFG+L+ E+ + + +R + L+ ++ PC E
Sbjct: 364 DVWSFGILLTELTTKGRVPYPGMVNREV---------------LDQVERGYRMPCPP-EC 407
Query: 676 MRCIH-VGLLCVQDQAMDRPTMPEVVCMLQNETMPLPPPKQPA 717
+H + C + +RPT + L++ P QP
Sbjct: 408 PESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQXQPG 450
>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc4b
pdb|3U51|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
pdb|3U51|B Chain B, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
Length = 275
Score = 94.7 bits (234), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 66/194 (34%), Positives = 104/194 (53%), Gaps = 9/194 (4%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
KLG+G FG V+ G VAIK L + F E +++ KL+H LV+L +
Sbjct: 14 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 71
Query: 497 HGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
E +V E+M SL DF G+ L + + I+ G+ Y+ R+ +H
Sbjct: 72 SEEPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 126
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKT 615
RDL+A+NIL+ + + K++DFG+AR+ E NE A + +PE A+ G +IK+
Sbjct: 127 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIKS 185
Query: 616 DVFSFGVLVLEIVS 629
DV+SFG+L+ E+ +
Sbjct: 186 DVWSFGILLTELTT 199
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 66/194 (34%), Positives = 104/194 (53%), Gaps = 9/194 (4%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
KLG+G FG V+ G VAIK L + F E +++ KL+H LV+L +
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 497 HGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
E +V E+M SL DF G+ L + + I+ G+ Y+ R+ +H
Sbjct: 83 SEEPIYIVIEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKT 615
RDL+A+NIL+ + + K++DFG+AR+ E NE A + +PE A+ G +IK+
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 196
Query: 616 DVFSFGVLVLEIVS 629
DV+SFG+L+ E+ +
Sbjct: 197 DVWSFGILLTELTT 210
>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
pdb|3SVV|B Chain B, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
Length = 286
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 66/194 (34%), Positives = 104/194 (53%), Gaps = 9/194 (4%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
KLG+G FG V+ G VAIK L + F E +++ KL+H LV+L +
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 497 HGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
E +V E+M SL DF G+ L + + I+ G+ Y+ R+ +H
Sbjct: 83 SEEPIYIVCEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKT 615
RDL+A+NIL+ + + K++DFG+AR+ E NE A + +PE A+ G +IK+
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 196
Query: 616 DVFSFGVLVLEIVS 629
DV+SFG+L+ E+ +
Sbjct: 197 DVWSFGILLTELTT 210
>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|2OIQ|B Chain B, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|3D7T|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3DQX|A Chain A, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3DQX|B Chain B, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3EN4|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN4|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN5|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN5|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN6|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN6|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN7|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EN7|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EL7|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 3
pdb|3EL8|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3EL8|B Chain B, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3F6X|A Chain A, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|B Chain B, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|C Chain C, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|D Chain D, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3G6G|A Chain A, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|3G6G|B Chain B, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|4AGW|A Chain A, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|4AGW|B Chain B, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|3UQF|A Chain A, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQF|B Chain B, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQG|A Chain A, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|3UQG|B Chain B, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|4DGG|A Chain A, C-Src Kinase Domain In Complex With Rm-1-176
pdb|4DGG|B Chain B, C-Src Kinase Domain In Complex With Rm-1-176
Length = 286
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 66/194 (34%), Positives = 104/194 (53%), Gaps = 9/194 (4%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
KLG+G FG V+ G VAIK L + F E +++ KL+H LV+L +
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 497 HGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
E +V E+M SL DF G+ L + + I+ G+ Y+ R+ +H
Sbjct: 83 SEEPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKT 615
RDL+A+NIL+ + + K++DFG+AR+ E NE A + +PE A+ G +IK+
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 196
Query: 616 DVFSFGVLVLEIVS 629
DV+SFG+L+ E+ +
Sbjct: 197 DVWSFGILLTELTT 210
>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain
pdb|1YOJ|B Chain B, Crystal Structure Of Src Kinase Domain
pdb|1YOM|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
pdb|1YOM|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
Length = 283
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 66/194 (34%), Positives = 105/194 (54%), Gaps = 9/194 (4%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
KLG+G FG V+ G VAIK L + F E +++ KL+H LV+L +
Sbjct: 22 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 79
Query: 497 HGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
E +V E+M SL DF +G+ L + + I+ G+ Y+ R+ +H
Sbjct: 80 SEEPIYIVTEYMNKGSLLDFLKGETGK--YLRLPQLVDMSAQIASGMAYVE---RMNYVH 134
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKT 615
RDL+A+NIL+ + + K++DFG+AR+ E NE A + +PE A+ G +IK+
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKF-PIKWTAPEAALYGRFTIKS 193
Query: 616 DVFSFGVLVLEIVS 629
DV+SFG+L+ E+ +
Sbjct: 194 DVWSFGILLTELTT 207
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 72/278 (25%), Positives = 137/278 (49%), Gaps = 22/278 (7%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+ ++G G FG VYKGK + V + ++ + Q + FKNEV ++ K +H N++
Sbjct: 25 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 84
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
+G S + +V ++ SL L S K +K I ++G+ YLH S
Sbjct: 85 FMGYSTK-PQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKS- 140
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM--- 607
+IHRDLK++NI L + KI DFG+A +++ G+ +M+PE
Sbjct: 141 --IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 608 SGIVSIKTDVFSFGVLVLEIVSGQKNHTR-HHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
S S ++DV++FG+++ E+++GQ ++ ++ D+ + ++G + P L
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRG-----------SLSPDL 247
Query: 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
+ +N R + C++ + +RP+ P ++ ++
Sbjct: 248 SK-VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284
>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|D Chain D, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 277
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 66/194 (34%), Positives = 104/194 (53%), Gaps = 9/194 (4%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
KLG+G FG V+ G VAIK L + F E +++ KL+H LV+L +
Sbjct: 16 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 73
Query: 497 HGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
E +V E+M SL DF G+ L + + I+ G+ Y+ R+ +H
Sbjct: 74 SEEPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 128
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKT 615
RDL+A+NIL+ + + K++DFG+AR+ E NE A + +PE A+ G +IK+
Sbjct: 129 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 187
Query: 616 DVFSFGVLVLEIVS 629
DV+SFG+L+ E+ +
Sbjct: 188 DVWSFGILLTELTT 201
>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a)
Length = 306
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 81/279 (29%), Positives = 136/279 (48%), Gaps = 40/279 (14%)
Query: 438 LGEGGFGPVYKGKLA----DEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLVRLL 492
+G G FG V G+L E VAIK L + + +F +E ++ + H N++ L
Sbjct: 37 IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE------GISQGLLYLH 546
G + +++ E+M N SLD FL RKN + RF +I+ GI G+ YL
Sbjct: 97 GVVTKCKPVMIITEYMENGSLDAFL----RKN----DGRFTVIQLVGMLRGIGSGMKYL- 147
Query: 547 KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT-YGYMSPEY 605
S + +HRDL A NIL++ + K+SDFGM+R+ E + A T R + +PE
Sbjct: 148 --SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 205
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664
+ +DV+S+G+++ E++S G++ + + I ++L P
Sbjct: 206 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRL----------PP 255
Query: 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
++ P + +++M L C Q + DRP ++V ML
Sbjct: 256 PMDCPIALHQLM------LDCWQKERSDRPKFGQIVNML 288
>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2-
Yl]amino}phenyl)acetic Acid
Length = 303
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 89/301 (29%), Positives = 142/301 (47%), Gaps = 42/301 (13%)
Query: 437 KLGEGGFGPVYKGKLAD------EQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLV 489
+LG+G FG VY+G D E VA+K ++ S+ + +EF NE ++ ++V
Sbjct: 21 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLF--------NSGRKNVLNWEKRFIIIEGISQG 541
RLLG G+ L+V E M + L +L N GR E + E I+ G
Sbjct: 81 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE-IADG 139
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEANTKRIVGTYGY 600
+ YL+ + +HRDL A N ++ KI DFGM R I E + K ++ +
Sbjct: 140 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR-W 195
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLE 660
M+PE G+ + +D++SFGV++ EI S L +Q LS+ + L+
Sbjct: 196 MAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVLK 240
Query: 661 LIDPS--LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLPPPKQPAF 718
+ L+QP + E R + +C Q RPT E+V +L+++ P P + +F
Sbjct: 241 FVMDGGYLDQPDNCPE--RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP--EVSF 296
Query: 719 F 719
F
Sbjct: 297 F 297
>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
pdb|3ETA|B Chain B, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
Length = 317
Score = 94.0 bits (232), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 89/301 (29%), Positives = 143/301 (47%), Gaps = 42/301 (13%)
Query: 437 KLGEGGFGPVYKGKLAD------EQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLV 489
+LG+G FG VY+G D E VA+K ++ S+ + +EF NE ++ ++V
Sbjct: 23 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLF--------NSGRKNVLNWEKRFIIIEGISQG 541
RLLG G+ L+V E M + L +L N GR E + E I+ G
Sbjct: 83 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE-IADG 141
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEANTKRIVGTYGY 600
+ YL+ + +HRDL A N ++ KI DFGM R I+E + K ++ +
Sbjct: 142 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-W 197
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLE 660
M+PE G+ + +D++SFGV++ EI S L +Q LS+ + L+
Sbjct: 198 MAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVLK 242
Query: 661 LIDPS--LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLPPPKQPAF 718
+ L+QP + E R + +C Q RPT E+V +L+++ P P + +F
Sbjct: 243 FVMDGGYLDQPDNCPE--RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP--EVSF 298
Query: 719 F 719
F
Sbjct: 299 F 299
>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With Peptide Substrate And Atp Analog
pdb|1GAG|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With A Bisubstrate Inhibitor
Length = 306
Score = 94.0 bits (232), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 87/294 (29%), Positives = 138/294 (46%), Gaps = 40/294 (13%)
Query: 437 KLGEGGFGPVYKGKLAD------EQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLV 489
+LG+G FG VY+G D E VA+K ++ S+ + +EF NE ++ ++V
Sbjct: 24 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLF--------NSGRKNVLNWEKRFIIIEGISQG 541
RLLG G+ L+V E M + L +L N GR E + E I+ G
Sbjct: 84 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE-IADG 142
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEANTKRIVGTYGY 600
+ YL+ + +HRDL A N ++ KI DFGM R I E + K ++ +
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR-W 198
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLE 660
M+PE G+ + +D++SFGV++ EI S L +Q LS+ + L+
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVLK 243
Query: 661 LIDPS--LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLPP 712
+ L+QP + E R + +C Q RPT E+V +L+++ P P
Sbjct: 244 FVMDGGYLDQPDNCPE--RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 295
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 94.0 bits (232), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 73/286 (25%), Positives = 140/286 (48%), Gaps = 24/286 (8%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+ ++G G FG VYKGK + V + ++ + Q + FKNEV ++ K +H N++
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
+G S + +V ++ SL L K K I +QG+ YLH S
Sbjct: 69 FMGYST-APQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS- 124
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM--- 607
+IHRDLK++NI L + + KI DFG+A + +++ G+ +M+PE
Sbjct: 125 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 608 SGIVSIKTDVFSFGVLVLEIVSGQKNHTR-HHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
S ++DV++FG+++ E+++GQ ++ ++ D+ + ++G + + P L
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY-----------LSPDL 231
Query: 667 EQPCS-ANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLP 711
+ S + M+ + C++ + +RP P+++ ++ LP
Sbjct: 232 SKVRSNCPKAMKRLMAE--CLKKKRDERPLFPQILASIELLARSLP 275
>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of
The Insulin Receptor Tyrosine Kinase
Length = 306
Score = 93.6 bits (231), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 87/294 (29%), Positives = 138/294 (46%), Gaps = 40/294 (13%)
Query: 437 KLGEGGFGPVYKGKLAD------EQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLV 489
+LG+G FG VY+G D E VA+K ++ S+ + +EF NE ++ ++V
Sbjct: 24 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLF--------NSGRKNVLNWEKRFIIIEGISQG 541
RLLG G+ L+V E M + L +L N GR E + E I+ G
Sbjct: 84 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE-IADG 142
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEANTKRIVGTYGY 600
+ YL+ + +HRDL A N ++ KI DFGM R I+E K ++ +
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVR-W 198
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLE 660
M+PE G+ + +D++SFGV++ EI S L +Q LS+ + L+
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVLK 243
Query: 661 LIDPS--LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLPP 712
+ L+QP + E R + +C Q RPT E+V +L+++ P P
Sbjct: 244 FVMDGGYLDQPDNCPE--RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 295
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 93.6 bits (231), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 89/301 (29%), Positives = 142/301 (47%), Gaps = 42/301 (13%)
Query: 437 KLGEGGFGPVYKGKLAD------EQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLV 489
+LG+G FG VY+G D E VA+K ++ S+ + +EF NE ++ ++V
Sbjct: 24 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLF--------NSGRKNVLNWEKRFIIIEGISQG 541
RLLG G+ L+V E M + L +L N GR E + E I+ G
Sbjct: 84 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE-IADG 142
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEANTKRIVGTYGY 600
+ YL+ + +HRDL A N ++ KI DFGM R I E + K ++ +
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR-W 198
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLE 660
M+PE G+ + +D++SFGV++ EI S L +Q LS+ + L+
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVLK 243
Query: 661 LIDPS--LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLPPPKQPAF 718
+ L+QP + E R + +C Q RPT E+V +L+++ P P + +F
Sbjct: 244 FVMDGGYLDQPDNCPE--RVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSFP--EVSF 299
Query: 719 F 719
F
Sbjct: 300 F 300
>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Vuf 12058
Length = 285
Score = 93.6 bits (231), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 81/281 (28%), Positives = 136/281 (48%), Gaps = 40/281 (14%)
Query: 438 LGEGGFGPVYKGKLA----DEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLVRLL 492
+G G FG V G+L E VAIK L + + +F +E ++ + H N++ L
Sbjct: 16 IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE------GISQGLLYLH 546
G + +++ E+M N SLD FL RKN + RF +I+ GI G+ YL
Sbjct: 76 GVVTKCKPVMIITEYMENGSLDAFL----RKN----DGRFTVIQLVGMLRGIGSGMKYL- 126
Query: 547 KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT-YGYMSPEY 605
S + +HRDL A NIL++ + K+SDFGM+R+ E + A T R + +PE
Sbjct: 127 --SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 184
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664
+ +DV+S+G+++ E++S G++ + + I ++L P
Sbjct: 185 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRL----------PP 234
Query: 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
++ P + +++M L C Q + DRP ++V ML
Sbjct: 235 PMDCPIALHQLM------LDCWQKERSDRPKFGQIVNMLDK 269
>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OEZ|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OF0|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3OF0|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3QLF|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLF|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLG|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
pdb|3QLG|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
Length = 286
Score = 93.6 bits (231), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 65/194 (33%), Positives = 104/194 (53%), Gaps = 9/194 (4%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
KLG+G FG V+ G VAIK L + F E +++ K++H LV+L +
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKIRHEKLVQLYAV-V 82
Query: 497 HGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
E +V E+M SL DF G+ L + + I+ G+ Y+ R+ +H
Sbjct: 83 SEEPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKT 615
RDL+A+NIL+ + + K++DFG+AR+ E NE A + +PE A+ G +IK+
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 196
Query: 616 DVFSFGVLVLEIVS 629
DV+SFG+L+ E+ +
Sbjct: 197 DVWSFGILLTELTT 210
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 93.6 bits (231), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 73/286 (25%), Positives = 140/286 (48%), Gaps = 24/286 (8%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+ ++G G FG VYKGK + V + ++ + Q + FKNEV ++ K +H N++
Sbjct: 14 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 73
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
+G S + +V ++ SL L K K I +QG+ YLH S
Sbjct: 74 FMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS- 129
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM--- 607
+IHRDLK++NI L + + KI DFG+A + +++ G+ +M+PE
Sbjct: 130 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 608 SGIVSIKTDVFSFGVLVLEIVSGQKNHTR-HHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
S ++DV++FG+++ E+++GQ ++ ++ D+ + ++G + + P L
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY-----------LSPDL 236
Query: 667 EQPCS-ANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLP 711
+ S + M+ + C++ + +RP P+++ ++ LP
Sbjct: 237 SKVRSNCPKAMKRLMAE--CLKKKRDERPLFPQILASIELLARSLP 280
>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain
pdb|2Y6O|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Dasatinib
Length = 291
Score = 93.6 bits (231), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 81/279 (29%), Positives = 136/279 (48%), Gaps = 40/279 (14%)
Query: 438 LGEGGFGPVYKGKLA----DEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLVRLL 492
+G G FG V G+L E VAIK L + + +F +E ++ + H N++ L
Sbjct: 22 IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE------GISQGLLYLH 546
G + +++ E+M N SLD FL RKN + RF +I+ GI G+ YL
Sbjct: 82 GVVTKCKPVMIITEYMENGSLDAFL----RKN----DGRFTVIQLVGMLRGIGSGMKYL- 132
Query: 547 KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT-YGYMSPEY 605
S + +HRDL A NIL++ + K+SDFGM+R+ E + A T R + +PE
Sbjct: 133 --SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 190
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664
+ +DV+S+G+++ E++S G++ + + I ++L P
Sbjct: 191 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRL----------PP 240
Query: 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
++ P + +++M L C Q + DRP ++V ML
Sbjct: 241 PMDCPIALHQLM------LDCWQKERSDRPKFGQIVNML 273
>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
pdb|3GEQ|B Chain B, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
Length = 286
Score = 93.6 bits (231), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 66/194 (34%), Positives = 103/194 (53%), Gaps = 9/194 (4%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
KLG+G FG V+ G VAIK L + F E +++ KL+H LV+L +
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 497 HGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
E +V E+M SL DF G+ L + + I+ G+ Y+ R+ +H
Sbjct: 83 SEEPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKT 615
RDL A+NIL+ + + K++DFG+AR+ E NE A + +PE A+ G +IK+
Sbjct: 138 RDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 196
Query: 616 DVFSFGVLVLEIVS 629
DV+SFG+L+ E+ +
Sbjct: 197 DVWSFGILLTELTT 210
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 93.2 bits (230), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 73/286 (25%), Positives = 140/286 (48%), Gaps = 24/286 (8%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+ ++G G FG VYKGK + V + ++ + Q + FKNEV ++ K +H N++
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
+G S + +V ++ SL L K K I +QG+ YLH S
Sbjct: 69 FMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS- 124
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM--- 607
+IHRDLK++NI L + + KI DFG+A + +++ G+ +M+PE
Sbjct: 125 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 608 SGIVSIKTDVFSFGVLVLEIVSGQKNHTR-HHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
S ++DV++FG+++ E+++GQ ++ ++ D+ + ++G + + P L
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY-----------LSPDL 231
Query: 667 EQPCS-ANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLP 711
+ S + M+ + C++ + +RP P+++ ++ LP
Sbjct: 232 SKVRSNCPKAMKRLMAE--CLKKKRDERPLFPQILASIELLARSLP 275
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 93.2 bits (230), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 79/294 (26%), Positives = 134/294 (45%), Gaps = 38/294 (12%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK---LADEQE---VAIKRLSRSSGQGIVEFKNEVRLIAKL 483
+N +LGEG FG V+ + L EQ+ VA+K L +S +F E L+ L
Sbjct: 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 72
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE----------KRFI 533
QH ++V+ G + G+ ++V+E+M + L+ FL G VL E +
Sbjct: 73 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLH 132
Query: 534 IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR 593
I + I+ G++YL + +HRDL N L+ + + KI DFGM+R +
Sbjct: 133 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 189
Query: 594 IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLL 653
+ +M PE M + ++DV+S GV++ EI + K W L
Sbjct: 190 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ---------------PWYQL 234
Query: 654 SDGKGLELIDPS--LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
S+ + +E I L++P + + + + +G C Q + R + + +LQN
Sbjct: 235 SNNEVIECITQGRVLQRPRTCPQEVYELMLG--CWQREPHMRKNIKGIHTLLQN 286
>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QQ7|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QI8|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|2QI8|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|3F3W|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3F3W|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3LOK|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
pdb|3LOK|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
Length = 286
Score = 93.2 bits (230), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 65/194 (33%), Positives = 103/194 (53%), Gaps = 9/194 (4%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
KLG+G FG V+ G VAIK L + F E +++ KL+H LV+L +
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 497 HGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
E +V E+M L DF G+ L + + I+ G+ Y+ R+ +H
Sbjct: 83 SEEPIYIVMEYMSKGCLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKT 615
RDL+A+NIL+ + + K++DFG+AR+ E NE A + +PE A+ G +IK+
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 196
Query: 616 DVFSFGVLVLEIVS 629
DV+SFG+L+ E+ +
Sbjct: 197 DVWSFGILLTELTT 210
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 93.2 bits (230), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 73/286 (25%), Positives = 140/286 (48%), Gaps = 24/286 (8%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+ ++G G FG VYKGK + V + ++ + Q + FKNEV ++ K +H N++
Sbjct: 14 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 73
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
+G S + +V ++ SL L K K I +QG+ YLH S
Sbjct: 74 FMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS- 129
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM--- 607
+IHRDLK++NI L + + KI DFG+A + +++ G+ +M+PE
Sbjct: 130 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 608 SGIVSIKTDVFSFGVLVLEIVSGQKNHTR-HHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
S ++DV++FG+++ E+++GQ ++ ++ D+ + ++G + + P L
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY-----------LSPDL 236
Query: 667 EQPCS-ANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLP 711
+ S + M+ + C++ + +RP P+++ ++ LP
Sbjct: 237 SKVRSNCPKAMKRLMAE--CLKKKRDERPLFPQILASIELLARSLP 280
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 93.2 bits (230), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 73/286 (25%), Positives = 140/286 (48%), Gaps = 24/286 (8%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+ ++G G FG VYKGK + V + ++ + Q + FKNEV ++ K +H N++
Sbjct: 11 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 70
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
+G S + +V ++ SL L K K I +QG+ YLH S
Sbjct: 71 FMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS- 126
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM--- 607
+IHRDLK++NI L + + KI DFG+A + +++ G+ +M+PE
Sbjct: 127 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 184
Query: 608 SGIVSIKTDVFSFGVLVLEIVSGQKNHTR-HHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
S ++DV++FG+++ E+++GQ ++ ++ D+ + ++G + + P L
Sbjct: 185 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY-----------LSPDL 233
Query: 667 EQPCS-ANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLP 711
+ S + M+ + C++ + +RP P+++ ++ LP
Sbjct: 234 SKVRSNCPKAMKRLMAE--CLKKKRDERPLFPQILASIELLARSLP 277
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 93.2 bits (230), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 67/195 (34%), Positives = 102/195 (52%), Gaps = 9/195 (4%)
Query: 436 NKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCS 495
KLG G FG V+ +VA+K + S + F E ++ LQH LV+L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV- 251
Query: 496 LHGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVI 554
+ E ++ EFM SL DF + G K L K I++G+ ++ + + I
Sbjct: 252 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YI 306
Query: 555 HRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIK 614
HRDL+A+NIL+ + KI+DFG+AR+ E NE A + +PE G +IK
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIK 365
Query: 615 TDVFSFGVLVLEIVS 629
+DV+SFG+L++EIV+
Sbjct: 366 SDVWSFGILLMEIVT 380
>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWO|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWP|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2HWP|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2QLQ|A Chain A, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|2QLQ|B Chain B, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|3F3T|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3T|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3U|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3U|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3V|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3F3V|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3G5D|A Chain A, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3G5D|B Chain B, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3TZ7|A Chain A, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ7|B Chain B, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ8|A Chain A, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ8|B Chain B, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ9|A Chain A, Kinase Domain Of Csrc In Complex With Rl130
pdb|3TZ9|B Chain B, Kinase Domain Of Csrc In Complex With Rl130
Length = 286
Score = 92.8 bits (229), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 65/194 (33%), Positives = 103/194 (53%), Gaps = 9/194 (4%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
KLG+G FG V+ G VAIK L + F E +++ KL+H LV+L +
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 497 HGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
E +V E+M L DF G+ L + + I+ G+ Y+ R+ +H
Sbjct: 83 SEEPIYIVTEYMSKGCLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKT 615
RDL+A+NIL+ + + K++DFG+AR+ E NE A + +PE A+ G +IK+
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 196
Query: 616 DVFSFGVLVLEIVS 629
DV+SFG+L+ E+ +
Sbjct: 197 DVWSFGILLTELTT 210
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 92.8 bits (229), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 67/195 (34%), Positives = 102/195 (52%), Gaps = 9/195 (4%)
Query: 436 NKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCS 495
KLG G FG V+ +VA+K + S + F E ++ LQH LV+L
Sbjct: 21 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV- 78
Query: 496 LHGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVI 554
+ E ++ EFM SL DF + G K L K I++G+ ++ + + I
Sbjct: 79 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YI 133
Query: 555 HRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIK 614
HRDL+A+NIL+ + KI+DFG+AR+ E NE A + +PE G +IK
Sbjct: 134 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI-KWTAPEAINFGSFTIK 192
Query: 615 TDVFSFGVLVLEIVS 629
+DV+SFG+L++EIV+
Sbjct: 193 SDVWSFGILLMEIVT 207
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 92.8 bits (229), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 77/275 (28%), Positives = 135/275 (49%), Gaps = 31/275 (11%)
Query: 438 LGEGGFGPVYKGKLA-----DEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLVRL 491
+G G FG VYKG L E VAIK L + + V+F E ++ + H N++RL
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 492 LGCSLHGEERLLVYEFMPNKSLDFFLF-NSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
G + +++ E+M N +LD FL G +VL ++ GI+ G+ YL +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVG---MLRGIAAGMKYL---AN 165
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT--YGYMSPEYAMS 608
+ +HRDL A NIL++ + K+SDFG++R+ E ++ EA G + +PE
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 609 GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668
+ +DV+SFG+++ E+++ + +RP W+ LS+ + ++ I+
Sbjct: 225 RKFTSASDVWSFGIVMWEVMT--------YGERPY------WE-LSNHEVMKAINDGFRL 269
Query: 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
P + + + C Q + RP ++V +L
Sbjct: 270 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 304
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 92.8 bits (229), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 73/286 (25%), Positives = 140/286 (48%), Gaps = 24/286 (8%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+ ++G G FG VYKGK + V + ++ + Q + FKNEV ++ K +H N++
Sbjct: 37 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 96
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
+G S + +V ++ SL L K K I +QG+ YLH S
Sbjct: 97 FMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS- 152
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM--- 607
+IHRDLK++NI L + + KI DFG+A + +++ G+ +M+PE
Sbjct: 153 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 608 SGIVSIKTDVFSFGVLVLEIVSGQKNHTR-HHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
S ++DV++FG+++ E+++GQ ++ ++ D+ + ++G + + P L
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY-----------LSPDL 259
Query: 667 EQPCS-ANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLP 711
+ S + M+ + C++ + +RP P+++ ++ LP
Sbjct: 260 SKVRSNCPKAMKRLMAE--CLKKKRDERPLFPQILASIELLARSLP 303
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 92.8 bits (229), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 73/286 (25%), Positives = 140/286 (48%), Gaps = 24/286 (8%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+ ++G G FG VYKGK + V + ++ + Q + FKNEV ++ K +H N++
Sbjct: 36 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 95
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
+G S + +V ++ SL L K K I +QG+ YLH S
Sbjct: 96 FMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS- 151
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM--- 607
+IHRDLK++NI L + + KI DFG+A + +++ G+ +M+PE
Sbjct: 152 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 209
Query: 608 SGIVSIKTDVFSFGVLVLEIVSGQKNHTR-HHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
S ++DV++FG+++ E+++GQ ++ ++ D+ + ++G + + P L
Sbjct: 210 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY-----------LSPDL 258
Query: 667 EQPCS-ANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLP 711
+ S + M+ + C++ + +RP P+++ ++ LP
Sbjct: 259 SKVRSNCPKAMKRLMAE--CLKKKRDERPLFPQILASIELLARSLP 302
>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|B Chain B, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|C Chain C, Human Trka In Complex With The Inhibitor Az-23
Length = 329
Score = 92.8 bits (229), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 82/297 (27%), Positives = 136/297 (45%), Gaps = 42/297 (14%)
Query: 437 KLGEGGFGPVYKGK---LADEQE---VAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+LGEG FG V+ + L EQ+ VA+K L +S +F+ E L+ LQH ++VR
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFN--------SGRKNV----LNWEKRFIIIEGI 538
G G L+V+E+M + L+ FL + +G ++V L + + +
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTY 598
+ G++YL + L +HRDL N L+ + KI DFGM+R + R +
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 599 GYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKG 658
+M PE + + ++DV+SFGV++ EI + K W LS+ +
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ---------------PWYQLSNTEA 269
Query: 659 LELIDPS--LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLPPP 713
++ I LE+P + + I G C Q + R ++ +V LQ + PP
Sbjct: 270 IDCITQGRELERPRACPPEVYAIMRG--CWQREPQQRHSIKDVHARLQ--ALAQAPP 322
>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka
pdb|4F0I|B Chain B, Crystal Structure Of Apo Trka
Length = 300
Score = 92.4 bits (228), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 82/297 (27%), Positives = 136/297 (45%), Gaps = 42/297 (14%)
Query: 437 KLGEGGFGPVYKGK---LADEQE---VAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+LGEG FG V+ + L EQ+ VA+K L +S +F+ E L+ LQH ++VR
Sbjct: 19 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFN--------SGRKNV----LNWEKRFIIIEGI 538
G G L+V+E+M + L+ FL + +G ++V L + + +
Sbjct: 79 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTY 598
+ G++YL + L +HRDL N L+ + KI DFGM+R + R +
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 599 GYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKG 658
+M PE + + ++DV+SFGV++ EI + K W LS+ +
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ---------------PWYQLSNTEA 240
Query: 659 LELIDPS--LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLPPP 713
++ I LE+P + + I G C Q + R ++ +V LQ + PP
Sbjct: 241 IDCITQGRELERPRACPPEVYAIMRG--CWQREPQQRHSIKDVHARLQ--ALAQAPP 293
>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The
Insulin Receptor Tyrosine Kinase
Length = 306
Score = 92.4 bits (228), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 88/301 (29%), Positives = 143/301 (47%), Gaps = 42/301 (13%)
Query: 437 KLGEGGFGPVYKGKLAD------EQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLV 489
+LG+G FG VY+G D E VA+K ++ S+ + +EF NE ++ ++V
Sbjct: 24 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLF--------NSGRKNVLNWEKRFIIIEGISQG 541
RLLG G+ L+V E M + L +L N GR E + E I+ G
Sbjct: 84 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE-IADG 142
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEANTKRIVGTYGY 600
+ YL+ + +HR+L A N ++ KI DFGM R I+E + K ++ +
Sbjct: 143 MAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-W 198
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLE 660
M+PE G+ + +D++SFGV++ EI S L +Q LS+ + L+
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVLK 243
Query: 661 LIDPS--LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLPPPKQPAF 718
+ L+QP + E R + +C Q RPT E+V +L+++ P P + +F
Sbjct: 244 FVMDGGYLDQPDNCPE--RVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSFP--EVSF 299
Query: 719 F 719
F
Sbjct: 300 F 300
>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
pdb|3EKN|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
Length = 307
Score = 92.4 bits (228), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 88/301 (29%), Positives = 143/301 (47%), Gaps = 42/301 (13%)
Query: 437 KLGEGGFGPVYKGKLAD------EQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLV 489
+LG+G FG VY+G D E VA+K ++ S+ + +EF NE ++ ++V
Sbjct: 25 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLF--------NSGRKNVLNWEKRFIIIEGISQG 541
RLLG G+ L+V E M + L +L N GR E + E I+ G
Sbjct: 85 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE-IADG 143
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEANTKRIVGTYGY 600
+ YL+ + +HR+L A N ++ KI DFGM R I+E + K ++ +
Sbjct: 144 MAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-W 199
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLE 660
M+PE G+ + +D++SFGV++ EI S L +Q LS+ + L+
Sbjct: 200 MAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVLK 244
Query: 661 LIDPS--LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLPPPKQPAF 718
+ L+QP + E R + +C Q RPT E+V +L+++ P P + +F
Sbjct: 245 FVMDGGYLDQPDNCPE--RVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSFP--EVSF 300
Query: 719 F 719
F
Sbjct: 301 F 301
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 92.4 bits (228), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 75/232 (32%), Positives = 116/232 (50%), Gaps = 33/232 (14%)
Query: 422 FQTIAAAANNFSTTNKLGEGGFGPVYKGKL------ADEQEVAIKRLS-RSSGQGIVEFK 474
+ I+ +A F +LGE FG VYKG L Q VAIK L ++ G EF+
Sbjct: 20 LKEISLSAVRF--MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR 77
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF-------------NSG 521
+E L A+LQH N+V LLG + +++ + + L FL +
Sbjct: 78 HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 137
Query: 522 RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581
K+ L ++ I+ G+ YL S V+H+DL N+L+ DK+N KISD G+ R
Sbjct: 138 VKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR- 193
Query: 582 FEVNESEANTKRIVGT----YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
EV A+ +++G +M+PE M G SI +D++S+GV++ E+ S
Sbjct: 194 -EV--YAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242
>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain
Length = 306
Score = 92.4 bits (228), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 82/297 (27%), Positives = 136/297 (45%), Gaps = 42/297 (14%)
Query: 437 KLGEGGFGPVYKGK---LADEQE---VAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+LGEG FG V+ + L EQ+ VA+K L +S +F+ E L+ LQH ++VR
Sbjct: 25 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFN--------SGRKNV----LNWEKRFIIIEGI 538
G G L+V+E+M + L+ FL + +G ++V L + + +
Sbjct: 85 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTY 598
+ G++YL + L +HRDL N L+ + KI DFGM+R + R +
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 599 GYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKG 658
+M PE + + ++DV+SFGV++ EI + K W LS+ +
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ---------------PWYQLSNTEA 246
Query: 659 LELIDPS--LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLPPP 713
++ I LE+P + + I G C Q + R ++ +V LQ + PP
Sbjct: 247 IDCITQGRELERPRACPPEVYAIMRG--CWQREPQQRHSIKDVHARLQ--ALAQAPP 299
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 92.4 bits (228), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 75/232 (32%), Positives = 116/232 (50%), Gaps = 33/232 (14%)
Query: 422 FQTIAAAANNFSTTNKLGEGGFGPVYKGKL------ADEQEVAIKRLS-RSSGQGIVEFK 474
+ I+ +A F +LGE FG VYKG L Q VAIK L ++ G EF+
Sbjct: 3 LKEISLSAVRF--MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR 60
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF-------------NSG 521
+E L A+LQH N+V LLG + +++ + + L FL +
Sbjct: 61 HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 522 RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581
K+ L ++ I+ G+ YL S V+H+DL N+L+ DK+N KISD G+ R
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR- 176
Query: 582 FEVNESEANTKRIVGT----YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
EV A+ +++G +M+PE M G SI +D++S+GV++ E+ S
Sbjct: 177 -EV--YAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5Q|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
Length = 348
Score = 92.4 bits (228), Expect = 9e-19, Method: Compositional matrix adjust.
Identities = 68/204 (33%), Positives = 103/204 (50%), Gaps = 19/204 (9%)
Query: 432 FSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKN---EVRLIAKLQHTN 487
FS ++G G FG VY + + + + VAIK++S S Q ++++ EVR + KL+H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
++ GC L LV E+ + D + K L + + G QGL YLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
++ +IHRD+KA NILL + K+ DFG A I A VGT +M+PE +
Sbjct: 173 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 223
Query: 608 S---GIVSIKTDVFSFGVLVLEIV 628
+ G K DV+S G+ +E+
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELA 247
>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure
pdb|2GCD|B Chain B, Tao2 Kinase Domain-Staurosporine Structure
Length = 309
Score = 92.0 bits (227), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 432 FSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKN---EVRLIAKLQHTN 487
FS ++G G FG VY + + + + VAIK++S S Q ++++ EVR + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
++ GC L LV E+ + D + K L + + G QGL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
++ +IHRD+KA NILL + K+ DFG A I A VGT +M+PE +
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184
Query: 608 S---GIVSIKTDVFSFGVLVLEI 627
+ G K DV+S G+ +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207
>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution.
pdb|1P4O|B Chain B, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution
Length = 322
Score = 91.3 bits (225), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 88/305 (28%), Positives = 140/305 (45%), Gaps = 48/305 (15%)
Query: 427 AAANNFSTTNKLGEGGFGPVY----KGKLADEQE--VAIKRLSRS-SGQGIVEFKNEVRL 479
A + + +LG+G FG VY KG + DE E VAIK ++ + S + +EF NE +
Sbjct: 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLN--------WEKR 531
+ + ++VRLLG G+ L++ E M L +L S R + N K
Sbjct: 82 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPAMANNPVLAPPSLSKM 140
Query: 532 FIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEAN 590
+ I+ G+ YL+ + +HRDL A N ++ + KI DFGM R I+E +
Sbjct: 141 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 197
Query: 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAW 650
K ++ +MSPE G+ + +DV+SFGV++ EI + L +
Sbjct: 198 GKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPY 241
Query: 651 QLLSDGKGLE------LIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
Q LS+ + L L+D P E+MR +C Q RP+ E++ ++
Sbjct: 242 QGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEIISSIK 295
Query: 705 NETMP 709
E P
Sbjct: 296 EEMEP 300
>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|B Chain B, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|C Chain C, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|D Chain D, Igf-1rk In Complex With Ligand Msc1609119a-1
Length = 304
Score = 91.3 bits (225), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 88/305 (28%), Positives = 140/305 (45%), Gaps = 48/305 (15%)
Query: 427 AAANNFSTTNKLGEGGFGPVY----KGKLADEQE--VAIKRLSRS-SGQGIVEFKNEVRL 479
A + + +LG+G FG VY KG + DE E VAIK ++ + S + +EF NE +
Sbjct: 12 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 71
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLN--------WEKR 531
+ + ++VRLLG G+ L++ E M L +L S R + N K
Sbjct: 72 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPAMANNPVLAPPSLSKM 130
Query: 532 FIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEAN 590
+ I+ G+ YL+ + +HRDL A N ++ + KI DFGM R I+E +
Sbjct: 131 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 187
Query: 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAW 650
K ++ +MSPE G+ + +DV+SFGV++ EI + L +
Sbjct: 188 GKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPY 231
Query: 651 QLLSDGKGLE------LIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
Q LS+ + L L+D P E+MR +C Q RP+ E++ ++
Sbjct: 232 QGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEIISSIK 285
Query: 705 NETMP 709
E P
Sbjct: 286 EEMEP 290
>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5)
Length = 295
Score = 91.3 bits (225), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 79/282 (28%), Positives = 135/282 (47%), Gaps = 28/282 (9%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLA----DEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
A+ + +G G FG V G+L E VAIK L + + +F E ++ +
Sbjct: 21 ASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQF 80
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF-NSGRKNVLNWEKRFIIIEGISQGL 542
H N++ L G + ++V E+M N SLD FL N G+ V+ + ++ GIS G+
Sbjct: 81 DHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVI---QLVGMLRGISAGM 137
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT-YGYM 601
YL S + +HRDL A NIL++ + K+SDFG++R+ E + A T R +
Sbjct: 138 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 194
Query: 602 SPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL 661
+PE + +DV+S+G+++ E+VS + +RP W+ +++ ++
Sbjct: 195 APEAIAFRKFTSASDVWSYGIVMWEVVS--------YGERPY------WE-MTNQDVIKA 239
Query: 662 IDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
++ P + + L C Q + RP E+V ML
Sbjct: 240 VEEGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNML 281
>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex
With An Hydantoin Inhibitor
Length = 305
Score = 90.9 bits (224), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 88/305 (28%), Positives = 140/305 (45%), Gaps = 48/305 (15%)
Query: 427 AAANNFSTTNKLGEGGFGPVY----KGKLADEQE--VAIKRLSRS-SGQGIVEFKNEVRL 479
A + + +LG+G FG VY KG + DE E VAIK ++ + S + +EF NE +
Sbjct: 13 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 72
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLN--------WEKR 531
+ + ++VRLLG G+ L++ E M L +L S R + N K
Sbjct: 73 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKM 131
Query: 532 FIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEAN 590
+ I+ G+ YL+ + +HRDL A N ++ + KI DFGM R I+E +
Sbjct: 132 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 188
Query: 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAW 650
K ++ +MSPE G+ + +DV+SFGV++ EI + L +
Sbjct: 189 GKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPY 232
Query: 651 QLLSDGKGLE------LIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
Q LS+ + L L+D P E+MR +C Q RP+ E++ ++
Sbjct: 233 QGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEIISSIK 286
Query: 705 NETMP 709
E P
Sbjct: 287 EEMEP 291
>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
pdb|1M7N|B Chain B, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
Length = 322
Score = 90.9 bits (224), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 88/305 (28%), Positives = 140/305 (45%), Gaps = 48/305 (15%)
Query: 427 AAANNFSTTNKLGEGGFGPVY----KGKLADEQE--VAIKRLSRS-SGQGIVEFKNEVRL 479
A + + +LG+G FG VY KG + DE E VAIK ++ + S + +EF NE +
Sbjct: 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLN--------WEKR 531
+ + ++VRLLG G+ L++ E M L +L S R + N K
Sbjct: 82 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKM 140
Query: 532 FIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEAN 590
+ I+ G+ YL+ + +HRDL A N ++ + KI DFGM R I+E +
Sbjct: 141 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 197
Query: 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAW 650
K ++ +MSPE G+ + +DV+SFGV++ EI + L +
Sbjct: 198 GKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPY 241
Query: 651 QLLSDGKGLE------LIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
Q LS+ + L L+D P E+MR +C Q RP+ E++ ++
Sbjct: 242 QGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEIISSIK 295
Query: 705 NETMP 709
E P
Sbjct: 296 EEMEP 300
>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|B Chain B, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|C Chain C, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|D Chain D, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
Length = 301
Score = 90.9 bits (224), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 88/305 (28%), Positives = 140/305 (45%), Gaps = 48/305 (15%)
Query: 427 AAANNFSTTNKLGEGGFGPVY----KGKLADEQE--VAIKRLSRS-SGQGIVEFKNEVRL 479
A + + +LG+G FG VY KG + DE E VAIK ++ + S + +EF NE +
Sbjct: 9 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLN--------WEKR 531
+ + ++VRLLG G+ L++ E M L +L S R + N K
Sbjct: 69 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKM 127
Query: 532 FIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEAN 590
+ I+ G+ YL+ + +HRDL A N ++ + KI DFGM R I+E +
Sbjct: 128 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 184
Query: 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAW 650
K ++ +MSPE G+ + +DV+SFGV++ EI + L +
Sbjct: 185 GKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPY 228
Query: 651 QLLSDGKGLE------LIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
Q LS+ + L L+D P E+MR +C Q RP+ E++ ++
Sbjct: 229 QGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEIISSIK 282
Query: 705 NETMP 709
E P
Sbjct: 283 EEMEP 287
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 90.9 bits (224), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 73/286 (25%), Positives = 139/286 (48%), Gaps = 24/286 (8%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+ ++G G FG VYKGK + V + ++ + Q + FKNEV ++ K +H N++
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
+G S + +V ++ SL L K K I +QG+ YLH S
Sbjct: 69 FMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS- 124
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM--- 607
+IHRDLK++NI L + + KI DFG+A +++ G+ +M+PE
Sbjct: 125 --IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 608 SGIVSIKTDVFSFGVLVLEIVSGQKNHTR-HHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
S ++DV++FG+++ E+++GQ ++ ++ D+ + ++G + + P L
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY-----------LSPDL 231
Query: 667 EQPCS-ANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLP 711
+ S + M+ + C++ + +RP P+++ ++ LP
Sbjct: 232 SKVRSNCPKAMKRLMAE--CLKKKRDERPLFPQILASIELLARSLP 275
>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain
pdb|1JQH|B Chain B, Igf-1 Receptor Kinase Domain
pdb|1JQH|C Chain C, Igf-1 Receptor Kinase Domain
Length = 308
Score = 90.9 bits (224), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 88/305 (28%), Positives = 140/305 (45%), Gaps = 48/305 (15%)
Query: 427 AAANNFSTTNKLGEGGFGPVY----KGKLADEQE--VAIKRLSRS-SGQGIVEFKNEVRL 479
A + + +LG+G FG VY KG + DE E VAIK ++ + S + +EF NE +
Sbjct: 16 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLN--------WEKR 531
+ + ++VRLLG G+ L++ E M L +L S R + N K
Sbjct: 76 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKM 134
Query: 532 FIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEAN 590
+ I+ G+ YL+ + +HRDL A N ++ + KI DFGM R I+E +
Sbjct: 135 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 191
Query: 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAW 650
K ++ +MSPE G+ + +DV+SFGV++ EI + L +
Sbjct: 192 GKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPY 235
Query: 651 QLLSDGKGLE------LIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
Q LS+ + L L+D P E+MR +C Q RP+ E++ ++
Sbjct: 236 QGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEIISSIK 289
Query: 705 NETMP 709
E P
Sbjct: 290 EEMEP 294
>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With Bms-754807
[1-(4-((5-Cyclopropyl-
1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2,
4]triazin-2-Yl)-N-
(6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide]
Length = 315
Score = 90.5 bits (223), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 88/305 (28%), Positives = 140/305 (45%), Gaps = 48/305 (15%)
Query: 427 AAANNFSTTNKLGEGGFGPVY----KGKLADEQE--VAIKRLSRS-SGQGIVEFKNEVRL 479
A + + +LG+G FG VY KG + DE E VAIK ++ + S + +EF NE +
Sbjct: 15 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLN--------WEKR 531
+ + ++VRLLG G+ L++ E M L +L S R + N K
Sbjct: 75 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKM 133
Query: 532 FIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEAN 590
+ I+ G+ YL+ + +HRDL A N ++ + KI DFGM R I+E +
Sbjct: 134 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 190
Query: 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAW 650
K ++ +MSPE G+ + +DV+SFGV++ EI + L +
Sbjct: 191 GKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPY 234
Query: 651 QLLSDGKGLE------LIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
Q LS+ + L L+D P E+MR +C Q RP+ E++ ++
Sbjct: 235 QGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEIISSIK 288
Query: 705 NETMP 709
E P
Sbjct: 289 EEMEP 293
>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A
Benzimidazole Inhibitor
pdb|3NW5|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11b)
pdb|3NW6|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11a)
pdb|3NW7|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (34)
Length = 307
Score = 90.5 bits (223), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 88/305 (28%), Positives = 140/305 (45%), Gaps = 48/305 (15%)
Query: 427 AAANNFSTTNKLGEGGFGPVY----KGKLADEQE--VAIKRLSRS-SGQGIVEFKNEVRL 479
A + + +LG+G FG VY KG + DE E VAIK ++ + S + +EF NE +
Sbjct: 15 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLN--------WEKR 531
+ + ++VRLLG G+ L++ E M L +L S R + N K
Sbjct: 75 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKM 133
Query: 532 FIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEAN 590
+ I+ G+ YL+ + +HRDL A N ++ + KI DFGM R I+E +
Sbjct: 134 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 190
Query: 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAW 650
K ++ +MSPE G+ + +DV+SFGV++ EI + L +
Sbjct: 191 GKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPY 234
Query: 651 QLLSDGKGLE------LIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
Q LS+ + L L+D P E+MR +C Q RP+ E++ ++
Sbjct: 235 QGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEIISSIK 288
Query: 705 NETMP 709
E P
Sbjct: 289 EEMEP 293
>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase
pdb|3COK|B Chain B, Crystal Structure Of Plk4 Kinase
Length = 278
Score = 90.5 bits (223), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 65/211 (30%), Positives = 109/211 (51%), Gaps = 11/211 (5%)
Query: 425 IAAAANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSS--GQGIVE-FKNEVRLI 480
I +F N LG+G F VY+ + + EVAIK + + + G+V+ +NEV++
Sbjct: 6 IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+L+H +++ L LV E N ++ +L N + N + F+ I
Sbjct: 66 CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFM--HQIIT 123
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
G+LYLH + ++HRDL SN+LL MN KI+DFG+A ++ + T + GT Y
Sbjct: 124 GMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNY 178
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+SPE A +++DV+S G + ++ G+
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 90.5 bits (223), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 72/215 (33%), Positives = 102/215 (47%), Gaps = 19/215 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSR-SSGQGIVEFKNEVRLIAK 482
N + LG G FG VY+G+++ +VA+K L S Q ++F E +I+K
Sbjct: 45 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 104
Query: 483 LQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNS----GRKNVLNWEKRFIIIEGI 538
L H N+VR +G SL R ++ E M L FL + + + L + I
Sbjct: 105 LNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 164
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILL---DDKMNPKISDFGMAR-IFEVNESEANTKRI 594
+ G YL + IHRD+ A N LL KI DFGMAR I+ + +
Sbjct: 165 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 221
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ +M PE M GI + KTD +SFGVL+ EI S
Sbjct: 222 LPV-KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255
>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma
Kinase Catalytic Domain
Length = 327
Score = 90.5 bits (223), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 72/215 (33%), Positives = 102/215 (47%), Gaps = 19/215 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSR-SSGQGIVEFKNEVRLIAK 482
N + LG G FG VY+G+++ +VA+K L S Q ++F E +I+K
Sbjct: 31 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 483 LQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNS----GRKNVLNWEKRFIIIEGI 538
L H N+VR +G SL R ++ E M L FL + + + L + I
Sbjct: 91 LNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILLD---DKMNPKISDFGMAR-IFEVNESEANTKRI 594
+ G YL + IHRD+ A N LL KI DFGMAR I+ + +
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 207
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ +M PE M GI + KTD +SFGVL+ EI S
Sbjct: 208 LPV-KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241
>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|B Chain B, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|C Chain C, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|D Chain D, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
Length = 336
Score = 90.5 bits (223), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 88/305 (28%), Positives = 140/305 (45%), Gaps = 48/305 (15%)
Query: 427 AAANNFSTTNKLGEGGFGPVY----KGKLADEQE--VAIKRLSRS-SGQGIVEFKNEVRL 479
A + + +LG+G FG VY KG + DE E VAIK ++ + S + +EF NE +
Sbjct: 44 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 103
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLN--------WEKR 531
+ + ++VRLLG G+ L++ E M L +L S R + N K
Sbjct: 104 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKM 162
Query: 532 FIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEAN 590
+ I+ G+ YL+ + +HRDL A N ++ + KI DFGM R I+E +
Sbjct: 163 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 219
Query: 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAW 650
K ++ +MSPE G+ + +DV+SFGV++ EI + L +
Sbjct: 220 GKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPY 263
Query: 651 QLLSDGKGLE------LIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
Q LS+ + L L+D P E+MR +C Q RP+ E++ ++
Sbjct: 264 QGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEIISSIK 317
Query: 705 NETMP 709
E P
Sbjct: 318 EEMEP 322
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 90.5 bits (223), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 73/286 (25%), Positives = 139/286 (48%), Gaps = 24/286 (8%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+ ++G G FG VYKGK + V + ++ + Q + FKNEV ++ K +H N++
Sbjct: 29 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 88
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
+G S + +V ++ SL L K K I +QG+ YLH S
Sbjct: 89 FMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS- 144
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM--- 607
+IHRDLK++NI L + + KI DFG+A +++ G+ +M+PE
Sbjct: 145 --IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 202
Query: 608 SGIVSIKTDVFSFGVLVLEIVSGQKNHTR-HHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
S ++DV++FG+++ E+++GQ ++ ++ D+ + ++G + + P L
Sbjct: 203 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY-----------LSPDL 251
Query: 667 EQPCS-ANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLP 711
+ S + M+ + C++ + +RP P+++ ++ LP
Sbjct: 252 SKVRSNCPKAMKRLMAE--CLKKKRDERPLFPQILASIELLARSLP 295
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 90.1 bits (222), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 73/286 (25%), Positives = 139/286 (48%), Gaps = 24/286 (8%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+ ++G G FG VYKGK + V + ++ + Q + FKNEV ++ K +H N++
Sbjct: 37 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 96
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
+G S + +V ++ SL L K K I +QG+ YLH S
Sbjct: 97 FMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS- 152
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM--- 607
+IHRDLK++NI L + + KI DFG+A +++ G+ +M+PE
Sbjct: 153 --IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 608 SGIVSIKTDVFSFGVLVLEIVSGQKNHTR-HHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
S ++DV++FG+++ E+++GQ ++ ++ D+ + ++G + + P L
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY-----------LSPDL 259
Query: 667 EQPCS-ANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLP 711
+ S + M+ + C++ + +RP P+++ ++ LP
Sbjct: 260 SKVRSNCPKAMKRLMAE--CLKKKRDERPLFPQILASIELLARSLP 303
>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor
Kinase
Length = 299
Score = 90.1 bits (222), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 84/301 (27%), Positives = 142/301 (47%), Gaps = 40/301 (13%)
Query: 427 AAANNFSTTNKLGEGGFGPVY----KGKLADEQE--VAIKRLSRS-SGQGIVEFKNEVRL 479
A + + +LG+G FG VY KG + DE E VAIK ++ + S + +EF NE +
Sbjct: 7 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 66
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLN--------WEKR 531
+ + ++VRLLG G+ L++ E M L +L S R + N K
Sbjct: 67 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKM 125
Query: 532 FIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEAN 590
+ I+ G+ YL+ + +HRDL A N ++ + KI DFGM R I E +
Sbjct: 126 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKG 182
Query: 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAW 650
K ++ +MSPE G+ + +DV+SFGV++ EI + L +
Sbjct: 183 GKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPY 226
Query: 651 QLLSDGKGLELIDPS--LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETM 708
Q LS+ + L + L++P + +++ + + +C Q RP+ E++ ++ E
Sbjct: 227 QGLSNEQVLRFVMEGGLLDKPDNCPDML--LELMRMCWQYNPKMRPSFLEIISSIKEEME 284
Query: 709 P 709
P
Sbjct: 285 P 285
>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|3F5P|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|E Chain E, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|F Chain F, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|G Chain G, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|H Chain H, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|I Chain I, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|J Chain J, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|K Chain K, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|M Chain M, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|L Chain L, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|R Chain R, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|S Chain S, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|T Chain T, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
Length = 308
Score = 90.1 bits (222), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 88/305 (28%), Positives = 139/305 (45%), Gaps = 48/305 (15%)
Query: 427 AAANNFSTTNKLGEGGFGPVY----KGKLADEQE--VAIKRLSRS-SGQGIVEFKNEVRL 479
A + + +LG+G FG VY KG + DE E VAIK ++ + S + +EF NE +
Sbjct: 16 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLN--------WEKR 531
+ + ++VRLLG G+ L++ E M L +L S R + N K
Sbjct: 76 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKM 134
Query: 532 FIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEAN 590
+ I+ G+ YL+ + +HRDL A N ++ + KI DFGM R I E +
Sbjct: 135 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKG 191
Query: 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAW 650
K ++ +MSPE G+ + +DV+SFGV++ EI + L +
Sbjct: 192 GKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPY 235
Query: 651 QLLSDGKGLE------LIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
Q LS+ + L L+D P E+MR +C Q RP+ E++ ++
Sbjct: 236 QGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEIISSIK 289
Query: 705 NETMP 709
E P
Sbjct: 290 EEMEP 294
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 90.1 bits (222), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 7/203 (3%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+ + ++G G FG V+ G ++ +VAIK + R +F E ++ KL H LV
Sbjct: 7 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 65
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+L G L LV+EFM + L +L ++ + E + + +G+ YL + S
Sbjct: 66 QLYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAS 123
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG 609
VIHRDL A N L+ + K+SDFGM R F +++ ++ + SPE
Sbjct: 124 ---VIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFS 179
Query: 610 IVSIKTDVFSFGVLVLEIVSGQK 632
S K+DV+SFGVL+ E+ S K
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGK 202
>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1
Receptor Kinase In Complex With Pqip
Length = 301
Score = 89.7 bits (221), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 84/301 (27%), Positives = 142/301 (47%), Gaps = 40/301 (13%)
Query: 427 AAANNFSTTNKLGEGGFGPVY----KGKLADEQE--VAIKRLSRS-SGQGIVEFKNEVRL 479
A + + +LG+G FG VY KG + DE E VAIK ++ + S + +EF NE +
Sbjct: 9 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLN--------WEKR 531
+ + ++VRLLG G+ L++ E M L +L S R + N K
Sbjct: 69 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKM 127
Query: 532 FIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEAN 590
+ I+ G+ YL+ + +HRDL A N + + KI DFGM R I+E +
Sbjct: 128 IQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKG 184
Query: 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAW 650
K ++ +MSPE G+ + +DV+SFGV++ EI + L +
Sbjct: 185 GKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPY 228
Query: 651 QLLSDGKGLELIDPS--LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETM 708
Q LS+ + L + L++P + +++ + + +C Q RP+ E++ ++ E
Sbjct: 229 QGLSNEQVLRFVMEGGLLDKPDNCPDML--LELMRMCWQYNPKMRPSFLEIISSIKEEME 286
Query: 709 P 709
P
Sbjct: 287 P 287
>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Nvp- Tae684
pdb|2XBA|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Pha-E429
Length = 315
Score = 89.4 bits (220), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 71/215 (33%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSR-SSGQGIVEFKNEVRLIAK 482
N + LG G FG VY+G+++ +VA+K L S Q ++F E +I+K
Sbjct: 22 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 81
Query: 483 LQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNS----GRKNVLNWEKRFIIIEGI 538
H N+VR +G SL R ++ E M L FL + + + L + I
Sbjct: 82 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 141
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILL---DDKMNPKISDFGMAR-IFEVNESEANTKRI 594
+ G YL + IHRD+ A N LL KI DFGMAR I+ + +
Sbjct: 142 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 198
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ +M PE M GI + KTD +SFGVL+ EI S
Sbjct: 199 LPV-KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232
>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Piperidine-Carboxamide Inhibitor 2
Length = 327
Score = 89.4 bits (220), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 71/215 (33%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSR-SSGQGIVEFKNEVRLIAK 482
N + LG G FG VY+G+++ +VA+K L S Q ++F E +I+K
Sbjct: 31 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 483 LQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNS----GRKNVLNWEKRFIIIEGI 538
H N+VR +G SL R ++ E M L FL + + + L + I
Sbjct: 91 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILLD---DKMNPKISDFGMAR-IFEVNESEANTKRI 594
+ G YL + IHRD+ A N LL KI DFGMAR I+ + +
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 207
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ +M PE M GI + KTD +SFGVL+ EI S
Sbjct: 208 LPV-KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241
>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma
Kinase In Complex With Ch5424802
Length = 344
Score = 89.0 bits (219), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 71/215 (33%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSR-SSGQGIVEFKNEVRLIAK 482
N + LG G FG VY+G+++ +VA+K L S Q ++F E +I+K
Sbjct: 47 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 106
Query: 483 LQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNS----GRKNVLNWEKRFIIIEGI 538
H N+VR +G SL R ++ E M L FL + + + L + I
Sbjct: 107 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 166
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILLD---DKMNPKISDFGMAR-IFEVNESEANTKRI 594
+ G YL + IHRD+ A N LL KI DFGMAR I+ + +
Sbjct: 167 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 223
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ +M PE M GI + KTD +SFGVL+ EI S
Sbjct: 224 LPV-KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257
>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 89.0 bits (219), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 71/215 (33%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSR-SSGQGIVEFKNEVRLIAK 482
N + LG G FG VY+G+++ +VA+K L S Q ++F E +I+K
Sbjct: 45 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 104
Query: 483 LQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNS----GRKNVLNWEKRFIIIEGI 538
H N+VR +G SL R ++ E M L FL + + + L + I
Sbjct: 105 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 164
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILL---DDKMNPKISDFGMAR-IFEVNESEANTKRI 594
+ G YL + IHRD+ A N LL KI DFGMAR I+ + +
Sbjct: 165 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 221
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ +M PE M GI + KTD +SFGVL+ EI S
Sbjct: 222 LPV-KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255
>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4DCE|B Chain B, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4FOD|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 36
Length = 333
Score = 89.0 bits (219), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 71/215 (33%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSR-SSGQGIVEFKNEVRLIAK 482
N + LG G FG VY+G+++ +VA+K L S Q ++F E +I+K
Sbjct: 37 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 96
Query: 483 LQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNS----GRKNVLNWEKRFIIIEGI 538
H N+VR +G SL R ++ E M L FL + + + L + I
Sbjct: 97 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 156
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILLD---DKMNPKISDFGMAR-IFEVNESEANTKRI 594
+ G YL + IHRD+ A N LL KI DFGMAR I+ + +
Sbjct: 157 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 213
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ +M PE M GI + KTD +SFGVL+ EI S
Sbjct: 214 LPV-KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247
>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In
Complex With Crizotinib (Pf-02341066)
Length = 327
Score = 89.0 bits (219), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 71/215 (33%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSR-SSGQGIVEFKNEVRLIAK 482
N + LG G FG VY+G+++ +VA+K L S Q ++F E +I+K
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 483 LQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNS----GRKNVLNWEKRFIIIEGI 538
H N+VR +G SL R ++ E M L FL + + + L + I
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILLD---DKMNPKISDFGMAR-IFEVNESEANTKRI 594
+ G YL + IHRD+ A N LL KI DFGMAR I+ + +
Sbjct: 150 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ +M PE M GI + KTD +SFGVL+ EI S
Sbjct: 207 LPV-KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In
Complex With Crizotinib
Length = 327
Score = 89.0 bits (219), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 71/215 (33%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSR-SSGQGIVEFKNEVRLIAK 482
N + LG G FG VY+G+++ +VA+K L S Q ++F E +I+K
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 483 LQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNS----GRKNVLNWEKRFIIIEGI 538
H N+VR +G SL R ++ E M L FL + + + L + I
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILLD---DKMNPKISDFGMAR-IFEVNESEANTKRI 594
+ G YL + IHRD+ A N LL KI DFGMAR I+ + +
Sbjct: 150 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ +M PE M GI + KTD +SFGVL+ EI S
Sbjct: 207 LPV-KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 89.0 bits (219), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 7/203 (3%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+ + ++G G FG V+ G ++ +VAIK + R +F E ++ KL H LV
Sbjct: 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 68
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+L G L LV+EFM + L +L ++ + E + + +G+ YL +
Sbjct: 69 QLYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC 126
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG 609
VIHRDL A N L+ + K+SDFGM R F +++ ++ + SPE
Sbjct: 127 ---VIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFS 182
Query: 610 IVSIKTDVFSFGVLVLEIVSGQK 632
S K+DV+SFGVL+ E+ S K
Sbjct: 183 RYSSKSDVWSFGVLMWEVFSEGK 205
>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 367
Score = 88.6 bits (218), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 71/215 (33%), Positives = 100/215 (46%), Gaps = 19/215 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSR-SSGQGIVEFKNEVRLIAK 482
N + LG G FG VY+G+++ +VA+K L S Q ++F E +I+K
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 483 LQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNS----GRKNVLNWEKRFIIIEGI 538
H N+VR +G SL R ++ E M L FL + + + L + I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILLD---DKMNPKISDFGMAR-IFEVNESEANTKRI 594
+ G YL + IHRD+ A N LL KI DFGMAR I+ +
Sbjct: 191 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ +M PE M GI + KTD +SFGVL+ EI S
Sbjct: 248 LPV-KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
pdb|3LCS|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 344
Score = 88.6 bits (218), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 71/215 (33%), Positives = 100/215 (46%), Gaps = 19/215 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSR-SSGQGIVEFKNEVRLIAK 482
N + LG G FG VY+G+++ +VA+K L S Q ++F E +I+K
Sbjct: 48 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 107
Query: 483 LQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNS----GRKNVLNWEKRFIIIEGI 538
H N+VR +G SL R ++ E M L FL + + + L + I
Sbjct: 108 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 167
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILL---DDKMNPKISDFGMAR-IFEVNESEANTKRI 594
+ G YL + IHRD+ A N LL KI DFGMAR I+ +
Sbjct: 168 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 224
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ +M PE M GI + KTD +SFGVL+ EI S
Sbjct: 225 LPV-KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 88.6 bits (218), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 7/203 (3%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+ + ++G G FG V+ G ++ +VAIK + R +F E ++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+L G L LV+EFM + L +L ++ + E + + +G+ YL +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG 609
VIHRDL A N L+ + K+SDFGM R F +++ ++ + SPE
Sbjct: 122 ---VIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 610 IVSIKTDVFSFGVLVLEIVSGQK 632
S K+DV+SFGVL+ E+ S K
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGK 200
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 88.6 bits (218), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 7/203 (3%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+ + ++G G FG V+ G ++ +VAIK + R +F E ++ KL H LV
Sbjct: 7 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 65
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+L G L LV+EFM + L +L ++ + E + + +G+ YL +
Sbjct: 66 QLYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC 123
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG 609
VIHRDL A N L+ + K+SDFGM R F +++ ++ + SPE
Sbjct: 124 ---VIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFS 179
Query: 610 IVSIKTDVFSFGVLVLEIVSGQK 632
S K+DV+SFGVL+ E+ S K
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGK 202
>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 1
pdb|4FOC|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 2
Length = 353
Score = 88.6 bits (218), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 71/215 (33%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSR-SSGQGIVEFKNEVRLIAK 482
N + LG G FG VY+G+++ +VA+K L S Q ++F E +I+K
Sbjct: 57 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 116
Query: 483 LQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNS----GRKNVLNWEKRFIIIEGI 538
H N+VR +G SL R ++ E M L FL + + + L + I
Sbjct: 117 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 176
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILLD---DKMNPKISDFGMAR-IFEVNESEANTKRI 594
+ G YL + IHRD+ A N LL KI DFGMAR I+ + +
Sbjct: 177 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 233
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ +M PE M GI + KTD +SFGVL+ EI S
Sbjct: 234 LPV-KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267
>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 88.2 bits (217), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 71/215 (33%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSRS-SGQGIVEFKNEVRLIAK 482
N + LG G FG VY+G+++ +VA+K L S Q ++F E +I+K
Sbjct: 45 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISK 104
Query: 483 LQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNS----GRKNVLNWEKRFIIIEGI 538
H N+VR +G SL R ++ E M L FL + + + L + I
Sbjct: 105 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 164
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILL---DDKMNPKISDFGMAR-IFEVNESEANTKRI 594
+ G YL + IHRD+ A N LL KI DFGMAR I+ + +
Sbjct: 165 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 221
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ +M PE M GI + KTD +SFGVL+ EI S
Sbjct: 222 LPV-KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 87.4 bits (215), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 65/202 (32%), Positives = 105/202 (51%), Gaps = 16/202 (7%)
Query: 438 LGEGGFGPVYKGKLADE-----QEVAIKRLS-RSSGQGIVEFKNEVRLIAKLQHTNLVRL 491
LGEG FG V + E ++VA+K L S G I + K E+ ++ L H N+V+
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 492 LG-CSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
G C+ G + L+ EF+P+ SL +L KN +N +++ I +G+ YL
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL---G 143
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTK--RIVGTYGYMSPEYAM 607
+ +HRDL A N+L++ + KI DFG+ + E ++ K R + Y +PE M
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLM 202
Query: 608 SGIVSIKTDVFSFGVLVLEIVS 629
I +DV+SFGV + E+++
Sbjct: 203 QSKFYIASDVWSFGVTLHELLT 224
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 87.4 bits (215), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 65/202 (32%), Positives = 105/202 (51%), Gaps = 16/202 (7%)
Query: 438 LGEGGFGPVYKGKLADE-----QEVAIKRLS-RSSGQGIVEFKNEVRLIAKLQHTNLVRL 491
LGEG FG V + E ++VA+K L S G I + K E+ ++ L H N+V+
Sbjct: 17 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 492 LG-CSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
G C+ G + L+ EF+P+ SL +L KN +N +++ I +G+ YL
Sbjct: 77 KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL---G 131
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTK--RIVGTYGYMSPEYAM 607
+ +HRDL A N+L++ + KI DFG+ + E ++ K R + Y +PE M
Sbjct: 132 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLM 190
Query: 608 SGIVSIKTDVFSFGVLVLEIVS 629
I +DV+SFGV + E+++
Sbjct: 191 QSKFYIASDVWSFGVTLHELLT 212
>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma
Kinase Catalytic Domain
pdb|4FNY|A Chain A, Crystal Structure Of The R1275q Anaplastic Lymphoma Kinase
Catalytic Domain In Complex With A Benzoxazole Inhibitor
Length = 327
Score = 87.4 bits (215), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 70/215 (32%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSR-SSGQGIVEFKNEVRLIAK 482
N + LG G FG VY+G+++ +VA+K L S Q ++F E +I+K
Sbjct: 31 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 483 LQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNS----GRKNVLNWEKRFIIIEGI 538
H N+VR +G SL R ++ E M L FL + + + L + I
Sbjct: 91 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILLD---DKMNPKISDFGMAR-IFEVNESEANTKRI 594
+ G YL + IHRD+ A N LL KI DFGMA+ I+ + +
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAM 207
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ +M PE M GI + KTD +SFGVL+ EI S
Sbjct: 208 LPV-KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241
>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
pdb|3GGF|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
Length = 301
Score = 87.4 bits (215), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 63/225 (28%), Positives = 117/225 (52%), Gaps = 13/225 (5%)
Query: 425 IAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLS-RSSGQGIVEFKNEVRLIAK 482
IA F+ ++G+G FG V+KG +Q VAIK + + I + + E+ ++++
Sbjct: 18 IADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQ 77
Query: 483 LQHTNLVRLLGCSLHGEERLLVYEFMPNKS-LDFFLFNSGRKNVLNWEKRFIIIEGISQG 541
+ + + G L G + ++ E++ S LD R + + +++ I +G
Sbjct: 78 CDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLL-----RAGPFDEFQIATMLKEILKG 132
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
L YLH + IHRD+KA+N+LL ++ + K++DFG+A ++ +++ VGT +M
Sbjct: 133 LDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWM 187
Query: 602 SPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
+PE K D++S G+ +E+ G+ ++ HP R L LI
Sbjct: 188 APEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI 232
>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase
pdb|3COM|B Chain B, Crystal Structure Of Mst1 Kinase
Length = 314
Score = 87.0 bits (214), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 65/233 (27%), Positives = 115/233 (49%), Gaps = 11/233 (4%)
Query: 416 ELKIFDFQTIAAAANN-FSTTNKLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVEF 473
+LK D ++ F KLGEG +G VYK + Q VAIK++ S + E
Sbjct: 14 QLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEI 71
Query: 474 KNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI 533
E+ ++ + ++V+ G + +V E+ S+ + R L ++
Sbjct: 72 IKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIAT 129
Query: 534 IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR 593
I++ +GL YLH +R IHRD+KA NILL+ + + K++DFG+A ++ + A
Sbjct: 130 ILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAG--QLTDXMAKRNX 184
Query: 594 IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
++GT +M+PE + D++S G+ +E+ G+ + HP R + +I
Sbjct: 185 VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI 237
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 87.0 bits (214), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 7/203 (3%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+ + ++G G FG V+ G ++ +VAIK + R +F E ++ KL H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+L G L LV EFM + L +L ++ + E + + +G+ YL +
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC 124
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG 609
VIHRDL A N L+ + K+SDFGM R F +++ ++ + SPE
Sbjct: 125 ---VIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFS 180
Query: 610 IVSIKTDVFSFGVLVLEIVSGQK 632
S K+DV+SFGVL+ E+ S K
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGK 203
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 87.0 bits (214), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 65/219 (29%), Positives = 117/219 (53%), Gaps = 25/219 (11%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQG-------IVEFKNEVRL 479
A N ++G+GGFG V+KG+L D+ VAIK L +G EF+ EV +
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
++ L H N+V+L G +H R +V EF+P L L + + + + W + ++ I+
Sbjct: 77 MSNLNHPNIVKLYGL-MHNPPR-MVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLD--DKMNP---KISDFGMARIFEVNESEANTKRI 594
G+ Y+ + ++HRDL++ NI L D+ P K++DFG+++ +S + +
Sbjct: 133 LGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGL 186
Query: 595 VGTYGYMSPEY--AMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+G + +M+PE A + K D +SF +++ I++G+
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 87.0 bits (214), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 7/203 (3%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+ + ++G G FG V+ G ++ +VAIK + S +F E ++ KL H LV
Sbjct: 27 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLV 85
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+L G L LV+EFM + L +L ++ + E + + +G+ YL +
Sbjct: 86 QLYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC 143
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG 609
VIHRDL A N L+ + K+SDFGM R F +++ ++ + SPE
Sbjct: 144 ---VIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFS 199
Query: 610 IVSIKTDVFSFGVLVLEIVSGQK 632
S K+DV+SFGVL+ E+ S K
Sbjct: 200 RYSSKSDVWSFGVLMWEVFSEGK 222
>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6
Length = 321
Score = 86.7 bits (213), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 65/207 (31%), Positives = 104/207 (50%), Gaps = 16/207 (7%)
Query: 437 KLGEGGFGPVYKGKLADEQ----EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLL 492
K+GEG G V LA E+ +VA+K + Q NEV ++ QH N+V +
Sbjct: 52 KIGEGSTGIVC---LAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMY 108
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
L GEE ++ EF+ +L + LN E+ + E + Q L YLH
Sbjct: 109 KSYLVGEELWVLMEFLQGGALTDIVSQVR----LNEEQIATVCEAVLQALAYLHAQG--- 161
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVS 612
VIHRD+K+ +ILL K+SDFG ++++ K +VGT +M+PE + +
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKXLVGTPYWMAPEVISRSLYA 219
Query: 613 IKTDVFSFGVLVLEIVSGQKNHTRHHP 639
+ D++S G++V+E+V G+ + P
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPYFSDSP 246
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 86.7 bits (213), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 77/276 (27%), Positives = 135/276 (48%), Gaps = 32/276 (11%)
Query: 438 LGEGGFGPVYKG--KLADEQE--VAIKRL-SRSSGQGIVEFKNEVRLIAKLQHTNLVRLL 492
+G G FG V G KL ++E VAIK L S + + +F +E ++ + H N++ L
Sbjct: 41 IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLF-NSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRL 551
G +++ EFM N SLD FL N G+ V+ ++ GI+ G+ YL + +
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVG---MLRGIAAGMKYL---ADM 154
Query: 552 RVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG---TYGYMSPEYAMS 608
+HRDL A NIL++ + K+SDFG++R E + S+ +G + +PE
Sbjct: 155 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 214
Query: 609 GIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667
+ +DV+S+G+++ E++S G++ + +N I ++L P ++
Sbjct: 215 RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL----------PPPMD 264
Query: 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
P + +++M L C Q RP ++V L
Sbjct: 265 CPSALHQLM------LDCWQKDRNHRPKFGQIVNTL 294
>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase
1)
Length = 294
Score = 86.7 bits (213), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 67/220 (30%), Positives = 116/220 (52%), Gaps = 17/220 (7%)
Query: 432 FSTTNKLGEGGFGPVYKGKLADEQEV-AIKRLS-RSSGQGIVEFKNEVRLIAKLQHTNLV 489
F+ +++G+G FG VYKG +EV AIK + + I + + E+ ++++ +
Sbjct: 21 FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 490 RLLGCSLHGEERLLVYEFMPNKS-LDFFLFNSGRKNVLNWEKRFI--IIEGISQGLLYLH 546
R G L + ++ E++ S LD L G E+ +I I+ I +GL YLH
Sbjct: 81 RYFGSYLKSTKLWIIMEYLGGGSALD--LLKPG-----PLEETYIATILREILKGLDYLH 133
Query: 547 KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYA 606
R IHRD+KA+N+LL ++ + K++DFG+A ++ +++ VGT +M+PE
Sbjct: 134 SE---RKIHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNXFVGTPFWMAPEVI 188
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
K D++S G+ +E+ G+ ++ HP R L LI
Sbjct: 189 KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 228
>pdb|4FIE|A Chain A, Full-Length Human Pak4
pdb|4FIE|B Chain B, Full-Length Human Pak4
Length = 423
Score = 86.3 bits (212), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 78/273 (28%), Positives = 129/273 (47%), Gaps = 26/273 (9%)
Query: 405 KSPEKD-QSISHELKIFDFQTIAAAANNFSTTN---KLGEGGFGPV------YKGKLADE 454
+SP+++ Q +SHE Q + + S + K+GEG G V GKL
Sbjct: 122 RSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKL--- 178
Query: 455 QEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLD 514
VA+K++ Q NEV ++ QH N+V + L G+E +V EF+ +L
Sbjct: 179 --VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 236
Query: 515 FFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKIS 574
+ ++ +N E+ + + Q L LH VIHRD+K+ +ILL K+S
Sbjct: 237 DIVTHTR----MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLS 289
Query: 575 DFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNH 634
DFG +V++ K +VGT +M+PE + D++S G++V+E+V G+ +
Sbjct: 290 DFGFC--AQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 347
Query: 635 TRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667
P + + +I L K L + PSL+
Sbjct: 348 FNEPPLKAMKMIRD--NLPPRLKNLHKVSPSLK 378
>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 86.3 bits (212), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 65/212 (30%), Positives = 107/212 (50%), Gaps = 21/212 (9%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKL----ADEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
A+ +G G G V G+L + VAIK L + + +F +E ++ +
Sbjct: 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF 107
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFL-FNSGRKNVLNWEKRFIIIEGISQGL 542
H N++RL G G ++V E+M N SLD FL + G+ ++ ++ G+ G+
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVG---MLRGVGAGM 164
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG--- 599
YL S L +HRDL A N+L+D + K+SDFG++R+ E + A T T G
Sbjct: 165 RYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTT----TGGKIP 217
Query: 600 --YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ +PE S +DV+SFGV++ E+++
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 85.9 bits (211), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 65/219 (29%), Positives = 116/219 (52%), Gaps = 25/219 (11%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQG-------IVEFKNEVRL 479
A N ++G+GGFG V+KG+L D+ VAIK L +G EF+ EV +
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
++ L H N+V+L G +H R +V EF+P L L + + + + W + ++ I+
Sbjct: 77 MSNLNHPNIVKLYGL-MHNPPR-MVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLD--DKMNP---KISDFGMARIFEVNESEANTKRI 594
G+ Y+ + ++HRDL++ NI L D+ P K++DFG ++ +S + +
Sbjct: 133 LGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVSGL 186
Query: 595 VGTYGYMSPEY--AMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+G + +M+PE A + K D +SF +++ I++G+
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225
>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIF|B Chain B, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIG|A Chain A, Catalytic Domain Of Human Pak4
pdb|4FIG|B Chain B, Catalytic Domain Of Human Pak4
pdb|4FIH|A Chain A, Catalytic Domain Of Human Pak4 With Qkftglprqw Peptide
pdb|4FII|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIJ|A Chain A, Catalytic Domain Of Human Pak4
Length = 346
Score = 85.9 bits (211), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 78/273 (28%), Positives = 129/273 (47%), Gaps = 26/273 (9%)
Query: 405 KSPEKD-QSISHELKIFDFQTIAAAANNFSTTN---KLGEGGFGPV------YKGKLADE 454
+SP+++ Q +SHE Q + + S + K+GEG G V GKL
Sbjct: 45 RSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKL--- 101
Query: 455 QEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLD 514
VA+K++ Q NEV ++ QH N+V + L G+E +V EF+ +L
Sbjct: 102 --VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 159
Query: 515 FFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKIS 574
+ ++ +N E+ + + Q L LH VIHRD+K+ +ILL K+S
Sbjct: 160 DIVTHTR----MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLS 212
Query: 575 DFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNH 634
DFG +V++ K +VGT +M+PE + D++S G++V+E+V G+ +
Sbjct: 213 DFGFC--AQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 270
Query: 635 TRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667
P + + +I L K L + PSL+
Sbjct: 271 FNEPPLKAMKMI--RDNLPPRLKNLHKVSPSLK 301
>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 85.9 bits (211), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 65/212 (30%), Positives = 107/212 (50%), Gaps = 21/212 (9%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKL----ADEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
A+ +G G G V G+L + VAIK L + + +F +E ++ +
Sbjct: 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF 107
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFL-FNSGRKNVLNWEKRFIIIEGISQGL 542
H N++RL G G ++V E+M N SLD FL + G+ ++ ++ G+ G+
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVG---MLRGVGAGM 164
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG--- 599
YL S L +HRDL A N+L+D + K+SDFG++R+ E + A T T G
Sbjct: 165 RYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT----TGGKIP 217
Query: 600 --YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ +PE S +DV+SFGV++ E+++
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1F3M|D Chain D, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1YHW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With One Point
Mutations (K299r)
Length = 297
Score = 85.5 bits (210), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 62/231 (26%), Positives = 114/231 (49%), Gaps = 10/231 (4%)
Query: 418 KIFDFQTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKNE 476
K+ ++ ++ K+G+G G VY +A QEVAI++++ NE
Sbjct: 8 KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE 67
Query: 477 VRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE 536
+ ++ + ++ N+V L L G+E +V E++ SL + + ++ + +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCR 123
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
Q L +LH +VIHRD+K+ NILL + K++DFG +S+ +T +VG
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVG 178
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIG 647
T +M+PE K D++S G++ +E++ G+ + +P R L LI
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 85.5 bits (210), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 73/295 (24%), Positives = 146/295 (49%), Gaps = 38/295 (12%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
A+ + ++G G FG VYKGK + V I ++ + + F+NEV ++ K +H N+
Sbjct: 35 ASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNI 94
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGI------SQGL 542
+ +G + + +V ++ SL K++ E +F + + I +QG+
Sbjct: 95 LLFMGY-MTKDNLAIVTQWCEGSSL--------YKHLHVQETKFQMFQLIDIARQTAQGM 145
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMS 602
YLH + +IHRD+K++NI L + + KI DFG+A + ++ G+ +M+
Sbjct: 146 DYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMA 202
Query: 603 PEYAM---SGIVSIKTDVFSFGVLVLEIVSGQKNHTR-HHPDRPLNLI--GYAWQLLSDG 656
PE + S ++DV+S+G+++ E+++G+ ++ ++ D+ + ++ GYA LS
Sbjct: 203 PEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLS-- 260
Query: 657 KGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLP 711
L + C + M+ + CV+ +RP P+++ ++ LP
Sbjct: 261 --------KLYKNCP--KAMKRLVAD--CVKKVKEERPLFPQILSSIELLQHSLP 303
>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point
Mutations (K299r, T423e)
pdb|2HY8|1 Chain 1, Pak1 Complex With St2001
Length = 297
Score = 85.1 bits (209), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 60/231 (25%), Positives = 113/231 (48%), Gaps = 10/231 (4%)
Query: 418 KIFDFQTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKNE 476
K+ ++ ++ K+G+G G VY +A QEVAI++++ NE
Sbjct: 8 KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE 67
Query: 477 VRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE 536
+ ++ + ++ N+V L L G+E +V E++ SL + + ++ + +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCR 123
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
Q L +LH +VIHRD+K+ NILL + K++DFG ++ ++ +VG
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSEMVG 178
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIG 647
T +M+PE K D++S G++ +E++ G+ + +P R L LI
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 85.1 bits (209), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 64/198 (32%), Positives = 100/198 (50%), Gaps = 25/198 (12%)
Query: 436 NKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCS 495
KLG G FG V+ +VA+K + S + F E ++ LQH LV+L
Sbjct: 188 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV- 245
Query: 496 LHGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVI 554
+ E ++ EFM SL DF + G K L K I++G+ ++ + + I
Sbjct: 246 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YI 300
Query: 555 HRDLKASNILLDDKMNPKISDFGMARI---FEVNESEANTKRIVGTYGYMSPEYAMSGIV 611
HRDL+A+NIL+ + KI+DFG+AR+ F + + +PE G
Sbjct: 301 HRDLRAANILVSASLVCKIADFGLARVGAKFPIK--------------WTAPEAINFGSF 346
Query: 612 SIKTDVFSFGVLVLEIVS 629
+IK+DV+SFG+L++EIV+
Sbjct: 347 TIKSDVWSFGILLMEIVT 364
>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Cgp74514a
pdb|2J0I|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 303
Score = 85.1 bits (209), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 78/272 (28%), Positives = 128/272 (47%), Gaps = 26/272 (9%)
Query: 406 SPEKD-QSISHELKIFDFQTIAAAANNFSTTN---KLGEGGFGPV------YKGKLADEQ 455
SP+++ Q +SHE Q + + S + K+GEG G V GKL
Sbjct: 3 SPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKL---- 58
Query: 456 EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDF 515
VA+K++ Q NEV ++ QH N+V + L G+E +V EF+ +L
Sbjct: 59 -VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD 117
Query: 516 FLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISD 575
+ ++ +N E+ + + Q L LH VIHRD+K+ +ILL K+SD
Sbjct: 118 IVTHTR----MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSD 170
Query: 576 FGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHT 635
FG +V++ K +VGT +M+PE + D++S G++V+E+V G+ +
Sbjct: 171 FGFC--AQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF 228
Query: 636 RHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667
P + + +I L K L + PSL+
Sbjct: 229 NEPPLKAMKMIRD--NLPPRLKNLHKVSPSLK 258
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 85.1 bits (209), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 78/272 (28%), Positives = 129/272 (47%), Gaps = 26/272 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQ-EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ + +KLG G +G VY G VA+K L + + + EF E ++ +++H NL
Sbjct: 32 TDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 90
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
V+LLG +V E+MP +L +L R+ V ++ + IS + YL K
Sbjct: 91 VQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQ-ISSAMEYLEKK 149
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIF--EVNESEANTKRIVGTYGYMSPEYA 606
+ IHRDL A N L+ + K++DFG++R+ + + A K + + +PE
Sbjct: 150 N---FIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESL 203
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
SIK+DV++FGVL+ EI + + +P L+ + + LL G +E +
Sbjct: 204 AYNTFSIKSDVWAFGVLLWEIATYGMS---PYPGIDLSQV---YDLLEKGYRMEQPEGC- 256
Query: 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPE 698
P E+MR C + DRP+ E
Sbjct: 257 --PPKVYELMRA------CWKWSPADRPSFAE 280
>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Lambda-Fl172
pdb|3FY0|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Dw1
pdb|4DAW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With The Ruthenium
Phthalimide Complex
Length = 297
Score = 84.7 bits (208), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 60/231 (25%), Positives = 113/231 (48%), Gaps = 10/231 (4%)
Query: 418 KIFDFQTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKNE 476
K+ ++ ++ K+G+G G VY +A QEVAI++++ NE
Sbjct: 8 KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE 67
Query: 477 VRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE 536
+ ++ + ++ N+V L L G+E +V E++ SL + + ++ + +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCR 123
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
Q L +LH +VIHRD+K+ NILL + K++DFG ++ ++ +VG
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSXMVG 178
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIG 647
T +M+PE K D++S G++ +E++ G+ + +P R L LI
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229
>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In
Complex With A Consensus Peptide
Length = 301
Score = 84.7 bits (208), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 78/272 (28%), Positives = 128/272 (47%), Gaps = 26/272 (9%)
Query: 406 SPEKD-QSISHELKIFDFQTIAAAANNFSTTN---KLGEGGFGPV------YKGKLADEQ 455
SP+++ Q +SHE Q + + S + K+GEG G V GKL
Sbjct: 1 SPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKL---- 56
Query: 456 EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDF 515
VA+K++ Q NEV ++ QH N+V + L G+E +V EF+ +L
Sbjct: 57 -VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD 115
Query: 516 FLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISD 575
+ ++ +N E+ + + Q L LH VIHRD+K+ +ILL K+SD
Sbjct: 116 IVTHTR----MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSD 168
Query: 576 FGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHT 635
FG +V++ K +VGT +M+PE + D++S G++V+E+V G+ +
Sbjct: 169 FGFC--AQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF 226
Query: 636 RHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667
P + + +I L K L + PSL+
Sbjct: 227 NEPPLKAMKMIRD--NLPPRLKNLHKVSPSLK 256
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound
To Appcp From D. Discoideum
Length = 287
Score = 84.7 bits (208), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 64/219 (29%), Positives = 116/219 (52%), Gaps = 25/219 (11%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQG-------IVEFKNEVRL 479
A N ++G+GGFG V+KG+L D+ VAIK L +G EF+ EV +
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
++ L H N+V+L G +H R +V EF+P L L + + + + W + ++ I+
Sbjct: 77 MSNLNHPNIVKLYGL-MHNPPR-MVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLD--DKMNP---KISDFGMARIFEVNESEANTKRI 594
G+ Y+ + ++HRDL++ NI L D+ P K++DF +++ +S + +
Sbjct: 133 LGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVSGL 186
Query: 595 VGTYGYMSPEY--AMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+G + +M+PE A + K D +SF +++ I++G+
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 84.7 bits (208), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 108/210 (51%), Gaps = 20/210 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-----VAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
F LG G FG VYKG E E VAIK L + S + E +E ++A +
Sbjct: 16 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF----NSGRKNVLNWEKRFIIIEGIS 539
+ ++ RLLG L +L++ + MP L ++ N G + +LNW + I+
Sbjct: 76 DNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 128
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+G+ YL R++HRDL A N+L+ + KI+DFG+A++ E E + +
Sbjct: 129 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 185
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+ E + I + ++DV+S+GV V E+++
Sbjct: 186 WMALESILHRIYTHQSDVWSYGVTVWELMT 215
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 84.7 bits (208), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 108/210 (51%), Gaps = 20/210 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-----VAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
F LG G FG VYKG E E VAIK L + S + E +E ++A +
Sbjct: 19 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF----NSGRKNVLNWEKRFIIIEGIS 539
+ ++ RLLG L +L++ + MP L ++ N G + +LNW + I+
Sbjct: 79 DNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 131
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+G+ YL R++HRDL A N+L+ + KI+DFG+A++ E E + +
Sbjct: 132 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 188
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+ E + I + ++DV+S+GV V E+++
Sbjct: 189 WMALESILHRIYTHQSDVWSYGVTVWELMT 218
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 84.7 bits (208), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 108/210 (51%), Gaps = 20/210 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-----VAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
F LG G FG VYKG E E VAIK L + S + E +E ++A +
Sbjct: 17 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF----NSGRKNVLNWEKRFIIIEGIS 539
+ ++ RLLG L +L++ + MP L ++ N G + +LNW + I+
Sbjct: 77 DNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+G+ YL R++HRDL A N+L+ + KI+DFG+A++ E E + +
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 186
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+ E + I + ++DV+S+GV V E+++
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMT 216
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 84.7 bits (208), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 108/210 (51%), Gaps = 20/210 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-----VAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
F LG G FG VYKG E E VAIK L + S + E +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF----NSGRKNVLNWEKRFIIIEGIS 539
+ ++ RLLG L +L++ + MP L ++ N G + +LNW + I+
Sbjct: 75 DNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+G+ YL R++HRDL A N+L+ + KI+DFG+A++ E E + +
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+ E + I + ++DV+S+GV V E+++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214
>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain
pdb|3Q53|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain In Complex
With Atp
Length = 306
Score = 84.7 bits (208), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 60/231 (25%), Positives = 113/231 (48%), Gaps = 10/231 (4%)
Query: 418 KIFDFQTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKNE 476
K+ ++ ++ K+G+G G VY +A QEVAI++++ NE
Sbjct: 9 KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE 68
Query: 477 VRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE 536
+ ++ + ++ N+V L L G+E +V E++ SL + + ++ + +
Sbjct: 69 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCR 124
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
Q L +LH +VIHRD+K+ NILL + K++DFG ++ ++ +VG
Sbjct: 125 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSXMVG 179
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIG 647
T +M+PE K D++S G++ +E++ G+ + +P R L LI
Sbjct: 180 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 230
>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain
pdb|3Q4Z|B Chain B, Structure Of Unphosphorylated Pak1 Kinase Domain
Length = 306
Score = 84.7 bits (208), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 64/239 (26%), Positives = 119/239 (49%), Gaps = 12/239 (5%)
Query: 410 DQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQ 468
D+ I +L+I ++ ++ K+G+G G VY +A QEVAI++++
Sbjct: 3 DEEILEKLRII--VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP 60
Query: 469 GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNW 528
NE+ ++ + ++ N+V L L G+E +V E++ SL + + ++
Sbjct: 61 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDE 116
Query: 529 EKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588
+ + Q L +LH +VIHR++K+ NILL + K++DFG +S+
Sbjct: 117 GQIAAVCRECLQALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 173
Query: 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIG 647
+T +VGT +M+PE K D++S G++ +E++ G+ + +P R L LI
Sbjct: 174 RST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 230
>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|B Chain B, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|C Chain C, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|D Chain D, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|E Chain E, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
Length = 326
Score = 84.3 bits (207), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 68/247 (27%), Positives = 110/247 (44%), Gaps = 18/247 (7%)
Query: 412 SISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIV 471
S + L D + A F +G G +G VYKG+ ++A ++ +G
Sbjct: 6 SPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE 65
Query: 472 EFKNEVRLIAKL-QHTNLVRLLGCSLH------GEERLLVYEFMPNKSLDFFLFNSGRKN 524
E K E+ ++ K H N+ G + ++ LV EF S+ + N+ + N
Sbjct: 66 EIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGN 124
Query: 525 VLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
L E I I +GL +LH++ +VIHRD+K N+LL + K+ DFG++ +
Sbjct: 125 TLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181
Query: 585 NESEANTKRIVGTYGYMSPEYAM-----SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHP 639
NT +GT +M+PE K+D++S G+ +E+ G HP
Sbjct: 182 TVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 239
Query: 640 DRPLNLI 646
R L LI
Sbjct: 240 MRALFLI 246
>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7)
pdb|3DKO|A Chain A, Complex Between The Kinase Domain Of Human Ephrin Type-A
Receptor 7 (Epha7) And Inhibitor Alw-Ii-49-7
Length = 318
Score = 84.3 bits (207), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 78/279 (27%), Positives = 138/279 (49%), Gaps = 40/279 (14%)
Query: 438 LGEGGFGPVYKGKLA----DEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLVRLL 492
+G G FG V G+L + VAIK L + + +F E ++ + H N+V L
Sbjct: 51 IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE------GISQGLLYLH 546
G G+ ++V EFM N +LD FL RK+ + +F +I+ GI+ G+ YL
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFL----RKH----DGQFTVIQLVGMLRGIAAGMRYL- 161
Query: 547 KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT--YGYMSPE 604
+ + +HRDL A NIL++ + K+SDFG++R+ E ++ EA G + +PE
Sbjct: 162 --ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIE-DDPEAVYTTTGGKIPVRWTAPE 218
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664
+ +DV+S+G+++ E++S + +RP + + + +G L P
Sbjct: 219 AIQYRKFTSASDVWSYGIVMWEVMS--------YGERPYWDMSNQDVIKAIEEGYRLPAP 270
Query: 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
++ P +++M L C Q + +RP ++V +L
Sbjct: 271 -MDCPAGLHQLM------LDCWQKERAERPKFEQIVGIL 302
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 84.3 bits (207), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 108/210 (51%), Gaps = 20/210 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-----VAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
F LG G FG VYKG E E VAIK L + S + E +E ++A +
Sbjct: 16 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF----NSGRKNVLNWEKRFIIIEGIS 539
+ ++ RLLG L +L++ + MP L ++ N G + +LNW + I+
Sbjct: 76 DNPHVCRLLGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IA 128
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+G+ YL R++HRDL A N+L+ + KI+DFG+A++ E E + +
Sbjct: 129 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 185
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+ E + I + ++DV+S+GV V E+++
Sbjct: 186 WMALESILHRIYTHQSDVWSYGVTVWELMT 215
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 84.3 bits (207), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 108/210 (51%), Gaps = 20/210 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-----VAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
F LG G FG VYKG E E VAIK L + S + E +E ++A +
Sbjct: 18 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF----NSGRKNVLNWEKRFIIIEGIS 539
+ ++ RLLG L +L++ + MP L ++ N G + +LNW + I+
Sbjct: 78 DNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+G+ YL R++HRDL A N+L+ + KI+DFG+A++ E E + +
Sbjct: 131 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+ E + I + ++DV+S+GV V E+++
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMT 217
>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3Q4T|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3SOC|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|3SOC|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|4ASX|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
pdb|4ASX|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
Length = 322
Score = 84.3 bits (207), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 22/205 (10%)
Query: 441 GGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE- 499
G FG V+K +L +E VA+K Q + + EV + ++H N+++ +G G
Sbjct: 35 GRFGCVWKAQLLNEY-VAVKIFPIQDKQSW-QNEYEVYSLPGMKHENILQFIGAEKRGTS 92
Query: 500 ---ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY-------S 549
+ L+ F SL FL + NV++W + I E +++GL YLH+
Sbjct: 93 VDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGH 148
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG 609
+ + HRD+K+ N+LL + + I+DFG+A FE +S +T VGT YM+PE
Sbjct: 149 KPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGA 208
Query: 610 I-----VSIKTDVFSFGVLVLEIVS 629
I ++ D+++ G+++ E+ S
Sbjct: 209 INFQRDAFLRIDMYAMGLVLWELAS 233
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 84.3 bits (207), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-----VAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
F LG G FG VYKG E E VAIK L + S + E +E ++A +
Sbjct: 12 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF----NSGRKNVLNWEKRFIIIEGIS 539
+ ++ RLLG L +L+ + MP L ++ N G + +LNW + I+
Sbjct: 72 DNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 124
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+G+ YL R++HRDL A N+L+ + KI+DFG+A++ E E + +
Sbjct: 125 EGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 181
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+ E + I + ++DV+S+GV V E+++
Sbjct: 182 WMALESILHRIYTHQSDVWSYGVTVWELMT 211
>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|B Chain B, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|C Chain C, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|D Chain D, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|E Chain E, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|F Chain F, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
Length = 294
Score = 84.3 bits (207), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 23/210 (10%)
Query: 432 FSTTNKLGEGGFGPVYKGKLADEQ----EVAIKRL---SRSSGQGIVEFKNEVRLIAKLQ 484
+ +KLG GG VY LA++ +VAIK + R + + F+ EV ++L
Sbjct: 13 YKIVDKLGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNV---LNWEKRFIIIEGISQG 541
H N+V ++ + LV E++ +L ++ + G +V +N+ + I++GI
Sbjct: 70 HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQ--ILDGIKHA 127
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
+R++HRD+K NIL+D KI DFG+A+ S T ++GT Y
Sbjct: 128 -------HDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYF 179
Query: 602 SPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
SPE A TD++S G+++ E++ G+
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGE 209
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 84.0 bits (206), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-----VAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
F LG G FG VYKG E E VAIK L + S + E +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF----NSGRKNVLNWEKRFIIIEGIS 539
+ ++ RLLG L +L+ + MP L ++ N G + +LNW + I+
Sbjct: 75 DNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+G+ YL R++HRDL A N+L+ + KI+DFG+A++ E E + +
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+ E + I + ++DV+S+GV V E+++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 84.0 bits (206), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-----VAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
F LG G FG VYKG E E VAIK L + S + E +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF----NSGRKNVLNWEKRFIIIEGIS 539
+ ++ RLLG L +L+ + MP L ++ N G + +LNW + I+
Sbjct: 75 DNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+G+ YL R++HRDL A N+L+ + KI+DFG+A++ E E + +
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+ E + I + ++DV+S+GV V E+++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 84.0 bits (206), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-----VAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
F LG G FG VYKG E E VAIK L + S + E +E ++A +
Sbjct: 21 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF----NSGRKNVLNWEKRFIIIEGIS 539
+ ++ RLLG L +L+ + MP L ++ N G + +LNW + I+
Sbjct: 81 DNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 133
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+G+ YL R++HRDL A N+L+ + KI+DFG+A++ E E + +
Sbjct: 134 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 190
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+ E + I + ++DV+S+GV V E+++
Sbjct: 191 WMALESILHRIYTHQSDVWSYGVTVWELMT 220
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 84.0 bits (206), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-----VAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
F LG G FG VYKG E E VAIK L + S + E +E ++A +
Sbjct: 18 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF----NSGRKNVLNWEKRFIIIEGIS 539
+ ++ RLLG L +L+ + MP L ++ N G + +LNW + I+
Sbjct: 78 DNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+G+ YL R++HRDL A N+L+ + KI+DFG+A++ E E + +
Sbjct: 131 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+ E + I + ++DV+S+GV V E+++
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMT 217
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 84.0 bits (206), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-----VAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
F LG G FG VYKG E E VAIK L + S + E +E ++A +
Sbjct: 17 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF----NSGRKNVLNWEKRFIIIEGIS 539
+ ++ RLLG L +L+ + MP L ++ N G + +LNW + I+
Sbjct: 77 DNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+G+ YL R++HRDL A N+L+ + KI+DFG+A++ E E + +
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 186
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+ E + I + ++DV+S+GV V E+++
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMT 216
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 84.0 bits (206), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-----VAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
F LG G FG VYKG E E VAIK L + S + E +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF----NSGRKNVLNWEKRFIIIEGIS 539
+ ++ RLLG L +L+ + MP L ++ N G + +LNW + I+
Sbjct: 75 DNPHVCRLLGICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+G+ YL R++HRDL A N+L+ + KI+DFG+A++ E E + +
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+ E + I + ++DV+S+GV V E+++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 84.0 bits (206), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-----VAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
F LG G FG VYKG E E VAIK L + S + E +E ++A +
Sbjct: 18 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF----NSGRKNVLNWEKRFIIIEGIS 539
+ ++ RLLG L +L+ + MP L ++ N G + +LNW + I+
Sbjct: 78 DNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+G+ YL R++HRDL A N+L+ + KI+DFG+A++ E E + +
Sbjct: 131 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+ E + I + ++DV+S+GV V E+++
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMT 217
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 84.0 bits (206), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-----VAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
F LG G FG VYKG E E VAIK L + S + E +E ++A +
Sbjct: 40 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF----NSGRKNVLNWEKRFIIIEGIS 539
+ ++ RLLG L +L+ + MP L ++ N G + +LNW + I+
Sbjct: 100 DNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 152
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+G+ YL R++HRDL A N+L+ + KI+DFG+A++ E E + +
Sbjct: 153 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 209
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+ E + I + ++DV+S+GV V E+++
Sbjct: 210 WMALESILHRIYTHQSDVWSYGVTVWELMT 239
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 84.0 bits (206), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-----VAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
F LG G FG VYKG E E VAIK L + S + E +E ++A +
Sbjct: 18 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF----NSGRKNVLNWEKRFIIIEGIS 539
+ ++ RLLG L +L+ + MP L ++ N G + +LNW + I+
Sbjct: 78 DNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+G+ YL R++HRDL A N+L+ + KI+DFG+A++ E E + +
Sbjct: 131 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+ E + I + ++DV+S+GV V E+++
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMT 217
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 84.0 bits (206), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-----VAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
F LG G FG VYKG E E VAIK L + S + E +E ++A +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF----NSGRKNVLNWEKRFIIIEGIS 539
+ ++ RLLG L +L+ + MP L ++ N G + +LNW + I+
Sbjct: 69 DNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 121
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+G+ YL R++HRDL A N+L+ + KI+DFG+A++ E E + +
Sbjct: 122 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+ E + I + ++DV+S+GV V E+++
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMT 208
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 84.0 bits (206), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 20/210 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-----VAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
F LG G FG VYKG E E VAIK L + S + E +E ++A +
Sbjct: 25 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF----NSGRKNVLNWEKRFIIIEGIS 539
+ ++ RLLG L +L+ + MP L ++ N G + +LNW I+
Sbjct: 85 DNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 137
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+G+ YL R++HRDL A N+L+ + KI+DFG+A++ E E + +
Sbjct: 138 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 194
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+ E + I + ++DV+S+GV V E+++
Sbjct: 195 WMALESILHRIYTHQSDVWSYGVTVWELMT 224
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 84.0 bits (206), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 78/273 (28%), Positives = 129/273 (47%), Gaps = 26/273 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQ-EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ + +KLG G +G VY+G VA+K L + + + EF E ++ +++H NL
Sbjct: 18 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 76
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
V+LLG ++ EFM +L +L R+ V N + IS + YL K
Sbjct: 77 VQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKK 135
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIF--EVNESEANTKRIVGTYGYMSPEYA 606
+ IHRDL A N L+ + K++DFG++R+ + + A K + + +PE
Sbjct: 136 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESL 189
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
SIK+DV++FGVL+ EI + + +P L+ + ++LL +E +
Sbjct: 190 AYNKFSIKSDVWAFGVLLWEIATYGMS---PYPGIDLSQV---YELLEKDYRMERPEGC- 242
Query: 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
P E+MR C Q DRP+ E+
Sbjct: 243 --PEKVYELMRA------CWQWNPSDRPSFAEI 267
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 84.0 bits (206), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 78/273 (28%), Positives = 129/273 (47%), Gaps = 26/273 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQ-EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ + +KLG G +G VY+G VA+K L + + + EF E ++ +++H NL
Sbjct: 18 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 76
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
V+LLG ++ EFM +L +L R+ V N + IS + YL K
Sbjct: 77 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKK 135
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIF--EVNESEANTKRIVGTYGYMSPEYA 606
+ IHRDL A N L+ + K++DFG++R+ + + A K + + +PE
Sbjct: 136 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESL 189
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
SIK+DV++FGVL+ EI + + +P L+ + ++LL +E +
Sbjct: 190 AYNKFSIKSDVWAFGVLLWEIATYGMS---PYPGIDLSQV---YELLEKDYRMERPEGC- 242
Query: 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
P E+MR C Q DRP+ E+
Sbjct: 243 --PEKVYELMRA------CWQWNPSDRPSFAEI 267
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 84.0 bits (206), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-----VAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
F LG G FG VYKG E E VAIK L + S + E +E ++A +
Sbjct: 22 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF----NSGRKNVLNWEKRFIIIEGIS 539
+ ++ RLLG L +L+ + MP L ++ N G + +LNW + I+
Sbjct: 82 DNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+G+ YL R++HRDL A N+L+ + KI+DFG+A++ E E + +
Sbjct: 135 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+ E + I + ++DV+S+GV V E+++
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMT 221
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 84.0 bits (206), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 78/273 (28%), Positives = 129/273 (47%), Gaps = 26/273 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQ-EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ + +KLG G +G VY+G VA+K L + + + EF E ++ +++H NL
Sbjct: 18 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 76
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
V+LLG ++ EFM +L +L R+ V N + IS + YL K
Sbjct: 77 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKK 135
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIF--EVNESEANTKRIVGTYGYMSPEYA 606
+ IHRDL A N L+ + K++DFG++R+ + + A K + + +PE
Sbjct: 136 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESL 189
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
SIK+DV++FGVL+ EI + + +P L+ + ++LL +E +
Sbjct: 190 AYNKFSIKSDVWAFGVLLWEIATYGMS---PYPGIDLSQV---YELLEKDYRMERPEGC- 242
Query: 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
P E+MR C Q DRP+ E+
Sbjct: 243 --PEKVYELMRA------CWQWNPSDRPSFAEI 267
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 84.0 bits (206), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 78/274 (28%), Positives = 128/274 (46%), Gaps = 28/274 (10%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQ-EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ + +KLG G FG VY+G VA+K L + + + EF E ++ +++H NL
Sbjct: 11 TDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 69
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
V+LLG ++ EFM +L +L R+ V ++ + IS + YL K
Sbjct: 70 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKK 128
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIF--EVNESEANTKRIVGTYGYMSPEYA 606
+ IHRDL A N L+ + K++DFG++R+ + + A K + + +PE
Sbjct: 129 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESL 182
Query: 607 MSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665
SIK+DV++FGVL+ EI + G + P + ++LL +E +
Sbjct: 183 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ-------VYELLEKDYRMERPEGC 235
Query: 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
P E+MR C Q DRP+ E+
Sbjct: 236 ---PEKVYELMRA------CWQWNPSDRPSFAEI 260
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 84.0 bits (206), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 78/273 (28%), Positives = 129/273 (47%), Gaps = 26/273 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQ-EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ + +KLG G +G VY+G VA+K L + + + EF E ++ +++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 71
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
V+LLG ++ EFM +L +L R+ V N + IS + YL K
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKK 130
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIF--EVNESEANTKRIVGTYGYMSPEYA 606
+ IHRDL A N L+ + K++DFG++R+ + + A K + + +PE
Sbjct: 131 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESL 184
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
SIK+DV++FGVL+ EI + + +P L+ + ++LL +E +
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMS---PYPGIDLSQV---YELLEKDYRMERPEGC- 237
Query: 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
P E+MR C Q DRP+ E+
Sbjct: 238 --PEKVYELMRA------CWQWNPSDRPSFAEI 262
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 83.6 bits (205), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 67/213 (31%), Positives = 113/213 (53%), Gaps = 16/213 (7%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFK-NEVRLIAKLQ 484
++++ F KLG G + VYKG VA+K + S +G E+ L+ +L+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 485 HTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFF----LFNSGRKNVLNWEKRFIIIEGIS 539
H N+VRL +H E +L LV+EFM N + + N+ R LN K F +
Sbjct: 62 HENIVRLYDV-IHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW--QLL 118
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
QGL + H+ +++HRDLK N+L++ + K+ DFG+AR F + + +++ V T
Sbjct: 119 QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE--VVTLW 173
Query: 600 YMSPEYAM-SGIVSIKTDVFSFGVLVLEIVSGQ 631
Y +P+ M S S D++S G ++ E+++G+
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 83.6 bits (205), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 78/273 (28%), Positives = 128/273 (46%), Gaps = 26/273 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQ-EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ + +KLG G +G VY+G VA+K L + + + EF E ++ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
V+LLG ++ EFM +L +L R+ V N + IS + YL K
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKK 134
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIF--EVNESEANTKRIVGTYGYMSPEYA 606
+ IHRDL A N L+ + K++DFG++R+ + + A K + + +PE
Sbjct: 135 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESL 188
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
SIK+DV++FGVL+ EI + +P L+ + ++LL +E +
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIAT---YGMSPYPGIDLSQV---YELLEKDYRMERPEGC- 241
Query: 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
P E+MR C Q DRP+ E+
Sbjct: 242 --PEKVYELMRA------CWQWNPSDRPSFAEI 266
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 83.6 bits (205), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 78/273 (28%), Positives = 129/273 (47%), Gaps = 26/273 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQ-EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ + +KLG G +G VY+G VA+K L + + + EF E ++ +++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 71
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
V+LLG ++ EFM +L +L R+ V N + IS + YL K
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKK 130
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIF--EVNESEANTKRIVGTYGYMSPEYA 606
+ IHRDL A N L+ + K++DFG++R+ + + A K + + +PE
Sbjct: 131 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESL 184
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
SIK+DV++FGVL+ EI + + +P L+ + ++LL +E +
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMS---PYPGIDLSQV---YELLEKDYRMERPEGC- 237
Query: 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
P E+MR C Q DRP+ E+
Sbjct: 238 --PEKVYELMRA------CWQWNPSDRPSFAEI 262
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 83.6 bits (205), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 78/273 (28%), Positives = 125/273 (45%), Gaps = 26/273 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQ-EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ + +KLG G +G VY+G VA+K L + + + EF E ++ +++H NL
Sbjct: 14 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 72
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
V+LLG ++ EFM +L +L R+ V N + IS + YL K
Sbjct: 73 VQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKK 131
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIF--EVNESEANTKRIVGTYGYMSPEYA 606
+ IHRDL A N L+ + K++DFG++R+ + + A K + + +PE
Sbjct: 132 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESL 185
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
SIK+DV++FGVL+ EI T P + ++LL +E +
Sbjct: 186 AYNKFSIKSDVWAFGVLLWEIA------TYGMSPYPGIDLSQVYELLEKDYRMERPEGC- 238
Query: 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
P E+MR C Q DRP+ E+
Sbjct: 239 --PEKVYELMRA------CWQWNPSDRPSFAEI 263
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 83.6 bits (205), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 61/201 (30%), Positives = 102/201 (50%), Gaps = 13/201 (6%)
Query: 437 KLGEGGFGPVYKGKLADEQE-----VAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRL 491
+LG+G FG V + Q+ VA+K+L S+ + + +F+ E+ ++ LQH N+V+
Sbjct: 20 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 492 LG-CSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
G C G L L+ EF+P SL +L K ++ K I +G+ YL
Sbjct: 80 KGVCYSAGRRNLKLIMEFLPYGSLREYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 134
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI-VGTYGYMSPEYAMS 608
R IHRDL NIL++++ KI DFG+ ++ ++ K + +PE
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 609 GIVSIKTDVFSFGVLVLEIVS 629
S+ +DV+SFGV++ E+ +
Sbjct: 195 SKFSVASDVWSFGVVLYELFT 215
>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Novel Bosutinib Isoform 1, Previously Thought
To Be Bosutinib
Length = 293
Score = 83.6 bits (205), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 59/220 (26%), Positives = 109/220 (49%), Gaps = 17/220 (7%)
Query: 432 FSTTNKLGEGGFGPVYKGKLADEQEVAI-KRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+ +LG+G FG VYK K + +A K + S + + ++ E+ ++A H +V+
Sbjct: 13 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 72
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
LLG H + ++ EF P ++D + R L + ++ + + L +LH
Sbjct: 73 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLHSK-- 128
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR--IVGTYGYMSPEYAMS 608
R+IHRDLKA N+L+ + + +++DFG++ + KR +GT +M+PE M
Sbjct: 129 -RIIHRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSFIGTPYWMAPEVVMC 183
Query: 609 GIVS-----IKTDVFSFGVLVLEIVSGQKNHTRHHPDRPL 643
+ K D++S G+ ++E+ + H +P R L
Sbjct: 184 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL 223
>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3PP0|B Chain B, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3RCD|A Chain A, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|B Chain B, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|C Chain C, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|D Chain D, Her2 Kinase Domain Complexed With Tak-285
Length = 338
Score = 83.6 bits (205), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 93/328 (28%), Positives = 151/328 (46%), Gaps = 62/328 (18%)
Query: 438 LGEGGFGPVYKGKLADEQE-----VAIKRLSR-SSGQGIVEFKNEVRLIAKLQHTNLVRL 491
LG G FG VYKG + E VAIK L +S + E +E ++A + + RL
Sbjct: 25 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 492 LGCSLHGEERLLVYEFMPNKSL-DFFLFNSGR---KNVLNWEKRFIIIEGISQGLLYLHK 547
LG L +L V + MP L D N GR +++LNW + I++G+ YL
Sbjct: 85 LGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQ------IAKGMSYLED 137
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
+R++HRDL A N+L+ + KI+DFG+AR+ +++E+E + +M+ E +
Sbjct: 138 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 194
Query: 608 SGIVSIKTDVFSFGVLVLEIVS-GQKNH----TRHHPDRPLNLIGYAWQLLSDGKGLELI 662
+ ++DV+S+GV V E+++ G K + R PD LL G+
Sbjct: 195 RRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-----------LLEKGE----- 238
Query: 663 DPSLEQP--CSANEVMRCIHVGLLCVQDQAMDRPTMPEVV-------------CMLQNET 707
L QP C+ + M + + C + RP E+V ++QNE
Sbjct: 239 --RLPQPPICTIDVYM----IMVKCWMIDSECRPRFRELVSEFSRMARDPQRFVVIQNED 292
Query: 708 MPLPPPKQPAFFINANADDQVPEVPDNE 735
+ P F+ + DD + ++ D E
Sbjct: 293 LGPASPLDSTFYRSLLEDDDMGDLVDAE 320
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 83.6 bits (205), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 77/274 (28%), Positives = 128/274 (46%), Gaps = 28/274 (10%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQ-EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ + +KLG G +G VY+G VA+K L + + + EF E ++ +++H NL
Sbjct: 11 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 69
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
V+LLG ++ EFM +L +L R+ V ++ + IS + YL K
Sbjct: 70 VQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKK 128
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIF--EVNESEANTKRIVGTYGYMSPEYA 606
+ IHRDL A N L+ + K++DFG++R+ + + A K + + +PE
Sbjct: 129 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESL 182
Query: 607 MSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665
SIK+DV++FGVL+ EI + G + P + ++LL +E +
Sbjct: 183 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ-------VYELLEKDYRMERPEGC 235
Query: 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
P E+MR C Q DRP+ E+
Sbjct: 236 ---PEKVYELMRA------CWQWNPSDRPSFAEI 260
>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|B Chain B, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|C Chain C, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|D Chain D, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
Length = 286
Score = 83.2 bits (204), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 76/276 (27%), Positives = 135/276 (48%), Gaps = 32/276 (11%)
Query: 438 LGEGGFGPVYKG--KLADEQE--VAIKRL-SRSSGQGIVEFKNEVRLIAKLQHTNLVRLL 492
+G G FG V G KL ++E VAIK L S + + +F +E ++ + H N++ L
Sbjct: 15 IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLF-NSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRL 551
G +++ EFM N SLD FL N G+ V+ + ++ GI+ G+ YL + +
Sbjct: 75 GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVI---QLVGMLRGIAAGMKYL---ADM 128
Query: 552 RVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG---TYGYMSPEYAMS 608
+HR L A NIL++ + K+SDFG++R E + S+ +G + +PE
Sbjct: 129 NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 188
Query: 609 GIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667
+ +DV+S+G+++ E++S G++ + +N I ++L P ++
Sbjct: 189 RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL----------PPPMD 238
Query: 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
P + +++M L C Q RP ++V L
Sbjct: 239 CPSALHQLM------LDCWQKDRNHRPKFGQIVNTL 268
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 83.2 bits (204), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 66/206 (32%), Positives = 110/206 (53%), Gaps = 13/206 (6%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAKLQHTN 487
+ K+GEG +G VYK K + + VA+KR+ + +GI E+ L+ +L H N
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 488 LVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLH 546
+V L+ +H E L LV+EFM K L L K L + I + + +G+ + H
Sbjct: 81 IVSLIDV-IHSERCLTLVFEFM-EKDLKKVL--DENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 547 KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYA 606
++ R++HRDLK N+L++ K++DFG+AR F + + T +V T Y +P+
Sbjct: 137 QH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV-TLWYRAPDVL 191
Query: 607 M-SGIVSIKTDVFSFGVLVLEIVSGQ 631
M S S D++S G + E+++G+
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITGK 217
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 83.2 bits (204), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 78/273 (28%), Positives = 128/273 (46%), Gaps = 26/273 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQ-EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ + +KLG G +G VY+G VA+K L + + + EF E ++ +++H NL
Sbjct: 18 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 76
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
V+LLG ++ EFM +L +L R+ V N + IS + YL K
Sbjct: 77 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKK 135
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIF--EVNESEANTKRIVGTYGYMSPEYA 606
+ IHRDL A N L+ + K++DFG++R+ + + A K + + +PE
Sbjct: 136 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESL 189
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
SIK+DV++FGVL+ EI + +P L+ + ++LL +E +
Sbjct: 190 AYNKFSIKSDVWAFGVLLWEIAT---YGMSPYPGIDLSQV---YELLEKDYRMERPEGC- 242
Query: 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
P E+MR C Q DRP+ E+
Sbjct: 243 --PEKVYELMRA------CWQWNPSDRPSFAEI 267
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 83.2 bits (204), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 78/273 (28%), Positives = 128/273 (46%), Gaps = 26/273 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQ-EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ + +KLG G +G VY+G VA+K L + + + EF E ++ +++H NL
Sbjct: 15 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 73
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
V+LLG ++ EFM +L +L R+ V N + IS + YL K
Sbjct: 74 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKK 132
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIF--EVNESEANTKRIVGTYGYMSPEYA 606
+ IHRDL A N L+ + K++DFG++R+ + + A K + + +PE
Sbjct: 133 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESL 186
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
SIK+DV++FGVL+ EI + +P L+ + ++LL +E +
Sbjct: 187 AYNKFSIKSDVWAFGVLLWEIAT---YGMSPYPGIDLSQV---YELLEKDYRMERPEGC- 239
Query: 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
P E+MR C Q DRP+ E+
Sbjct: 240 --PEKVYELMRA------CWQWNPSDRPSFAEI 264
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 83.2 bits (204), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 78/273 (28%), Positives = 128/273 (46%), Gaps = 26/273 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQ-EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ + +KLG G +G VY+G VA+K L + + + EF E ++ +++H NL
Sbjct: 26 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 84
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
V+LLG ++ EFM +L +L R+ V N + IS + YL K
Sbjct: 85 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKK 143
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIF--EVNESEANTKRIVGTYGYMSPEYA 606
+ IHRDL A N L+ + K++DFG++R+ + + A K + + +PE
Sbjct: 144 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESL 197
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
SIK+DV++FGVL+ EI + +P L+ + ++LL +E +
Sbjct: 198 AYNKFSIKSDVWAFGVLLWEIAT---YGMSPYPGIDLSQV---YELLEKDYRMERPEGC- 250
Query: 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
P E+MR C Q DRP+ E+
Sbjct: 251 --PEKVYELMRA------CWQWNPSDRPSFAEI 275
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 83.2 bits (204), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-----VAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
F LG G FG VYKG E E VAIK L + S + E +E ++A +
Sbjct: 19 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF----NSGRKNVLNWEKRFIIIEGIS 539
+ ++ RLLG L +L++ + MP L ++ N G + +LNW + I+
Sbjct: 79 DNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 131
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+G+ YL R++HRDL A N+L+ + KI+DFG A++ E E + +
Sbjct: 132 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 188
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+ E + I + ++DV+S+GV V E+++
Sbjct: 189 WMALESILHRIYTHQSDVWSYGVTVWELMT 218
>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Su11274
pdb|4AOT|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4AOT|B Chain B, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4EQU|A Chain A, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
pdb|4EQU|B Chain B, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
Length = 302
Score = 83.2 bits (204), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 59/220 (26%), Positives = 109/220 (49%), Gaps = 17/220 (7%)
Query: 432 FSTTNKLGEGGFGPVYKGKLADEQEVAI-KRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+ +LG+G FG VYK K + +A K + S + + ++ E+ ++A H +V+
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
LLG H + ++ EF P ++D + R L + ++ + + L +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLHSK-- 136
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR--IVGTYGYMSPEYAMS 608
R+IHRDLKA N+L+ + + +++DFG++ + KR +GT +M+PE M
Sbjct: 137 -RIIHRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSFIGTPYWMAPEVVMC 191
Query: 609 GIVS-----IKTDVFSFGVLVLEIVSGQKNHTRHHPDRPL 643
+ K D++S G+ ++E+ + H +P R L
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL 231
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 83.2 bits (204), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-----VAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
F LG G FG VYKG E E VAIK L + S + E +E ++A +
Sbjct: 17 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF----NSGRKNVLNWEKRFIIIEGIS 539
+ ++ RLLG L +L++ + MP L ++ N G + +LNW + I+
Sbjct: 77 DNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+G+ YL R++HRDL A N+L+ + KI+DFG A++ E E + +
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+ E + I + ++DV+S+GV V E+++
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMT 216
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 83.2 bits (204), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-----VAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
F LG G FG VYKG E E VAIK L + S + E +E ++A +
Sbjct: 17 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF----NSGRKNVLNWEKRFIIIEGIS 539
+ ++ RLLG L +L++ + MP L ++ N G + +LNW + I+
Sbjct: 77 DNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+G+ YL R++HRDL A N+L+ + KI+DFG A++ E E + +
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+ E + I + ++DV+S+GV V E+++
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMT 216
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 83.2 bits (204), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 78/273 (28%), Positives = 125/273 (45%), Gaps = 26/273 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQ-EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ + +KLG G +G VY+G VA+K L + + + EF E ++ +++H NL
Sbjct: 15 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 73
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
V+LLG ++ EFM +L +L R+ V N + IS + YL K
Sbjct: 74 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKK 132
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIF--EVNESEANTKRIVGTYGYMSPEYA 606
+ IHRDL A N L+ + K++DFG++R+ + + A K + + +PE
Sbjct: 133 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESL 186
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
SIK+DV++FGVL+ EI T P + ++LL +E +
Sbjct: 187 AYNKFSIKSDVWAFGVLLWEIA------TYGMSPYPGIDLSQVYELLEKDYRMERPEGC- 239
Query: 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
P E+MR C Q DRP+ E+
Sbjct: 240 --PEKVYELMRA------CWQWNPSDRPSFAEI 264
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 82.8 bits (203), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 66/206 (32%), Positives = 110/206 (53%), Gaps = 13/206 (6%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAKLQHTN 487
+ K+GEG +G VYK K + + VA+KR+ + +GI E+ L+ +L H N
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 488 LVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLH 546
+V L+ +H E L LV+EFM K L L K L + I + + +G+ + H
Sbjct: 81 IVSLIDV-IHSERCLTLVFEFM-EKDLKKVL--DENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 547 KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYA 606
++ R++HRDLK N+L++ K++DFG+AR F + + T +V T Y +P+
Sbjct: 137 QH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV-TLWYRAPDVL 191
Query: 607 M-SGIVSIKTDVFSFGVLVLEIVSGQ 631
M S S D++S G + E+++G+
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITGK 217
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 82.8 bits (203), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 70/210 (33%), Positives = 113/210 (53%), Gaps = 17/210 (8%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAK 482
+ NF K+GEG +G VYK KL E VA+K++ + +G+ E+ L+ +
Sbjct: 1 GSMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKE 59
Query: 483 LQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQ 540
L H N+V+LL +H E +L LV+EF+ ++ L F+ S + L K ++ + Q
Sbjct: 60 LNHPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLF--QLLQ 115
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
GL + H + RV+HRDLK N+L++ + K++DFG+AR F V T +V T Y
Sbjct: 116 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWY 170
Query: 601 MSPEYAMS-GIVSIKTDVFSFGVLVLEIVS 629
+PE + S D++S G + E+V+
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 82.8 bits (203), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 436 NKLGEGGFGPVYKGKLADEQE-----VAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+LG+G FG V + Q+ VA+K+L S+ + + +F+ E+ ++ LQH N+V+
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 491 LLG-CSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
G C G L L+ E++P SL +L K ++ K I +G+ YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 161
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT-YGYMSPEYAM 607
R IHRDL NIL++++ KI DFG+ ++ ++ K + + +PE
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 221
Query: 608 SGIVSIKTDVFSFGVLVLEIVS 629
S+ +DV+SFGV++ E+ +
Sbjct: 222 ESKFSVASDVWSFGVVLYELFT 243
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 82.8 bits (203), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 70/207 (33%), Positives = 112/207 (54%), Gaps = 17/207 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAKLQH 485
NF K+GEG +G VYK KL E VA+K++ + +G+ E+ L+ +L H
Sbjct: 10 ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 486 TNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQGLL 543
N+V+LL +H E +L LV+EF+ ++ L F+ S + L K ++ + QGL
Sbjct: 69 PNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLF--QLLQGLA 124
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
+ H + RV+HRDLK N+L++ + K++DFG+AR F V T +V T Y +P
Sbjct: 125 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAP 179
Query: 604 EYAMS-GIVSIKTDVFSFGVLVLEIVS 629
E + S D++S G + E+V+
Sbjct: 180 EILLGCKYYSTAVDIWSLGCIFAEMVT 206
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 82.8 bits (203), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 20/210 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-----VAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
F LG G FG VYKG E E VAIK L + S + E +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF----NSGRKNVLNWEKRFIIIEGIS 539
+ ++ RLLG L +L+ + MP L ++ N G + +LNW + I+
Sbjct: 75 DNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+G+ YL R++HRDL A N+L+ + KI+DFG A++ E E + +
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 184
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+ E + I + ++DV+S+GV V E+++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 82.8 bits (203), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 70/207 (33%), Positives = 112/207 (54%), Gaps = 17/207 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAKLQH 485
NF K+GEG +G VYK KL E VA+K++ + +G+ E+ L+ +L H
Sbjct: 7 ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 486 TNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQGLL 543
N+V+LL +H E +L LV+EF+ ++ L F+ S + L K ++ + QGL
Sbjct: 66 PNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLF--QLLQGLA 121
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
+ H + RV+HRDLK N+L++ + K++DFG+AR F V T +V T Y +P
Sbjct: 122 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAP 176
Query: 604 EYAMS-GIVSIKTDVFSFGVLVLEIVS 629
E + S D++S G + E+V+
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVT 203
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 82.8 bits (203), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 70/207 (33%), Positives = 112/207 (54%), Gaps = 17/207 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAKLQH 485
NF K+GEG +G VYK KL E VA+K++ + +G+ E+ L+ +L H
Sbjct: 10 ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 486 TNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQGLL 543
N+V+LL +H E +L LV+EF+ ++ L F+ S + L K ++ + QGL
Sbjct: 69 PNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLF--QLLQGLA 124
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
+ H + RV+HRDLK N+L++ + K++DFG+AR F V T +V T Y +P
Sbjct: 125 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAP 179
Query: 604 EYAMS-GIVSIKTDVFSFGVLVLEIVS 629
E + S D++S G + E+V+
Sbjct: 180 EILLGXKYYSTAVDIWSLGCIFAEMVT 206
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 82.8 bits (203), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 60/201 (29%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 437 KLGEGGFGPVYKGKLADEQE-----VAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRL 491
+LG+G FG V + Q+ VA+K+L S+ + + +F+ E+ ++ LQH N+V+
Sbjct: 22 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 492 LG-CSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
G C G L L+ E++P SL +L K ++ K I +G+ YL
Sbjct: 82 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 136
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT-YGYMSPEYAMS 608
R IHRDL NIL++++ KI DFG+ ++ ++ K + + +PE
Sbjct: 137 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 196
Query: 609 GIVSIKTDVFSFGVLVLEIVS 629
S+ +DV+SFGV++ E+ +
Sbjct: 197 SKFSVASDVWSFGVVLYELFT 217
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 82.8 bits (203), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 78/273 (28%), Positives = 128/273 (46%), Gaps = 26/273 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQ-EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ + +KLG G +G VY+G VA+K L + + + EF E ++ +++H NL
Sbjct: 14 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 72
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
V+LLG ++ EFM +L +L R+ V N + IS + YL K
Sbjct: 73 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKK 131
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIF--EVNESEANTKRIVGTYGYMSPEYA 606
+ IHRDL A N L+ + K++DFG++R+ + + A K + + +PE
Sbjct: 132 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI---KWTAPESL 185
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
SIK+DV++FGVL+ EI + +P L+ + ++LL +E +
Sbjct: 186 AYNKFSIKSDVWAFGVLLWEIAT---YGMSPYPGIDLSQV---YELLEKDYRMERPEGC- 238
Query: 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
P E+MR C Q DRP+ E+
Sbjct: 239 --PEKVYELMRA------CWQWNPSDRPSFAEI 263
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 82.8 bits (203), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 22/217 (10%)
Query: 436 NKLGEGGFGPVYKGKL------ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+LGEG FG V+ + D+ VA+K L + +F+ E L+ LQH ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSG-------------RKNVLNWEKRFIIIE 536
+ G G+ ++V+E+M + L+ FL G K L + I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
I+ G++YL + +HRDL N L+ + KI DFGM+R + +
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKN 633
+M PE M + ++DV+SFGV++ EI + K
Sbjct: 198 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 234
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 82.8 bits (203), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 70/207 (33%), Positives = 112/207 (54%), Gaps = 17/207 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAKLQH 485
NF K+GEG +G VYK KL E VA+K++ + +G+ E+ L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 486 TNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQGLL 543
N+V+LL +H E +L LV+EF+ ++ L F+ S + L K ++ + QGL
Sbjct: 61 PNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLF--QLLQGLA 116
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
+ H + RV+HRDLK N+L++ + K++DFG+AR F V T +V T Y +P
Sbjct: 117 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAP 171
Query: 604 EYAMS-GIVSIKTDVFSFGVLVLEIVS 629
E + S D++S G + E+V+
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVT 198
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 82.8 bits (203), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 60/201 (29%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 437 KLGEGGFGPVYKGKLADEQE-----VAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRL 491
+LG+G FG V + Q+ VA+K+L S+ + + +F+ E+ ++ LQH N+V+
Sbjct: 20 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 492 LG-CSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
G C G L L+ E++P SL +L K ++ K I +G+ YL
Sbjct: 80 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 134
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT-YGYMSPEYAMS 608
R IHRDL NIL++++ KI DFG+ ++ ++ K + + +PE
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 609 GIVSIKTDVFSFGVLVLEIVS 629
S+ +DV+SFGV++ E+ +
Sbjct: 195 SKFSVASDVWSFGVVLYELFT 215
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 82.8 bits (203), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 20/210 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-----VAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
F LG G FG VYKG E E VAIK L + S + E +E ++A +
Sbjct: 17 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF----NSGRKNVLNWEKRFIIIEGIS 539
+ ++ RLLG L +L+ + MP L ++ N G + +LNW + I+
Sbjct: 77 DNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+G+ YL R++HRDL A N+L+ + KI+DFG A++ E E + +
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+ E + I + ++DV+S+GV V E+++
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMT 216
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 82.8 bits (203), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 70/207 (33%), Positives = 112/207 (54%), Gaps = 17/207 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAKLQH 485
NF K+GEG +G VYK KL E VA+K++ + +G+ E+ L+ +L H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 486 TNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQGLL 543
N+V+LL +H E +L LV+EF+ ++ L F+ S + L K ++ + QGL
Sbjct: 62 PNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLF--QLLQGLA 117
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
+ H + RV+HRDLK N+L++ + K++DFG+AR F V T +V T Y +P
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAP 172
Query: 604 EYAMS-GIVSIKTDVFSFGVLVLEIVS 629
E + S D++S G + E+V+
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVT 199
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 82.8 bits (203), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 70/207 (33%), Positives = 112/207 (54%), Gaps = 17/207 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAKLQH 485
NF K+GEG +G VYK KL E VA+K++ + +G+ E+ L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 486 TNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQGLL 543
N+V+LL +H E +L LV+EF+ ++ L F+ S + L K ++ + QGL
Sbjct: 61 PNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLF--QLLQGLA 116
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
+ H + RV+HRDLK N+L++ + K++DFG+AR F V T +V T Y +P
Sbjct: 117 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAP 171
Query: 604 EYAMS-GIVSIKTDVFSFGVLVLEIVS 629
E + S D++S G + E+V+
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVT 198
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 82.8 bits (203), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 436 NKLGEGGFGPVYKGKLADEQE-----VAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+LG+G FG V + Q+ VA+K+L S+ + + +F+ E+ ++ LQH N+V+
Sbjct: 14 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 491 LLG-CSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
G C G L L+ E++P SL +L K ++ K I +G+ YL
Sbjct: 74 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 128
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT-YGYMSPEYAM 607
R IHRDL NIL++++ KI DFG+ ++ ++ K + + +PE
Sbjct: 129 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 188
Query: 608 SGIVSIKTDVFSFGVLVLEIVS 629
S+ +DV+SFGV++ E+ +
Sbjct: 189 ESKFSVASDVWSFGVVLYELFT 210
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 82.8 bits (203), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 60/201 (29%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 437 KLGEGGFGPVYKGKLADEQE-----VAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRL 491
+LG+G FG V + Q+ VA+K+L S+ + + +F+ E+ ++ LQH N+V+
Sbjct: 24 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 492 LG-CSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
G C G L L+ E++P SL +L K ++ K I +G+ YL
Sbjct: 84 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 138
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT-YGYMSPEYAMS 608
R IHRDL NIL++++ KI DFG+ ++ ++ K + + +PE
Sbjct: 139 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 198
Query: 609 GIVSIKTDVFSFGVLVLEIVS 629
S+ +DV+SFGV++ E+ +
Sbjct: 199 SKFSVASDVWSFGVVLYELFT 219
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 82.8 bits (203), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 70/207 (33%), Positives = 112/207 (54%), Gaps = 17/207 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAKLQH 485
NF K+GEG +G VYK KL E VA+K++ + +G+ E+ L+ +L H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 486 TNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQGLL 543
N+V+LL +H E +L LV+EF+ ++ L F+ S + L K ++ + QGL
Sbjct: 62 PNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLF--QLLQGLA 117
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
+ H + RV+HRDLK N+L++ + K++DFG+AR F V T +V T Y +P
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAP 172
Query: 604 EYAMS-GIVSIKTDVFSFGVLVLEIVS 629
E + S D++S G + E+V+
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVT 199
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 82.8 bits (203), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 60/201 (29%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 437 KLGEGGFGPVYKGKLADEQE-----VAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRL 491
+LG+G FG V + Q+ VA+K+L S+ + + +F+ E+ ++ LQH N+V+
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 492 LG-CSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
G C G L L+ E++P SL +L K ++ K I +G+ YL
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 131
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT-YGYMSPEYAMS 608
R IHRDL NIL++++ KI DFG+ ++ ++ K + + +PE
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 609 GIVSIKTDVFSFGVLVLEIVS 629
S+ +DV+SFGV++ E+ +
Sbjct: 192 SKFSVASDVWSFGVVLYELFT 212
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 82.4 bits (202), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 70/207 (33%), Positives = 112/207 (54%), Gaps = 17/207 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAKLQH 485
NF K+GEG +G VYK KL E VA+K++ + +G+ E+ L+ +L H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 486 TNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQGLL 543
N+V+LL +H E +L LV+EF+ ++ L F+ S + L K ++ + QGL
Sbjct: 62 PNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLF--QLLQGLA 117
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
+ H + RV+HRDLK N+L++ + K++DFG+AR F V T +V T Y +P
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAP 172
Query: 604 EYAMS-GIVSIKTDVFSFGVLVLEIVS 629
E + S D++S G + E+V+
Sbjct: 173 EILLGXKYYSTAVDIWSLGCIFAEMVT 199
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 82.4 bits (202), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 78/273 (28%), Positives = 125/273 (45%), Gaps = 26/273 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQ-EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ + +KLG G +G VY+G VA+K L + + + EF E ++ +++H NL
Sbjct: 15 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 73
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
V+LLG ++ EFM +L +L R+ V N + IS + YL K
Sbjct: 74 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKK 132
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIF--EVNESEANTKRIVGTYGYMSPEYA 606
+ IHRDL A N L+ + K++DFG++R+ + + A K + + +PE
Sbjct: 133 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI---KWTAPESL 186
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
SIK+DV++FGVL+ EI T P + ++LL +E +
Sbjct: 187 AYNKFSIKSDVWAFGVLLWEIA------TYGMSPYPGIDLSQVYELLEKDYRMERPEGC- 239
Query: 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
P E+MR C Q DRP+ E+
Sbjct: 240 --PEKVYELMRA------CWQWNPSDRPSFAEI 264
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 82.4 bits (202), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 20/210 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-----VAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
F LG G FG VYKG E E VAIK L + S + E +E ++A +
Sbjct: 22 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF----NSGRKNVLNWEKRFIIIEGIS 539
+ ++ RLLG L +L+ + MP L ++ N G + +LNW + I+
Sbjct: 82 DNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+G+ YL R++HRDL A N+L+ + KI+DFG A++ E E + +
Sbjct: 135 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 191
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+ E + I + ++DV+S+GV V E+++
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMT 221
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 82.4 bits (202), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 68/208 (32%), Positives = 109/208 (52%), Gaps = 15/208 (7%)
Query: 428 AANNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAKL 483
+ NF K+GEG +G VYK KL E VA+K++ + +G+ E+ L+ +L
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 484 QHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
H N+V+LL +H E +L LV+EF+ DF ++ L K ++ + QGL
Sbjct: 60 NHPNIVKLLDV-IHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLF--QLLQGL 116
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMS 602
+ H + RV+HRDLK N+L++ + K++DFG+AR F V + V T Y +
Sbjct: 117 AFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRA 171
Query: 603 PEYAMS-GIVSIKTDVFSFGVLVLEIVS 629
PE + S D++S G + E+V+
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 82.4 bits (202), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 13/202 (6%)
Query: 436 NKLGEGGFGPVYKGKLADEQE-----VAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+LG+G FG V + Q+ VA+K+L S+ + + +F+ E+ ++ LQH N+V+
Sbjct: 20 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 491 LLG-CSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
G C G L L+ E++P SL +L K ++ K I +G+ YL
Sbjct: 80 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 134
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI-VGTYGYMSPEYAM 607
R IHRDL NIL++++ KI DFG+ ++ ++ K + +PE
Sbjct: 135 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 194
Query: 608 SGIVSIKTDVFSFGVLVLEIVS 629
S+ +DV+SFGV++ E+ +
Sbjct: 195 ESKFSVASDVWSFGVVLYELFT 216
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 82.4 bits (202), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 60/201 (29%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 437 KLGEGGFGPVYKGKLADEQE-----VAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRL 491
+LG+G FG V + Q+ VA+K+L S+ + + +F+ E+ ++ LQH N+V+
Sbjct: 16 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 492 LG-CSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
G C G L L+ E++P SL +L K ++ K I +G+ YL
Sbjct: 76 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 130
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT-YGYMSPEYAMS 608
R IHRDL NIL++++ KI DFG+ ++ ++ K + + +PE
Sbjct: 131 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 190
Query: 609 GIVSIKTDVFSFGVLVLEIVS 629
S+ +DV+SFGV++ E+ +
Sbjct: 191 SKFSVASDVWSFGVVLYELFT 211
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 82.4 bits (202), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 60/201 (29%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 437 KLGEGGFGPVYKGKLADEQE-----VAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRL 491
+LG+G FG V + Q+ VA+K+L S+ + + +F+ E+ ++ LQH N+V+
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 492 LG-CSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
G C G L L+ E++P SL +L K ++ K I +G+ YL
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 131
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT-YGYMSPEYAMS 608
R IHRDL NIL++++ KI DFG+ ++ ++ K + + +PE
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 609 GIVSIKTDVFSFGVLVLEIVS 629
S+ +DV+SFGV++ E+ +
Sbjct: 192 SKFSVASDVWSFGVVLYELFT 212
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 82.4 bits (202), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 77/273 (28%), Positives = 129/273 (47%), Gaps = 26/273 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQ-EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ + +KLG G +G VY+G VA+K L + + + EF E ++ +++H NL
Sbjct: 18 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 76
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
V+LLG ++ EFM +L +L R+ V ++ + IS + YL K
Sbjct: 77 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKK 135
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIF--EVNESEANTKRIVGTYGYMSPEYA 606
+ IHRDL A N L+ + K++DFG++R+ + + A K + + +PE
Sbjct: 136 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESL 189
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
SIK+DV++FGVL+ EI + +P L+ + ++LL +E +
Sbjct: 190 AYNKFSIKSDVWAFGVLLWEIAT---YGMSPYPGIDLSQV---YELLEKDYRMERPEGC- 242
Query: 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
P E+MR C Q DRP+ E+
Sbjct: 243 --PEKVYELMRA------CWQWNPSDRPSFAEI 267
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 82.4 bits (202), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 436 NKLGEGGFGPVYKGKLADEQE-----VAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+LG+G FG V + Q+ VA+K+L S+ + + +F+ E+ ++ LQH N+V+
Sbjct: 22 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 491 LLG-CSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
G C G L L+ E++P SL +L K ++ K I +G+ YL
Sbjct: 82 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 136
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT-YGYMSPEYAM 607
R IHRDL NIL++++ KI DFG+ ++ ++ K + + +PE
Sbjct: 137 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 196
Query: 608 SGIVSIKTDVFSFGVLVLEIVS 629
S+ +DV+SFGV++ E+ +
Sbjct: 197 ESKFSVASDVWSFGVVLYELFT 218
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 82.4 bits (202), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 77/273 (28%), Positives = 129/273 (47%), Gaps = 26/273 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQ-EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ + +KLG G +G VY+G VA+K L + + + EF E ++ +++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 71
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
V+LLG ++ EFM +L +L R+ V ++ + IS + YL K
Sbjct: 72 VQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKK 130
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIF--EVNESEANTKRIVGTYGYMSPEYA 606
+ IHRDL A N L+ + K++DFG++R+ + + A K + + +PE
Sbjct: 131 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESL 184
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
SIK+DV++FGVL+ EI + +P L+ + ++LL +E +
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIAT---YGMSPYPGIDLSQV---YELLEKDYRMERPEGC- 237
Query: 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
P E+MR C Q DRP+ E+
Sbjct: 238 --PEKVYELMRA------CWQWNPSDRPSFAEI 262
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 82.4 bits (202), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 68/209 (32%), Positives = 109/209 (52%), Gaps = 15/209 (7%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAK 482
+ NF K+GEG +G VYK KL E VA+K++ + +G+ E+ L+ +
Sbjct: 3 GSMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 483 LQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQG 541
L H N+V+LL +H E +L LV+EF+ DF ++ L K ++ + QG
Sbjct: 62 LNHPNIVKLLDV-IHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLF--QLLQG 118
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
L + H + RV+HRDLK N+L++ + K++DFG+AR F V + V T Y
Sbjct: 119 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYR 173
Query: 602 SPEYAMS-GIVSIKTDVFSFGVLVLEIVS 629
+PE + S D++S G + E+V+
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVT 202
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 82.4 bits (202), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 77/273 (28%), Positives = 129/273 (47%), Gaps = 26/273 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQ-EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ + +KLG G +G VY+G VA+K L + + + EF E ++ +++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 71
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
V+LLG ++ EFM +L +L R+ V ++ + IS + YL K
Sbjct: 72 VQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKK 130
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIF--EVNESEANTKRIVGTYGYMSPEYA 606
+ IHRDL A N L+ + K++DFG++R+ + + A K + + +PE
Sbjct: 131 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESL 184
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
SIK+DV++FGVL+ EI + +P L+ + ++LL +E +
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIAT---YGMSPYPGIDLSQV---YELLEKDYRMERPEGC- 237
Query: 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
P E+MR C Q DRP+ E+
Sbjct: 238 --PEKVYELMRA------CWQWNPSDRPSFAEI 262
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 82.4 bits (202), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 77/273 (28%), Positives = 129/273 (47%), Gaps = 26/273 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQ-EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ + +KLG G +G VY+G VA+K L + + + EF E ++ +++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 71
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
V+LLG ++ EFM +L +L R+ V ++ + IS + YL K
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKK 130
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIF--EVNESEANTKRIVGTYGYMSPEYA 606
+ IHRDL A N L+ + K++DFG++R+ + + A K + + +PE
Sbjct: 131 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESL 184
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
SIK+DV++FGVL+ EI + +P L+ + ++LL +E +
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIAT---YGMSPYPGIDLSQV---YELLEKDYRMERPEGC- 237
Query: 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
P E+MR C Q DRP+ E+
Sbjct: 238 --PEKVYELMRA------CWQWNPSDRPSFAEI 262
>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta
pdb|3ZHP|D Chain D, Human Mst3 (stk24) In Complex With Mo25beta
Length = 294
Score = 82.4 bits (202), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 62/218 (28%), Positives = 110/218 (50%), Gaps = 13/218 (5%)
Query: 432 FSTTNKLGEGGFGPVYKGKLADEQEV-AIKRLS-RSSGQGIVEFKNEVRLIAKLQHTNLV 489
F+ K+G+G FG V+KG Q+V AIK + + I + + E+ ++++ +
Sbjct: 29 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 490 RLLGCSLHGEERLLVYEFMPNKS-LDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
+ G L + ++ E++ S LD L+ + I+ I +GL YLH
Sbjct: 89 KYYGSYLKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHSE 143
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS 608
+ IHRD+KA+N+LL + K++DFG+A ++ +++ VGT +M+PE
Sbjct: 144 KK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQ 198
Query: 609 GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
K D++S G+ +E+ G+ H+ HP + L LI
Sbjct: 199 SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI 236
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 82.4 bits (202), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 65/229 (28%), Positives = 111/229 (48%), Gaps = 33/229 (14%)
Query: 430 NNFSTTNKLGEGGFGPVYK----GKLADE--QEVAIKRLSRSSGQGI-VEFKNEVRLIAK 482
NN +GEG FG V++ G L E VA+K L + + +F+ E L+A+
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 483 LQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFN--------------SGRKNV--- 525
+ N+V+LLG G+ L++E+M L+ FL + S R V
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 526 ----LNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR- 580
L+ ++ I ++ G+ YL S + +HRDL N L+ + M KI+DFG++R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 581 IFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
I+ + +A+ + +M PE + ++DV+++GV++ EI S
Sbjct: 224 IYSADYYKADGNDAIPI-RWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 82.4 bits (202), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 77/273 (28%), Positives = 129/273 (47%), Gaps = 26/273 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQ-EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ + +KLG G +G VY+G VA+K L + + + EF E ++ +++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 71
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
V+LLG ++ EFM +L +L R+ V ++ + IS + YL K
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKK 130
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIF--EVNESEANTKRIVGTYGYMSPEYA 606
+ IHRDL A N L+ + K++DFG++R+ + + A K + + +PE
Sbjct: 131 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESL 184
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
SIK+DV++FGVL+ EI + +P L+ + ++LL +E +
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIAT---YGMSPYPGIDLSQV---YELLEKDYRMERPEGC- 237
Query: 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
P E+MR C Q DRP+ E+
Sbjct: 238 --PEKVYELMRA------CWQWNPSDRPSFAEI 262
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 82.4 bits (202), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 69/210 (32%), Positives = 112/210 (53%), Gaps = 17/210 (8%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAK 482
+ NF K+GEG +G VYK KL E VA+K++ + +G+ E+ L+ +
Sbjct: 3 GSMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 483 LQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQ 540
L H N+V+LL +H E +L LV+EF+ ++ L F+ S + L K ++ + Q
Sbjct: 62 LNHPNIVKLLDV-IHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLF--QLLQ 117
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
GL + H + RV+HRDLK N+L++ + K++DFG+AR F V + V T Y
Sbjct: 118 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWY 172
Query: 601 MSPEYAMS-GIVSIKTDVFSFGVLVLEIVS 629
+PE + S D++S G + E+V+
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 60/201 (29%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 437 KLGEGGFGPVYKGKLADEQE-----VAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRL 491
+LG+G FG V + Q+ VA+K+L S+ + + +F+ E+ ++ LQH N+V+
Sbjct: 35 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 492 LG-CSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
G C G L L+ E++P SL +L K ++ K I +G+ YL
Sbjct: 95 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 149
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT-YGYMSPEYAMS 608
R IHRDL NIL++++ KI DFG+ ++ ++ K + + +PE
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 609 GIVSIKTDVFSFGVLVLEIVS 629
S+ +DV+SFGV++ E+ +
Sbjct: 210 SKFSVASDVWSFGVVLYELFT 230
>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2OSC|A Chain A, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2P4I|A Chain A, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|2P4I|B Chain B, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|3L8P|A Chain A, Crystal Structure Of Cytoplasmic Kinase Domain Of Tie2
Complexed With Inhibitor Cep11207
Length = 317
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 66/220 (30%), Positives = 110/220 (50%), Gaps = 28/220 (12%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADE---QEVAIKRLSR-SSGQGIVEFKNEVRLIAKL-Q 484
N+ + +GEG FG V K ++ + + AIKR+ +S +F E+ ++ KL
Sbjct: 15 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSL-DF------------FLFNSGRKNVLNWEKR 531
H N++ LLG H L E+ P+ +L DF F + + L+ ++
Sbjct: 75 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 532 FIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANT 591
+++G+ YL S+ + IHRDL A NIL+ + KI+DFG++R EV
Sbjct: 135 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV-----YV 186
Query: 592 KRIVGT--YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
K+ +G +M+ E + + +DV+S+GVL+ EIVS
Sbjct: 187 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226
>pdb|3A7F|A Chain A, Human Mst3 Kinase
pdb|3A7G|A Chain A, Human Mst3 Kinase
pdb|3A7G|B Chain B, Human Mst3 Kinase
pdb|3A7H|A Chain A, Human Mst3 Kinase In Complex With Atp
pdb|3A7H|B Chain B, Human Mst3 Kinase In Complex With Atp
pdb|3A7I|A Chain A, Human Mst3 Kinase In Complex With Adenine
pdb|3A7J|A Chain A, Human Mst3 Kinase In Complex With Mnadp
Length = 303
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 62/218 (28%), Positives = 110/218 (50%), Gaps = 13/218 (5%)
Query: 432 FSTTNKLGEGGFGPVYKGKLADEQEV-AIKRLS-RSSGQGIVEFKNEVRLIAKLQHTNLV 489
F+ K+G+G FG V+KG Q+V AIK + + I + + E+ ++++ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 490 RLLGCSLHGEERLLVYEFMPNKS-LDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
+ G L + ++ E++ S LD L+ + I+ I +GL YLH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHSE 138
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS 608
+ IHRD+KA+N+LL + K++DFG+A ++ +++ VGT +M+PE
Sbjct: 139 KK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNXFVGTPFWMAPEVIKQ 193
Query: 609 GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
K D++S G+ +E+ G+ H+ HP + L LI
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI 231
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 68/209 (32%), Positives = 109/209 (52%), Gaps = 15/209 (7%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAK 482
+ NF K+GEG +G VYK KL E VA+K++ + +G+ E+ L+ +
Sbjct: 2 GSMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKE 60
Query: 483 LQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQG 541
L H N+V+LL +H E +L LV+EF+ DF ++ L K ++ + QG
Sbjct: 61 LNHPNIVKLLDV-IHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLF--QLLQG 117
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
L + H + RV+HRDLK N+L++ + K++DFG+AR F V + V T Y
Sbjct: 118 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYR 172
Query: 602 SPEYAMS-GIVSIKTDVFSFGVLVLEIVS 629
+PE + S D++S G + E+V+
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVT 201
>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24)
Length = 304
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 64/218 (29%), Positives = 109/218 (50%), Gaps = 13/218 (5%)
Query: 432 FSTTNKLGEGGFGPVYKGKLADEQEV-AIKRLS-RSSGQGIVEFKNEVRLIAKLQHTNLV 489
F+ K+G+G FG V+KG Q+V AIK + + I + + E+ ++++ +
Sbjct: 9 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 490 RLLGCSLHGEERLLVYEFMPNKS-LDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
+ G L + ++ E++ S LD L+ + I+ I +GL YLH
Sbjct: 69 KYYGSYLKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHSE 123
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS 608
+ IHRD+KA+N+LL + K++DFG+A + + NT VGT +M+PE
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQ 178
Query: 609 GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
K D++S G+ +E+ G+ H+ HP + L LI
Sbjct: 179 SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI 216
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 69/209 (33%), Positives = 112/209 (53%), Gaps = 17/209 (8%)
Query: 428 AANNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAKL 483
+ NF K+GEG +G VYK KL E VA+K++ + +G+ E+ L+ +L
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 484 QHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQG 541
H N+V+LL +H E +L LV+EF+ ++ L F+ S + L K ++ + QG
Sbjct: 60 NHPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLF--QLLQG 115
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
L + H + RV+HRDLK N+L++ + K++DFG+AR F V + V T Y
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYR 170
Query: 602 SPEYAMS-GIVSIKTDVFSFGVLVLEIVS 629
+PE + S D++S G + E+V+
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVT 199
>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24) In Complex With Staurosporine
Length = 304
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 62/218 (28%), Positives = 110/218 (50%), Gaps = 13/218 (5%)
Query: 432 FSTTNKLGEGGFGPVYKGKLADEQEV-AIKRLS-RSSGQGIVEFKNEVRLIAKLQHTNLV 489
F+ K+G+G FG V+KG Q+V AIK + + I + + E+ ++++ +
Sbjct: 9 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 490 RLLGCSLHGEERLLVYEFMPNKS-LDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
+ G L + ++ E++ S LD L+ + I+ I +GL YLH
Sbjct: 69 KYYGSYLKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHSE 123
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS 608
+ IHRD+KA+N+LL + K++DFG+A ++ +++ VGT +M+PE
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNXFVGTPFWMAPEVIKQ 178
Query: 609 GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
K D++S G+ +E+ G+ H+ HP + L LI
Sbjct: 179 SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI 216
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 70/207 (33%), Positives = 112/207 (54%), Gaps = 17/207 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAKLQH 485
NF K+GEG +G VYK KL E VA+K++ + +G+ E+ L+ +L H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 486 TNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQGLL 543
N+V+LL +H E +L LV+EF+ ++ L F+ S + L K ++ + QGL
Sbjct: 62 PNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLF--QLLQGLS 117
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
+ H + RV+HRDLK N+L++ + K++DFG+AR F V T +V T Y +P
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAP 172
Query: 604 EYAMS-GIVSIKTDVFSFGVLVLEIVS 629
E + S D++S G + E+V+
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVT 199
>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With
Ind E804
Length = 324
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 67/202 (33%), Positives = 110/202 (54%), Gaps = 17/202 (8%)
Query: 436 NKLGEGGFGPVYKGK--LADEQEVAIK--RLSRSSGQGIVEFKNEVRLIAKLQHTNLVRL 491
+KLGEG + VYKGK L D VA+K RL G + EV L+ L+H N+V L
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTL 65
Query: 492 LGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
+H E+ L LV+E++ +K L +L + G N++N + + + +GL Y H R
Sbjct: 66 HDI-IHTEKSLTLVFEYL-DKDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCH---R 118
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM-SG 609
+V+HRDLK N+L++++ K++DFG+AR + + + V T Y P+ + S
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE--VVTLWYRPPDILLGST 176
Query: 610 IVSIKTDVFSFGVLVLEIVSGQ 631
S + D++ G + E+ +G+
Sbjct: 177 DYSTQIDMWGVGCIFYEMATGR 198
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 60/201 (29%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 437 KLGEGGFGPVYKGKLADEQE-----VAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRL 491
+LG+G FG V + Q+ VA+K+L S+ + + +F+ E+ ++ LQH N+V+
Sbjct: 35 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 492 LG-CSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
G C G L L+ E++P SL +L K ++ K I +G+ YL
Sbjct: 95 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 149
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT-YGYMSPEYAMS 608
R IHRDL NIL++++ KI DFG+ ++ ++ K + + +PE
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 609 GIVSIKTDVFSFGVLVLEIVS 629
S+ +DV+SFGV++ E+ +
Sbjct: 210 SKFSVASDVWSFGVVLYELFT 230
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 68/206 (33%), Positives = 107/206 (51%), Gaps = 15/206 (7%)
Query: 430 NNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLSRSSGQGIVEFK-NEVRLIAKLQHT 486
NF K+GEG +G VYK KL E K + +G+ E+ L+ +L H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 487 NLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQGLLY 544
N+V+LL +H E +L LV+EF+ ++ L F+ S + L K ++ + QGL +
Sbjct: 63 NIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLF--QLLQGLAF 118
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
H + RV+HRDLK N+L++ + K++DFG+AR F V T +V T Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPE 173
Query: 605 YAMS-GIVSIKTDVFSFGVLVLEIVS 629
+ S D++S G + E+V+
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 68/206 (33%), Positives = 107/206 (51%), Gaps = 15/206 (7%)
Query: 430 NNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLSRSSGQGIVEFK-NEVRLIAKLQHT 486
NF K+GEG +G VYK KL E K + +G+ E+ L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 487 NLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQGLLY 544
N+V+LL +H E +L LV+EF+ ++ L F+ S + L K ++ + QGL +
Sbjct: 62 NIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLF--QLLQGLAF 117
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
H + RV+HRDLK N+L++ + K++DFG+AR F V T +V T Y +PE
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPE 172
Query: 605 YAMS-GIVSIKTDVFSFGVLVLEIVS 629
+ S D++S G + E+V+
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVT 198
>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor
Length = 292
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 88/304 (28%), Positives = 137/304 (45%), Gaps = 37/304 (12%)
Query: 406 SPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQ----EVAIKR 461
+PE Q++ H + I ++ +G G FG VY G L D A+K
Sbjct: 5 NPELVQAVQHVV-------IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 57
Query: 462 LSRSSGQG-IVEFKNEVRLIAKLQHTNLVRLLGCSLHGE-ERLLVYEFMPNKSLDFFLFN 519
L+R + G + +F E ++ H N++ LLG L E L+V +M + L F+ N
Sbjct: 58 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 117
Query: 520 SGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579
+ F + +++G+ YL + + +HRDL A N +LD+K K++DFG+A
Sbjct: 118 ETHNPTVKDLIGFGL--QVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 172
Query: 580 RIFEVNE--SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRH 637
R E S N +M+ E + + K+DV+SFGVL+ E++ TR
Sbjct: 173 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM------TRG 226
Query: 638 HPDRP-LNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTM 696
P P +N LL +G L+ P P EVM L C +A RP+
Sbjct: 227 APPYPDVNTFDITVYLL---QGRRLLQPEY-CPDPLYEVM------LKCWHPKAEMRPSF 276
Query: 697 PEVV 700
E+V
Sbjct: 277 SELV 280
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
Length = 336
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 66/227 (29%), Positives = 109/227 (48%), Gaps = 40/227 (17%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+N +G G +G VYKG L DE+ VA+K S ++ Q + KN R + ++H N+
Sbjct: 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYR-VPLMEHDNIA 70
Query: 490 RLLGCSLHGEER---------LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
R + G+ER LLV E+ PN SL +L + +W + +++
Sbjct: 71 RFIV----GDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRLAHSVTR 122
Query: 541 GLLYLH------KYSRLRVIHRDLKASNILLDDKMNPKISDFGMA------RIFEVNESE 588
GL YLH + + + HRDL + N+L+ + ISDFG++ R+ E +
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 589 ANTKRIVGTYGYMSPEYAMSGIVSIK--------TDVFSFGVLVLEI 627
VGT YM+PE + G V+++ D+++ G++ EI
Sbjct: 183 NAAISEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEI 228
>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase
pdb|3RHK|A Chain A, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
pdb|3RHK|B Chain B, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
Length = 318
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 88/304 (28%), Positives = 137/304 (45%), Gaps = 37/304 (12%)
Query: 406 SPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQ----EVAIKR 461
+PE Q++ H + I ++ +G G FG VY G L D A+K
Sbjct: 31 NPELVQAVQHVV-------IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 83
Query: 462 LSRSSGQG-IVEFKNEVRLIAKLQHTNLVRLLGCSLHGE-ERLLVYEFMPNKSLDFFLFN 519
L+R + G + +F E ++ H N++ LLG L E L+V +M + L F+ N
Sbjct: 84 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 143
Query: 520 SGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579
+ F + +++G+ YL + + +HRDL A N +LD+K K++DFG+A
Sbjct: 144 ETHNPTVKDLIGFGL--QVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 198
Query: 580 RIFEVNE--SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRH 637
R E S N +M+ E + + K+DV+SFGVL+ E++ TR
Sbjct: 199 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM------TRG 252
Query: 638 HPDRP-LNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTM 696
P P +N LL +G L+ P P EVM L C +A RP+
Sbjct: 253 APPYPDVNTFDITVYLL---QGRRLLQPEY-CPDPLYEVM------LKCWHPKAEMRPSF 302
Query: 697 PEVV 700
E+V
Sbjct: 303 SELV 306
>pdb|1FVR|A Chain A, Tie2 Kinase Domain
pdb|1FVR|B Chain B, Tie2 Kinase Domain
Length = 327
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 66/220 (30%), Positives = 110/220 (50%), Gaps = 28/220 (12%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADE---QEVAIKRLSR-SSGQGIVEFKNEVRLIAKL-Q 484
N+ + +GEG FG V K ++ + + AIKR+ +S +F E+ ++ KL
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSL-DF------------FLFNSGRKNVLNWEKR 531
H N++ LLG H L E+ P+ +L DF F + + L+ ++
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 532 FIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANT 591
+++G+ YL S+ + IHRDL A NIL+ + KI+DFG++R EV
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV-----YV 196
Query: 592 KRIVGT--YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
K+ +G +M+ E + + +DV+S+GVL+ EIVS
Sbjct: 197 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 69/210 (32%), Positives = 112/210 (53%), Gaps = 17/210 (8%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAK 482
+ NF K+GEG +G VYK KL E VA+K++ + +G+ E+ L+ +
Sbjct: 3 GSMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 483 LQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQ 540
L H N+V+LL +H E +L LV+EF+ ++ L F+ S + L K ++ + Q
Sbjct: 62 LNHPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLF--QLLQ 117
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
GL + H + RV+HRDLK N+L++ + K++DFG+AR F V + V T Y
Sbjct: 118 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWY 172
Query: 601 MSPEYAMS-GIVSIKTDVFSFGVLVLEIVS 629
+PE + S D++S G + E+V+
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 69/210 (32%), Positives = 112/210 (53%), Gaps = 17/210 (8%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAK 482
+ NF K+GEG +G VYK KL E VA+K++ + +G+ E+ L+ +
Sbjct: 2 GSMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKE 60
Query: 483 LQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQ 540
L H N+V+LL +H E +L LV+EF+ ++ L F+ S + L K ++ + Q
Sbjct: 61 LNHPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLF--QLLQ 116
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
GL + H + RV+HRDLK N+L++ + K++DFG+AR F V + V T Y
Sbjct: 117 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWY 171
Query: 601 MSPEYAMS-GIVSIKTDVFSFGVLVLEIVS 629
+PE + S D++S G + E+V+
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 77/274 (28%), Positives = 128/274 (46%), Gaps = 28/274 (10%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQ-EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ + +KLG G +G VY+G VA+K L + + + EF E ++ +++H NL
Sbjct: 11 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 69
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
V+LLG ++ EFM +L +L R+ V ++ + IS + YL K
Sbjct: 70 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKK 128
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIF--EVNESEANTKRIVGTYGYMSPEYA 606
+ IHRDL A N L+ + K++DFG++R+ + + A K + + +PE
Sbjct: 129 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPI---KWTAPESL 182
Query: 607 MSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665
SIK+DV++FGVL+ EI + G + P + ++LL +E +
Sbjct: 183 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ-------VYELLEKDYRMERPEGC 235
Query: 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
P E+MR C Q DRP+ E+
Sbjct: 236 ---PEKVYELMRA------CWQWNPSDRPSFAEI 260
>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880
(Gsk1
Length = 302
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 88/304 (28%), Positives = 137/304 (45%), Gaps = 37/304 (12%)
Query: 406 SPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQ----EVAIKR 461
+PE Q++ H + I ++ +G G FG VY G L D A+K
Sbjct: 11 NPELVQAVQHVV-------IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 63
Query: 462 LSRSSGQG-IVEFKNEVRLIAKLQHTNLVRLLGCSLHGE-ERLLVYEFMPNKSLDFFLFN 519
L+R + G + +F E ++ H N++ LLG L E L+V +M + L F+ N
Sbjct: 64 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 123
Query: 520 SGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579
+ F + +++G+ YL + + +HRDL A N +LD+K K++DFG+A
Sbjct: 124 ETHNPTVKDLIGFGL--QVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 178
Query: 580 RIFEVNE--SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRH 637
R E S N +M+ E + + K+DV+SFGVL+ E++ TR
Sbjct: 179 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM------TRG 232
Query: 638 HPDRP-LNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTM 696
P P +N LL +G L+ P P EVM L C +A RP+
Sbjct: 233 APPYPDVNTFDITVYLL---QGRRLLQPEY-CPDPLYEVM------LKCWHPKAEMRPSF 282
Query: 697 PEVV 700
E+V
Sbjct: 283 SELV 286
>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
pdb|3F66|B Chain B, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
Length = 298
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 88/304 (28%), Positives = 137/304 (45%), Gaps = 37/304 (12%)
Query: 406 SPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQ----EVAIKR 461
+PE Q++ H + I ++ +G G FG VY G L D A+K
Sbjct: 8 NPELVQAVQHVV-------IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 60
Query: 462 LSRSSGQG-IVEFKNEVRLIAKLQHTNLVRLLGCSLHGE-ERLLVYEFMPNKSLDFFLFN 519
L+R + G + +F E ++ H N++ LLG L E L+V +M + L F+ N
Sbjct: 61 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 120
Query: 520 SGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579
+ F + +++G+ YL + + +HRDL A N +LD+K K++DFG+A
Sbjct: 121 ETHNPTVKDLIGFGL--QVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175
Query: 580 RIFEVNE--SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRH 637
R E S N +M+ E + + K+DV+SFGVL+ E++ TR
Sbjct: 176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM------TRG 229
Query: 638 HPDRP-LNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTM 696
P P +N LL +G L+ P P EVM L C +A RP+
Sbjct: 230 APPYPDVNTFDITVYLL---QGRRLLQPEY-CPDPLYEVM------LKCWHPKAEMRPSF 279
Query: 697 PEVV 700
E+V
Sbjct: 280 SELV 283
>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Amp-Pnp
pdb|2ITO|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Iressa
pdb|2ITP|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Aee788
pdb|2ITQ|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Afn941
Length = 327
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 20/210 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-----VAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
F L G FG VYKG E E VAIK L + S + E +E ++A +
Sbjct: 15 TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF----NSGRKNVLNWEKRFIIIEGIS 539
+ ++ RLLG L +L+ + MP L ++ N G + +LNW + I+
Sbjct: 75 DNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+G+ YL R++HRDL A N+L+ + KI+DFG+A++ E E + +
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+ E + I + ++DV+S+GV V E+++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 69/210 (32%), Positives = 112/210 (53%), Gaps = 17/210 (8%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAK 482
+ NF K+GEG +G VYK KL E VA+K++ + +G+ E+ L+ +
Sbjct: 2 GSMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKE 60
Query: 483 LQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQ 540
L H N+V+LL +H E +L LV+EF+ ++ L F+ S + L K ++ + Q
Sbjct: 61 LNHPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLF--QLLQ 116
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
GL + H + RV+HRDLK N+L++ + K++DFG+AR F V + V T Y
Sbjct: 117 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWY 171
Query: 601 MSPEYAMS-GIVSIKTDVFSFGVLVLEIVS 629
+PE + S D++S G + E+V+
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 81.6 bits (200), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 69/210 (32%), Positives = 112/210 (53%), Gaps = 17/210 (8%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAK 482
+ NF K+GEG +G VYK KL E VA+K++ + +G+ E+ L+ +
Sbjct: 3 GSMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 483 LQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQ 540
L H N+V+LL +H E +L LV+EF+ ++ L F+ S + L K ++ + Q
Sbjct: 62 LNHPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLF--QLLQ 117
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
GL + H + RV+HRDLK N+L++ + K++DFG+AR F V + V T Y
Sbjct: 118 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWY 172
Query: 601 MSPEYAMS-GIVSIKTDVFSFGVLVLEIVS 629
+PE + S D++S G + E+V+
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202
>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN The Apo Form
pdb|3UG2|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Gefitinib
pdb|3VJN|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Amppnp
Length = 334
Score = 81.6 bits (200), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-----VAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
F L G FG VYKG E E VAIK L + S + E +E ++A +
Sbjct: 22 TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF----NSGRKNVLNWEKRFIIIEGIS 539
+ ++ RLLG L +L++ + MP L ++ N G + +LNW + I+
Sbjct: 82 DNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+G+ YL R++HRDL A N+L+ + KI+DFG+A++ E E + +
Sbjct: 135 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+ E + I + ++DV+S+GV V E+++
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMT 221
>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine
Inhibitor 13
pdb|3U6H|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 26
pdb|3U6I|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 58a
pdb|4DEG|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridazine Inhibitor 2
pdb|4DEH|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 3
pdb|4DEI|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 24
Length = 309
Score = 81.6 bits (200), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 88/304 (28%), Positives = 137/304 (45%), Gaps = 37/304 (12%)
Query: 406 SPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQ----EVAIKR 461
+PE Q++ H + I ++ +G G FG VY G L D A+K
Sbjct: 12 NPELVQAVQHVV-------IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 64
Query: 462 LSRSSGQG-IVEFKNEVRLIAKLQHTNLVRLLGCSLHGE-ERLLVYEFMPNKSLDFFLFN 519
L+R + G + +F E ++ H N++ LLG L E L+V +M + L F+ N
Sbjct: 65 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 124
Query: 520 SGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579
+ F + +++G+ YL + + +HRDL A N +LD+K K++DFG+A
Sbjct: 125 ETHNPTVKDLIGFGL--QVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 179
Query: 580 RIFEVNE--SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRH 637
R E S N +M+ E + + K+DV+SFGVL+ E++ TR
Sbjct: 180 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM------TRG 233
Query: 638 HPDRP-LNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTM 696
P P +N LL +G L+ P P EVM L C +A RP+
Sbjct: 234 APPYPDVNTFDITVYLL---QGRRLLQPEY-CPDPLYEVM------LKCWHPKAEMRPSF 283
Query: 697 PEVV 700
E+V
Sbjct: 284 SELV 287
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 81.6 bits (200), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 69/210 (32%), Positives = 112/210 (53%), Gaps = 17/210 (8%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAK 482
+ NF K+GEG +G VYK KL E VA+K++ + +G+ E+ L+ +
Sbjct: 2 GSMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKE 60
Query: 483 LQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQ 540
L H N+V+LL +H E +L LV+EF+ ++ L F+ S + L K ++ + Q
Sbjct: 61 LNHPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLF--QLLQ 116
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
GL + H + RV+HRDLK N+L++ + K++DFG+AR F V + V T Y
Sbjct: 117 GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWY 171
Query: 601 MSPEYAMS-GIVSIKTDVFSFGVLVLEIVS 629
+PE + S D++S G + E+V+
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201
>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In
Complex With An Mk-2461 Analog With Specificity For The
Activated Receptor
pdb|3R7O|A Chain A, Structure Of Dually Phosphorylated C-Met Receptor Kinase
In Complex With An Mk-2461 Analog
Length = 307
Score = 81.6 bits (200), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 88/304 (28%), Positives = 137/304 (45%), Gaps = 37/304 (12%)
Query: 406 SPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQ----EVAIKR 461
+PE Q++ H + I ++ +G G FG VY G L D A+K
Sbjct: 12 NPELVQAVQHVV-------IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 64
Query: 462 LSRSSGQG-IVEFKNEVRLIAKLQHTNLVRLLGCSLHGE-ERLLVYEFMPNKSLDFFLFN 519
L+R + G + +F E ++ H N++ LLG L E L+V +M + L F+ N
Sbjct: 65 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 124
Query: 520 SGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579
+ F + +++G+ YL + + +HRDL A N +LD+K K++DFG+A
Sbjct: 125 ETHNPTVKDLIGFGL--QVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 179
Query: 580 RIFEVNE--SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRH 637
R E S N +M+ E + + K+DV+SFGVL+ E++ TR
Sbjct: 180 RDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM------TRG 233
Query: 638 HPDRP-LNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTM 696
P P +N LL +G L+ P P EVM L C +A RP+
Sbjct: 234 APPYPDVNTFDITVYLL---QGRRLLQPEY-CPDPLYEVM------LKCWHPKAEMRPSF 283
Query: 697 PEVV 700
E+V
Sbjct: 284 SELV 287
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 81.6 bits (200), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 69/209 (33%), Positives = 112/209 (53%), Gaps = 17/209 (8%)
Query: 428 AANNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAKL 483
+ NF K+GEG +G VYK KL E VA+K++ + +G+ E+ L+ +L
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 484 QHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQG 541
H N+V+LL +H E +L LV+EF+ ++ L F+ S + L K ++ + QG
Sbjct: 60 NHPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLF--QLLQG 115
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
L + H + RV+HRDLK N+L++ + K++DFG+AR F V + V T Y
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYR 170
Query: 602 SPEYAMS-GIVSIKTDVFSFGVLVLEIVS 629
+PE + S D++S G + E+V+
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVT 199
>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The
Dually-Phosphorylated, Activated State
Length = 308
Score = 81.6 bits (200), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 88/304 (28%), Positives = 137/304 (45%), Gaps = 37/304 (12%)
Query: 406 SPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQ----EVAIKR 461
+PE Q++ H + I ++ +G G FG VY G L D A+K
Sbjct: 13 NPELVQAVQHVV-------IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 65
Query: 462 LSRSSGQG-IVEFKNEVRLIAKLQHTNLVRLLGCSLHGE-ERLLVYEFMPNKSLDFFLFN 519
L+R + G + +F E ++ H N++ LLG L E L+V +M + L F+ N
Sbjct: 66 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 125
Query: 520 SGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579
+ F + +++G+ YL + + +HRDL A N +LD+K K++DFG+A
Sbjct: 126 ETHNPTVKDLIGFGL--QVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 180
Query: 580 RIFEVNE--SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRH 637
R E S N +M+ E + + K+DV+SFGVL+ E++ TR
Sbjct: 181 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM------TRG 234
Query: 638 HPDRP-LNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTM 696
P P +N LL +G L+ P P EVM L C +A RP+
Sbjct: 235 APPYPDVNTFDITVYLL---QGRRLLQPEY-CPDPLYEVM------LKCWHPKAEMRPSF 284
Query: 697 PEVV 700
E+V
Sbjct: 285 SELV 288
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 81.6 bits (200), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 69/210 (32%), Positives = 112/210 (53%), Gaps = 17/210 (8%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAK 482
+ NF K+GEG +G VYK KL E VA+K++ + +G+ E+ L+ +
Sbjct: 4 GSMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKE 62
Query: 483 LQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQ 540
L H N+V+LL +H E +L LV+EF+ ++ L F+ S + L K ++ + Q
Sbjct: 63 LNHPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLF--QLLQ 118
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
GL + H + RV+HRDLK N+L++ + K++DFG+AR F V + V T Y
Sbjct: 119 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWY 173
Query: 601 MSPEYAMS-GIVSIKTDVFSFGVLVLEIVS 629
+PE + S D++S G + E+V+
Sbjct: 174 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 203
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 81.6 bits (200), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 69/209 (33%), Positives = 112/209 (53%), Gaps = 17/209 (8%)
Query: 428 AANNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAKL 483
+ NF K+GEG +G VYK KL E VA+K++ + +G+ E+ L+ +L
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 484 QHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQG 541
H N+V+LL +H E +L LV+EF+ ++ L F+ S + L K ++ + QG
Sbjct: 60 NHPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLF--QLLQG 115
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
L + H + RV+HRDLK N+L++ + K++DFG+AR F V + V T Y
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYR 170
Query: 602 SPEYAMS-GIVSIKTDVFSFGVLVLEIVS 629
+PE + S D++S G + E+V+
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVT 199
>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
pdb|4GG7|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
Length = 319
Score = 81.6 bits (200), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 88/304 (28%), Positives = 137/304 (45%), Gaps = 37/304 (12%)
Query: 406 SPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQ----EVAIKR 461
+PE Q++ H + I ++ +G G FG VY G L D A+K
Sbjct: 32 NPELVQAVQHVV-------IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 84
Query: 462 LSRSSGQG-IVEFKNEVRLIAKLQHTNLVRLLGCSLHGE-ERLLVYEFMPNKSLDFFLFN 519
L+R + G + +F E ++ H N++ LLG L E L+V +M + L F+ N
Sbjct: 85 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 144
Query: 520 SGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579
+ F + +++G+ YL + + +HRDL A N +LD+K K++DFG+A
Sbjct: 145 ETHNPTVKDLIGFGL--QVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 199
Query: 580 RIFEVNE--SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRH 637
R E S N +M+ E + + K+DV+SFGVL+ E++ TR
Sbjct: 200 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM------TRG 253
Query: 638 HPDRP-LNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTM 696
P P +N LL +G L+ P P EVM L C +A RP+
Sbjct: 254 APPYPDVNTFDITVYLL---QGRRLLQPEY-CPDPLYEVM------LKCWHPKAEMRPSF 303
Query: 697 PEVV 700
E+V
Sbjct: 304 SELV 307
>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain
Of C-Met
pdb|2WKM|A Chain A, X-Ray Structure Of Pha-00665752 Bound To The Kinase Domain
Of C-Met
pdb|3ZXZ|A Chain A, X-Ray Structure Of Pf-04217903 Bound To The Kinase Domain
Of C-Met
pdb|3ZZE|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
N'-
((3z)-4-Chloro-7-Methyl-2-Oxo-1,2-Dihydro-3h-Indol-3-
Ylidene)-2-(4-Hydroxyphenyl)propanohydrazide
pdb|4AOI|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( 3-((1h-
Pyrrolo(2,3-B)pyridin-3-Yl)methyl)-(1,2,4)triazolo(
4,3-B)(1,2,4) Triazin-6-Yl)benzonitrile
pdb|4AP7|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( (6-(4-
Fluorophenyl)-(1,2,4)triazolo(4,3-B)(1,2,
4)triazin-3-Yl)methyl) Phenol
Length = 306
Score = 81.6 bits (200), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 88/304 (28%), Positives = 137/304 (45%), Gaps = 37/304 (12%)
Query: 406 SPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQ----EVAIKR 461
+PE Q++ H + I ++ +G G FG VY G L D A+K
Sbjct: 10 NPELVQAVQHVV-------IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 62
Query: 462 LSRSSGQG-IVEFKNEVRLIAKLQHTNLVRLLGCSLHGE-ERLLVYEFMPNKSLDFFLFN 519
L+R + G + +F E ++ H N++ LLG L E L+V +M + L F+ N
Sbjct: 63 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 122
Query: 520 SGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579
+ F + +++G+ YL + + +HRDL A N +LD+K K++DFG+A
Sbjct: 123 ETHNPTVKDLIGFGL--QVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 177
Query: 580 RIFEVNE--SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRH 637
R E S N +M+ E + + K+DV+SFGVL+ E++ TR
Sbjct: 178 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM------TRG 231
Query: 638 HPDRP-LNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTM 696
P P +N LL +G L+ P P EVM L C +A RP+
Sbjct: 232 APPYPDVNTFDITVYLL---QGRRLLQPEY-CPDPLYEVM------LKCWHPKAEMRPSF 281
Query: 697 PEVV 700
E+V
Sbjct: 282 SELV 285
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 81.6 bits (200), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 69/207 (33%), Positives = 111/207 (53%), Gaps = 17/207 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAKLQH 485
NF K+GEG +G VYK KL E VA+K++ + +G+ E+ L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 486 TNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQGLL 543
N+V+LL +H E +L LV+EF+ ++ L F+ S + L K ++ + QGL
Sbjct: 61 PNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLF--QLLQGLA 116
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
+ H + RV+HRDLK N+L++ + K++DFG+AR F V + V T Y +P
Sbjct: 117 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAP 171
Query: 604 EYAMS-GIVSIKTDVFSFGVLVLEIVS 629
E + S D++S G + E+V+
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVT 198
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 81.6 bits (200), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 69/210 (32%), Positives = 112/210 (53%), Gaps = 17/210 (8%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAK 482
+ NF K+GEG +G VYK KL E VA+K++ + +G+ E+ L+ +
Sbjct: 1 GSMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKE 59
Query: 483 LQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQ 540
L H N+V+LL +H E +L LV+EF+ ++ L F+ S + L K ++ + Q
Sbjct: 60 LNHPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLF--QLLQ 115
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
GL + H + RV+HRDLK N+L++ + K++DFG+AR F V + V T Y
Sbjct: 116 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWY 170
Query: 601 MSPEYAMS-GIVSIKTDVFSFGVLVLEIVS 629
+PE + S D++S G + E+V+
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 81.6 bits (200), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 69/209 (33%), Positives = 112/209 (53%), Gaps = 17/209 (8%)
Query: 428 AANNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAKL 483
+ NF K+GEG +G VYK KL E VA+K++ + +G+ E+ L+ +L
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 484 QHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQG 541
H N+V+LL +H E +L LV+EF+ ++ L F+ S + L K ++ + QG
Sbjct: 60 NHPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLF--QLLQG 115
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
L + H + RV+HRDLK N+L++ + K++DFG+AR F V + V T Y
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYR 170
Query: 602 SPEYAMS-GIVSIKTDVFSFGVLVLEIVS 629
+PE + S D++S G + E+V+
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVT 199
>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor.
pdb|2RFN|B Chain B, X-ray Structure Of C-met With Inhibitor.
pdb|2RFS|A Chain A, X-Ray Structure Of Su11274 Bound To C-Met
pdb|3CCN|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3CD8|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3EFJ|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFJ|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFK|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 50
pdb|3EFK|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 50
Length = 310
Score = 81.6 bits (200), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 88/304 (28%), Positives = 137/304 (45%), Gaps = 37/304 (12%)
Query: 406 SPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQ----EVAIKR 461
+PE Q++ H + I ++ +G G FG VY G L D A+K
Sbjct: 13 NPELVQAVQHVV-------IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 65
Query: 462 LSRSSGQG-IVEFKNEVRLIAKLQHTNLVRLLGCSLHGE-ERLLVYEFMPNKSLDFFLFN 519
L+R + G + +F E ++ H N++ LLG L E L+V +M + L F+ N
Sbjct: 66 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 125
Query: 520 SGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579
+ F + +++G+ YL + + +HRDL A N +LD+K K++DFG+A
Sbjct: 126 ETHNPTVKDLIGFGL--QVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 180
Query: 580 RIFEVNE--SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRH 637
R E S N +M+ E + + K+DV+SFGVL+ E++ TR
Sbjct: 181 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM------TRG 234
Query: 638 HPDRP-LNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTM 696
P P +N LL +G L+ P P EVM L C +A RP+
Sbjct: 235 APPYPDVNTFDITVYLL---QGRRLLQPEY-CPDPLYEVM------LKCWHPKAEMRPSF 284
Query: 697 PEVV 700
E+V
Sbjct: 285 SELV 288
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 81.6 bits (200), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 69/207 (33%), Positives = 111/207 (53%), Gaps = 17/207 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAKLQH 485
NF K+GEG +G VYK KL E VA+K++ + +G+ E+ L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 486 TNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQGLL 543
N+V+LL +H E +L LV+EF+ ++ L F+ S + L K ++ + QGL
Sbjct: 61 PNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLF--QLLQGLA 116
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
+ H + RV+HRDLK N+L++ + K++DFG+AR F V + V T Y +P
Sbjct: 117 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAP 171
Query: 604 EYAMS-GIVSIKTDVFSFGVLVLEIVS 629
E + S D++S G + E+V+
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVT 198
>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And
Inactive Conformations Suggests A Mechanism Of
Activation For Tec Family Kinases
Length = 283
Score = 81.6 bits (200), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 73/267 (27%), Positives = 124/267 (46%), Gaps = 24/267 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+ + +LG G FG V GK + +VAIK + S EF E +++ L H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 82
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+L G ++ E+M N L +L ++ ++ + + + + + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK- 139
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG 609
+ +HRDL A N L++D+ K+SDFG++R + +++ E ++ + PE M
Sbjct: 140 --QFLHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEETSSVGSKFPVRWSPPEVLMYS 196
Query: 610 IVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668
S K+D+++FGVL+ EI S G+ + R I +GL L P L
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI---------AQGLRLYRPHL-- 245
Query: 669 PCSANEVMRCIHVGLLCVQDQAMDRPT 695
A+E + I C ++A +RPT
Sbjct: 246 ---ASEKVYTIMYS--CWHEKADERPT 267
>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A
Pyrimidinopyridone Inhibitor
Length = 333
Score = 81.6 bits (200), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 85/303 (28%), Positives = 139/303 (45%), Gaps = 48/303 (15%)
Query: 430 NNFSTTNKLGEGGFGPVYK------GKLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAK 482
NN LG G FG V + GK +VA+K L ++ E +E+++++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 483 L-QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG---- 537
L QH N+V LLG HG L++ E+ L FL R VL + F I
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSR--VLETDPAFAIANSTLST 163
Query: 538 ---------ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES- 587
++QG+ +L + IHRD+ A N+LL + KI DFG+AR +N+S
Sbjct: 164 RDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI-MNDSN 219
Query: 588 ---EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLN 644
+ N + V +M+PE + ++++DV+S+G+L+ EI S N +P +N
Sbjct: 220 YIVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN---PYPGILVN 273
Query: 645 LIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
Y +L+ D G ++ P+ P + +M+ C + RPT ++ LQ
Sbjct: 274 SKFY--KLVKD--GYQMAQPAFA-PKNIYSIMQA------CWALEPTHRPTFQQICSFLQ 322
Query: 705 NET 707
+
Sbjct: 323 EQA 325
>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An
Arylamide Inhibitor
Length = 333
Score = 81.6 bits (200), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 85/303 (28%), Positives = 139/303 (45%), Gaps = 48/303 (15%)
Query: 430 NNFSTTNKLGEGGFGPVYK------GKLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAK 482
NN LG G FG V + GK +VA+K L ++ E +E+++++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 483 L-QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG---- 537
L QH N+V LLG HG L++ E+ L FL R VL + F I
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSR--VLETDPAFAIANSTAST 163
Query: 538 ---------ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES- 587
++QG+ +L + IHRD+ A N+LL + KI DFG+AR +N+S
Sbjct: 164 RDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI-MNDSN 219
Query: 588 ---EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLN 644
+ N + V +M+PE + ++++DV+S+G+L+ EI S N +P +N
Sbjct: 220 YIVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN---PYPGILVN 273
Query: 645 LIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
Y +L+ D G ++ P+ P + +M+ C + RPT ++ LQ
Sbjct: 274 SKFY--KLVKD--GYQMAQPAFA-PKNIYSIMQA------CWALEPTHRPTFQQICSFLQ 322
Query: 705 NET 707
+
Sbjct: 323 EQA 325
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 81.6 bits (200), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 69/207 (33%), Positives = 111/207 (53%), Gaps = 17/207 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAKLQH 485
NF K+GEG +G VYK KL E VA+K++ + +G+ E+ L+ +L H
Sbjct: 4 ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 486 TNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQGLL 543
N+V+LL +H E +L LV+EF+ ++ L F+ S + L K ++ + QGL
Sbjct: 63 PNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLF--QLLQGLA 118
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
+ H + RV+HRDLK N+L++ + K++DFG+AR F V + V T Y +P
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAP 173
Query: 604 EYAMS-GIVSIKTDVFSFGVLVLEIVS 629
E + S D++S G + E+V+
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVT 200
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 81.6 bits (200), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 69/210 (32%), Positives = 112/210 (53%), Gaps = 17/210 (8%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAK 482
+ NF K+GEG +G VYK KL E VA+K++ + +G+ E+ L+ +
Sbjct: 1 GSMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKE 59
Query: 483 LQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQ 540
L H N+V+LL +H E +L LV+EF+ ++ L F+ S + L K ++ + Q
Sbjct: 60 LNHPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLF--QLLQ 115
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
GL + H + RV+HRDLK N+L++ + K++DFG+AR F V + V T Y
Sbjct: 116 GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWY 170
Query: 601 MSPEYAMS-GIVSIKTDVFSFGVLVLEIVS 629
+PE + S D++S G + E+V+
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200
>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s)
Length = 334
Score = 81.3 bits (199), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 20/210 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-----VAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
F L G FG VYKG E E VAIK L + S + E +E ++A +
Sbjct: 22 TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF----NSGRKNVLNWEKRFIIIEGIS 539
+ ++ RLLG L +L+ + MP L ++ N G + +LNW + I+
Sbjct: 82 DNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+G+ YL R++HRDL A N+L+ + KI+DFG+A++ E E + +
Sbjct: 135 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+ E + I + ++DV+S+GV V E+++
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMT 221
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 81.3 bits (199), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 436 NKLGEGGFGPVYKGKLADEQE-----VAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+LG+G FG V + Q+ VA+K+L S+ + + +F+ E+ ++ LQH N+V+
Sbjct: 19 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 491 LLG-CSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
G C G L L+ E++P SL +L + ++ K I +G+ YL
Sbjct: 79 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAER--IDHIKLLQYTSQICKGMEYL--- 133
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT-YGYMSPEYAM 607
R IHRDL NIL++++ KI DFG+ ++ ++ K + + +PE
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 608 SGIVSIKTDVFSFGVLVLEIVS 629
S+ +DV+SFGV++ E+ +
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 81.3 bits (199), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 20/210 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-----VAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
F LG G FG VYKG E E VAI L + S + E +E ++A +
Sbjct: 49 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF----NSGRKNVLNWEKRFIIIEGIS 539
+ ++ RLLG L +L+ + MP L ++ N G + +LNW I+
Sbjct: 109 DNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 161
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+G+ YL R++HRDL A N+L+ + KI+DFG+A++ E E + +
Sbjct: 162 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 218
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+ E + I + ++DV+S+GV V E+++
Sbjct: 219 WMALESILHRIYTHQSDVWSYGVTVWELMT 248
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 81.3 bits (199), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 77/272 (28%), Positives = 125/272 (45%), Gaps = 26/272 (9%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQ-EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+ + +KLG G +G VY+G VA+K L + + + EF E ++ +++H NLV
Sbjct: 218 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 276
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+LLG ++ EFM +L +L R+ V N + IS + YL K +
Sbjct: 277 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN 335
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIF--EVNESEANTKRIVGTYGYMSPEYAM 607
IHR+L A N L+ + K++DFG++R+ + + A K + + +PE
Sbjct: 336 ---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLA 389
Query: 608 SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667
SIK+DV++FGVL+ EI T P + ++LL +E +
Sbjct: 390 YNKFSIKSDVWAFGVLLWEIA------TYGMSPYPGIDLSQVYELLEKDYRMERPEGC-- 441
Query: 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
P E+MR C Q DRP+ E+
Sbjct: 442 -PEKVYELMRA------CWQWNPSDRPSFAEI 466
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 80.9 bits (198), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 77/272 (28%), Positives = 125/272 (45%), Gaps = 26/272 (9%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQ-EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+ + +KLG G +G VY+G VA+K L + + + EF E ++ +++H NLV
Sbjct: 260 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 318
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+LLG ++ EFM +L +L R+ V N + IS + YL K +
Sbjct: 319 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN 377
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIF--EVNESEANTKRIVGTYGYMSPEYAM 607
IHR+L A N L+ + K++DFG++R+ + + A K + + +PE
Sbjct: 378 ---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLA 431
Query: 608 SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667
SIK+DV++FGVL+ EI T P + ++LL +E +
Sbjct: 432 YNKFSIKSDVWAFGVLLWEIA------TYGMSPYPGIDLSQVYELLEKDYRMERPEGC-- 483
Query: 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
P E+MR C Q DRP+ E+
Sbjct: 484 -PEKVYELMRA------CWQWNPSDRPSFAEI 508
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 80.9 bits (198), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 60/201 (29%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 437 KLGEGGFGPVYKGKLADEQE-----VAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRL 491
+LG+G FG V + Q+ VA+K+L S+ + + +F+ E+ ++ LQH N+V+
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 492 LG-CSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
G C G L L+ E++P SL +L K ++ K I +G+ YL
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 131
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT-YGYMSPEYAMS 608
R IHRDL NIL++++ KI DFG+ ++ ++ K + + +PE
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE 191
Query: 609 GIVSIKTDVFSFGVLVLEIVS 629
S+ +DV+SFGV++ E+ +
Sbjct: 192 SKFSVASDVWSFGVVLYELFT 212
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 80.9 bits (198), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 76/272 (27%), Positives = 126/272 (46%), Gaps = 26/272 (9%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQ-EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+ + +KLG G +G VY+G VA+K L + + + EF E ++ +++H NLV
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 279
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+LLG ++ EFM +L +L R+ V ++ + IS + YL K +
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKKN 338
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIF--EVNESEANTKRIVGTYGYMSPEYAM 607
IHR+L A N L+ + K++DFG++R+ + + A K + + +PE
Sbjct: 339 ---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLA 392
Query: 608 SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667
SIK+DV++FGVL+ EI T P + ++LL +E +
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIA------TYGMSPYPGIDLSQVYELLEKDYRMERPEGC-- 444
Query: 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
P E+MR C Q DRP+ E+
Sbjct: 445 -PEKVYELMRA------CWQWNPSDRPSFAEI 469
>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
pdb|2BVA|B Chain B, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 292
Score = 80.5 bits (197), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 67/232 (28%), Positives = 112/232 (48%), Gaps = 12/232 (5%)
Query: 437 KLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCS 495
K+GEG G V + + VA+K++ Q NEV ++ QH N+V +
Sbjct: 27 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 496 LHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
L G+E +V EF+ +L + ++ +N E+ + + Q L LH VIH
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQG---VIH 139
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKT 615
RD+K+ +ILL K+SDFG +V++ K +VGT +M+PE +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 197
Query: 616 DVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667
D++S G++V+E+V G+ + P + + +I L K L + PSL+
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD--NLPPRLKNLHKVSPSLK 247
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 80.5 bits (197), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 69/210 (32%), Positives = 111/210 (52%), Gaps = 17/210 (8%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAK 482
+ NF K+GEG +G VYK KL E VA+K++ + +G+ E+ L+ +
Sbjct: 3 GSMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 483 LQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQ 540
L H N+V+LL +H E +L LV+EF+ + L F+ S + L K ++ + Q
Sbjct: 62 LNHPNIVKLLDV-IHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLF--QLLQ 117
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
GL + H + RV+HRDLK N+L++ + K++DFG+AR F V + V T Y
Sbjct: 118 GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWY 172
Query: 601 MSPEYAMS-GIVSIKTDVFSFGVLVLEIVS 629
+PE + S D++S G + E+V+
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202
>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r
In Complex With Dasatinib
Length = 265
Score = 80.5 bits (197), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 72/267 (26%), Positives = 124/267 (46%), Gaps = 24/267 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+ + +LG G FG V GK + +VAIK + S EF E +++ L H LV
Sbjct: 9 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 67
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+L G ++ E+M N L +L ++ ++ + + + + + YL
Sbjct: 68 QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK- 124
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG 609
+ +HRDL A N L++D+ K+SDFG++R + +++ +++ + PE M
Sbjct: 125 --QFLHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSRGSKFPVRWSPPEVLMYS 181
Query: 610 IVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668
S K+D+++FGVL+ EI S G+ + R I +GL L P L
Sbjct: 182 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI---------AQGLRLYRPHL-- 230
Query: 669 PCSANEVMRCIHVGLLCVQDQAMDRPT 695
A+E + I C ++A +RPT
Sbjct: 231 ---ASEKVYTIMYS--CWHEKADERPT 252
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 80.5 bits (197), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 69/210 (32%), Positives = 111/210 (52%), Gaps = 17/210 (8%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAK 482
+ NF K+GEG +G VYK KL E VA+K++ + +G+ E+ L+ +
Sbjct: 1 GSMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKE 59
Query: 483 LQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQ 540
L H N+V+LL +H E +L LV+EF+ + L F+ S + L K ++ + Q
Sbjct: 60 LNHPNIVKLLDV-IHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLF--QLLQ 115
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
GL + H + RV+HRDLK N+L++ + K++DFG+AR F V + V T Y
Sbjct: 116 GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWY 170
Query: 601 MSPEYAMS-GIVSIKTDVFSFGVLVLEIVS 629
+PE + S D++S G + E+V+
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200
>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972
pdb|3QTI|B Chain B, C-Met Kinase In Complex With Nvp-Bvu972
Length = 314
Score = 80.5 bits (197), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 87/304 (28%), Positives = 137/304 (45%), Gaps = 37/304 (12%)
Query: 406 SPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQ----EVAIKR 461
+PE Q++ H + I ++ +G G FG VY G L D A+K
Sbjct: 13 NPELVQAVQHVV-------IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 65
Query: 462 LSRSSGQG-IVEFKNEVRLIAKLQHTNLVRLLGCSLHGE-ERLLVYEFMPNKSLDFFLFN 519
L+R + G + +F E ++ H N++ LLG L E L+V +M + L F+ N
Sbjct: 66 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 125
Query: 520 SGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579
+ F + +++G+ +L + + +HRDL A N +LD+K K++DFG+A
Sbjct: 126 ETHNPTVKDLIGFGL--QVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 180
Query: 580 RIFEVNE--SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRH 637
R E S N +M+ E + + K+DV+SFGVL+ E++ TR
Sbjct: 181 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM------TRG 234
Query: 638 HPDRP-LNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTM 696
P P +N LL +G L+ P P EVM L C +A RP+
Sbjct: 235 APPYPDVNTFDITVYLL---QGRRLLQPEY-CPDPLYEVM------LKCWHPKAEMRPSF 284
Query: 697 PEVV 700
E+V
Sbjct: 285 SELV 288
>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain
Of Csf-1r
Length = 329
Score = 80.1 bits (196), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 81/297 (27%), Positives = 139/297 (46%), Gaps = 40/297 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYK------GKLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAK 482
NN LG G FG V + GK +VA+K L ++ E +E+++++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 483 L-QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG---- 537
L QH N+V LLG HG L++ E+ L FL ++ + R + +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 165
Query: 538 ---ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES----EAN 590
++QG+ +L + IHRD+ A N+LL + KI DFG+AR +N+S + N
Sbjct: 166 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI-MNDSNYIVKGN 221
Query: 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAW 650
+ V +M+PE + ++++DV+S+G+L+ EI S N +P +N Y
Sbjct: 222 ARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN---PYPGILVNSKFY-- 273
Query: 651 QLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707
+L+ D G ++ P+ P + +M+ C + RPT ++ LQ +
Sbjct: 274 KLVKD--GYQMAQPAFA-PKNIYSIMQA------CWALEPTHRPTFQQICSFLQEQA 321
>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent
Protein Kinase Cgd3_920 From Cryptosporidium Parvum
Length = 286
Score = 80.1 bits (196), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 16/208 (7%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQG--IVEFKNEVRLIAKLQH 485
A ++ LG+G FG V K K +QE A+K ++++S + EV L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
N+++L +V E L + R + + + II+ + G+ Y+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYM 137
Query: 546 HKYSRLRVIHRDLKASNILLDDK---MNPKISDFGMARIFEVNESEANTKRIVGTYGYMS 602
HK++ ++HRDLK NILL+ K + KI DFG++ F+ N K +GT Y++
Sbjct: 138 HKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIA 191
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
PE + G K DV+S GV++ ++SG
Sbjct: 192 PE-VLRGTYDEKCDVWSAGVILYILLSG 218
>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolotriazine Based Inhibitor
Length = 373
Score = 80.1 bits (196), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 82/272 (30%), Positives = 126/272 (46%), Gaps = 30/272 (11%)
Query: 438 LGEGGFGPVYKGKLADEQ----EVAIKRLSRSSGQG-IVEFKNEVRLIAKLQHTNLVRLL 492
+G G FG VY G L D A+K L+R + G + +F E ++ H N++ LL
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 493 GCSLHGE-ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRL 551
G L E L+V +M + L F+ N + F + +++G+ +L +
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 211
Query: 552 RVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE--SEANTKRIVGTYGYMSPEYAMSG 609
+ +HRDL A N +LD+K K++DFG+AR E S N +M+ E +
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 271
Query: 610 IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRP-LNLIGYAWQLLSDGKGLELIDPSLEQ 668
+ K+DV+SFGVL+ E++ TR P P +N LL +G L+ P
Sbjct: 272 KFTTKSDVWSFGVLLWELM------TRGAPPYPDVNTFDITVYLL---QGRRLLQPEY-C 321
Query: 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVV 700
P EVM L C +A RP+ E+V
Sbjct: 322 PDPLYEVM------LKCWHPKAEMRPSFSELV 347
>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase
Domain
Length = 317
Score = 80.1 bits (196), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 81/297 (27%), Positives = 139/297 (46%), Gaps = 40/297 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYK------GKLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAK 482
NN LG G FG V + GK +VA+K L ++ E +E+++++
Sbjct: 38 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 483 L-QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG---- 537
L QH N+V LLG HG L++ E+ L FL ++ + R + +
Sbjct: 98 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 157
Query: 538 ---ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES----EAN 590
++QG+ +L + IHRD+ A N+LL + KI DFG+AR +N+S + N
Sbjct: 158 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI-MNDSNYIVKGN 213
Query: 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAW 650
+ V +M+PE + ++++DV+S+G+L+ EI S N +P +N Y
Sbjct: 214 ARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN---PYPGILVNSKFY-- 265
Query: 651 QLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707
+L+ D G ++ P+ P + +M+ C + RPT ++ LQ +
Sbjct: 266 KLVKD--GYQMAQPAFA-PKNIYSIMQA------CWALEPTHRPTFQQICSFLQEQA 313
>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
pdb|3S95|B Chain B, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
Length = 310
Score = 80.1 bits (196), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 20/205 (9%)
Query: 438 LGEGGFGPVYKGKLADEQEVAI-KRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
LG+G FG K + EV + K L R + F EV+++ L+H N+++ +G L
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV-L 76
Query: 497 HGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
+ ++RL + E++ +L + + W +R + I+ G+ YLH + +IH
Sbjct: 77 YKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIH 131
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR------------IVGTYGYMSP 603
RDL + N L+ + N ++DFG+AR+ +++ R +VG +M+P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 604 EYAMSGIVSIKTDVFSFGVLVLEIV 628
E K DVFSFG+++ EI+
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEII 216
>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium
Parvum Calcium Dependent Protein Kinase In Complex With
3- Mb-Pp1
Length = 287
Score = 80.1 bits (196), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 16/208 (7%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQG--IVEFKNEVRLIAKLQH 485
A ++ LG+G FG V K K +QE A+K ++++S + EV L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
N+++L +V E L + R + + + II+ + G+ Y+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYM 137
Query: 546 HKYSRLRVIHRDLKASNILLDDK---MNPKISDFGMARIFEVNESEANTKRIVGTYGYMS 602
HK++ ++HRDLK NILL+ K + KI DFG++ F+ N K +GT Y++
Sbjct: 138 HKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIA 191
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
PE + G K DV+S GV++ ++SG
Sbjct: 192 PE-VLRGTYDEKCDVWSAGVILYILLSG 218
>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Pf-03758309
pdb|4APP|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With (S)-N-(5-(3-Benzyl-1-Methylpiperazine-4-
Carbonyl)-6,6-Dimethyl-1,4,5,6-Tetrahydropyrrolo(3,4-C)
Pyrazol-3-Yl)-3-Phenoxybenzamide
Length = 296
Score = 80.1 bits (196), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 67/232 (28%), Positives = 112/232 (48%), Gaps = 12/232 (5%)
Query: 437 KLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCS 495
K+GEG G V + + VA+K++ Q NEV ++ QH N+V +
Sbjct: 31 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 496 LHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
L G+E +V EF+ +L + ++ +N E+ + + Q L LH VIH
Sbjct: 91 LVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQG---VIH 143
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKT 615
RD+K+ +ILL K+SDFG +V++ K +VGT +M+PE +
Sbjct: 144 RDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 201
Query: 616 DVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667
D++S G++V+E+V G+ + P + + +I L K L + PSL+
Sbjct: 202 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD--NLPPRLKNLHKVSPSLK 251
>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With
6-Benzyloxyquinoline Inhibitor
Length = 319
Score = 80.1 bits (196), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 87/304 (28%), Positives = 137/304 (45%), Gaps = 37/304 (12%)
Query: 406 SPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQ----EVAIKR 461
+PE Q++ H + I ++ +G G FG VY G L D A+K
Sbjct: 18 NPELVQAVQHVV-------IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 70
Query: 462 LSRSSGQG-IVEFKNEVRLIAKLQHTNLVRLLGCSLHGE-ERLLVYEFMPNKSLDFFLFN 519
L+R + G + +F E ++ H N++ LLG L E L+V +M + L F+ N
Sbjct: 71 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 130
Query: 520 SGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579
+ F + +++G+ +L + + +HRDL A N +LD+K K++DFG+A
Sbjct: 131 ETHNPTVKDLIGFGL--QVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 185
Query: 580 RIFEVNE--SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRH 637
R E S N +M+ E + + K+DV+SFGVL+ E++ TR
Sbjct: 186 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM------TRG 239
Query: 638 HPDRP-LNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTM 696
P P +N LL +G L+ P P EVM L C +A RP+
Sbjct: 240 APPYPDVNTFDITVYLL---QGRRLLQPEY-CPDPLYEVM------LKCWHPKAEMRPSF 289
Query: 697 PEVV 700
E+V
Sbjct: 290 SELV 293
>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CTJ|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CE3|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolopyridinepyridone Based Inhibitor
pdb|3F82|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
N-
(4-(2-Amino-3-Chloropyridin-4-Yloxy)-3-Fluorophenyl)-4-
Ethoxy-1-(4-Fluorophenyl)-2-Oxo-1,2-Dihydropyridine-3-
Carboxamide
pdb|3L8V|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepat Growth Factor Receptor C-Met In Complex With A
Biarylamine Inhibitor
Length = 314
Score = 80.1 bits (196), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 87/304 (28%), Positives = 137/304 (45%), Gaps = 37/304 (12%)
Query: 406 SPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQ----EVAIKR 461
+PE Q++ H + I ++ +G G FG VY G L D A+K
Sbjct: 13 NPELVQAVQHVV-------IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 65
Query: 462 LSRSSGQG-IVEFKNEVRLIAKLQHTNLVRLLGCSLHGE-ERLLVYEFMPNKSLDFFLFN 519
L+R + G + +F E ++ H N++ LLG L E L+V +M + L F+ N
Sbjct: 66 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 125
Query: 520 SGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579
+ F + +++G+ +L + + +HRDL A N +LD+K K++DFG+A
Sbjct: 126 ETHNPTVKDLIGFGL--QVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 180
Query: 580 RIFEVNE--SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRH 637
R E S N +M+ E + + K+DV+SFGVL+ E++ TR
Sbjct: 181 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM------TRG 234
Query: 638 HPDRP-LNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTM 696
P P +N LL +G L+ P P EVM L C +A RP+
Sbjct: 235 APPYPDVNTFDITVYLL---QGRRLLQPEY-CPDPLYEVM------LKCWHPKAEMRPSF 284
Query: 697 PEVV 700
E+V
Sbjct: 285 SELV 288
>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
The Microbial Alkaloid K-252a
pdb|1R1W|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met
Length = 312
Score = 80.1 bits (196), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 87/304 (28%), Positives = 137/304 (45%), Gaps = 37/304 (12%)
Query: 406 SPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQ----EVAIKR 461
+PE Q++ H + I ++ +G G FG VY G L D A+K
Sbjct: 11 NPELVQAVQHVV-------IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 63
Query: 462 LSRSSGQG-IVEFKNEVRLIAKLQHTNLVRLLGCSLHGE-ERLLVYEFMPNKSLDFFLFN 519
L+R + G + +F E ++ H N++ LLG L E L+V +M + L F+ N
Sbjct: 64 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 123
Query: 520 SGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579
+ F + +++G+ +L + + +HRDL A N +LD+K K++DFG+A
Sbjct: 124 ETHNPTVKDLIGFGL--QVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 178
Query: 580 RIFEVNE--SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRH 637
R E S N +M+ E + + K+DV+SFGVL+ E++ TR
Sbjct: 179 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM------TRG 232
Query: 638 HPDRP-LNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTM 696
P P +N LL +G L+ P P EVM L C +A RP+
Sbjct: 233 APPYPDVNTFDITVYLL---QGRRLLQPEY-CPDPLYEVM------LKCWHPKAEMRPSF 282
Query: 697 PEVV 700
E+V
Sbjct: 283 SELV 286
>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine
Kinase Bound To A Pyrrolopyrimidine-Containing Compound
Length = 283
Score = 80.1 bits (196), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 76/269 (28%), Positives = 123/269 (45%), Gaps = 28/269 (10%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+ + +LG G FG V GK + +VAIK + S EF E +++ L H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 82
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+L G ++ E+M N L +L ++ ++ + + + + + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK- 139
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE--SEANTKRIVGTYGYMSPEYAM 607
+ +HRDL A N L++D+ K+SDFG++R +E S +K V + PE M
Sbjct: 140 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV---RWSPPEVLM 194
Query: 608 SGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
S K+D+++FGVL+ EI S G+ + R I +GL L P L
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI---------AQGLRLYRPHL 245
Query: 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPT 695
A+E + I C ++A +RPT
Sbjct: 246 -----ASEKVYTIMYS--CWHEKADERPT 267
>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1
pdb|3DKF|A Chain A, Sgx Clone 5698a65kfg1h1
Length = 317
Score = 79.7 bits (195), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 87/304 (28%), Positives = 137/304 (45%), Gaps = 37/304 (12%)
Query: 406 SPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQ----EVAIKR 461
+PE Q++ H + I ++ +G G FG VY G L D A+K
Sbjct: 14 NPELVQAVQHVV-------IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 66
Query: 462 LSRSSGQG-IVEFKNEVRLIAKLQHTNLVRLLGCSLHGE-ERLLVYEFMPNKSLDFFLFN 519
L+R + G + +F E ++ H N++ LLG L E L+V +M + L F+ N
Sbjct: 67 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 126
Query: 520 SGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579
+ F + +++G+ +L + + +HRDL A N +LD+K K++DFG+A
Sbjct: 127 ETHNPTVKDLIGFGL--QVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 181
Query: 580 RIFEVNE--SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRH 637
R E S N +M+ E + + K+DV+SFGVL+ E++ TR
Sbjct: 182 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM------TRG 235
Query: 638 HPDRP-LNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTM 696
P P +N LL +G L+ P P EVM L C +A RP+
Sbjct: 236 APPYPDVNTFDITVYLL---QGRRLLQPEY-CPDPLYEVM------LKCWHPKAEMRPSF 285
Query: 697 PEVV 700
E+V
Sbjct: 286 SELV 289
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 79.7 bits (195), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 69/207 (33%), Positives = 111/207 (53%), Gaps = 17/207 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAKLQH 485
NF K+GEG +G VYK KL E VA+K++ + +G+ E+ L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 486 TNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQGLL 543
N+V+LL +H E +L LV+E + ++ L F+ S + L K ++ + QGL
Sbjct: 61 PNIVKLLDV-IHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLF--QLLQGLA 116
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
+ H + RV+HRDLK N+L++ + K++DFG+AR F V T +V T Y +P
Sbjct: 117 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAP 171
Query: 604 EYAMS-GIVSIKTDVFSFGVLVLEIVS 629
E + S D++S G + E+V+
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVT 198
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 79.7 bits (195), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 59/201 (29%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 437 KLGEGGFGPVYKGKLADEQE-----VAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRL 491
+LG+G FG V + Q+ VA+K+L S+ + + +F+ E+ ++ LQH N+V+
Sbjct: 18 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 492 LG-CSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
G C G L L+ E++P SL +L K ++ K I +G+ YL
Sbjct: 78 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 132
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT-YGYMSPEYAMS 608
R IHR+L NIL++++ KI DFG+ ++ ++ K + + +PE
Sbjct: 133 TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE 192
Query: 609 GIVSIKTDVFSFGVLVLEIVS 629
S+ +DV+SFGV++ E+ +
Sbjct: 193 SKFSVASDVWSFGVVLYELFT 213
>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A
Thiazolopyrimidine Inhibitor
Length = 324
Score = 79.7 bits (195), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 65/220 (29%), Positives = 110/220 (50%), Gaps = 28/220 (12%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADE---QEVAIKRLSR-SSGQGIVEFKNEVRLIAKL-Q 484
N+ + +GEG FG V K ++ + + AIKR+ +S +F E+ ++ KL
Sbjct: 22 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSL-DF------------FLFNSGRKNVLNWEKR 531
H N++ LLG H L E+ P+ +L DF F + + L+ ++
Sbjct: 82 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 532 FIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANT 591
+++G+ YL S+ + IHR+L A NIL+ + KI+DFG++R EV
Sbjct: 142 LHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEV-----YV 193
Query: 592 KRIVGT--YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
K+ +G +M+ E + + +DV+S+GVL+ EIVS
Sbjct: 194 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233
>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1
Length = 317
Score = 79.7 bits (195), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 87/304 (28%), Positives = 137/304 (45%), Gaps = 37/304 (12%)
Query: 406 SPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQ----EVAIKR 461
+PE Q++ H + I ++ +G G FG VY G L D A+K
Sbjct: 14 NPELVQAVQHVV-------IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 66
Query: 462 LSRSSGQG-IVEFKNEVRLIAKLQHTNLVRLLGCSLHGE-ERLLVYEFMPNKSLDFFLFN 519
L+R + G + +F E ++ H N++ LLG L E L+V +M + L F+ N
Sbjct: 67 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 126
Query: 520 SGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579
+ F + +++G+ +L + + +HRDL A N +LD+K K++DFG+A
Sbjct: 127 ETHNPTVKDLIGFGL--QVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 181
Query: 580 RIFEVNE--SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRH 637
R E S N +M+ E + + K+DV+SFGVL+ E++ TR
Sbjct: 182 RDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM------TRG 235
Query: 638 HPDRP-LNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTM 696
P P +N LL +G L+ P P EVM L C +A RP+
Sbjct: 236 APPYPDVNTFDITVYLL---QGRRLLQPEY-CPDPLYEVM------LKCWHPKAEMRPSF 285
Query: 697 PEVV 700
E+V
Sbjct: 286 SELV 289
>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Isopropyl-7-
(4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3-
Ylamino)-2h- Phthalazin-1-One
pdb|3PIY|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With R406
pdb|3PIZ|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
(5-Amino-1-O-
Tolyl-1h-Pyrazol-4-Yl)-[3-(1-Methanesulfonyl-Piperidin-
4-Yl)-Phenyl]- Methanone
pdb|3PJ1|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
3-(2,6-Dichloro-
Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-Phenylamino]-1-
Methyl-3,4- Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3PJ2|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-[4-(2-
Diethylamino-Ethoxy)-Phenylamino]-6-(4-Fluoro-Phenoxy)-
8-Methyl-8h- Pyrido[2,3-D]pyrimidin-7-One
pdb|3PJ3|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Methyl-5-[(E)-
(3-Phenyl-Acryloyl)amino]-N-(2-Phenyl-3h-Imidazo[4,
5-B]pyridin-6-Yl)- Benzamide
Length = 274
Score = 79.3 bits (194), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 76/269 (28%), Positives = 123/269 (45%), Gaps = 28/269 (10%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+ + +LG G FG V GK + +VAIK + S EF E +++ L H LV
Sbjct: 15 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 73
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+L G ++ E+M N L +L ++ ++ + + + + + YL
Sbjct: 74 QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK- 130
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE--SEANTKRIVGTYGYMSPEYAM 607
+ +HRDL A N L++D+ K+SDFG++R +E S +K V + PE M
Sbjct: 131 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV---RWSPPEVLM 185
Query: 608 SGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
S K+D+++FGVL+ EI S G+ + R I +GL L P L
Sbjct: 186 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI---------AQGLRLYRPHL 236
Query: 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPT 695
A+E + I C ++A +RPT
Sbjct: 237 -----ASEKVYTIMYS--CWHEKADERPT 258
>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain
pdb|3P08|B Chain B, Crystal Structure Of The Human Btk Kinase Domain
Length = 267
Score = 79.3 bits (194), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 75/270 (27%), Positives = 124/270 (45%), Gaps = 30/270 (11%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+ + +LG G FG V GK + +VAIK + S EF E +++ L H LV
Sbjct: 8 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 66
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+L G ++ E+M N L +L ++ ++ + + + + + YL
Sbjct: 67 QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK- 123
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT---YGYMSPEYA 606
+ +HRDL A N L++D+ K+SDFG++R +E ++ VG+ + PE
Sbjct: 124 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVL 177
Query: 607 MSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665
M S K+D+++FGVL+ EI S G+ + R I +GL L P
Sbjct: 178 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI---------AQGLRLYRPH 228
Query: 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPT 695
L A+E + I C ++A +RPT
Sbjct: 229 L-----ASEKVYTIMYS--CWHEKADERPT 251
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 79.3 bits (194), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 73/257 (28%), Positives = 111/257 (43%), Gaps = 26/257 (10%)
Query: 375 IPLLCYLCYVTWRKLKAKDNVSLLPTYGKRKSPEKDQSISHELKIFDFQTIAAAANNFST 434
IPLL T + L K V L R P+ ++HE +
Sbjct: 78 IPLLIDHLLSTQQPLTKKSGVVL-----HRAVPKDKWVLNHE--------------DLVL 118
Query: 435 TNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGI-VEFKNEVRLIAKLQHTNLVRLL 492
++G G FG V+ G+L AD VA+K + + +F E R++ + H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
G + +V E + FL G + L + ++ + G+ YL
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGAR--LRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVS 612
IHRDL A N L+ +K KISDFGM+R A+ + +PE G S
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 613 IKTDVFSFGVLVLEIVS 629
++DV+SFG+L+ E S
Sbjct: 294 SESDVWSFGILLWETFS 310
>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex
With Inhibitor Cgi1746
Length = 271
Score = 79.3 bits (194), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 76/269 (28%), Positives = 123/269 (45%), Gaps = 28/269 (10%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+ + +LG G FG V GK + +VAIK + S EF E +++ L H LV
Sbjct: 9 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 67
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+L G ++ E+M N L +L ++ ++ + + + + + YL
Sbjct: 68 QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK- 124
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE--SEANTKRIVGTYGYMSPEYAM 607
+ +HRDL A N L++D+ K+SDFG++R +E S +K V + PE M
Sbjct: 125 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV---RWSPPEVLM 179
Query: 608 SGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
S K+D+++FGVL+ EI S G+ + R I +GL L P L
Sbjct: 180 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI---------AQGLRLYRPHL 230
Query: 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPT 695
A+E + I C ++A +RPT
Sbjct: 231 -----ASEKVYTIMYS--CWHEKADERPT 252
>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb
Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP
Length = 311
Score = 79.0 bits (193), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 15/212 (7%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQG---IVEFKNEVRLIAKLQHTNLVRLLG 493
LG GG V+ + L D ++VA+K L + + F+ E + A L H +V +
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 494 C----SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+ G +V E++ +L + G + ++ +I Q L + H+
Sbjct: 80 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG 136
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEANTKRIVGTYGYMSPEYAMS 608
+IHRD+K +NI++ K+ DFG+AR I + S T ++GT Y+SPE A
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 609 GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPD 640
V ++DV+S G ++ E+++G+ T PD
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPD 225
>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain
pdb|1K2P|B Chain B, Crystal Structure Of Bruton's Tyrosine Kinase Domain
Length = 263
Score = 79.0 bits (193), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 75/270 (27%), Positives = 124/270 (45%), Gaps = 30/270 (11%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+ + +LG G FG V GK + +VAIK + S EF E +++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+L G ++ E+M N L +L ++ ++ + + + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK- 119
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT---YGYMSPEYA 606
+ +HRDL A N L++D+ K+SDFG++R +E ++ VG+ + PE
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVL 173
Query: 607 MSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665
M S K+D+++FGVL+ EI S G+ + R I +GL L P
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI---------AQGLRLYRPH 224
Query: 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPT 695
L A+E + I C ++A +RPT
Sbjct: 225 L-----ASEKVYTIMYS--CWHEKADERPT 247
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 79.0 bits (193), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 73/257 (28%), Positives = 111/257 (43%), Gaps = 26/257 (10%)
Query: 375 IPLLCYLCYVTWRKLKAKDNVSLLPTYGKRKSPEKDQSISHELKIFDFQTIAAAANNFST 434
IPLL T + L K V L R P+ ++HE +
Sbjct: 78 IPLLIDHLLSTQQPLTKKSGVVL-----HRAVPKDKWVLNHE--------------DLVL 118
Query: 435 TNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGI-VEFKNEVRLIAKLQHTNLVRLL 492
++G G FG V+ G+L AD VA+K + + +F E R++ + H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
G + +V E + FL G + L + ++ + G+ YL
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGAR--LRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVS 612
IHRDL A N L+ +K KISDFGM+R A+ + +PE G S
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 613 IKTDVFSFGVLVLEIVS 629
++DV+SFG+L+ E S
Sbjct: 294 SESDVWSFGILLWETFS 310
>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1,
Cgd3_920
pdb|3MWU|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Rm-1-95
pdb|3NCG|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Nm-Pp1
Length = 486
Score = 79.0 bits (193), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 16/208 (7%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQG--IVEFKNEVRLIAKLQH 485
A ++ LG+G FG V K K +QE A+K ++++S + EV L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
N+++L +V E L + R + + + II+ + G+ Y+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYM 137
Query: 546 HKYSRLRVIHRDLKASNILLDDK---MNPKISDFGMARIFEVNESEANTKRIVGTYGYMS 602
HK++ ++HRDLK NILL+ K + KI DFG++ F+ N K +GT Y++
Sbjct: 138 HKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIA 191
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
PE + G K DV+S GV++ ++SG
Sbjct: 192 PE-VLRGTYDEKCDVWSAGVILYILLSG 218
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 78.6 bits (192), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 68/210 (32%), Positives = 111/210 (52%), Gaps = 17/210 (8%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAK 482
+ NF K+GEG +G VYK KL E VA+K++ + +G+ E+ L+ +
Sbjct: 3 GSMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 483 LQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQ 540
L H N+V+LL +H E +L LV+E + ++ L F+ S + L K ++ + Q
Sbjct: 62 LNHPNIVKLLDV-IHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSYLF--QLLQ 117
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
GL + H + RV+HRDLK N+L++ + K++DFG+AR F V + V T Y
Sbjct: 118 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWY 172
Query: 601 MSPEYAMS-GIVSIKTDVFSFGVLVLEIVS 629
+PE + S D++S G + E+V+
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202
>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled
Receptor Kinase 2 And Heterotrimeric G Protein Beta 1
And Gamma 2 Subunits
pdb|1YM7|A Chain A, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|B Chain B, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|C Chain C, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|D Chain D, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|2BCJ|A Chain A, Crystal Structure Of G Protein-coupled Receptor Kinase 2
In Complex With Galpha-q And Gbetagamma Subunits
pdb|3UZS|A Chain A, Structure Of The C13.28 Rna Aptamer Bound To The G
Protein-Coupled Receptor Kinase 2-Heterotrimeric G
Protein Beta 1 And Gamma 2 Subunit Complex
pdb|3UZT|A Chain A, Structure Of The C13.18 Rna Aptamer In Complex With G
Protein-Coupled Receptor Kinase 2
Length = 689
Score = 78.6 bits (192), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 73/232 (31%), Positives = 112/232 (48%), Gaps = 26/232 (11%)
Query: 425 IAAAANNFSTTNKLGEGGFGPVYKGKLADEQEV-AIKRLSRSS---GQGIVEFKNEVRLI 480
I N+FS +G GGFG VY + AD ++ A+K L + QG NE R++
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIM 242
Query: 481 AKLQHTNLVRLLGC---SLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE 536
L T + C + H ++L + + M L + L G + + RF E
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS--EADMRFYAAE 300
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
I GL ++H +R V++RDLK +NILLD+ + +ISD G+A F + A+ VG
Sbjct: 301 -IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VG 352
Query: 597 TYGYMSPEYAMSGIV-SIKTDVFSFGVLVLEIVSG------QKNHTRHHPDR 641
T+GYM+PE G+ D FS G ++ +++ G K +H DR
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 404
>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits
pdb|3PVU|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd101)
pdb|3PVW|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd103a)
Length = 695
Score = 78.6 bits (192), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 73/232 (31%), Positives = 112/232 (48%), Gaps = 26/232 (11%)
Query: 425 IAAAANNFSTTNKLGEGGFGPVYKGKLADEQEV-AIKRLSRSS---GQGIVEFKNEVRLI 480
I N+FS +G GGFG VY + AD ++ A+K L + QG NE R++
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIM 242
Query: 481 AKLQHTNLVRLLGC---SLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE 536
L T + C + H ++L + + M L + L G + + RF E
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS--EADMRFYAAE 300
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
I GL ++H +R V++RDLK +NILLD+ + +ISD G+A F + A+ VG
Sbjct: 301 -IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VG 352
Query: 597 TYGYMSPEYAMSGIV-SIKTDVFSFGVLVLEIVSG------QKNHTRHHPDR 641
T+GYM+PE G+ D FS G ++ +++ G K +H DR
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 404
>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A
Pyrrolo-Pyridine Inhibitor
Length = 273
Score = 78.6 bits (192), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 431 NFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNL 488
++ LGEG +G V E+ VA+K + E K E+ + A L H N+
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENV 67
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE---KRFIIIEGISQGLLYL 545
V+ G G + L E+ L F+ ++ E +RF + G++YL
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFF--HQLMAGVVYL 121
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
H + + HRD+K N+LLD++ N KISDFG+A +F N E ++ GT Y++PE
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 606 AMSGIVSIK-TDVFSFGVLVLEIVSGQ 631
+ DV+S G+++ +++G+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205
>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|B Chain B, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|C Chain C, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|D Chain D, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
Length = 290
Score = 78.6 bits (192), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 77/289 (26%), Positives = 134/289 (46%), Gaps = 35/289 (12%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQ-GIVEFKNEVRLIAKLQHTN 487
+++ +G G V A ++E VAIKR++ Q + E E++ +++ H N
Sbjct: 10 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKS-LDFF--LFNSG--RKNVLNWEKRFIIIEGISQGL 542
+V + +E LV + + S LD + G + VL+ I+ + +GL
Sbjct: 70 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF----EVNESEANTKRIVGTY 598
YLHK + IHRD+KA NILL + + +I+DFG++ ++ ++ K VGT
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR-KTFVGTP 185
Query: 599 GYMSPEYAMSGI--VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG 656
+M+PE M + K D++SFG+ +E+ +G + ++ P + L L
Sbjct: 186 CWMAPE-VMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT---------- 234
Query: 657 KGLELIDPSLEQPCSANEVMRCIHVGL-----LCVQDQAMDRPTMPEVV 700
L+ PSLE E+++ LC+Q RPT E++
Sbjct: 235 --LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281
>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYN|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYO|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
pdb|3NYO|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
Length = 576
Score = 78.2 bits (191), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 17/209 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYK------GKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL 483
N F LG+GGFG V GK+ +++ KR+ + G+ + NE +++ K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKV 241
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLL 543
+V L + LV M L F +++ G+ F E I GL
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLE 300
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANT-KRIVGTYGYMS 602
LH R R+++RDLK NILLDD + +ISD G+A V+ E T K VGT GYM+
Sbjct: 301 DLH---RERIVYRDLKPENILLDDHGHIRISDLGLA----VHVPEGQTIKGRVGTVGYMA 353
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
PE + + D ++ G L+ E+++GQ
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits
pdb|3V5W|A Chain A, Human G Protein-Coupled Receptor Kinase 2 In Complex With
Soluble Gbetagamma Subunits And Paroxetine
Length = 689
Score = 78.2 bits (191), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 73/232 (31%), Positives = 112/232 (48%), Gaps = 26/232 (11%)
Query: 425 IAAAANNFSTTNKLGEGGFGPVYKGKLADEQEV-AIKRLSRSS---GQGIVEFKNEVRLI 480
I N+FS +G GGFG VY + AD ++ A+K L + QG NE R++
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIM 242
Query: 481 AKLQHTNLVRLLGC---SLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE 536
L T + C + H ++L + + M L + L G + + RF E
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS--EADMRFYAAE 300
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
I GL ++H +R V++RDLK +NILLD+ + +ISD G+A F + A+ VG
Sbjct: 301 -IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VG 352
Query: 597 TYGYMSPEYAMSGIV-SIKTDVFSFGVLVLEIVSG------QKNHTRHHPDR 641
T+GYM+PE G+ D FS G ++ +++ G K +H DR
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 404
>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded
Form)
Length = 325
Score = 78.2 bits (191), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 25/219 (11%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAI-KRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCS 495
+LG+G FG VYK + + +A K + S + + ++ E+ ++A H N+V+LL
Sbjct: 44 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 496 LHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
+ ++ EF ++D + R L + ++ + L YLH ++IH
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDN---KIIH 158
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI------VGTYGYMSPEYAMSG 609
RDLKA NIL + K++DFG+ S NT+ I +GT +M+PE M
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGV--------SAKNTRXIQRRDSFIGTPYWMAPEVVMCE 210
Query: 610 I-----VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPL 643
K DV+S G+ ++E+ + H +P R L
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL 249
>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Soak)
pdb|3KRX|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Co-Crystal)
Length = 688
Score = 78.2 bits (191), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 73/232 (31%), Positives = 112/232 (48%), Gaps = 26/232 (11%)
Query: 425 IAAAANNFSTTNKLGEGGFGPVYKGKLADEQEV-AIKRLSRSS---GQGIVEFKNEVRLI 480
I N+FS +G GGFG VY + AD ++ A+K L + QG NE R++
Sbjct: 183 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIM 241
Query: 481 AKLQHTNLVRLLGC---SLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE 536
L T + C + H ++L + + M L + L G + + RF E
Sbjct: 242 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS--EADMRFYAAE 299
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
I GL ++H +R V++RDLK +NILLD+ + +ISD G+A F + A+ VG
Sbjct: 300 -IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VG 351
Query: 597 TYGYMSPEYAMSGIV-SIKTDVFSFGVLVLEIVSG------QKNHTRHHPDR 641
T+GYM+PE G+ D FS G ++ +++ G K +H DR
Sbjct: 352 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 403
>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|E Chain E, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|F Chain F, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|G Chain G, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|H Chain H, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORZ|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3OTU|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator Js30
Length = 316
Score = 78.2 bits (191), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 10/205 (4%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQH 485
+F LGEG F V + LA +E AIK L + + E ++++L H
Sbjct: 37 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
V+L C E+ + N L ++ G + RF E +S L YL
Sbjct: 97 PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVS-ALEYL 153
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
H +IHRDLK NILL++ M+ +I+DFG A++ +A VGT Y+SPE
Sbjct: 154 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 210
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVSG 630
+D+++ G ++ ++V+G
Sbjct: 211 LTEKSACKSSDLWALGCIIYQLVAG 235
>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (
Diphosphorylated Form) Bound To 5- Amino-3-((4-(
Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide
Length = 325
Score = 78.2 bits (191), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 25/219 (11%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAI-KRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCS 495
+LG+G FG VYK + + +A K + S + + ++ E+ ++A H N+V+LL
Sbjct: 44 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 496 LHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
+ ++ EF ++D + R L + ++ + L YLH ++IH
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDN---KIIH 158
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI------VGTYGYMSPEYAMSG 609
RDLKA NIL + K++DFG+ S NT+ I +GT +M+PE M
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGV--------SAKNTRXIQRRDXFIGTPYWMAPEVVMCE 210
Query: 610 I-----VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPL 643
K DV+S G+ ++E+ + H +P R L
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL 249
>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|B Chain B, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|C Chain C, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|D Chain D, Structure Of The Osr1 Kinase, A Hypertension Drug Target
Length = 303
Score = 78.2 bits (191), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 77/289 (26%), Positives = 134/289 (46%), Gaps = 35/289 (12%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQ-GIVEFKNEVRLIAKLQHTN 487
+++ +G G V A ++E VAIKR++ Q + E E++ +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKS-LDFF--LFNSG--RKNVLNWEKRFIIIEGISQGL 542
+V + +E LV + + S LD + G + VL+ I+ + +GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF----EVNESEANTKRIVGTY 598
YLHK + IHRD+KA NILL + + +I+DFG++ ++ ++ K VGT
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR-KTFVGTP 190
Query: 599 GYMSPEYAMSGI--VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG 656
+M+PE M + K D++SFG+ +E+ +G + ++ P + L L
Sbjct: 191 CWMAPE-VMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT---------- 239
Query: 657 KGLELIDPSLEQPCSANEVMRCIHVGL-----LCVQDQAMDRPTMPEVV 700
L+ PSLE E+++ LC+Q RPT E++
Sbjct: 240 --LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286
>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5-
Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide
Length = 325
Score = 78.2 bits (191), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 25/219 (11%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAI-KRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCS 495
+LG+G FG VYK + + +A K + S + + ++ E+ ++A H N+V+LL
Sbjct: 44 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 496 LHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
+ ++ EF ++D + R L + ++ + L YLH ++IH
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDN---KIIH 158
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI------VGTYGYMSPEYAMSG 609
RDLKA NIL + K++DFG+ S NT+ I +GT +M+PE M
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGV--------SAKNTRTIQRRDSFIGTPYWMAPEVVMCE 210
Query: 610 I-----VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPL 643
K DV+S G+ ++E+ + H +P R L
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL 249
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 78.2 bits (191), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 72/248 (29%), Positives = 113/248 (45%), Gaps = 36/248 (14%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKL------ADEQEVAIKRLSR-SSGQGIVEFKNEVRLIAK 482
N LGEG FG V K A VA+K L +S + + +E ++ +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 483 LQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGR-------------------- 522
+ H ++++L G LL+ E+ SL FL S +
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 523 -KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581
+ L ISQG+ YL + ++++HRDL A NIL+ + KISDFG++R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR- 198
Query: 582 FEVNESEANTKRIVGT--YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHH 638
+V E ++ KR G +M+ E I + ++DV+SFGVL+ EIV+ G +
Sbjct: 199 -DVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257
Query: 639 PDRPLNLI 646
P+R NL+
Sbjct: 258 PERLFNLL 265
>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
pdb|2ACX|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
Length = 576
Score = 77.8 bits (190), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 17/209 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYK------GKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL 483
N F LG+GGFG V GK+ +++ KR+ + G+ + NE +++ K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKV 241
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLL 543
+V L + LV M L F +++ G+ F E I GL
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLE 300
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANT-KRIVGTYGYMS 602
LH R R+++RDLK NILLDD + +ISD G+A V+ E T K VGT GYM+
Sbjct: 301 DLH---RERIVYRDLKPENILLDDHGHIRISDLGLA----VHVPEGQTIKGRVGTVGYMA 353
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
PE + + D ++ G L+ E+++GQ
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol
Length = 315
Score = 77.8 bits (190), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 66/217 (30%), Positives = 101/217 (46%), Gaps = 18/217 (8%)
Query: 417 LKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNE 476
L + D++ I +G G FG V K K ++VAIK++ S + F E
Sbjct: 3 LHMIDYKEI-------EVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERK--AFIVE 52
Query: 477 VRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE 536
+R ++++ H N+V+L G L+ LV E+ SL L +
Sbjct: 53 LRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCL 110
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILL-DDKMNPKISDFGMARIFEVNESEANTKRIV 595
SQG+ YLH +IHRDLK N+LL KI DFG A ++ N K
Sbjct: 111 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA--CDIQTHMTNNK--- 165
Query: 596 GTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQK 632
G+ +M+PE S K DVFS+G+++ E+++ +K
Sbjct: 166 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 202
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 77.4 bits (189), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 72/248 (29%), Positives = 113/248 (45%), Gaps = 36/248 (14%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKL------ADEQEVAIKRLSR-SSGQGIVEFKNEVRLIAK 482
N LGEG FG V K A VA+K L +S + + +E ++ +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 483 LQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGR-------------------- 522
+ H ++++L G LL+ E+ SL FL S +
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 523 -KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581
+ L ISQG+ YL + ++++HRDL A NIL+ + KISDFG++R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR- 198
Query: 582 FEVNESEANTKRIVGT--YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHH 638
+V E ++ KR G +M+ E I + ++DV+SFGVL+ EIV+ G +
Sbjct: 199 -DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257
Query: 639 PDRPLNLI 646
P+R NL+
Sbjct: 258 PERLFNLL 265
>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With
Its Activating Protein Tab1
pdb|2YIY|A Chain A, Crystal Structure Of Compound 8 Bound To Tak1-Tab
Length = 307
Score = 77.4 bits (189), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 66/217 (30%), Positives = 101/217 (46%), Gaps = 18/217 (8%)
Query: 417 LKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNE 476
L + D++ I +G G FG V K K ++VAIK++ S + F E
Sbjct: 2 LHMIDYKEI-------EVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERK--AFIVE 51
Query: 477 VRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE 536
+R ++++ H N+V+L G L+ LV E+ SL L +
Sbjct: 52 LRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCL 109
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILL-DDKMNPKISDFGMARIFEVNESEANTKRIV 595
SQG+ YLH +IHRDLK N+LL KI DFG A ++ N K
Sbjct: 110 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA--CDIQTHMTNNK--- 164
Query: 596 GTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQK 632
G+ +M+PE S K DVFS+G+++ E+++ +K
Sbjct: 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 201
>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin.
pdb|2BFY|B Chain B, Complex Of Aurora-B With Incenp And Hesperidin
Length = 284
Score = 77.4 bits (189), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 71/240 (29%), Positives = 116/240 (48%), Gaps = 28/240 (11%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSS--GQGIV-EFKNEVRLIAK 482
++F LG+G FG VY LA E++ +A+K L +S +G+ + + E+ + +
Sbjct: 14 DDFDIVRPLGKGKFGNVY---LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSH 70
Query: 483 LQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQG 541
L+H N++R+ H +R+ L+ EF P L L GR + ++ +E ++
Sbjct: 71 LRHPNILRMYN-YFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADA 126
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
L Y H+ +VIHRD+K N+L+ K KI+DFG + V+ + + GT Y+
Sbjct: 127 LHYCHER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYL 179
Query: 602 SPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ-----KNHTRHHPDRPLNLIGYAWQLLSDG 656
PE K D++ GVL E + G +HT H R +N+ LSDG
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH-RRIVNVDLKFPPFLSDG 238
>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
pdb|3F69|B Chain B, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
Length = 311
Score = 77.4 bits (189), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 15/211 (7%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQG---IVEFKNEVRLIAKLQHTNLVRLLG 493
LG GG V+ + L D ++VA+K L + + F+ E + A L H +V +
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 494 C----SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+ G +V E++ +L + G + ++ +I Q L + H+
Sbjct: 80 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG 136
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEANTKRIVGTYGYMSPEYAMS 608
+IHRD+K +NIL+ K+ DFG+AR I + S T ++GT Y+SPE A
Sbjct: 137 ---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARG 193
Query: 609 GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHP 639
V ++DV+S G ++ E+++G+ T P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224
>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5
pdb|2F57|B Chain B, Crystal Structure Of The Human P21-activated Kinase 5
Length = 317
Score = 77.4 bits (189), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 59/199 (29%), Positives = 101/199 (50%), Gaps = 16/199 (8%)
Query: 437 KLGEGGFGPVYKGKLADEQ----EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLL 492
K+GEG G V +A E+ +VA+K++ Q NEV ++ H N+V +
Sbjct: 52 KIGEGSTGIVC---IATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMY 108
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
L G+E +V EF+ +L + ++ +N E+ + + + L YLH
Sbjct: 109 SSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIATVCLSVLRALSYLHNQG--- 161
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVS 612
VIHRD+K+ +ILL K+SDFG +V++ K +VGT +M+PE
Sbjct: 162 VIHRDIKSDSILLTSDGRIKLSDFGFCA--QVSKEVPKRKXLVGTPYWMAPEVISRLPYG 219
Query: 613 IKTDVFSFGVLVLEIVSGQ 631
+ D++S G++V+E++ G+
Sbjct: 220 TEVDIWSLGIMVIEMIDGE 238
>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6
Length = 302
Score = 77.0 bits (188), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 77/277 (27%), Positives = 133/277 (48%), Gaps = 17/277 (6%)
Query: 438 LGEGGFGPV--YKGKLADE---QEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRL 491
LGEG FG V Y ++ + VA+K L G Q +K E+ ++ L H ++++
Sbjct: 22 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 492 LGCSL-HGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
GC GE+ L LV E++P SL +L ++ + + + + I +G+ YLH
Sbjct: 82 KGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHAQ- 136
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEANTKRIVGTYGYMSPEYAMS 608
IHR+L A N+LLD+ KI DFG+A+ + E +E + + +PE
Sbjct: 137 --HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 194
Query: 609 GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668
+DV+SFGV + E+++ + ++ P + L LIG A ++ + EL++
Sbjct: 195 YKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERL 253
Query: 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
P H+ C + +A RPT ++ +L+
Sbjct: 254 PRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKT 290
>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With
Quinoline-Thiadiazole- Thiophene Inhibitor
Length = 302
Score = 77.0 bits (188), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 77/277 (27%), Positives = 133/277 (48%), Gaps = 17/277 (6%)
Query: 438 LGEGGFGPV--YKGKLADE---QEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRL 491
LGEG FG V Y ++ + VA+K L G Q +K E+ ++ L H ++++
Sbjct: 22 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 492 LGCSL-HGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
GC GE+ L LV E++P SL +L ++ + + + + I +G+ YLH
Sbjct: 82 KGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHSQ- 136
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEANTKRIVGTYGYMSPEYAMS 608
IHR+L A N+LLD+ KI DFG+A+ + E +E + + +PE
Sbjct: 137 --HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 194
Query: 609 GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668
+DV+SFGV + E+++ + ++ P + L LIG A ++ + EL++
Sbjct: 195 YKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERL 253
Query: 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
P H+ C + +A RPT ++ +L+
Sbjct: 254 PRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKT 290
>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1
Length = 278
Score = 77.0 bits (188), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 426 AAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKL 483
A ++ LGEG +G V E+ VA+K + E K E+ + L
Sbjct: 1 APFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 60
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE---KRFIIIEGISQ 540
H N+V+ G G + L E+ L F+ ++ E +RF +
Sbjct: 61 NHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFF--HQLMA 114
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
G++YLH + + HRD+K N+LLD++ N KISDFG+A +F N E ++ GT Y
Sbjct: 115 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 171
Query: 601 MSPE-YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
++PE + DV+S G+++ +++G+
Sbjct: 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 203
>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 77.0 bits (188), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 431 NFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNL 488
++ LGEG +G V E+ VA+K + E K E+ + L H N+
Sbjct: 7 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE---KRFIIIEGISQGLLYL 545
V+ G G + L E+ L F+ ++ E +RF + G++YL
Sbjct: 67 VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFF--HQLMAGVVYL 120
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE- 604
H + + HRD+K N+LLD++ N KISDFG+A +F N E ++ GT Y++PE
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ DV+S G+++ +++G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 77.0 bits (188), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 73/248 (29%), Positives = 112/248 (45%), Gaps = 36/248 (14%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKL------ADEQEVAIKRLSR-SSGQGIVEFKNEVRLIAK 482
N LGEG FG V K A VA+K L +S + + +E ++ +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 483 LQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGR-------------------- 522
+ H ++++L G LL+ E+ SL FL S +
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 523 -KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581
+ L ISQG+ YL + S ++HRDL A NIL+ + KISDFG++R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGRKMKISDFGLSR- 198
Query: 582 FEVNESEANTKRIVGT--YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHH 638
+V E ++ KR G +M+ E I + ++DV+SFGVL+ EIV+ G +
Sbjct: 199 -DVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257
Query: 639 PDRPLNLI 646
P+R NL+
Sbjct: 258 PERLFNLL 265
>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017
pdb|2E9V|B Chain B, Structure Of H-Chk1 Complexed With A859017
Length = 268
Score = 77.0 bits (188), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 15/209 (7%)
Query: 429 ANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHT 486
++ LGEG +G V E+ VA+K + E K E+ + L H
Sbjct: 5 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE---KRFIIIEGISQGLL 543
N+V+ G G + L E+ L F+ ++ E +RF + G++
Sbjct: 65 NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFF--HQLMAGVV 118
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
YLH + + HRD+K N+LLD++ N KISDFG+A +F N E ++ GT Y++P
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 604 EYAMSGIVSIK-TDVFSFGVLVLEIVSGQ 631
E + DV+S G+++ +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204
>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156.
pdb|2X4F|B Chain B, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156
Length = 373
Score = 76.6 bits (187), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 67/221 (30%), Positives = 111/221 (50%), Gaps = 19/221 (8%)
Query: 420 FDFQTIAA---AANNFSTTNK---LGEGGFGPVYK-GKLADEQEVAIKRLSRSSGQGIVE 472
FD + + A A N+F T +K LG G FG V+K + A ++A K + + E
Sbjct: 73 FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE 132
Query: 473 FKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKR 531
KNE+ ++ +L H NL++L + +LV E++ L D + S L+
Sbjct: 133 VKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELD---T 189
Query: 532 FIIIEGISQGLLYLHKYSRLRVIHRDLKASNILL--DDKMNPKISDFGMARIFEVNESEA 589
+ ++ I +G+ ++H ++ ++H DLK NIL D KI DFG+AR ++ E
Sbjct: 190 ILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244
Query: 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
K GT +++PE VS TD++S GV+ ++SG
Sbjct: 245 -LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994
pdb|2YWP|A Chain A, Crystal Structure Of Chk1 With A Urea Inhibitor
pdb|2E9N|A Chain A, Structure Of H-chk1 Complexed With A767085
pdb|2E9O|A Chain A, Structure Of H-Chk1 Complexed With Aa582939
pdb|2E9P|A Chain A, Structure Of H-Chk1 Complexed With A771129
pdb|2E9U|A Chain A, Structure Of H-Chk1 Complexed With A780125
Length = 269
Score = 76.6 bits (187), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 15/209 (7%)
Query: 429 ANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHT 486
++ LGEG +G V E+ VA+K + E K E+ + L H
Sbjct: 5 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE---KRFIIIEGISQGLL 543
N+V+ G G + L E+ L F+ ++ E +RF + G++
Sbjct: 65 NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFF--HQLMAGVV 118
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
YLH + + HRD+K N+LLD++ N KISDFG+A +F N E ++ GT Y++P
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 604 E-YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
E + DV+S G+++ +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204
>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site
Inhibitor Showing High Selectivity Within The Janus
Kinase Family
Length = 315
Score = 76.6 bits (187), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 61/212 (28%), Positives = 107/212 (50%), Gaps = 21/212 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK---LADEQE--VAIKRLSRSSGQGIVEFKNEVRLIAKLQ 484
+ ++LG+G FG V + L D VA+K+L S +F+ E++++ L
Sbjct: 11 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 70
Query: 485 HTNLVRLLGCSL-HGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
+V+ G S G + L LV E++P+ L FL + L+ + + I +G+
Sbjct: 71 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGM 128
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES-----EANTKRIVGT 597
YL R +HRDL A NIL++ + + KI+DFG+A++ +++ E I
Sbjct: 129 EYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF-- 183
Query: 598 YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ +PE I S ++DV+SFGV++ E+ +
Sbjct: 184 --WYAPESLSDNIFSRQSDVWSFGVVLYELFT 213
>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
pdb|2YDJ|B Chain B, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 76.6 bits (187), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 431 NFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNL 488
++ LGEG +G V E+ VA+K + E K E+ + L H N+
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 67
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE---KRFIIIEGISQGLLYL 545
V+ G G + L E+ L F+ ++ E +RF + G++YL
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFF--HQLMAGVVYL 121
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE- 604
H + + HRD+K N+LLD++ N KISDFG+A +F N E ++ GT Y++PE
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 178
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ DV+S G+++ +++G+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205
>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|B Chain B, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|C Chain C, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|D Chain D, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORK|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 2)
pdb|3ORL|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 3)
pdb|3ORO|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 4)
pdb|3ORP|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 5)
pdb|3ORT|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 6)
Length = 311
Score = 76.6 bits (187), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 15/211 (7%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQG---IVEFKNEVRLIAKLQHTNLVRLLG 493
LG GG V+ + L D ++VA+K L + + F+ E + A L H +V +
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 494 C----SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+ G +V E++ +L + G + ++ +I Q L + H+
Sbjct: 80 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG 136
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEANTKRIVGTYGYMSPEYAMS 608
+IHRD+K +NI++ K+ DFG+AR I + S T ++GT Y+SPE A
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 609 GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHP 639
V ++DV+S G ++ E+++G+ T P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224
>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXP|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 318
Score = 76.6 bits (187), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 77/277 (27%), Positives = 132/277 (47%), Gaps = 17/277 (6%)
Query: 438 LGEGGFGPV--YKGKLADE---QEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRL 491
LGEG FG V Y ++ + VA+K L +G Q +K E+ ++ L H ++++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 492 LGCSLH-GEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
GC G L LV E++P SL +L ++ + + + + I +G+ YLH
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHAQ- 153
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEANTKRIVGTYGYMSPEYAMS 608
IHRDL A N+LLD+ KI DFG+A+ + E +E + + +PE
Sbjct: 154 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKE 211
Query: 609 GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668
+DV+SFGV + E+++ + ++ P + L LIG A ++ + EL++
Sbjct: 212 YKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERL 270
Query: 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
P H+ C + +A RPT ++ +L+
Sbjct: 271 PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT 307
>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 76.6 bits (187), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 431 NFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNL 488
++ LGEG +G V E+ VA+K + E K E+ + L H N+
Sbjct: 7 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE---KRFIIIEGISQGLLYL 545
V+ G G + L E+ L F+ ++ E +RF + G++YL
Sbjct: 67 VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFF--HQLMAGVVYL 120
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE- 604
H + + HRD+K N+LLD++ N KISDFG+A +F N E ++ GT Y++PE
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ DV+S G+++ +++G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204
>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor
Length = 269
Score = 76.6 bits (187), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 15/209 (7%)
Query: 429 ANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHT 486
++ LGEG +G V E+ VA+K + E K E+ + L H
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE---KRFIIIEGISQGLL 543
N+V+ G G + L E+ L F+ ++ E +RF + G++
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFF--HQLMAGVV 119
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
YLH + + HRD+K N+LLD++ N KISDFG+A +F N E ++ GT Y++P
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 604 EYAMSGIVSIK-TDVFSFGVLVLEIVSGQ 631
E + DV+S G+++ +++G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YER|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YEX|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YDK|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 76.6 bits (187), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 431 NFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNL 488
++ LGEG +G V E+ VA+K + E K E+ + L H N+
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE---KRFIIIEGISQGLLYL 545
V+ G G + L E+ L F+ ++ E +RF + G++YL
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFF--HQLMAGVVYL 121
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE- 604
H + + HRD+K N+LLD++ N KISDFG+A +F N E ++ GT Y++PE
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ DV+S G+++ +++G+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205
>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
pdb|3JVS|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
Length = 271
Score = 76.6 bits (187), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 15/209 (7%)
Query: 429 ANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHT 486
++ LGEG +G V E+ VA+K + E K E+ + L H
Sbjct: 5 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE---KRFIIIEGISQGLL 543
N+V+ G G + L E+ L F+ ++ E +RF + G++
Sbjct: 65 NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFF--HQLMAGVV 118
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
YLH + + HRD+K N+LLD++ N KISDFG+A +F N E ++ GT Y++P
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 604 EYAMSGIVSIK-TDVFSFGVLVLEIVSGQ 631
E + DV+S G+++ +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204
>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXL|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 327
Score = 76.6 bits (187), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 61/212 (28%), Positives = 107/212 (50%), Gaps = 21/212 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK---LADEQE--VAIKRLSRSSGQGIVEFKNEVRLIAKLQ 484
+ ++LG+G FG V + L D VA+K+L S +F+ E++++ L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 485 HTNLVRLLGCSLH-GEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
+V+ G S G + L LV E++P+ L FL + L+ + + I +G+
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGM 140
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES-----EANTKRIVGT 597
YL R +HRDL A NIL++ + + KI+DFG+A++ +++ E I
Sbjct: 141 EYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF-- 195
Query: 598 YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ +PE I S ++DV+SFGV++ E+ +
Sbjct: 196 --WYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex
With A Staurosporine Analogue
Length = 290
Score = 76.6 bits (187), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 61/209 (29%), Positives = 108/209 (51%), Gaps = 15/209 (7%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK---LADEQE--VAIKRLSRSSGQGIVEFKNEVRLIAKLQ 484
+ ++LG+G FG V + L D VA+K+L S +F+ E++++ L
Sbjct: 7 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 66
Query: 485 HTNLVRLLGCSLHGEER---LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQG 541
+V+ G S +G R LV E++P+ L FL + L+ + + I +G
Sbjct: 67 SDFIVKYRGVS-YGPGRPELRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKG 123
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI-VGTYGY 600
+ YL SR R +HRDL A NIL++ + + KI+DFG+A++ +++ + +
Sbjct: 124 MEYLG--SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFW 180
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+PE I S ++DV+SFGV++ E+ +
Sbjct: 181 YAPESLSDNIFSRQSDVWSFGVVLYELFT 209
>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-1,2,2-trimethyl-propyl)-amide
pdb|4HVG|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-2-hydroxy-1,2-dimethyl-propyl)- Amide
pdb|4HVH|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-2-hydroxy-1,2-dimethyl-propyl
pdb|4HVI|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-1-methyl-2-oxo-2-piperidin-1-yl- Ethyl)-amide
Length = 314
Score = 76.3 bits (186), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 61/212 (28%), Positives = 107/212 (50%), Gaps = 21/212 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK---LADEQE--VAIKRLSRSSGQGIVEFKNEVRLIAKLQ 484
+ ++LG+G FG V + L D VA+K+L S +F+ E++++ L
Sbjct: 10 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 69
Query: 485 HTNLVRLLGCSLH-GEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
+V+ G S G + L LV E++P+ L FL + L+ + + I +G+
Sbjct: 70 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGM 127
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES-----EANTKRIVGT 597
YL R +HRDL A NIL++ + + KI+DFG+A++ +++ E I
Sbjct: 128 EYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF-- 182
Query: 598 YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ +PE I S ++DV+SFGV++ E+ +
Sbjct: 183 --WYAPESLSDNIFSRQSDVWSFGVVLYELFT 212
>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20
pdb|2HXL|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1
pdb|2HXQ|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2
pdb|2HY0|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 22
pdb|3F9N|A Chain A, Crystal Structure Of Chk1 Kinase In Complex With Inhibitor
38
Length = 322
Score = 76.3 bits (186), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 431 NFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNL 488
++ LGEG +G V E+ VA+K + E K E+ + L H N+
Sbjct: 7 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE---KRFIIIEGISQGLLYL 545
V+ G G + L E+ L F+ ++ E +RF + G++YL
Sbjct: 67 VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFF--HQLMAGVVYL 120
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE- 604
H + + HRD+K N+LLD++ N KISDFG+A +F N E ++ GT Y++PE
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ DV+S G+++ +++G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204
>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439
pdb|2VRX|B Chain B, Structure Of Aurora B Kinase In Complex With Zm447439
Length = 285
Score = 76.3 bits (186), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 71/240 (29%), Positives = 116/240 (48%), Gaps = 28/240 (11%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSS--GQGIV-EFKNEVRLIAK 482
++F LG+G FG VY LA E++ +A+K L +S +G+ + + E+ + +
Sbjct: 15 DDFDIGRPLGKGKFGNVY---LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSH 71
Query: 483 LQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQG 541
L+H N++R+ H +R+ L+ EF P L L GR + ++ +E ++
Sbjct: 72 LRHPNILRMYN-YFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADA 127
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
L Y H+ +VIHRD+K N+L+ K KI+DFG + V+ + + GT Y+
Sbjct: 128 LHYCHER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYL 180
Query: 602 SPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ-----KNHTRHHPDRPLNLIGYAWQLLSDG 656
PE K D++ GVL E + G +HT H R +N+ LSDG
Sbjct: 181 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH-RRIVNVDLKFPPFLSDG 239
>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1
pdb|4FSQ|A Chain A, Crystal Structure Of The Chk1
pdb|4FSR|A Chain A, Crystal Structure Of The Chk1
pdb|4FT0|A Chain A, Crystal Structure Of The Chk1
pdb|4FT5|A Chain A, Crystal Structure Of The Chk1
pdb|4FT7|A Chain A, Crystal Structure Of The Chk1
pdb|4FT9|A Chain A, Crystal Structure Of The Chk1
pdb|4FTI|A Chain A, Crystal Structure Of The Chk1
pdb|4FTJ|A Chain A, Crystal Structure Of The Chk1
pdb|4FTK|A Chain A, Crystal Structure Of The Chk1
pdb|4FTL|A Chain A, Crystal Structure Of The Chk1
pdb|4FTM|A Chain A, Crystal Structure Of The Chk1
pdb|4FTO|A Chain A, Crystal Structure Of The Chk1
pdb|4FTR|A Chain A, Crystal Structure Of The Chk1
pdb|4FTT|A Chain A, Crystal Structure Of The Chk1
pdb|4FTU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 76.3 bits (186), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 431 NFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNL 488
++ LGEG +G V E+ VA+K + E K E+ + L H N+
Sbjct: 7 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE---KRFIIIEGISQGLLYL 545
V+ G G + L E+ L F+ ++ E +RF + G++YL
Sbjct: 67 VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFF--HQLMAGVVYL 120
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE- 604
H + + HRD+K N+LLD++ N KISDFG+A +F N E ++ GT Y++PE
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ DV+S G+++ +++G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204
>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
pdb|3HYH|B Chain B, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
Length = 275
Score = 76.3 bits (186), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 66/211 (31%), Positives = 110/211 (52%), Gaps = 29/211 (13%)
Query: 426 AAAANNFSTTNKLGEGGFGPVYKGKLADE----QEVAIK-----RLSRSSGQGIVEFKNE 476
A N+ LGEG FG V KLA Q+VA+K L++S QG +E E
Sbjct: 9 GAHIGNYQIVKTLGEGSFGKV---KLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--RE 63
Query: 477 VRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE 536
+ + L+H ++++L +E ++V E+ N+ D+ + R + E R +
Sbjct: 64 ISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV---QRDKMSEQEARRFFQQ 120
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN-TKRIV 595
IS + Y H++ +++HRDLK N+LLD+ +N KI+DFG++ I ++ N K
Sbjct: 121 IIS-AVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSC 172
Query: 596 GTYGYMSPEYAMSGIVSI--KTDVFSFGVLV 624
G+ Y +PE +SG + + DV+S GV++
Sbjct: 173 GSPNYAAPE-VISGKLYAGPEVDVWSCGVIL 202
>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human
Chk1 Kinase Domain
pdb|3OT8|A Chain A, X-Ray Crystal Structure Of Compound 17r Bound To Human
Chk1 Kinase Domain
pdb|3PA3|A Chain A, X-Ray Crystal Structure Of Compound 70 Bound To Human Chk1
Kinase Domain
pdb|3PA4|A Chain A, X-Ray Crystal Structure Of Compound 2a Bound To Human Chk1
Kinase Domain
pdb|3PA5|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
pdb|3U9N|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
Length = 273
Score = 76.3 bits (186), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 431 NFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNL 488
++ LGEG +G V E+ VA+K + E K E+ + L H N+
Sbjct: 7 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE---KRFIIIEGISQGLLYL 545
V+ G G + L E+ L F+ ++ E +RF + G++YL
Sbjct: 67 VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFF--HQLMAGVVYL 120
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE- 604
H + + HRD+K N+LLD++ N KISDFG+A +F N E ++ GT Y++PE
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ DV+S G+++ +++G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204
>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
pdb|3DAE|B Chain B, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
Length = 283
Score = 76.3 bits (186), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 66/211 (31%), Positives = 110/211 (52%), Gaps = 29/211 (13%)
Query: 426 AAAANNFSTTNKLGEGGFGPVYKGKLADE----QEVAIK-----RLSRSSGQGIVEFKNE 476
A N+ LGEG FG V KLA Q+VA+K L++S QG +E E
Sbjct: 10 GAHIGNYQIVKTLGEGSFGKV---KLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--RE 64
Query: 477 VRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE 536
+ + L+H ++++L +E ++V E+ N+ D+ + R + E R +
Sbjct: 65 ISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV---QRDKMSEQEARRFFQQ 121
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN-TKRIV 595
IS + Y H++ +++HRDLK N+LLD+ +N KI+DFG++ I ++ N K
Sbjct: 122 IIS-AVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSC 173
Query: 596 GTYGYMSPEYAMSGIVSI--KTDVFSFGVLV 624
G+ Y +PE +SG + + DV+S GV++
Sbjct: 174 GSPNYAAPE-VISGKLYAGPEVDVWSCGVIL 203
>pdb|2BFX|A Chain A, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2BFX|B Chain B, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2VGP|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGP|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGO|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|2VGO|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|3ZTX|A Chain A, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen.
pdb|3ZTX|B Chain B, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen
Length = 284
Score = 76.3 bits (186), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 71/240 (29%), Positives = 116/240 (48%), Gaps = 28/240 (11%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSS--GQGIV-EFKNEVRLIAK 482
++F LG+G FG VY LA E++ +A+K L +S +G+ + + E+ + +
Sbjct: 14 DDFDIGRPLGKGKFGNVY---LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSH 70
Query: 483 LQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQG 541
L+H N++R+ H +R+ L+ EF P L L GR + ++ +E ++
Sbjct: 71 LRHPNILRMYN-YFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADA 126
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
L Y H+ +VIHRD+K N+L+ K KI+DFG + V+ + + GT Y+
Sbjct: 127 LHYCHER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYL 179
Query: 602 SPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ-----KNHTRHHPDRPLNLIGYAWQLLSDG 656
PE K D++ GVL E + G +HT H R +N+ LSDG
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH-RRIVNVDLKFPPFLSDG 238
>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54
pdb|2QHM|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2a
pdb|2QHN|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1a
pdb|3TKH|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S01
pdb|3TKI|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S25
Length = 323
Score = 76.3 bits (186), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 431 NFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNL 488
++ LGEG +G V E+ VA+K + E K E+ + L H N+
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE---KRFIIIEGISQGLLYL 545
V+ G G + L E+ L F+ ++ E +RF + G++YL
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFF--HQLMAGVVYL 121
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE- 604
H + + HRD+K N+LLD++ N KISDFG+A +F N E ++ GT Y++PE
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ DV+S G+++ +++G+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205
>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of
The Saccharomyces Cerevisiae Ampk Homolog Snf1
Length = 271
Score = 76.3 bits (186), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 66/210 (31%), Positives = 110/210 (52%), Gaps = 29/210 (13%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLADE----QEVAIK-----RLSRSSGQGIVEFKNEV 477
A N+ LGEG FG V KLA Q+VA+K L++S QG +E E+
Sbjct: 1 AHIGNYQIVKTLGEGSFGKV---KLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REI 55
Query: 478 RLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG 537
+ L+H ++++L +E ++V E+ N+ D+ + R + E R +
Sbjct: 56 SYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV---QRDKMSEQEARRFFQQI 112
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN-TKRIVG 596
IS + Y H++ +++HRDLK N+LLD+ +N KI+DFG++ I ++ N K G
Sbjct: 113 IS-AVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCG 164
Query: 597 TYGYMSPEYAMSGIVSI--KTDVFSFGVLV 624
+ Y +PE +SG + + DV+S GV++
Sbjct: 165 SPNYAAPE-VISGKLYAGPEVDVWSCGVIL 193
>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast
Snf1
Length = 274
Score = 76.3 bits (186), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 112/211 (53%), Gaps = 29/211 (13%)
Query: 426 AAAANNFSTTNKLGEGGFGPVYKGKLADE----QEVAIK-----RLSRSSGQGIVEFKNE 476
A N+ LGEG FG V KLA Q+VA+K L++S QG +E E
Sbjct: 4 GAHIGNYQIVKTLGEGSFGKV---KLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--RE 58
Query: 477 VRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE 536
+ + L+H ++++L +E ++V E+ N+ D+ + +++ ++ ++ +
Sbjct: 59 ISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQ 114
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN-TKRIV 595
I + Y H++ +++HRDLK N+LLD+ +N KI+DFG++ I ++ N K
Sbjct: 115 QIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSC 167
Query: 596 GTYGYMSPEYAMSGIVSI--KTDVFSFGVLV 624
G+ Y +PE +SG + + DV+S GV++
Sbjct: 168 GSPNYAAPE-VISGKLYAGPEVDVWSCGVIL 197
>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRB|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRG|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRH|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRM|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRN|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRO|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2C3J|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3K|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3L|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2CGU|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGV|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGW|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGX|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|3NLB|A Chain A, Novel Kinase Profile Highlights The Temporal Basis Of
Context Dependent Checkpoint Pathways To Cell Death
Length = 297
Score = 76.3 bits (186), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 431 NFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNL 488
++ LGEG +G V E+ VA+K + E K E+ + L H N+
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE---KRFIIIEGISQGLLYL 545
V+ G G + L E+ L F+ ++ E +RF + G++YL
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFF--HQLMAGVVYL 121
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE- 604
H + + HRD+K N+LLD++ N KISDFG+A +F N E ++ GT Y++PE
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ DV+S G+++ +++G+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205
>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint
Kinase Chk1
pdb|1NVQ|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1UCN-01
pdb|1NVR|A Chain A, The Complex Structure Of Checkpoint Kinase
Chk1STAUROSPORINE
pdb|1NVS|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1SB218078
pdb|2WMQ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMR|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMS|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMT|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMU|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMV|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMX|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMW|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEY|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XF0|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEZ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2X8D|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2X8I|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YM3|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM4|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM5|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM6|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM7|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM8|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YDI|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 289
Score = 76.3 bits (186), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 431 NFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNL 488
++ LGEG +G V E+ VA+K + E K E+ + L H N+
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE---KRFIIIEGISQGLLYL 545
V+ G G + L E+ L F+ ++ E +RF + G++YL
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFF--HQLMAGVVYL 121
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE- 604
H + + HRD+K N+LLD++ N KISDFG+A +F N E ++ GT Y++PE
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ DV+S G+++ +++G+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205
>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine
Analog
pdb|2GDO|A Chain A, 4-(aminoalkylamino)-3-benzimidazole-quinolinones As Potent
Chk1 Inhibitors
Length = 295
Score = 76.3 bits (186), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 431 NFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNL 488
++ LGEG +G V E+ VA+K + E K E+ + L H N+
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE---KRFIIIEGISQGLLYL 545
V+ G G + L E+ L F+ ++ E +RF + G++YL
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFF--HQLMAGVVYL 121
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE- 604
H + + HRD+K N+LLD++ N KISDFG+A +F N E ++ GT Y++PE
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ DV+S G+++ +++G+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205
>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase
Domain From Human
Length = 314
Score = 76.3 bits (186), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 23/208 (11%)
Query: 439 GEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG 498
G FG V+K +L ++ VA+K Q + + E+ ++H NL++ + G
Sbjct: 24 ARGRFGCVWKAQLMNDF-VAVKIFPLQDKQSW-QSEREIFSTPGMKHENLLQFIAAEKRG 81
Query: 499 E----ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK------- 547
E L+ F SL +L + N++ W + + E +S+GL YLH+
Sbjct: 82 SNLEVELWLITAFHDKGSLTDYL----KGNIITWNELCHVAETMSRGLSYLHEDVPWCRG 137
Query: 548 -YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYA 606
+ + HRD K+ N+LL + ++DFG+A FE + +T VGT YM+PE
Sbjct: 138 EGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVL 197
Query: 607 MSGI-----VSIKTDVFSFGVLVLEIVS 629
I ++ D+++ G+++ E+VS
Sbjct: 198 EGAINFQRDAFLRIDMYAMGLVLWELVS 225
>pdb|4FST|A Chain A, Crystal Structure Of The Chk1
Length = 269
Score = 76.3 bits (186), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 15/209 (7%)
Query: 429 ANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHT 486
++ LGEG +G V E+ VA+K + E K E+ + L H
Sbjct: 5 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE---KRFIIIEGISQGLL 543
N+V+ G G + L E+ L F+ ++ E +RF + G++
Sbjct: 65 NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFF--HQLMAGVV 118
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
YLH + + HRD+K N+LLD++ N KISDFG+A +F N E ++ GT Y++P
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 604 E-YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
E + DV+S G+++ +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204
>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|B Chain B, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|C Chain C, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|D Chain D, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
Length = 543
Score = 76.3 bits (186), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 16/202 (7%)
Query: 438 LGEGGFGPVYK------GKLADEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVR 490
LG GGFG V+ GKL +++ KRL + G QG + E +++AK+ +V
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM---VEKKILAKVHSRFIVS 249
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG-ISQGLLYLHKYS 549
L + LV M + + ++N N E R I I GL +LH+ +
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG 609
+I+RDLK N+LLDD N +ISD G+A E+ + TK GT G+M+PE +
Sbjct: 310 ---IIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 610 IVSIKTDVFSFGVLVLEIVSGQ 631
D F+ GV + E+++ +
Sbjct: 365 EYDFSVDYFALGVTLYEMIAAR 386
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 76.3 bits (186), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 71/247 (28%), Positives = 111/247 (44%), Gaps = 19/247 (7%)
Query: 436 NKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCS 495
+LG G FG V GK + +VA+K + S EF E + + KL H LV+ G
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 496 LHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
+V E++ N L +L + G+ L + + + +G+ +L + + IH
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVCEGMAFLESH---QFIH 127
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNE--SEANTKRIVGTYGYMSPEYAMSGIVSI 613
RDL A N L+D + K+SDFGM R ++ S TK V + +PE S
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPV---KWSAPEVFHYFKYSS 184
Query: 614 KTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSAN 673
K+DV++FG+L+ E+ S K P +L + +L +G L P L
Sbjct: 185 KSDVWAFGILMWEVFSLGK--------MPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQ 236
Query: 674 EVMRCIH 680
+ C H
Sbjct: 237 IMYSCWH 243
>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 76.3 bits (186), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 21/210 (10%)
Query: 438 LGEGGFGPVYKG------KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKL-QHTNLV 489
LG G FG V + K A + VA+K L + +E++++ + H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 490 RLLG-CSLHGEERLLVYEF---------MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
LLG C+ G +++ EF + +K +F + K+ L E ++
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+G+ +L + + IHRDL A NILL +K KI DFG+AR +
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+PE + +I++DV+SFGVL+ EI S
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241
>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4X|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4Y|A Chain A, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Y|B Chain B, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Z|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 1.84a
pdb|3C50|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C50|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C51|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
pdb|3C51|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
Length = 543
Score = 75.9 bits (185), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 16/202 (7%)
Query: 438 LGEGGFGPVYK------GKLADEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVR 490
LG GGFG V+ GKL +++ KRL + G QG + E +++AK+ +V
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM---VEKKILAKVHSRFIVS 249
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG-ISQGLLYLHKYS 549
L + LV M + + ++N N E R I I GL +LH+ +
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG 609
+I+RDLK N+LLDD N +ISD G+A E+ + TK GT G+M+PE +
Sbjct: 310 ---IIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 610 IVSIKTDVFSFGVLVLEIVSGQ 631
D F+ GV + E+++ +
Sbjct: 365 EYDFSVDYFALGVTLYEMIAAR 386
>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone
Inhibitor
pdb|2I0Y|A Chain A, Cfms Tyrosine Kinase (Fgf Kid) In Complex With An
Arylamide Inhibitor
pdb|3DPK|A Chain A, Cfms Tyrosine Kinase In Complex With A Pyridopyrimidinone
Inhibitor
pdb|3KRJ|A Chain A, Cfms Tyrosine Kinase In Complex With
4-Cyano-1h-Imidazole-2-Carboxylic Acid
(2-Cyclohex-1-Enyl-4-Piperidin-4-Yl-Phenyl)-Amide
pdb|3KRL|A Chain A, Cfms Tyrosine Kinase In Complex With
5-Cyano-Furan-2-Carboxylic Acid
[4-(4-Methyl-Piperazin-1-Yl)-2-Piperidin-1-Yl-Phenyl]-
Amide
Length = 335
Score = 75.9 bits (185), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 82/303 (27%), Positives = 138/303 (45%), Gaps = 46/303 (15%)
Query: 430 NNFSTTNKLGEGGFGPVYK------GKLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAK 482
NN LG G FG V + GK +VA+K L ++ E +E+++++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 483 L-QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFL-----------FNSGRKNVLNWEK 530
L QH N+V LLG HG L++ E+ L FL +N
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 531 RFII--IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES- 587
R ++ ++QG+ +L + IHRD+ A N+LL + KI DFG+AR +N+S
Sbjct: 166 RDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI-MNDSN 221
Query: 588 ---EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLN 644
+ N + V +M+PE + ++++DV+S+G+L+ EI S N +P +N
Sbjct: 222 YIVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN---PYPGILVN 275
Query: 645 LIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
Y +L+ D G ++ P+ P + +M+ C + RPT ++ LQ
Sbjct: 276 SKFY--KLVKD--GYQMAQPAFA-PKNIYSIMQA------CWALEPTHRPTFQQICSFLQ 324
Query: 705 NET 707
+
Sbjct: 325 EQA 327
>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution
Length = 543
Score = 75.9 bits (185), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 16/202 (7%)
Query: 438 LGEGGFGPVYK------GKLADEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVR 490
LG GGFG V+ GKL +++ KRL + G QG + E +++AK+ +V
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM---VEKKILAKVHSRFIVS 249
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG-ISQGLLYLHKYS 549
L + LV M + + ++N N E R I I GL +LH+ +
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG 609
+I+RDLK N+LLDD N +ISD G+A E+ + TK GT G+M+PE +
Sbjct: 310 ---IIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 610 IVSIKTDVFSFGVLVLEIVSGQ 631
D F+ GV + E+++ +
Sbjct: 365 EYDFSVDYFALGVTLYEMIAAR 386
>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
pdb|3C4W|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
Length = 543
Score = 75.9 bits (185), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 16/202 (7%)
Query: 438 LGEGGFGPVYK------GKLADEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVR 490
LG GGFG V+ GKL +++ KRL + G QG + E +++AK+ +V
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM---VEKKILAKVHSRFIVS 249
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG-ISQGLLYLHKYS 549
L + LV M + + ++N N E R I I GL +LH+ +
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG 609
+I+RDLK N+LLDD N +ISD G+A E+ + TK GT G+M+PE +
Sbjct: 310 ---IIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 610 IVSIKTDVFSFGVLVLEIVSGQ 631
D F+ GV + E+++ +
Sbjct: 365 EYDFSVDYFALGVTLYEMIAAR 386
>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1
pdb|4FTA|A Chain A, Crystal Structure Of The Chk1
pdb|4FTC|A Chain A, Crystal Structure Of The Chk1
pdb|4FTN|A Chain A, Crystal Structure Of The Chk1
pdb|4FTQ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 75.9 bits (185), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 431 NFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNL 488
++ LGEG +G V E+ VA+K + E K E+ + L H N+
Sbjct: 7 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE---KRFIIIEGISQGLLYL 545
V+ G G + L E+ L F+ ++ E +RF + G++YL
Sbjct: 67 VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFF--HQLMAGVVYL 120
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE- 604
H + + HRD+K N+LLD++ N KISDFG+A +F N E ++ GT Y++PE
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ DV+S G+++ +++G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204
>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1
pdb|4GH2|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 75.9 bits (185), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 431 NFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNL 488
++ LGEG +G V E+ VA+K + E K E+ + L H N+
Sbjct: 7 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE---KRFIIIEGISQGLLYL 545
V+ G G + L E+ L F+ ++ E +RF + G++YL
Sbjct: 67 VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFF--HQLMAGVVYL 120
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE- 604
H + + HRD+K N+LLD++ N KISDFG+A +F N E ++ GT Y++PE
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ DV+S G+++ +++G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204
>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human
Pdk1 Complex 2
Length = 311
Score = 75.9 bits (185), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 10/205 (4%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQH 485
+F LGEG F V + LA +E AIK L + + E ++++L H
Sbjct: 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
V+L E+ + N L ++ G + RF E +S L YL
Sbjct: 92 PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFD--ETCTRFYTAEIVS-ALEYL 148
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
H +IHRDLK NILL++ M+ +I+DFG A++ +A VGT Y+SPE
Sbjct: 149 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 205
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVSG 630
S +D+++ G ++ ++V+G
Sbjct: 206 LTEKSASKSSDLWALGCIIYQLVAG 230
>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120
Length = 316
Score = 75.5 bits (184), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 64/213 (30%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 438 LGEGGFGPVYKG------KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKL-QHTNLV 489
LG G FG V + K A + VA+K L + +E++++ + H N+V
Sbjct: 37 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 490 RLLG-CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE-----KRFIIIEG------ 537
LLG C+ G +++ EF +L +L S R + ++ K F+ +E
Sbjct: 97 NLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKPEDLYKDFLTLEHLIXYSF 155
Query: 538 -ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+++G+ +L + + IHRDL A NILL +K KI DFG+AR +
Sbjct: 156 QVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+PE + +I++DV+SFGVL+ EI S
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 75.5 bits (184), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 21/210 (10%)
Query: 438 LGEGGFGPVYKG------KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKL-QHTNLV 489
LG G FG V + K A + VA+K L + +E++++ + H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 490 RLLG-CSLHGEERLLVYEF---------MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
LLG C+ G +++ EF + +K +F + K+ L E ++
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+G+ +L + + IHRDL A NILL +K KI DFG+AR +
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+PE + +I++DV+SFGVL+ EI S
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241
>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea
Inhibitor
Length = 316
Score = 75.5 bits (184), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 438 LGEGGFGPVYKG------KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKL-QHTNLV 489
LG G FG V + K A + VA+K L + +E++++ + H N+V
Sbjct: 36 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 490 RLLG-CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE------KRFIIIEG----- 537
LLG C+ G +++ EF +L +L S R + ++ K F+ +E
Sbjct: 96 NLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKTPEDLYKDFLTLEHLICYS 154
Query: 538 --ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIV 595
+++G+ +L + + IHRDL A NILL +K KI DFG+AR +
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 596 GTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+PE + +I++DV+SFGVL+ EI S
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex
pdb|3F88|B Chain B, Glycogen Synthase Kinase 3beta Inhibitor Complex
Length = 349
Score = 75.1 bits (183), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 21/211 (9%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKN-EVRLIAKLQHTNL 488
+++ T +G G FG VY+ KL D E VAIK++ + FKN E++++ KL H N+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 75
Query: 489 VRLLGCSL-HGEERLLVY-----EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
VRL GE++ +VY +++P S K L + + + + L
Sbjct: 76 VRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 543 LYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
Y+H + + HRD+K N+LLD D K+ DFG A+ ++ E N I Y Y
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY-YR 189
Query: 602 SPEYAMSGI-VSIKTDVFSFGVLVLEIVSGQ 631
+PE + DV+S G ++ E++ GQ
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel
4-amino-furo[2,3-d]pyrimidine
Length = 316
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 27/215 (12%)
Query: 438 LGEGGFGPVYKG------KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKL-QHTNLV 489
LG G FG V + K A + VA+K L + +E++++ + H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 490 RLLG-CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE-------KRFIIIEG---- 537
LLG C+ G +++ EF +L +L S R + ++ K F+ +E
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 538 ---ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+++G+ +L + + IHRDL A NILL +K KI DFG+AR +
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+PE + +I++DV+SFGVL+ EI S
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
pdb|3SAY|B Chain B, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
Length = 430
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKN-EVRLIAKLQHTNL 488
+++ T +G G FG VY+ KL D E VAIK++ + FKN E++++ KL H N+
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 109
Query: 489 VRLLGCSLHGEERL------LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
VRL E+ LV +++P S K L + + + + L
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 543 LYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
Y+H + + HRD+K N+LLD D K+ DFG A+ ++ E N I Y Y
Sbjct: 170 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY-YR 223
Query: 602 SPEYAMSGI-VSIKTDVFSFGVLVLEIVSGQ 631
+PE + DV+S G ++ E++ GQ
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain
pdb|4BBM|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
pdb|4BBM|B Chain B, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
Length = 331
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 67/213 (31%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVE--FKNEVRLIAKLQ 484
+ + +GEG +G V K + D + VAIK+ S +V+ E++L+ +L+
Sbjct: 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLD-FFLFNSGRKNVLNWEKRFIIIEGISQGLL 543
H NLV LL + LV+EF+ + LD LF +G + + F II GI
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIG---- 138
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF----EVNESEANTKRIVGTYG 599
+ H ++ +IHRD+K NIL+ K+ DFG AR EV + E V T
Sbjct: 139 FCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE------VATRW 189
Query: 600 YMSPEYAMSGIVSIK-TDVFSFGVLVLEIVSGQ 631
Y +PE + + K DV++ G LV E+ G+
Sbjct: 190 YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A19|C Chain C, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A1A|B Chain B, Pkr Kinase Domain-Eif2alpha Complex
Length = 284
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 28/215 (13%)
Query: 431 NFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+F +G GGFG V+K K D + IKR+ ++ + + EV+ +AKL H N+V
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA----EREVKALAKLDHVNIV 67
Query: 490 RLLGC----------SLHGEER------LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI 533
GC S R + EF +L+ ++ R L+
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALE 126
Query: 534 IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR 593
+ E I++G+ Y+H ++I+RDLK SNI L D KI DFG+ +++ R
Sbjct: 127 LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRXR 180
Query: 594 IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIV 628
GT YMSPE S + D+++ G+++ E++
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 60/211 (28%), Positives = 112/211 (53%), Gaps = 15/211 (7%)
Query: 425 IAAAANNFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLS---RSSGQGIVEFK--NEVR 478
+ + A + + LGEG F VYK + + Q VAIK++ RS + + E++
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGI 538
L+ +L H N++ LL H LV++FM L+ + ++ + K ++++
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLM--T 121
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTY 598
QGL YLH++ ++HRDLK +N+LLD+ K++DFG+A+ F + + A ++V T
Sbjct: 122 LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYXHQVV-TR 176
Query: 599 GYMSPEYAMSG-IVSIKTDVFSFGVLVLEIV 628
Y +PE + + D+++ G ++ E++
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELL 207
>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|1Q5K|B Chain B, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|3I4B|A Chain A, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3I4B|B Chain B, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3L1S|A Chain A, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
pdb|3L1S|B Chain B, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
Length = 414
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKN-EVRLIAKLQHTNL 488
+++ T +G G FG VY+ KL D E VAIK++ + FKN E++++ KL H N+
Sbjct: 49 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 103
Query: 489 VRLLGCSLHGEERL------LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
VRL E+ LV +++P S K L + + + + L
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 163
Query: 543 LYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
Y+H + + HRD+K N+LLD D K+ DFG A+ ++ E N I Y Y
Sbjct: 164 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY-YR 217
Query: 602 SPEYAMSGI-VSIKTDVFSFGVLVLEIVSGQ 631
+PE + DV+S G ++ E++ GQ
Sbjct: 218 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 248
>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7
pdb|2WQN|A Chain A, Structure Of Adp-Bound Human Nek7
Length = 310
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 18/210 (8%)
Query: 431 NFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLS---RSSGQGIVEFKNEVRLIAKLQHT 486
NF K+G G F VY+ L D VA+K++ + + E+ L+ +L H
Sbjct: 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL- 545
N+++ + E +V E L + + + +KR I + + + L
Sbjct: 93 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKK------QKRLIPERTVWKYFVQLC 146
Query: 546 ----HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
H +SR RV+HRD+K +N+ + K+ D G+ R F + A++ +VGT YM
Sbjct: 147 SALEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 203
Query: 602 SPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
SPE + K+D++S G L+ E+ + Q
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQ 233
>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1)
Catalytic Domain
Length = 317
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 61/198 (30%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 438 LGEGGFGPVYKGKLADEQEV-AIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLG 493
LG+GGF Y+ D +EV A K + +S + E+ + L + ++V G
Sbjct: 50 LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 494 CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRV 553
+ +V E +SL + RK V E R+ + + I QG+ YLH RV
Sbjct: 110 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 163
Query: 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI 613
IHRDLK N+ L+D M+ KI DFG+A E + T + GT Y++PE S
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT--LCGTPNYIAPEVLCKKGHSF 221
Query: 614 KTDVFSFGVLVLEIVSGQ 631
+ D++S G ++ ++ G+
Sbjct: 222 EVDIWSLGCILYTLLVGK 239
>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662
Length = 279
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 63/217 (29%), Positives = 105/217 (48%), Gaps = 18/217 (8%)
Query: 425 IAAAANNFSTTNKLGEGGFGPVYK------GKLADEQEVAIKRLSRSSGQGIVEFKNEVR 478
+ + A ++ +G G +G K GK+ +E+ ++ + Q +V +EV
Sbjct: 1 MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV---SEVN 57
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLL--VYEFMPNKSLDFFLFNSGRKNVLNWEKRFI--I 534
L+ +L+H N+VR + L V E+ L + G K ++ F+ +
Sbjct: 58 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI-TKGTKERQYLDEEFVLRV 116
Query: 535 IEGISQGLLYLHKYSR--LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTK 592
+ ++ L H+ S V+HRDLK +N+ LD K N K+ DFG+ARI +N E K
Sbjct: 117 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDEDFAK 174
Query: 593 RIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
VGT YMSPE + K+D++S G L+ E+ +
Sbjct: 175 EFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211
>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
pdb|2OW3|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
Length = 352
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKN-EVRLIAKLQHTNL 488
+++ T +G G FG VY+ KL D E VAIK++ + FKN E++++ KL H N+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 75
Query: 489 VRLLGCSLHGEERL------LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
VRL E+ LV +++P S K L + + + + L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 543 LYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
Y+H + + HRD+K N+LLD D K+ DFG A+ ++ E N I Y Y
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY-YR 189
Query: 602 SPEYAMSGI-VSIKTDVFSFGVLVLEIVSGQ 631
+PE + DV+S G ++ E++ GQ
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta.
pdb|1H8F|B Chain B, Glycogen Synthase Kinase 3 Beta
Length = 352
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKN-EVRLIAKLQHTNL 488
+++ T +G G FG VY+ KL D E VAIK++ + FKN E++++ KL H N+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNI 75
Query: 489 VRLLGCSLHGEERL------LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
VRL E+ LV +++P S K L + + + + L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 543 LYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
Y+H + + HRD+K N+LLD D K+ DFG A+ ++ E N I Y Y
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY-YR 189
Query: 602 SPEYAMSGI-VSIKTDVFSFGVLVLEIVSGQ 631
+PE + DV+S G ++ E++ GQ
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
pdb|1R0E|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
Length = 391
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKN-EVRLIAKLQHTNL 488
+++ T +G G FG VY+ KL D E VAIK++ + FKN E++++ KL H N+
Sbjct: 26 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 80
Query: 489 VRLLGCSLHGEERL------LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
VRL E+ LV +++P S K L + + + + L
Sbjct: 81 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 140
Query: 543 LYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
Y+H + + HRD+K N+LLD D K+ DFG A+ ++ E N I Y Y
Sbjct: 141 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY-YR 194
Query: 602 SPEYAMSGI-VSIKTDVFSFGVLVLEIVSGQ 631
+PE + DV+S G ++ E++ GQ
Sbjct: 195 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 225
>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1I09|B Chain B, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1J1B|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1B|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1C|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|1J1C|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|2JLD|A Chain A, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|2JLD|B Chain B, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|3M1S|A Chain A, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3M1S|B Chain B, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3PUP|A Chain A, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
pdb|3PUP|B Chain B, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
Length = 420
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKN-EVRLIAKLQHTNL 488
+++ T +G G FG VY+ KL D E VAIK++ + FKN E++++ KL H N+
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 109
Query: 489 VRLLGCSLHGEERL------LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
VRL E+ LV +++P S K L + + + + L
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 543 LYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
Y+H + + HRD+K N+LLD D K+ DFG A+ ++ E N I Y Y
Sbjct: 170 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY-YR 223
Query: 602 SPEYAMSGI-VSIKTDVFSFGVLVLEIVSGQ 631
+PE + DV+S G ++ E++ GQ
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide
Length = 350
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKN-EVRLIAKLQHTNL 488
+++ T +G G FG VY+ KL D E VAIK++ + FKN E++++ KL H N+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNI 75
Query: 489 VRLLGCSLHGEERL------LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
VRL E+ LV +++P S K L + + + + L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 543 LYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
Y+H + + HRD+K N+LLD D K+ DFG A+ ++ E N I Y Y
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY-YR 189
Query: 602 SPEYAMSGI-VSIKTDVFSFGVLVLEIVSGQ 631
+PE + DV+S G ++ E++ GQ
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
pdb|1GNG|B Chain B, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
Length = 378
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKN-EVRLIAKLQHTNL 488
+++ T +G G FG VY+ KL D E VAIK++ + FKN E++++ KL H N+
Sbjct: 40 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 94
Query: 489 VRLLGCSLHGEERL------LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
VRL E+ LV +++P S K L + + + + L
Sbjct: 95 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 154
Query: 543 LYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
Y+H + + HRD+K N+LLD D K+ DFG A+ ++ E N I Y Y
Sbjct: 155 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY-YR 208
Query: 602 SPEYAMSGI-VSIKTDVFSFGVLVLEIVSGQ 631
+PE + DV+S G ++ E++ GQ
Sbjct: 209 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 239
>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 15/207 (7%)
Query: 431 NFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNL 488
++ LGEG G V E+ VA+K + E K E+ + L H N+
Sbjct: 7 DWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE---KRFIIIEGISQGLLYL 545
V+ G G + L E+ L F+ ++ E +RF + G++YL
Sbjct: 67 VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFF--HQLMAGVVYL 120
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE- 604
H + + HRD+K N+LLD++ N KISDFG+A +F N E ++ GT Y++PE
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ DV+S G+++ +++G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204
>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3D|B Chain B, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3W|A Chain A, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q3W|B Chain B, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q41|A Chain A, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q41|B Chain B, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q4L|A Chain A, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|1Q4L|B Chain B, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|3Q3B|A Chain A, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
pdb|3Q3B|B Chain B, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
Length = 424
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKN-EVRLIAKLQHTNL 488
+++ T +G G FG VY+ KL D E VAIK++ + FKN E++++ KL H N+
Sbjct: 59 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 113
Query: 489 VRLLGCSLHGEERL------LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
VRL E+ LV +++P S K L + + + + L
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 173
Query: 543 LYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
Y+H + + HRD+K N+LLD D K+ DFG A+ ++ E N I Y Y
Sbjct: 174 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY-YR 227
Query: 602 SPEYAMSGI-VSIKTDVFSFGVLVLEIVSGQ 631
+PE + DV+S G ++ E++ GQ
Sbjct: 228 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 258
>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp
pdb|1PYX|B Chain B, Gsk-3 Beta Complexed With Amp-Pnp
pdb|3DU8|A Chain A, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
pdb|3DU8|B Chain B, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
Length = 422
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKN-EVRLIAKLQHTNL 488
+++ T +G G FG VY+ KL D E VAIK++ + FKN E++++ KL H N+
Sbjct: 57 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 111
Query: 489 VRLLGCSLHGEERL------LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
VRL E+ LV +++P S K L + + + + L
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 171
Query: 543 LYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
Y+H + + HRD+K N+LLD D K+ DFG A+ ++ E N I Y Y
Sbjct: 172 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY-YR 225
Query: 602 SPEYAMSGI-VSIKTDVFSFGVLVLEIVSGQ 631
+PE + DV+S G ++ E++ GQ
Sbjct: 226 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 256
>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
pdb|3F7Z|B Chain B, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
Length = 350
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKN-EVRLIAKLQHTNL 488
+++ T +G G FG VY+ KL D E VAIK++ + FKN E++++ KL H N+
Sbjct: 22 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 76
Query: 489 VRLLGCSLHGEERL------LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
VRL E+ LV +++P S K L + + + + L
Sbjct: 77 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 136
Query: 543 LYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
Y+H + + HRD+K N+LLD D K+ DFG A+ ++ E N I Y Y
Sbjct: 137 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY-YR 190
Query: 602 SPEYAMSGI-VSIKTDVFSFGVLVLEIVSGQ 631
+PE + DV+S G ++ E++ GQ
Sbjct: 191 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 221
>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRK|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRM|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
pdb|3ZRM|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
Length = 371
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKN-EVRLIAKLQHTNL 488
+++ T +G G FG VY+ KL D E VAIK++ + FKN E++++ KL H N+
Sbjct: 33 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 87
Query: 489 VRLLGCSLHGEERL------LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
VRL E+ LV +++P S K L + + + + L
Sbjct: 88 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 147
Query: 543 LYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
Y+H + + HRD+K N+LLD D K+ DFG A+ ++ E N I Y Y
Sbjct: 148 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY-YR 201
Query: 602 SPEYAMSGI-VSIKTDVFSFGVLVLEIVSGQ 631
+PE + DV+S G ++ E++ GQ
Sbjct: 202 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 232
>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr)
Kinase Domain
Length = 316
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 27/215 (12%)
Query: 438 LGEGGFGPVYKG------KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKL-QHTNLV 489
LG G FG V + K A + VA+K L + +E++++ + H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 490 RLLG-CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE-------KRFIIIEG---- 537
LLG C+ G +++ EF +L +L S R + ++ K F+ +E
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 538 ---ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+++G+ +L + + IHRDL A NILL +K KI DFG+AR +
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDA 210
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+PE + +I++DV+SFGVL+ EI S
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex
Length = 353
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKN-EVRLIAKLQHTNL 488
+++ T +G G FG VY+ KL D E VAIK++ + FKN E++++ KL H N+
Sbjct: 25 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 79
Query: 489 VRLLGCSLHGEERL------LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
VRL E+ LV +++P S K L + + + + L
Sbjct: 80 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 139
Query: 543 LYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
Y+H + + HRD+K N+LLD D K+ DFG A+ ++ E N I Y Y
Sbjct: 140 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY-YR 193
Query: 602 SPEYAMSGI-VSIKTDVFSFGVLVLEIVSGQ 631
+PE + DV+S G ++ E++ GQ
Sbjct: 194 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 224
>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent
Kinase- 1 (Pdk-1)catalytic Domain Bound To A
Dibenzonaphthyridine Inhibitor
pdb|3ION|A Chain A, Pdk1 In Complex With Compound 8h
Length = 312
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQH 485
+F LGEG F V + LA +E AIK L + + E ++++L H
Sbjct: 33 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEK----------RFIII 535
V+L + F ++ L F L + +L + + RF
Sbjct: 93 PFFVKL------------YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 140
Query: 536 EGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIV 595
E +S L YLH +IHRDLK NILL++ M+ +I+DFG A++ +A V
Sbjct: 141 EIVS-ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 196
Query: 596 GTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y+SPE +D+++ G ++ ++V+G
Sbjct: 197 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231
>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Imidazopyridine Inhibitor
Length = 382
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKN-EVRLIAKLQHTNL 488
+++ T +G G FG VY+ KL D E VAIK++ + FKN E++++ KL H N+
Sbjct: 33 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 87
Query: 489 VRLLGCSLHGEERL------LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
VRL E+ LV +++P S K L + + + + L
Sbjct: 88 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 147
Query: 543 LYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
Y+H + + HRD+K N+LLD D K+ DFG A+ ++ E N I Y Y
Sbjct: 148 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY-YR 201
Query: 602 SPEYAMSGI-VSIKTDVFSFGVLVLEIVSGQ 631
+PE + DV+S G ++ E++ GQ
Sbjct: 202 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 232
>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 291
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 78/281 (27%), Positives = 130/281 (46%), Gaps = 25/281 (8%)
Query: 438 LGEGGFGPV--YKGKLADE---QEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLVRL 491
LGEG FG V Y ++ + VA+K L G + ++ E+ ++ L H ++V+
Sbjct: 17 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 492 LGCSL-HGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
GC GE+ + LV E++P SL +L ++ + + + + I +G+ YLH
Sbjct: 77 KGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLHAQ- 131
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEANTKRIVGTYGYMSPEYAMS 608
IHR L A N+LLD+ KI DFG+A+ + E +E + + +PE
Sbjct: 132 --HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 189
Query: 609 GIVSIKTDVFSFGVLVLEIV----SGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664
+DV+SFGV + E++ S Q HT+ LIG+ ++ + EL++
Sbjct: 190 CKFYYASDVWSFGVTLYELLTYCDSNQSPHTKF-----TELIGHTQGQMTVLRLTELLER 244
Query: 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
P H+ C + +A RPT +V +LQ
Sbjct: 245 GERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQT 285
>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|2P2I|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|3EFL|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
pdb|3EFL|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
Length = 314
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 27/215 (12%)
Query: 438 LGEGGFGPVYKG------KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKL-QHTNLV 489
LG G FG V + K A + VA+K L + +E++++ + H N+V
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 490 RLLG-CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE-------KRFIIIEG---- 537
LLG C+ G +++ EF +L +L S R + ++ K F+ +E
Sbjct: 86 NLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 538 ---ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+++G+ +L + + IHRDL A NILL +K KI DFG+AR +
Sbjct: 145 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+PE + +I++DV+SFGVL+ EI S
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236
>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
pdb|4AFJ|B Chain B, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
Length = 367
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKN-EVRLIAKLQHTNL 488
+++ T +G G FG VY+ KL D E VAIK++ + FKN E++++ KL H N+
Sbjct: 29 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 83
Query: 489 VRLLGCSLHGEERL------LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
VRL E+ LV +++P S K L + + + + L
Sbjct: 84 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 143
Query: 543 LYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
Y+H + + HRD+K N+LLD D K+ DFG A+ ++ E N I Y Y
Sbjct: 144 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY-YR 197
Query: 602 SPEYAMSGI-VSIKTDVFSFGVLVLEIVSGQ 631
+PE + DV+S G ++ E++ GQ
Sbjct: 198 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 228
>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACC|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACD|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACD|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACG|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACG|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACH|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACH|B Chain B, Gsk3b In Complex With Inhibitor
Length = 465
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKN-EVRLIAKLQHTNL 488
+++ T +G G FG VY+ KL D E VAIK++ + FKN E++++ KL H N+
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 154
Query: 489 VRLLGCSLHGEERL------LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
VRL E+ LV +++P S K L + + + + L
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 214
Query: 543 LYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
Y+H + + HRD+K N+LLD D K+ DFG A+ ++ E N I Y Y
Sbjct: 215 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY-YR 268
Query: 602 SPEYAMSGI-VSIKTDVFSFGVLVLEIVSGQ 631
+PE + DV+S G ++ E++ GQ
Sbjct: 269 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 299
>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300
Length = 280
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQ--GIV-EFKNEVRLI 480
A +F LG+G FG VY LA E++ +A+K L ++ + G+ + + EV +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ L+H N++RL G L+ E+ P L + + + ++ I ++
Sbjct: 63 SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 119
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
L Y H RVIHRD+K N+LL KI+DFG + V+ + + GT Y
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTELCGTLDY 172
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ PE + K D++S GVL E + G+
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203
>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Inhibitor 7d
Length = 350
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKN-EVRLIAKLQHTNL 488
+++ T +G G FG VY+ KL D E VAIK++ + FKN E++++ KL H N+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 75
Query: 489 VRLLGCSLHGEERL------LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
VRL E+ LV +++P S K L + + + + L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 543 LYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
Y+H + + HRD+K N+LLD D K+ DFG A+ ++ E N I Y Y
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY-YR 189
Query: 602 SPEYAMSGI-VSIKTDVFSFGVLVLEIVSGQ 631
+PE + DV+S G ++ E++ GQ
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1
Catalytic Domain
pdb|1UVR|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-8
Length = 289
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 10/205 (4%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQH 485
+F LGEG F V + LA +E AIK L + + E ++++L H
Sbjct: 10 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
V+L E+ + N L ++ G + RF E +S L YL
Sbjct: 70 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVS-ALEYL 126
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
H +IHRDLK NILL++ M+ +I+DFG A++ +A VGT Y+SPE
Sbjct: 127 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 183
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVSG 630
+D+++ G ++ ++V+G
Sbjct: 184 LTEKSACKSSDLWALGCIIYQLVAG 208
>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
pdb|3QC4|B Chain B, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
Length = 314
Score = 74.3 bits (181), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQH 485
+F LGEG F V + LA +E AIK L + + E ++++L H
Sbjct: 35 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEK----------RFIII 535
V+L + F ++ L F L + +L + + RF
Sbjct: 95 PFFVKL------------YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 142
Query: 536 EGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIV 595
E +S L YLH +IHRDLK NILL++ M+ +I+DFG A++ +A V
Sbjct: 143 EIVS-ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 198
Query: 596 GTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y+SPE +D+++ G ++ ++V+G
Sbjct: 199 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 233
>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Ly333531
pdb|1UU7|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-2
pdb|1UU8|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-1
pdb|1OKY|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Staurosporine
pdb|1OKZ|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Ucn-01
Length = 310
Score = 74.3 bits (181), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQH 485
+F LGEG F V + LA +E AIK L + + E ++++L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEK----------RFIII 535
V+L + F ++ L F L + +L + + RF
Sbjct: 90 PFFVKL------------YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 137
Query: 536 EGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIV 595
E +S L YLH +IHRDLK NILL++ M+ +I+DFG A++ +A V
Sbjct: 138 EIVS-ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 193
Query: 596 GTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y+SPE +D+++ G ++ ++V+G
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228
>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In
Complex With Compound 9
Length = 311
Score = 74.3 bits (181), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQH 485
+F LGEG F V + LA +E AIK L + + E ++++L H
Sbjct: 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEK----------RFIII 535
V+L + F ++ L F L + +L + + RF
Sbjct: 92 PFFVKL------------YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 139
Query: 536 EGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIV 595
E +S L YLH +IHRDLK NILL++ M+ +I+DFG A++ +A V
Sbjct: 140 EIVS-ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 195
Query: 596 GTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y+SPE +D+++ G ++ ++V+G
Sbjct: 196 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230
>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 74.3 bits (181), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQH 485
+F LGEG F V + LA +E AIK L + + E ++++L H
Sbjct: 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEK----------RFIII 535
V+L + F ++ L F L + +L + + RF
Sbjct: 92 PFFVKL------------YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 139
Query: 536 EGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIV 595
E +S L YLH +IHRDLK NILL++ M+ +I+DFG A++ +A V
Sbjct: 140 EIVS-ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 195
Query: 596 GTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y+SPE +D+++ G ++ ++V+G
Sbjct: 196 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230
>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With
6-Bromoindirubin-3'-Oxime
Length = 350
Score = 73.9 bits (180), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKN-EVRLIAKLQHTNL 488
+++ T +G G FG VY+ KL D E VAIK++ + FKN E++++ KL H N+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNI 75
Query: 489 VRLLGCSLHGEERL------LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
VRL E+ LV +++P S K L + + + + L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 543 LYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
Y+H + + HRD+K N+LLD D K+ DFG A+ ++ E N I Y Y
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY-YR 189
Query: 602 SPEYAMSGI-VSIKTDVFSFGVLVLEIVSGQ 631
+PE + DV+S G ++ E++ GQ
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i
pdb|3QCQ|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-(3-
Amino-1h-Indazol-6-Yl)-N4-Ethyl-2,4-Pyrimidinediamine
pdb|3QCS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-[2-
Amino-6-(4-Morpholinyl)-4-Pyrimidinyl]-1h-Indazol-3-
Amine
pdb|3QCX|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-{2-
Amino-6-[(3r)-3-Methyl-4-Morpholinyl]-4-Pyrimidinyl}-1h-
Indazol-3- Amine
pdb|3QCY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 4-[2-
Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-N-
Phenyl-2- Morpholinecarboxamide
pdb|3QD0|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With (2r,5s)-
1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-6-
Methyl-N- Phenyl-3-Piperidinecarboxamide
pdb|3QD3|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1- Dimethylethyl
{(3r,6s)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-6-Methyl-3-Piperidinyl}carbamate
pdb|3QD4|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1-
Dimethylethyl{(3r,
5r)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-5-Methyl-3-Piperidinyl}carbamate
Length = 312
Score = 73.9 bits (180), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQH 485
+F LGEG F V + LA +E AIK L + + E ++++L H
Sbjct: 33 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEK----------RFIII 535
V+L + F ++ L F L + +L + + RF
Sbjct: 93 PFFVKL------------YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 140
Query: 536 EGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIV 595
E +S L YLH +IHRDLK NILL++ M+ +I+DFG A++ +A V
Sbjct: 141 EIVS-ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 196
Query: 596 GTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y+SPE +D+++ G ++ ++V+G
Sbjct: 197 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231
>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 73.9 bits (180), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQH 485
+F LGEG F V + LA +E AIK L + + E ++++L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEK----------RFIII 535
V+L + F ++ L F L + +L + + RF
Sbjct: 90 PFFVKL------------YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 137
Query: 536 EGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIV 595
E +S L YLH +IHRDLK NILL++ M+ +I+DFG A++ +A V
Sbjct: 138 EIVS-ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 193
Query: 596 GTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y+SPE +D+++ G ++ ++V+G
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228
>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 290
Score = 73.9 bits (180), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 78/281 (27%), Positives = 130/281 (46%), Gaps = 25/281 (8%)
Query: 438 LGEGGFGPV--YKGKLADE---QEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLVRL 491
LGEG FG V Y ++ + VA+K L G + ++ E+ ++ L H ++V+
Sbjct: 16 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 492 LGCSL-HGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
GC GE+ + LV E++P SL +L ++ + + + + I +G+ YLH
Sbjct: 76 KGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLHAQ- 130
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEANTKRIVGTYGYMSPEYAMS 608
IHR L A N+LLD+ KI DFG+A+ + E +E + + +PE
Sbjct: 131 --HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 188
Query: 609 GIVSIKTDVFSFGVLVLEIV----SGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664
+DV+SFGV + E++ S Q HT+ LIG+ ++ + EL++
Sbjct: 189 CKFYYASDVWSFGVTLYELLTYCDSNQSPHTKF-----TELIGHTQGQMTVLRLTELLER 243
Query: 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
P H+ C + +A RPT +V +LQ
Sbjct: 244 GERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQT 284
>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through
Fragment-Based Lead Discovery
pdb|3RWQ|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 73.9 bits (180), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQH 485
+F LGEG F V + LA +E AIK L + + E ++++L H
Sbjct: 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEK----------RFIII 535
V+L + F ++ L F L + +L + + RF
Sbjct: 92 PFFVKL------------YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 139
Query: 536 EGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIV 595
E +S L YLH +IHRDLK NILL++ M+ +I+DFG A++ +A V
Sbjct: 140 EIVS-ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 195
Query: 596 GTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y+SPE +D+++ G ++ ++V+G
Sbjct: 196 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230
>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Benzoimidazol Inhibitor
Length = 372
Score = 73.9 bits (180), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKN-EVRLIAKLQHTNL 488
+++ T +G G FG VY+ KL D E VAIK++ + FKN E++++ KL H N+
Sbjct: 34 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 88
Query: 489 VRLLGCSLHGEERL------LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
VRL E+ LV +++P S K L + + + + L
Sbjct: 89 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 148
Query: 543 LYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
Y+H + + HRD+K N+LLD D K+ DFG A+ ++ E N I Y Y
Sbjct: 149 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY-YR 202
Query: 602 SPEYAMSGI-VSIKTDVFSFGVLVLEIVSGQ 631
+PE + DV+S G ++ E++ GQ
Sbjct: 203 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 233
>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626
pdb|2J4Z|B Chain B, Structure Of Aurora-2 In Complex With Pha-680626
Length = 306
Score = 73.9 bits (180), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQ--GIV-EFKNEVRLI 480
A +F LG+G FG VY LA E++ +A+K L ++ + G+ + + EV +
Sbjct: 32 ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 88
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ L+H N++RL G L+ E+ P L + + + ++ I ++
Sbjct: 89 SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 145
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
L Y H RVIHRD+K N+LL KI+DFG + V+ + + GT Y
Sbjct: 146 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDY 198
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ PE + K D++S GVL E + G+
Sbjct: 199 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229
>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|3SD0|B Chain B, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|4B7T|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Leucettine L4
Length = 350
Score = 73.9 bits (180), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKN-EVRLIAKLQHTNL 488
+++ T +G G FG VY+ KL D E VAIK++ + FKN E++++ KL H N+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 75
Query: 489 VRLLGCSLHGEERL------LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
VRL E+ LV +++P S K L + + + + L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 543 LYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
Y+H + + HRD+K N+LLD D K+ DFG A+ ++ E N I Y Y
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY-YR 189
Query: 602 SPEYAMSGI-VSIKTDVFSFGVLVLEIVSGQ 631
+PE + DV+S G ++ E++ GQ
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridinyl-Triazine Inhibitor
pdb|2QU5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzimidazole Inhibitor
pdb|2QU6|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|2QU6|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|3B8Q|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8Q|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|2RL5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A 2,3-Dihydro-1,4-Benzoxazine Inhibitor
pdb|3BE2|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzamide Inhibitor
pdb|3CP9|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CP9|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPB|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPB|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPC|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPC|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3DTW|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
pdb|3DTW|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
Length = 314
Score = 73.9 bits (180), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 27/215 (12%)
Query: 438 LGEGGFGPVYKG------KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKL-QHTNLV 489
LG G FG V + K A + VA+K L + +E++++ + H N+V
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 490 RLLG-CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE-------KRFIIIEG---- 537
LLG C+ G +++ EF +L +L S R + ++ K F+ +E
Sbjct: 86 NLLGACTKPGGPLMVITEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 538 ---ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+++G+ +L + + IHRDL A NILL +K KI DFG+AR +
Sbjct: 145 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+PE + +I++DV+SFGVL+ EI S
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236
>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2
With A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 318
Score = 73.9 bits (180), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 27/215 (12%)
Query: 438 LGEGGFGPVYKG------KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKL-QHTNLV 489
LG G FG V + K A + VA+K L + +E++++ + H N+V
Sbjct: 37 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 490 RLLG-CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE-------KRFIIIEG---- 537
LLG C+ G +++ EF +L +L S R + ++ K F+ +E
Sbjct: 97 NLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKEAPEDLYKDFLTLEHLICY 155
Query: 538 ---ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+++G+ +L + + IHRDL A NILL +K KI DFG+AR +
Sbjct: 156 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 212
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+PE + +I++DV+SFGVL+ EI S
Sbjct: 213 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247
>pdb|1Z5M|A Chain A, Crystal Structure Of
N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl)
Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2-
Dimethylpropanediamide Complexed With Human Pdk1
pdb|2PE0|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
5-Hydroxy-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-1,
3-Dihydro- Indol-2-One Complex
pdb|2PE1|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
{2-Oxo-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-2,
3-Dihydro-1h- Indol-5-Yl}-Urea {bx-517} Complex
pdb|2PE2|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
3-{5-[2-Oxo-5-Ureido-1,
2-Dihydro-Indol-(3z)-Ylidenemethyl]-1h-
Pyrrol-3-Yl}-N-(2-Piperidin-1-Yl-Ethyl)-Benzamide
Complex
Length = 286
Score = 73.9 bits (180), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 10/205 (4%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQH 485
+F LGEG F V + LA +E AIK L + + E ++++L H
Sbjct: 7 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
V+L E+ + N L ++ G + RF E +S L YL
Sbjct: 67 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVS-ALEYL 123
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
H +IHRDLK NILL++ M+ +I+DFG A++ +A VGT Y+SPE
Sbjct: 124 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 180
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVSG 630
+D+++ G ++ ++V+G
Sbjct: 181 LTEKSACKSSDLWALGCIIYQLVAG 205
>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain
Length = 310
Score = 73.9 bits (180), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQH 485
+F LGEG F V + LA +E AIK L + + E ++++L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEK----------RFIII 535
V+L + F ++ L F L + +L + + RF
Sbjct: 90 PFFVKL------------YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 137
Query: 536 EGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIV 595
E +S L YLH +IHRDLK NILL++ M+ +I+DFG A++ +A V
Sbjct: 138 EIVS-ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFV 193
Query: 596 GTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y+SPE +D+++ G ++ ++V+G
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228
>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|B Chain B, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|C Chain C, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|D Chain D, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|E Chain E, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|F Chain F, Aurora-2 T287d T288d Complexed With Pha-680632
Length = 306
Score = 73.9 bits (180), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQ--GIV-EFKNEVRLI 480
A +F LG+G FG VY LA E++ +A+K L ++ + G+ + + EV +
Sbjct: 32 ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 88
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ L+H N++RL G L+ E+ P L + + + ++ I ++
Sbjct: 89 SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 145
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
L Y H RVIHRD+K N+LL KI+DFG + V+ + + GT Y
Sbjct: 146 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDY 198
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ PE + K D++S GVL E + G+
Sbjct: 199 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229
>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8
pdb|3NUU|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment11
pdb|3NUY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment17
Length = 286
Score = 73.9 bits (180), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQH 485
+F LGEG F V + LA +E AIK L + + E ++++L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEK----------RFIII 535
V+L + F ++ L F L + +L + + RF
Sbjct: 68 PFFVKL------------YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 115
Query: 536 EGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIV 595
E +S L YLH +IHRDLK NILL++ M+ +I+DFG A++ +A V
Sbjct: 116 EIVS-ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 171
Query: 596 GTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y+SPE +D+++ G ++ ++V+G
Sbjct: 172 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206
>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain
pdb|3UIU|B Chain B, Crystal Structure Of Apo-Pkr Kinase Domain
Length = 306
Score = 73.9 bits (180), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 65/227 (28%), Positives = 103/227 (45%), Gaps = 39/227 (17%)
Query: 431 NFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+F +G GGFG V+K K D + I+R+ ++ + + EV+ +AKL H N+V
Sbjct: 13 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKA----EREVKALAKLDHVNIV 68
Query: 490 RLLGC-------SLHGEERLLVYEFMPNKSLD---------FFLFNSGRKNVL-NW-EKR 531
GC ++ L ++ P S + F K L W EKR
Sbjct: 69 HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 532 ----------FIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581
+ E I++G+ Y+H ++IHRDLK SNI L D KI DFG+
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 582 FEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIV 628
+++ R GT YMSPE S + D+++ G+++ E++
Sbjct: 186 L---KNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229
>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-3
Length = 286
Score = 73.9 bits (180), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 10/205 (4%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQH 485
+F LGEG F V + LA +E AIK L + + E ++++L H
Sbjct: 9 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
V+L E+ + N L ++ G + RF E +S L YL
Sbjct: 69 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVS-ALEYL 125
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
H +IHRDLK NILL++ M+ +I+DFG A++ +A VGT Y+SPE
Sbjct: 126 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 182
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVSG 630
+D+++ G ++ ++V+G
Sbjct: 183 LTEKSACKSSDLWALGCIIYQLVAG 207
>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287,
Thr288 And Bound To Tpx2 1-43
pdb|1OL7|A Chain A, Structure Of Human Aurora-A 122-403 Phosphorylated On
Thr287, Thr288
Length = 282
Score = 73.9 bits (180), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQ--GIV-EFKNEVRLI 480
A +F LG+G FG VY LA E++ +A+K L ++ + G+ + + EV +
Sbjct: 8 ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 64
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ L+H N++RL G L+ E+ P L + + + ++ I ++
Sbjct: 65 SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 121
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
L Y H RVIHRD+K N+LL KI+DFG + V+ + + GT Y
Sbjct: 122 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDY 174
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ PE + K D++S GVL E + G+
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205
>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain
In Complex With Atp
pdb|3HRF|A Chain A, Crystal Structure Of Human Pdk1 Kinase Domain In Complex
With An Allosteric Activator Bound To The Pif-Pocket
pdb|3RCJ|A Chain A, Rapid Preparation Of Triazolyl Substituted Nh-Heterocyclic
Kinase Inhibitors Via One-Pot Sonogashira Coupling
Tms-Deprotection Cuaac Sequence
pdb|4A06|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps114 Bound To The Pif-Pocket
pdb|4AW1|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Compound Ps210 Bound To The Pif-Pocket
Length = 311
Score = 73.9 bits (180), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQH 485
+F LGEG F V + LA +E AIK L + + E ++++L H
Sbjct: 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEK----------RFIII 535
V+L + F ++ L F L + +L + + RF
Sbjct: 92 PFFVKL------------YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 139
Query: 536 EGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIV 595
E +S L YLH +IHRDLK NILL++ M+ +I+DFG A++ +A V
Sbjct: 140 EIVS-ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 195
Query: 596 GTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y+SPE +D+++ G ++ ++V+G
Sbjct: 196 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230
>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1
(Plk1) Catalytic Domain In Complex With Adp
Length = 317
Score = 73.9 bits (180), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 61/198 (30%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 438 LGEGGFGPVYKGKLADEQEV-AIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLG 493
LG+GGF Y+ D +EV A K + +S + E+ + L + ++V G
Sbjct: 50 LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 494 CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRV 553
+ +V E +SL + RK V E R+ + + I QG+ YLH RV
Sbjct: 110 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 163
Query: 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI 613
IHRDLK N+ L+D M+ KI DFG+A E + K + GT Y++PE S
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE--RKKXLCGTPNYIAPEVLCKKGHSF 221
Query: 614 KTDVFSFGVLVLEIVSGQ 631
+ D++S G ++ ++ G+
Sbjct: 222 EVDIWSLGCILYTLLVGK 239
>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358
pdb|2J50|B Chain B, Structure Of Aurora-2 In Complex With Pha-739358
Length = 280
Score = 73.6 bits (179), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQ--GIV-EFKNEVRLI 480
A +F LG+G FG VY LA E++ +A+K L ++ + G+ + + EV +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ L+H N++RL G L+ E+ P L + + + ++ I ++
Sbjct: 63 SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 119
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
L Y H RVIHRD+K N+LL KI+DFG + V+ + + GT Y
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDY 172
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ PE + K D++S GVL E + G+
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203
>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps171 Bound To The Pif-Pocket
pdb|4AW0|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Compound Ps182 Bound To The Pif-Pocket
Length = 311
Score = 73.6 bits (179), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQH 485
+F LGEG F V + LA +E AIK L + + E ++++L H
Sbjct: 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEK----------RFIII 535
V+L + F ++ L F L + +L + + RF
Sbjct: 92 PFFVKL------------YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 139
Query: 536 EGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIV 595
E +S L YLH +IHRDLK NILL++ M+ +I+DFG A++ +A V
Sbjct: 140 EIVS-ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 195
Query: 596 GTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y+SPE +D+++ G ++ ++V+G
Sbjct: 196 GTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230
>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy)
Quinolin-4-Yloxy)benzofuran-3-Carboxamide)
pdb|4AG8|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Axitinib (Ag-013736)
(N-Methyl-2-(3-((E)-2-Pyridin-2-
Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-Benzamide)
Length = 316
Score = 73.6 bits (179), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 27/215 (12%)
Query: 438 LGEGGFGPVYKG------KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKL-QHTNLV 489
LG G FG V + K A + VA+K L + +E++++ + H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 490 RLLG-CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE-------KRFIIIEG---- 537
LLG C+ G +++ EF +L +L S R + ++ K F+ +E
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 538 ---ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+++G+ +L + + IHRDL A NILL +K KI DFG+AR +
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+PE + +I++DV+SFGVL+ EI S
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii,
Tgme49_101440, In Presence Of Calcium
Length = 508
Score = 73.6 bits (179), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 69/231 (29%), Positives = 116/231 (50%), Gaps = 41/231 (17%)
Query: 419 IFDFQTIAAAANNFSTTNKLGEGGFGPVY--KGKLADEQEVAIKRLSRSSGQGIVEFKN- 475
+F + A ++ + LG+G FG V K K+ QE A+K +S+ + + ++
Sbjct: 39 MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITG-QECAVKVISKRQVKQKTDKESL 97
Query: 476 --EVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFL----FNSGRK-NVLNW 528
EV+L+ +L H N+++L YEF +K F+L + G + +
Sbjct: 98 LREVQLLKQLDHPNIMKL-------------YEFFEDKGY-FYLVGEVYTGGELFDEIIS 143
Query: 529 EKRFI------IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDK---MNPKISDFGMA 579
KRF II + G+ Y+HK +++HRDLK N+LL+ K N +I DFG++
Sbjct: 144 RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS 200
Query: 580 RIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
FE ++ K +GT Y++PE + G K DV+S GV++ ++SG
Sbjct: 201 THFEASK---KMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247
>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679
pdb|3UNZ|B Chain B, Aurora A In Complex With Rpm1679
pdb|3UO4|A Chain A, Aurora A In Complex With Rpm1680
pdb|3UO5|A Chain A, Aurora A In Complex With Yl1-038-31
pdb|3UO6|A Chain A, Aurora A In Complex With Yl5-083
pdb|3UO6|B Chain B, Aurora A In Complex With Yl5-083
pdb|3UOD|A Chain A, Aurora A In Complex With Rpm1693
pdb|3UOH|A Chain A, Aurora A In Complex With Rpm1722
pdb|3UOH|B Chain B, Aurora A In Complex With Rpm1722
pdb|3UOJ|A Chain A, Aurora A In Complex With Rpm1715
pdb|3UOJ|B Chain B, Aurora A In Complex With Rpm1715
pdb|3UOK|A Chain A, Aurora A In Complex With Yl5-81-1
pdb|3UOK|B Chain B, Aurora A In Complex With Yl5-81-1
pdb|3UOL|A Chain A, Aurora A In Complex With So2-162
pdb|3UOL|B Chain B, Aurora A In Complex With So2-162
pdb|3UP2|A Chain A, Aurora A In Complex With Rpm1686
pdb|3UP7|A Chain A, Aurora A In Complex With Yl1-038-09
pdb|4DEA|A Chain A, Aurora A In Complex With Yl1-038-18
pdb|4DEB|A Chain A, Aurora A In Complex With Rk2-17-01
pdb|4DED|A Chain A, Aurora A In Complex With Yl1-038-21
pdb|4DEE|A Chain A, Aurora A In Complex With Adp
Length = 279
Score = 73.6 bits (179), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQ--GIV-EFKNEVRLI 480
A +F LG+G FG VY LA E++ +A+K L ++ + G+ + + EV +
Sbjct: 7 ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 63
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ L+H N++RL G L+ E+ P L + + + ++ I ++
Sbjct: 64 SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 120
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
L Y H RVIHRD+K N+LL KI+DFG + V+ + + GT Y
Sbjct: 121 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDTLCGTLDY 173
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ PE + K D++S GVL E + G+
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1)
pdb|3I7B|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Nm-Pp1
pdb|3N51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor
Rm-1-95
pdb|3SX9|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-132
pdb|3SXF|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-89
pdb|3T3U|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-130
pdb|3T3V|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-87
pdb|3UPX|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1300
pdb|3UPZ|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumpless Bki Analog Uw1243
pdb|3V51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Rm-1-176
pdb|3V5P|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1288
pdb|3V5T|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1299
Length = 484
Score = 73.6 bits (179), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 69/231 (29%), Positives = 116/231 (50%), Gaps = 41/231 (17%)
Query: 419 IFDFQTIAAAANNFSTTNKLGEGGFGPVY--KGKLADEQEVAIKRLSRSSGQGIVEFKN- 475
+F + A ++ + LG+G FG V K K+ QE A+K +S+ + + ++
Sbjct: 15 MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITG-QECAVKVISKRQVKQKTDKESL 73
Query: 476 --EVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFL----FNSGRK-NVLNW 528
EV+L+ +L H N+++L YEF +K F+L + G + +
Sbjct: 74 LREVQLLKQLDHPNIMKL-------------YEFFEDKGY-FYLVGEVYTGGELFDEIIS 119
Query: 529 EKRFI------IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDK---MNPKISDFGMA 579
KRF II + G+ Y+HK +++HRDLK N+LL+ K N +I DFG++
Sbjct: 120 RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS 176
Query: 580 RIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
FE ++ K +GT Y++PE + G K DV+S GV++ ++SG
Sbjct: 177 THFEASK---KMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors
Length = 283
Score = 73.6 bits (179), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQ--GIV-EFKNEVRLI 480
A +F LG+G FG VY LA E++ +A+K L ++ + G+ + + EV +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 65
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ L+H N++RL G L+ E+ P L + + + ++ I ++
Sbjct: 66 SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 122
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
L Y H RVIHRD+K N+LL KI+DFG + V+ + + GT Y
Sbjct: 123 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDY 175
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ PE + K D++S GVL E + G+
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206
>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor
pdb|2X6E|A Chain A, Aurora-A Bound To An Inhibitor
Length = 285
Score = 73.6 bits (179), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQ--GIV-EFKNEVRLI 480
A +F LG+G FG VY LA E++ +A+K L ++ + G+ + + EV +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 67
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ L+H N++RL G L+ E+ P L + + + ++ I ++
Sbjct: 68 SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 124
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
L Y H RVIHRD+K N+LL KI+DFG + V+ + + GT Y
Sbjct: 125 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDY 177
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ PE + K D++S GVL E + G+
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208
>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From
Toxoplasma Gondii, Tgme49.101440
Length = 507
Score = 73.6 bits (179), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 69/231 (29%), Positives = 116/231 (50%), Gaps = 41/231 (17%)
Query: 419 IFDFQTIAAAANNFSTTNKLGEGGFGPVY--KGKLADEQEVAIKRLSRSSGQGIVEFKN- 475
+F + A ++ + LG+G FG V K K+ QE A+K +S+ + + ++
Sbjct: 38 MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITG-QECAVKVISKRQVKQKTDKESL 96
Query: 476 --EVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFL----FNSGRK-NVLNW 528
EV+L+ +L H N+++L YEF +K F+L + G + +
Sbjct: 97 LREVQLLKQLDHPNIMKL-------------YEFFEDKGY-FYLVGEVYTGGELFDEIIS 142
Query: 529 EKRFI------IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDK---MNPKISDFGMA 579
KRF II + G+ Y+HK +++HRDLK N+LL+ K N +I DFG++
Sbjct: 143 RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS 199
Query: 580 RIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
FE ++ K +GT Y++PE + G K DV+S GV++ ++SG
Sbjct: 200 THFEASK---KMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246
>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain.
pdb|3DB8|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 041
pdb|3DBC|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 257
pdb|3DBD|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 094
Length = 317
Score = 73.6 bits (179), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 61/198 (30%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 438 LGEGGFGPVYKGKLADEQEV-AIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLG 493
LG+GGF Y+ D +EV A K + +S + E+ + L + ++V G
Sbjct: 50 LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 494 CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRV 553
+ +V E +SL + RK V E R+ + + I QG+ YLH RV
Sbjct: 110 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 163
Query: 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI 613
IHRDLK N+ L+D M+ KI DFG+A E + K + GT Y++PE S
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE--RKKDLCGTPNYIAPEVLCKKGHSF 221
Query: 614 KTDVFSFGVLVLEIVSGQ 631
+ D++S G ++ ++ G+
Sbjct: 222 EVDIWSLGCILYTLLVGK 239
>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7
Length = 311
Score = 73.6 bits (179), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQH 485
+F LGEG F V + LA +E AIK L + + E ++++L H
Sbjct: 29 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEK----------RFIII 535
V+L + F ++ L F L + +L + + RF
Sbjct: 89 PFFVKL------------YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 136
Query: 536 EGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIV 595
E +S L YLH +IHRDLK NILL++ M+ +I+DFG A++ +A V
Sbjct: 137 EIVS-ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 192
Query: 596 GTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y+SPE +D+++ G ++ ++V+G
Sbjct: 193 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227
>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6
pdb|3NAY|B Chain B, Pdk1 In Complex With Inhibitor Mp6
Length = 311
Score = 73.6 bits (179), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQH 485
+F LGEG F V + LA +E AIK L + + E ++++L H
Sbjct: 29 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEK----------RFIII 535
V+L + F ++ L F L + +L + + RF
Sbjct: 89 PFFVKL------------YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 136
Query: 536 EGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIV 595
E +S L YLH +IHRDLK NILL++ M+ +I+DFG A++ +A V
Sbjct: 137 EIVS-ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 192
Query: 596 GTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y+SPE +D+++ G ++ ++V+G
Sbjct: 193 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227
>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead
Compound
Length = 292
Score = 73.6 bits (179), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQH 485
+F LGEG F V + LA +E AIK L + + E ++++L H
Sbjct: 14 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEK----------RFIII 535
V+L + F ++ L F L + +L + + RF
Sbjct: 74 PFFVKL------------YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 121
Query: 536 EGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIV 595
E +S L YLH +IHRDLK NILL++ M+ +I+DFG A++ +A V
Sbjct: 122 EIVS-ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 177
Query: 596 GTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y+SPE +D+++ G ++ ++V+G
Sbjct: 178 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 212
>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine
Inhibitor
Length = 283
Score = 73.6 bits (179), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQ--GIV-EFKNEVRLI 480
A +F LG+G FG VY LA E++ +A+K L ++ + G+ + + EV +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 65
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ L+H N++RL G L+ E+ P L + + + ++ I ++
Sbjct: 66 SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 122
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
L Y H RVIHRD+K N+LL KI+DFG + V+ + + GT Y
Sbjct: 123 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDY 175
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ PE + K D++S GVL E + G+
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206
>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A
Inhibitors: Structure Basis For Potency And Specificity
pdb|3K5U|A Chain A, Identification, Sar Studies And X-Ray Cocrystal Analysis
Of A Novel Furano-Pyrimidine Aurora Kinase A Inhibitor
pdb|3M11|A Chain A, Crystal Structure Of Aurora A Kinase Complexed With
Inhibitor
Length = 279
Score = 73.6 bits (179), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQ--GIV-EFKNEVRLI 480
A +F LG+G FG VY LA E++ +A+K L ++ + G+ + + EV +
Sbjct: 7 ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 63
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ L+H N++RL G L+ E+ P L + + + ++ I ++
Sbjct: 64 SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 120
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
L Y H RVIHRD+K N+LL KI+DFG + V+ + + GT Y
Sbjct: 121 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDY 173
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ PE + K D++S GVL E + G+
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyrazolone Inhibitor
Length = 314
Score = 73.6 bits (179), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 27/215 (12%)
Query: 438 LGEGGFGPVYKG------KLADEQEVAIKRLSRSSGQG-IVEFKNEVRLIAKL-QHTNLV 489
LG G FG V + K A + VA+K L + +E++++ + H N+V
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 490 RLLG-CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE-------KRFIIIEG---- 537
LLG C+ G +++ EF +L +L S R + ++ K F+ +E
Sbjct: 86 NLLGACTKPGGPLMVITEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 538 ---ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+++G+ +L + + IHRDL A NILL +K KI DFG+AR +
Sbjct: 145 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+PE + +I++DV+SFGVL+ EI S
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236
>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
pdb|2C6E|B Chain B, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
Length = 283
Score = 73.2 bits (178), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQ--GIV-EFKNEVRLI 480
A +F LG+G FG VY LA E++ +A+K L ++ + G+ + + EV +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 67
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ L+H N++RL G L+ E+ P L + + + ++ I ++
Sbjct: 68 SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 124
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
L Y H RVIHRD+K N+LL KI+DFG + V+ + + GT Y
Sbjct: 125 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDY 177
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ PE + K D++S GVL E + G+
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208
>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha
pdb|3OHT|B Chain B, Crystal Structure Of Salmo Salar P38alpha
Length = 389
Score = 73.2 bits (178), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 62/228 (27%), Positives = 111/228 (48%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + T + +G G +G V + ++A+K+LSR Q I+ K E+R
Sbjct: 44 KTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRP-FQSIIHAKRTYRELR 102
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P SL+ F L + N++ +K
Sbjct: 103 LLKHMKHENVIGLLDV------------FTPATSLEEFNDVYLVTHLMGADLNNIVKCQK 150
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 151 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 202
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGI-VSIKTDVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + ++ D++S G ++ E+++G+
Sbjct: 203 -HTDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249
>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form)
Length = 285
Score = 73.2 bits (178), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQ--GIV-EFKNEVRLI 480
A +F LG+G FG VY LA E++ +A+K L ++ + G+ + + EV +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 67
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ L+H N++RL G L+ E+ P + L + + ++ I ++
Sbjct: 68 SHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELAN 124
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
L Y H RVIHRD+K N+LL KI+DFG + V+ + + GT Y
Sbjct: 125 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDY 177
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ PE + K D++S GVL E + G+
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208
>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant
Length = 311
Score = 73.2 bits (178), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQG---IVEFKNEVRLIAKLQHTNLVRLLG 493
LG GG V+ + L ++VA+K L + + F+ E + A L H +V +
Sbjct: 20 LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYA 79
Query: 494 C----SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+ G +V E++ +L + G + ++ +I Q L + H+
Sbjct: 80 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG 136
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEANTKRIVGTYGYMSPEYAMS 608
+IHRD+K +NI++ K+ DFG+AR I + S T ++GT Y+SPE A
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 609 GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHP 639
V ++DV+S G ++ E+++G+ T P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224
>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure
pdb|2WTV|B Chain B, Aurora-A Inhibitor Structure
pdb|2WTV|C Chain C, Aurora-A Inhibitor Structure
pdb|2WTV|D Chain D, Aurora-A Inhibitor Structure
Length = 285
Score = 73.2 bits (178), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQ--GIV-EFKNEVRLI 480
A +F LG+G FG VY LA E++ +A+K L ++ + G+ + + EV +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 67
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ L+H N++RL G L+ E+ P + L + + ++ I ++
Sbjct: 68 SHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELAN 124
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
L Y H RVIHRD+K N+LL KI+DFG + V+ + + GT Y
Sbjct: 125 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLXGTLDY 177
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ PE + K D++S GVL E + G+
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208
>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|3R22|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|4DHF|A Chain A, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
pdb|4DHF|B Chain B, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
Length = 271
Score = 73.2 bits (178), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQ--GIV-EFKNEVRLI 480
A +F LG+G FG VY LA E++ +A+K L ++ + G+ + + EV +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 65
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ L+H N++RL G L+ E+ P L + + + ++ I ++
Sbjct: 66 SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 122
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
L Y H RVIHRD+K N+LL KI+DFG + V+ + + GT Y
Sbjct: 123 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDY 175
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ PE + K D++S GVL E + G+
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206
>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And
Compound 10
Length = 268
Score = 73.2 bits (178), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQ--GIV-EFKNEVRLI 480
A +F LG+G FG VY LA E++ +A+K L ++ + G+ + + EV +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ L+H N++RL G L+ E+ P L + + + ++ I ++
Sbjct: 63 SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 119
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
L Y H RVIHRD+K N+LL KI+DFG + V+ + + GT Y
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDY 172
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ PE + K D++S GVL E + G+
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203
>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And
Tpx2
Length = 268
Score = 73.2 bits (178), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQ--GIV-EFKNEVRLI 480
A +F LG+G FG VY LA E++ +A+K L ++ + G+ + + EV +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ L+H N++RL G L+ E+ P L + + + ++ I ++
Sbjct: 63 SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 119
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
L Y H RVIHRD+K N+LL KI+DFG + V+ + + GT Y
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTXLCGTLDY 172
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ PE + K D++S GVL E + G+
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203
>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 73.2 bits (178), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 430 NNFSTTNKLGEGGFGP-VYKGKLADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQH 485
+F LGEG F V +LA +E AIK L + + E ++++L H
Sbjct: 30 EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEK----------RFIII 535
V+L + F ++ L F L + +L + + RF
Sbjct: 90 PFFVKL------------YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 137
Query: 536 EGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIV 595
E +S L YLH +IHRDLK NILL++ M+ +I+DFG A++ +A V
Sbjct: 138 EIVS-ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 193
Query: 596 GTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y+SPE +D+++ G ++ ++V+G
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228
>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|B Chain B, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|C Chain C, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H10|A Chain A, Aurora A Inhibitor Complex
pdb|3H10|B Chain B, Aurora A Inhibitor Complex
pdb|3H10|D Chain D, Aurora A Inhibitor Complex
pdb|3P9J|A Chain A, Aurora A Kinase Domain With Phthalazinone Pyrazole
Inhibitor
Length = 268
Score = 73.2 bits (178), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQ--GIV-EFKNEVRLI 480
A +F LG+G FG VY LA E++ +A+K L ++ + G+ + + EV +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ L+H N++RL G L+ E+ P L + + + ++ I ++
Sbjct: 63 SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 119
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
L Y H RVIHRD+K N+LL KI+DFG + V+ + + GT Y
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDY 172
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ PE + K D++S GVL E + G+
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203
>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 902
pdb|3D5X|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Wortmannin.
pdb|3DBE|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 557
pdb|3DBF|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 562
Length = 301
Score = 73.2 bits (178), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 61/198 (30%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 438 LGEGGFGPVYKGKLADEQEV-AIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLG 493
LG+GGF Y+ D +EV A K + +S + E+ + L + ++V G
Sbjct: 34 LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 494 CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRV 553
+ +V E +SL + RK V E R+ + + I QG+ YLH RV
Sbjct: 94 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 147
Query: 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI 613
IHRDLK N+ L+D M+ KI DFG+A E + K + GT Y++PE S
Sbjct: 148 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE--RKKDLCGTPNYIAPEVLCKKGHSF 205
Query: 614 KTDVFSFGVLVLEIVSGQ 631
+ D++S G ++ ++ G+
Sbjct: 206 EVDIWSLGCILYTLLVGK 223
>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A
Gsk3beta Inhibitor
Length = 287
Score = 73.2 bits (178), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQ--GIV-EFKNEVRLI 480
A +F LG+G FG VY LA E++ +A+K L ++ + G+ + + EV +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ L+H N++RL G L+ E+ P L + + + ++ I ++
Sbjct: 63 SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 119
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
L Y H RVIHRD+K N+LL KI+DFG + V+ + + GT Y
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDY 172
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ PE + K D++S GVL E + G+
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203
>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
pdb|3MA6|B Chain B, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
Length = 298
Score = 73.2 bits (178), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 67/230 (29%), Positives = 115/230 (50%), Gaps = 39/230 (16%)
Query: 419 IFDFQTIAAAANNFSTTNKLGEGGFGPVY--KGKLADEQEVAIKRLSRSSGQGIVEFKN- 475
+F + A ++ + LG+G FG V K K+ QE A+K +S+ + + ++
Sbjct: 21 MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITG-QECAVKVISKRQVKQKTDKESL 79
Query: 476 --EVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFL---FNSGRK-NVLNWE 529
EV+L+ +L H N+++L YEF +K + + + G + +
Sbjct: 80 LREVQLLKQLDHPNIMKL-------------YEFFEDKGYFYLVGEVYTGGELFDEIISR 126
Query: 530 KRFI------IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDK---MNPKISDFGMAR 580
KRF II + G+ Y+HK +++HRDLK N+LL+ K N +I DFG++
Sbjct: 127 KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST 183
Query: 581 IFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
FE ++ K +GT Y++PE + G K DV+S GV++ ++SG
Sbjct: 184 HFEASK---KMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229
>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridyl-Pyrimidine Benzimidazole Inhibitor
Length = 314
Score = 73.2 bits (178), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 27/215 (12%)
Query: 438 LGEGGFGPVYKG------KLADEQEVAIKRLSRSSGQG-IVEFKNEVRLIAKL-QHTNLV 489
LG G FG V + K A + VA+K L + +E++++ + H N+V
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 490 RLLG-CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE-------KRFIIIEG---- 537
LLG C+ G +++ EF +L +L S R + ++ K F+ +E
Sbjct: 86 NLLGACTKPGGPLMVITEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 538 ---ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+++G+ +L + + IHRDL A NILL +K KI DFG+AR +
Sbjct: 145 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+PE + +I++DV+SFGVL+ EI S
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236
>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680
Length = 292
Score = 73.2 bits (178), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 66/217 (30%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 421 DFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSS--GQGIV-EF 473
D T ++F LG+G FG VY LA E++ VA+K L +S +G+ +
Sbjct: 14 DILTRHFTIDDFEIGRPLGKGKFGNVY---LAREKKSHFIVALKVLFKSQIEKEGVEHQL 70
Query: 474 KNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI 533
+ E+ + A L H N++RL L+ E+ P L L S + ++
Sbjct: 71 RREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSC---TFDEQRTAT 127
Query: 534 IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR 593
I+E ++ L+Y H +VIHRD+K N+LL K KI+DFG + V+ K
Sbjct: 128 IMEELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFG----WSVHAPSLRRKT 180
Query: 594 IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
+ GT Y+ PE + + K D++ GVL E++ G
Sbjct: 181 MCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217
>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With
Adpnp
Length = 275
Score = 73.2 bits (178), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQ--GIV-EFKNEVRLI 480
A +F LG+G FG VY LA E++ +A+K L ++ + G+ + + EV +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ L+H N++RL G L+ E+ P L + + + ++ I ++
Sbjct: 63 SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 119
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
L Y H RVIHRD+K N+LL KI+DFG + V+ + + GT Y
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDY 172
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ PE + K D++S GVL E + G+
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203
>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine-
Threonine Kinase
Length = 297
Score = 73.2 bits (178), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQ--GIV-EFKNEVRLI 480
A +F LG+G FG VY LA E++ +A+K L ++ + G+ + + EV +
Sbjct: 23 ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 79
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ L+H N++RL G L+ E+ P L + + + ++ I ++
Sbjct: 80 SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 136
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
L Y H RVIHRD+K N+LL KI+DFG + V+ + + GT Y
Sbjct: 137 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDY 189
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ PE + K D++S GVL E + G+
Sbjct: 190 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 220
>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O50|B Chain B, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O51|A Chain A, Crystal Structure Of Anthranilamide 10 Bound To Auroraa
pdb|3EFW|A Chain A, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
pdb|3EFW|B Chain B, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
Length = 267
Score = 73.2 bits (178), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQ--GIV-EFKNEVRLI 480
A +F LG+G FG VY LA E++ +A+K L ++ + G+ + + EV +
Sbjct: 5 ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 61
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ L+H N++RL G L+ E+ P L + + + ++ I ++
Sbjct: 62 SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 118
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
L Y H RVIHRD+K N+LL KI+DFG + V+ + + GT Y
Sbjct: 119 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDY 171
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ PE + K D++S GVL E + G+
Sbjct: 172 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 202
>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase
pdb|2NP8|A Chain A, Structural Basis For The Inhibition Of Aurora A Kinase By
A Novel Class Of High Affinity Disubstituted Pyrimidine
Inhibitors
pdb|2X81|A Chain A, Structure Of Aurora A In Complex With Mln8054
pdb|3MYG|A Chain A, Aurora A Kinase Complexed With Sch 1473759
pdb|3VAP|A Chain A, Synthesis And Sar Studies Of Imidazo-[1,2-A]-Pyrazine
Aurora Kinase Inhibitors With Improved Off Target Kinase
Selectivity
Length = 272
Score = 73.2 bits (178), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQ--GIV-EFKNEVRLI 480
A +F LG+G FG VY LA E++ +A+K L ++ + G+ + + EV +
Sbjct: 10 ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 66
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ L+H N++RL G L+ E+ P L + + + ++ I ++
Sbjct: 67 SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 123
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
L Y H RVIHRD+K N+LL KI+DFG + V+ + + GT Y
Sbjct: 124 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDY 176
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ PE + K D++S GVL E + G+
Sbjct: 177 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 207
>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase
Domain Of Csf-1r
Length = 324
Score = 73.2 bits (178), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 81/310 (26%), Positives = 135/310 (43%), Gaps = 53/310 (17%)
Query: 430 NNFSTTNKLGEGGFGPVYK------GKLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAK 482
NN LG G FG V + GK +VA+K L ++ E +E+++++
Sbjct: 31 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 483 L-QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNV---------------- 525
L QH N+V LLG HG L++ E+ L FL +
Sbjct: 91 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKE 150
Query: 526 ----LNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581
L ++QG+ +L + IHRD+ A N+LL + KI DFG+AR
Sbjct: 151 DGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 207
Query: 582 FEVNES----EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRH 637
+N+S + N + V +M+PE + ++++DV+S+G+L+ EI S N
Sbjct: 208 I-MNDSNYIVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN---P 260
Query: 638 HPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMP 697
+P +N Y +L+ D G ++ P+ P + +M+ C + RPT
Sbjct: 261 YPGILVNSKFY--KLVKD--GYQMAQPAF-APKNIYSIMQA------CWALEPTHRPTFQ 309
Query: 698 EVVCMLQNET 707
++ LQ +
Sbjct: 310 QICSFLQEQA 319
>pdb|1RJB|A Chain A, Crystal Structure Of Flt3
Length = 344
Score = 73.2 bits (178), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 81/302 (26%), Positives = 129/302 (42%), Gaps = 47/302 (15%)
Query: 431 NFSTTNKLGEGGFGPVYKG------KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKL 483
N LG G FG V K +VA+K L + E +E++++ +L
Sbjct: 46 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105
Query: 484 -QHTNLVRLLG-CSLHGEERLLVYEFMPNKSLDFFLFNSGRK------------------ 523
H N+V LLG C+L G L++E+ L +L + K
Sbjct: 106 GSHENIVNLLGACTLSGP-IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 524 --NVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581
NVL +E +++G+ +L S +HRDL A N+L+ KI DFG+AR
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 582 FEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDR 641
+ + +M+PE GI +IK+DV+S+G+L+ EI S N +P
Sbjct: 222 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN---PYPGI 278
Query: 642 PLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701
P++ Y +L+ +G ++QP A E + I C + RP+ P +
Sbjct: 279 PVDANFY--KLIQNG-------FKMDQPFYATEEIYIIMQS--CWAFDSRKRPSFPNLTS 327
Query: 702 ML 703
L
Sbjct: 328 FL 329
>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Axitinib (Ag-013736)
(N-Methyl-2-(
3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-
Benzamide)
pdb|4AGD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sunitinib (Su11248) (N-2-
Diethylaminoethyl)-5-((Z)-(5-Fluoro-2-Oxo-1h-Indol-3-
Ylidene)methyl)-2,4-Dimethyl-1h-Pyrrole-3-Carboxamide)
pdb|4ASD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sorafenib (Bay 43-9006)
pdb|4ASE|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Tivozanib (Av-951)
Length = 353
Score = 73.2 bits (178), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 27/215 (12%)
Query: 438 LGEGGFGPVYKG------KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKL-QHTNLV 489
LG G FG V + K A + VA+K L + +E++++ + H N+V
Sbjct: 72 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 490 RLLG-CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE-------KRFIIIEG---- 537
LLG C+ G +++ EF +L +L S R + ++ K F+ +E
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFLTLEHLICY 190
Query: 538 ---ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+++G+ +L + + IHRDL A NILL +K KI DFG+AR +
Sbjct: 191 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 247
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+PE + +I++DV+SFGVL+ EI S
Sbjct: 248 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282
>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant
Length = 262
Score = 72.8 bits (177), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQ--GIV-EFKNEVRLI 480
A +F LG+G FG VY LA E++ +A+K L ++ + G+ + + EV +
Sbjct: 3 ALEDFEIGRPLGKGKFGNVY---LAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQ 59
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ L+H N++RL G L+ E+ P L + + + ++ I ++
Sbjct: 60 SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 116
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
L Y H RVIHRD+K N+LL KI+DFG + V+ + + GT Y
Sbjct: 117 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDY 169
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ PE + K D++S GVL E + G+
Sbjct: 170 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 200
>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1G|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 72.8 bits (177), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQ--GIV-EFKNEVRLI 480
A +F LG+G FG VY LA E++ +A+K L ++ + G+ + + EV +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 65
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ L+H N++RL G L+ E+ P L + + + ++ I ++
Sbjct: 66 SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 122
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
L Y H RVIHRD+K N+LL KI+DFG + V+ + + GT Y
Sbjct: 123 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDY 175
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ PE + K D++S GVL E + G+
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206
>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1E|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1F|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 72.8 bits (177), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQ--GIV-EFKNEVRLI 480
A +F LG+G FG VY LA E++ +A+K L ++ + G+ + + EV +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 65
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ L+H N++RL G L+ E+ P L + + + ++ I ++
Sbjct: 66 SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 122
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
L Y H RVIHRD+K N+LL KI+DFG + V+ + + GT Y
Sbjct: 123 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDY 175
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ PE + K D++S GVL E + G+
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206
>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|2P0C|B Chain B, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|3BRB|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BRB|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BPR|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|C Chain C, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|D Chain D, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3TCP|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
pdb|3TCP|B Chain B, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
Length = 313
Score = 72.8 bits (177), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 28/220 (12%)
Query: 438 LGEGGFGPVYKGKLADEQ----EVAIK--RLSRSSGQGIVEFKNEVRLIAKLQHTNLVRL 491
LGEG FG V +G L E +VA+K +L SS + I EF +E + H N++RL
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 492 LGCSLHGEER-----LLVYEFMPNKSLDFFLFNS----GRKNV-LNWEKRFIIIEGISQG 541
LG + + +++ FM L +L S G K++ L +F++ I+ G
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV--DIALG 159
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
+ YL S +HRDL A N +L D M ++DFG+++ + + ++
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 602 SPEYAMSGIVSIKTDVFSFGVLVLEIVS-------GQKNH 634
+ E + + K+DV++FGV + EI + G +NH
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH 256
>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
pdb|3FE3|B Chain B, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
Length = 328
Score = 72.8 bits (177), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 25/220 (11%)
Query: 424 TIAAAAN------NFSTTNKLGEGGFGPVYKGKLADE----QEVAIKRLSRS--SGQGIV 471
+IA+ A+ N+ +G+G F V KLA +EVAIK + ++ + +
Sbjct: 3 SIASCADEQPHIGNYRLLKTIGKGNFAKV---KLARHILTGREVAIKIIDKTQLNPTSLQ 59
Query: 472 EFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKR 531
+ EVR++ L H N+V+L + L+ E+ + +L GR +
Sbjct: 60 KLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSK 119
Query: 532 FIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANT 591
F I + Y H+ R++HRDLKA N+LLD MN KI+DFG + F V
Sbjct: 120 F---RQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKL 170
Query: 592 KRIVGTYGYMSPE-YAMSGIVSIKTDVFSFGVLVLEIVSG 630
G Y +PE + + DV+S GV++ +VSG
Sbjct: 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210
>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
pdb|2QNJ|B Chain B, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
Length = 328
Score = 72.8 bits (177), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADE----QEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQ 484
N+ +G+G F V KLA +EVAIK + ++ + + + EVR++ L
Sbjct: 13 NYRLLKTIGKGNFAKV---KLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN 69
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
H N+V+L + L+ E+ + +L GR +F I + Y
Sbjct: 70 HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF---RQIVSAVQY 126
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
H+ R++HRDLKA N+LLD MN KI+DFG + F V G+ Y +PE
Sbjct: 127 CHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKLDTFCGSPPYAAPE 180
Query: 605 -YAMSGIVSIKTDVFSFGVLVLEIVSG 630
+ + DV+S GV++ +VSG
Sbjct: 181 LFQGKKYDGPEVDVWSLGVILYTLVSG 207
>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5
pdb|1OB3|B Chain B, Structure Of P. Falciparum Pfpk5
pdb|1V0P|A Chain A, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
pdb|1V0P|B Chain B, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
Length = 288
Score = 72.8 bits (177), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 66/206 (32%), Positives = 110/206 (53%), Gaps = 19/206 (9%)
Query: 432 FSTTNKLGEGGFGPVYKGKLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAKLQHTNLV 489
+ K+GEG +G VYK + + A+K++ +GI E+ ++ +L+H+N+V
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 490 RLLGCSLHGEERL-LVYEFMPN---KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
+L +H ++RL LV+E + K LD + G ++V K F++ + G+ Y
Sbjct: 64 KLYDV-IHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVT--AKSFLL--QLLNGIAYC 116
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
H RV+HRDLK N+L++ + KI+DFG+AR F + T IV T Y +P+
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIV-TLWYRAPDV 171
Query: 606 AM-SGIVSIKTDVFSFGVLVLEIVSG 630
M S S D++S G + E+V+G
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNG 197
>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound
pdb|2WQO|A Chain A, Structure Of Nek2 Bound To The Aminopyridine Cct241950
pdb|2XK3|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 35
pdb|2XK4|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 17
pdb|2XK6|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 36
pdb|2XK7|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 23
pdb|2XK8|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 15
pdb|2XKC|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 14
pdb|2XKD|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 12
pdb|2XKF|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 2
pdb|2XKE|A Chain A, Structure Of Nek2 Bound To Aminipyrazine Compound 5
pdb|2XNM|A Chain A, Structure Of Nek2 Bound To Cct
pdb|2XNN|A Chain A, Structure Of Nek2 Bound To Cct242430
pdb|2XNO|A Chain A, Structure Of Nek2 Bound To Cct243779
pdb|2XNP|A Chain A, Structure Of Nek2 Bound To Cct244858
pdb|4AFE|A Chain A, Nek2 Bound To Hybrid Compound 21
Length = 279
Score = 72.8 bits (177), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 63/217 (29%), Positives = 105/217 (48%), Gaps = 18/217 (8%)
Query: 425 IAAAANNFSTTNKLGEGGFGPVYK------GKLADEQEVAIKRLSRSSGQGIVEFKNEVR 478
+ + A ++ +G G +G K GK+ +E+ ++ + Q +V +EV
Sbjct: 1 MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV---SEVN 57
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLL--VYEFMPNKSLDFFLFNSGRKNVLNWEKRFI--I 534
L+ +L+H N+VR + L V E+ L + G K ++ F+ +
Sbjct: 58 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI-TKGTKERQYLDEEFVLRV 116
Query: 535 IEGISQGLLYLHKYSR--LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTK 592
+ ++ L H+ S V+HRDLK +N+ LD K N K+ DFG+ARI + S A T
Sbjct: 117 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT- 175
Query: 593 RIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
VGT YMSPE + K+D++S G L+ E+ +
Sbjct: 176 -FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211
>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb.
pdb|1MRU|B Chain B, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb
Length = 311
Score = 72.4 bits (176), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQG---IVEFKNEVRLIAKLQHTNLVRLLG 493
LG GG V+ + L ++VA+K L + + F+ E + A L H +V +
Sbjct: 20 LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 494 C----SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+ G +V E++ +L + G + ++ +I Q L + H+
Sbjct: 80 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG 136
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEANTKRIVGTYGYMSPEYAMS 608
+IHRD+K +NI++ K+ DFG+AR I + S T ++GT Y+SPE A
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 609 GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHP 639
V ++DV+S G ++ E+++G+ T P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224
>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand
pdb|2W5B|A Chain A, Human Nek2 Kinase Atpgammas-bound
pdb|2W5H|A Chain A, Human Nek2 Kinase Apo
Length = 279
Score = 72.4 bits (176), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 18/217 (8%)
Query: 425 IAAAANNFSTTNKLGEGGFGPVYK------GKLADEQEVAIKRLSRSSGQGIVEFKNEVR 478
+ + A ++ +G G +G K GK+ +E+ ++ + Q +V +EV
Sbjct: 1 MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV---SEVN 57
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLL--VYEFMPNKSLDFFLFNSGRKNVLNWEKRFI--I 534
L+ +L+H N+VR + L V E+ L + G K ++ F+ +
Sbjct: 58 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI-TKGTKERQYLDEEFVLRV 116
Query: 535 IEGISQGLLYLHKYSR--LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTK 592
+ ++ L H+ S V+HRDLK +N+ LD K N K+ DFG+ARI +N + K
Sbjct: 117 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAK 174
Query: 593 RIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
VGT YMSPE + K+D++S G L+ E+ +
Sbjct: 175 AFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211
>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp
Length = 285
Score = 72.4 bits (176), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQ--GIV-EFKNEVRLI 480
A +F LG+G FG VY LA E++ +A+K L ++ + G+ + + EV +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 67
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ L+H N++RL G L+ E+ P L + + + ++ I ++
Sbjct: 68 SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 124
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
L Y H RVIHRD+K N+LL KI+DFG + V+ + + GT Y
Sbjct: 125 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDY 177
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ PE K D++S GVL E + G+
Sbjct: 178 LPPEXIEGRXHDEKVDLWSLGVLCYEFLVGK 208
>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk-1 Bound To Amp-Pcp
pdb|2Z7R|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Staurosporine
pdb|2Z7S|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Purvalnol A
Length = 321
Score = 72.4 bits (176), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 69/231 (29%), Positives = 119/231 (51%), Gaps = 23/231 (9%)
Query: 409 KDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSR 464
K+ SI+H +K + A ++F LG+G FG V+ + + A+K L +
Sbjct: 10 KEISITHHVKA---GSEKADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKK 66
Query: 465 SS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSG 521
++ + V K E ++A + H +V+L + E +L L+ +F+ L F
Sbjct: 67 ATLKVRDRVRTKMERDILADVNHPFVVKL-HYAFQTEGKLYLILDFLRGGDL----FTRL 121
Query: 522 RKNVLNWEK--RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579
K V+ E+ +F + E ++ GL +LH L +I+RDLK NILLD++ + K++DFG++
Sbjct: 122 SKEVMFTEEDVKFYLAE-LALGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLS 177
Query: 580 RIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
+ E + E GT YM+PE S D +S+GVL+ E+++G
Sbjct: 178 K--EAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226
>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70
Length = 613
Score = 72.4 bits (176), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 70/268 (26%), Positives = 128/268 (47%), Gaps = 25/268 (9%)
Query: 387 RKLKAKDNVSLLPTYGKRKSPEKDQSISHELKIF-----------DFQTIAAAANNFSTT 435
R++ ++ P + SP+K + + + +F D + N
Sbjct: 282 RRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIAD 341
Query: 436 NKLGEGGFGPVYKG--KLADEQ-EVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLVRL 491
+LG G FG V +G ++ +Q +VAIK L + + + E E +++ +L + +VRL
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 492 LGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRL 551
+G E +LV E L FL G++ + ++ +S G+ YL + +
Sbjct: 402 IGVC-QAEALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEKN-- 456
Query: 552 RVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTY--GYMSPEYAMSG 609
+HR+L A N+LL ++ KISDFG+++ ++S T R G + + +PE
Sbjct: 457 -FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAPECINFR 514
Query: 610 IVSIKTDVFSFGVLVLEIVS-GQKNHTR 636
S ++DV+S+GV + E +S GQK + +
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQKPYKK 542
>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.28 A Resolution
pdb|4G34|A Chain A, Crystal Structure Of Gsk6924 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.70 A Resolution
Length = 299
Score = 72.4 bits (176), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 66/224 (29%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 431 NFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNL 488
+F LG GGFG V++ K D+ AIKR+ + + E EV+ +AKL+H +
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNW-------EKR-----FIIIE 536
VR L + P L + ++N+ +W E+R I
Sbjct: 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNIL--LDDKMNPKISDFGMARIFEVNESE------ 588
I++ + +LH ++HRDLK SNI +DD + K+ DFG+ + +E E
Sbjct: 126 QIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVV--KVGDFGLVTAMDQDEEEQTVLTP 180
Query: 589 ----ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIV 628
A VGT YMSPE S K D+FS G+++ E++
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
pdb|1V0O|B Chain B, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
Length = 288
Score = 72.4 bits (176), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 110/206 (53%), Gaps = 19/206 (9%)
Query: 432 FSTTNKLGEGGFGPVYKGKLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAKLQHTNLV 489
+ K+GEG +G VYK + + A+K++ +GI E+ ++ +L+H+N+V
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 490 RLLGCSLHGEERL-LVYEFMPN---KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
+L +H ++RL LV+E + K LD + G ++V K F++ + G+ Y
Sbjct: 64 KLYDV-IHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVT--AKSFLL--QLLNGIAYC 116
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
H RV+HRDLK N+L++ + KI+DFG+AR F + + + V T Y +P+
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE--VVTLWYRAPDV 171
Query: 606 AM-SGIVSIKTDVFSFGVLVLEIVSG 630
M S S D++S G + E+V+G
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNG 197
>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5
pdb|1V0B|B Chain B, Crystal Structure Of The T198a Mutant Of Pfpk5
Length = 288
Score = 72.0 bits (175), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 110/206 (53%), Gaps = 19/206 (9%)
Query: 432 FSTTNKLGEGGFGPVYKGKLADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAKLQHTNLV 489
+ K+GEG +G VYK + + A+K++ +GI E+ ++ +L+H+N+V
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 490 RLLGCSLHGEERL-LVYEFMPN---KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
+L +H ++RL LV+E + K LD + G ++V K F++ + G+ Y
Sbjct: 64 KLYDV-IHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVT--AKSFLL--QLLNGIAYC 116
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
H RV+HRDLK N+L++ + KI+DFG+AR F + + + V T Y +P+
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE--VVTLWYRAPDV 171
Query: 606 AM-SGIVSIKTDVFSFGVLVLEIVSG 630
M S S D++S G + E+V+G
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNG 197
>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor
Discovered Through Site-Directed Dynamic Tethering
Length = 272
Score = 72.0 bits (175), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 20/208 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQ--GIV-EFKNEVRLIAK 482
+F LG+G FG VY LA E++ +A+K L ++ + G+ + + EV + +
Sbjct: 12 EDFDIGRPLGKGKFGNVY---LARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSH 68
Query: 483 LQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
L+H N++RL G L+ E+ P ++ L R + ++ I ++ L
Sbjct: 69 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR---FDEQRTATYITELANAL 125
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMS 602
Y H RVIHRD+K N+LL KI+DFG + V+ + + GT Y+
Sbjct: 126 SYCHSK---RVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRDTLCGTLDYLP 178
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
PE + K D++S GVL E + G
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVG 206
>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex
With Staurosporine
Length = 287
Score = 72.0 bits (175), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 14/207 (6%)
Query: 437 KLGEGGFGPVYKG--KLADEQ-EVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLVRLL 492
+LG G FG V +G ++ +Q +VAIK L + + + E E +++ +L + +VRL+
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
G E +LV E L FL G++ + ++ +S G+ YL + +
Sbjct: 77 GVC-QAEALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEKN--- 130
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTY--GYMSPEYAMSGI 610
+HRDL A N+LL ++ KISDFG+++ ++S T R G + + +PE
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAPECINFRK 189
Query: 611 VSIKTDVFSFGVLVLEIVS-GQKNHTR 636
S ++DV+S+GV + E +S GQK + +
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQKPYKK 216
>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly,
Lys240->arg, Met302- >leu) In Complex With
1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]-
Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea
pdb|3DJ5|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 290.
pdb|3DJ6|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 823.
pdb|3DJ7|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 130.
pdb|3D15|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
1-(3-Chloro-Phenyl)-3-
{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)-
Ethyl]-Thiazol-2- Yl}-Urea [sns-314]
pdb|3D2I|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With 1-{5-[2-(1-Methyl-1h-
Pyrazolo[4,
3-D]pyrimidin-7-Ylamino)-Ethyl]-Thiazol-2-Yl}-3-
(3-Trifluoromethyl-Phenyl)-Urea
pdb|3D2K|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
[7-(2-{2-[3-(3-Chloro-
Phenyl)-Ureido]-Thiazol-5-Yl}-Ethylamino)-Pyrazolo[4,3-
D]pyrimidin-1-Yl]-Acetic Acid
Length = 272
Score = 72.0 bits (175), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 20/208 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQ--GIV-EFKNEVRLIAK 482
+F LG+G FG VY LA E++ +A+K L ++ + G+ + + EV + +
Sbjct: 12 EDFDIGRPLGKGKFGNVY---LARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSH 68
Query: 483 LQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
L+H N++RL G L+ E+ P ++ L R + ++ I ++ L
Sbjct: 69 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR---FDEQRTATYITELANAL 125
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMS 602
Y H RVIHRD+K N+LL KI+DFG + V+ + + GT Y+
Sbjct: 126 SYCHSK---RVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRTTLCGTLDYLP 178
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
PE + K D++S GVL E + G
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVG 206
>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain
In Complex With A Monocyclic Pyrazolone Inhibitor
Length = 360
Score = 72.0 bits (175), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 15 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELR 73
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 74 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 122 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 174 -HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With
Inhibitor Pg-874743
pdb|2GHM|A Chain A, Mutated Map Kinase P38 (Mus Musculus) In Complex With
Inhbitor Pg-895449
Length = 348
Score = 72.0 bits (175), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 11 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELR 69
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 70 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 117
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 118 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 169
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 170 -HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|2UV2|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To
4-(4-(
5-Cyclopropyl-1h-Pyrazol-3-Ylamino)-Quinazolin-2-
Ylamino)- Phenyl)-Acetonitrile
Length = 287
Score = 72.0 bits (175), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 101/216 (46%), Gaps = 19/216 (8%)
Query: 438 LGE-GGFGPVYKGKLADEQEVAI-KRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCS 495
+GE G FG VYK + + +A K + S + + ++ E+ ++A H N+V+LL
Sbjct: 17 IGELGDFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 76
Query: 496 LHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
+ ++ EF ++D + R L + ++ + L YLH ++IH
Sbjct: 77 YYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDN---KIIH 131
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR---IVGTYGYMSPEYAMSGI-- 610
RDLKA NIL + K++DFG++ + +R +GT +M+PE M
Sbjct: 132 RDLKAGNILFTLDGDIKLADFGVS----AKNTRTXIQRRDSFIGTPYWMAPEVVMCETSK 187
Query: 611 ---VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPL 643
K DV+S G+ ++E+ + H +P R L
Sbjct: 188 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL 223
>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38)
Length = 360
Score = 71.6 bits (174), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 15 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELR 73
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 74 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 122 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 174 -HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium
Tuberculosis
pdb|2FUM|A Chain A, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|B Chain B, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|C Chain C, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|D Chain D, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
Length = 299
Score = 71.6 bits (174), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQG---IVEFKNEVRLIAKLQHTNLVRLLG 493
LG GG V+ + L ++VA+K L + + F+ E + A L H +V +
Sbjct: 37 LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 96
Query: 494 C----SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+ G +V E++ +L + G + ++ +I Q L + H+
Sbjct: 97 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG 153
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEANTKRIVGTYGYMSPEYAMS 608
+IHRD+K +NI++ K+ DFG+AR I + S T ++GT Y+SPE A
Sbjct: 154 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 210
Query: 609 GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHP 639
V ++DV+S G ++ E+++G+ T P
Sbjct: 211 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 241
>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 269
Score = 71.6 bits (174), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 61/194 (31%), Positives = 102/194 (52%), Gaps = 15/194 (7%)
Query: 438 LGEGGFGPVYKGKLADEQEVAIKRLSR-SSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
+G+G FG V G + VA+K + ++ Q F E ++ +L+H+NLV+LLG +
Sbjct: 20 IGKGEFGDVMLGDYRGNK-VAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 75
Query: 497 HGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
+ L +V E+M SL +L + GR +VL + + + + YL + +H
Sbjct: 76 EEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 131
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKT 615
RDL A N+L+ + K+SDFG+ + E + ++ K V + +PE S K+
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPV---KWTAPEALREAAFSTKS 186
Query: 616 DVFSFGVLVLEIVS 629
DV+SFG+L+ EI S
Sbjct: 187 DVWSFGILLWEIYS 200
>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2
pdb|3NYV|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Non-Specific Inhibitor
Whi-P180
Length = 484
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 68/227 (29%), Positives = 112/227 (49%), Gaps = 41/227 (18%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVY--KGKLADEQEVAIKRLSRSSGQGIVEFKN---EV 477
+ A ++ + LG+G FG V K K+ QE A+K +S+ + + ++ EV
Sbjct: 19 HSTAIFSDRYKGQRVLGKGSFGEVILCKDKITG-QECAVKVISKRQVKQKTDKESLLREV 77
Query: 478 RLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFL----FNSGRK-NVLNWEKRF 532
+L+ +L H N+ +L YEF +K F+L + G + + KRF
Sbjct: 78 QLLKQLDHPNIXKL-------------YEFFEDKGY-FYLVGEVYTGGELFDEIISRKRF 123
Query: 533 I------IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDK---MNPKISDFGMARIFE 583
II + G+ Y HK +++HRDLK N+LL+ K N +I DFG++ FE
Sbjct: 124 SEVDAARIIRQVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180
Query: 584 VNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
++ K +GT Y++PE + G K DV+S GV++ ++SG
Sbjct: 181 ASK---KXKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a
Length = 282
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQ--GIV-EFKNEVRLI 480
A +F LG+G FG VY LA E++ +A+K L ++ + G+ + + EV +
Sbjct: 8 ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 64
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ L+H N++RL G L+ E+ P L + + + ++ I ++
Sbjct: 65 SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 121
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
L Y H RVIHRD+K N+LL KI++FG + V+ + + GT Y
Sbjct: 122 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDY 174
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ PE + K D++S GVL E + G+
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205
>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|B Chain B, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|C Chain C, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|D Chain D, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|E Chain E, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|F Chain F, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
Length = 450
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 61/194 (31%), Positives = 102/194 (52%), Gaps = 15/194 (7%)
Query: 438 LGEGGFGPVYKGKLADEQEVAIKRLSR-SSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
+G+G FG V G + VA+K + ++ Q F E ++ +L+H+NLV+LLG +
Sbjct: 201 IGKGEFGDVMLGDYRGNK-VAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 256
Query: 497 HGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
+ L +V E+M SL +L + GR +VL + + + + YL + +H
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 312
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKT 615
RDL A N+L+ + K+SDFG+ + E + ++ K V + +PE S K+
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPV---KWTAPEALREKKFSTKS 367
Query: 616 DVFSFGVLVLEIVS 629
DV+SFG+L+ EI S
Sbjct: 368 DVWSFGILLWEIYS 381
>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With
Inhibitor Pg-892579
pdb|2GTN|A Chain A, Mutated Map Kinase P38 (mus Musculus) In Complex With
Inhbitor Pg-951717
Length = 348
Score = 71.2 bits (173), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 11 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELR 69
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 70 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 117
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 118 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 169
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 170 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Nuclear Substrate Mef2a
pdb|1LEZ|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Activator Mkk3b
Length = 360
Score = 71.2 bits (173), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 15 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELR 73
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 74 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 122 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 174 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2OZA|B Chain B, Structure Of P38alpha Complex
pdb|3P78|A Chain A, P38 Inhibitor-Bound
pdb|3P79|A Chain A, P38 Inhibitor-Bound
pdb|3P7A|A Chain A, P38 Inhibitor-Bound
pdb|3P7B|A Chain A, P38 Inhibitor-Bound
pdb|3P7C|A Chain A, P38 Inhibitor-Bound
pdb|3P5K|A Chain A, P38 Inhibitor-Bound
Length = 366
Score = 71.2 bits (173), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 21 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELR 79
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 80 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 127
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 128 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 179
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 180 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|C Chain C, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|D Chain D, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|E Chain E, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|F Chain F, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|G Chain G, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|H Chain H, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
Length = 328
Score = 71.2 bits (173), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADE----QEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQ 484
N+ +G+G F V KLA +EVA+K + ++ + + + EVR++ L
Sbjct: 16 NYRLQKTIGKGNFAKV---KLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILN 72
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
H N+V+L + LV E+ + +L GR +F I + Y
Sbjct: 73 HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQY 129
Query: 545 LH-KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
H KY ++HRDLKA N+LLD MN KI+DFG + F V G+ Y +P
Sbjct: 130 CHQKY----IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNK---LDTFCGSPPYAAP 182
Query: 604 E-YAMSGIVSIKTDVFSFGVLVLEIVSG 630
E + + DV+S GV++ +VSG
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVILYTLVSG 210
>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655
pdb|1P38|A Chain A, The Structure Of The Map Kinase P38 At 2.1 Angstoms
Resolution
Length = 379
Score = 71.2 bits (173), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 34 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELR 92
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 93 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 140
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 141 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 192
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 193 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239
>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk
Docking Partner
Length = 380
Score = 71.2 bits (173), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 35 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELR 93
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 94 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 141
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 142 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 193
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 194 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240
>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase
Length = 360
Score = 71.2 bits (173), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 15 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 73
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 74 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 122 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 174 -HTDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase
Length = 380
Score = 71.2 bits (173), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 35 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELR 93
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 94 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 141
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 142 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 193
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 194 -HTDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240
>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
pdb|3LMG|B Chain B, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
Length = 344
Score = 71.2 bits (173), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 438 LGEGGFGPVYKGKLADEQE-----VAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRL 491
LG G FG V+KG E E V IK + SG Q + + I L H ++VRL
Sbjct: 39 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 492 LGCSLHGEERLLVYEFMPNKSLDFFLFNS----GRKNVLNWEKRFIIIEGISQGLLYLHK 547
LG G LV +++P SL + G + +LNW + I++G+ YL +
Sbjct: 99 LGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGMYYLEE 151
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
+ ++HR+L A N+LL +++DFG+A + ++ + +M+ E
Sbjct: 152 HG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 208
Query: 608 SGIVSIKTDVFSFGVLVLEIVS 629
G + ++DV+S+GV V E+++
Sbjct: 209 FGKYTHQSDVWSYGVTVWELMT 230
>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A
Diaminopyrimidine
Length = 281
Score = 70.9 bits (172), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQ--GIV-EFKNEVRLI 480
A +F LG+G FG VY LA E++ +A+K L ++ + G+ + + EV +
Sbjct: 7 ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 63
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ L+H N++RL G L+ E+ P L + + + ++ I ++
Sbjct: 64 SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 120
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
L Y H RVIHRD+K N+LL KI+DFG + + + + GT Y
Sbjct: 121 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSCHAPSSRRTTLSGTLDY 173
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ PE + K D++S GVL E + G+
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine
Inhibitor
Length = 272
Score = 70.9 bits (172), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQ--GIV-EFKNEVRLI 480
A +F LG+G FG VY LA E++ +A+K L ++ + G+ + + EV +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 65
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ L+H N++RL G L+ E+ P L + + + ++ I ++
Sbjct: 66 SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 122
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
L Y H RVIHRD+K N+LL KI++FG + V+ + + GT Y
Sbjct: 123 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDY 175
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ PE + K D++S GVL E + G+
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206
>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
pdb|3KEX|B Chain B, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
Length = 325
Score = 70.9 bits (172), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 438 LGEGGFGPVYKGKLADEQE-----VAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRL 491
LG G FG V+KG E E V IK + SG Q + + I L H ++VRL
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 492 LGCSLHGEERLLVYEFMPNKSLDFFLFNS----GRKNVLNWEKRFIIIEGISQGLLYLHK 547
LG G LV +++P SL + G + +LNW + I++G+ YL +
Sbjct: 81 LGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGMYYLEE 133
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
+ ++HR+L A N+LL +++DFG+A + ++ + +M+ E
Sbjct: 134 HG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 608 SGIVSIKTDVFSFGVLVLEIVS 629
G + ++DV+S+GV V E+++
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMT 212
>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
pdb|3COH|B Chain B, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
Length = 268
Score = 70.9 bits (172), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 16/209 (7%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQEV-AIKRLSRSSGQ--GIV-EFKNEVRLIAKL 483
A +F LG+G FG VY + + + + A+K L ++ + G+ + + EV + + L
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 484 QHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
+H N++RL G H R+ L+ E+ P L + + + ++ I ++ L
Sbjct: 66 RHPNILRLYGY-FHDSTRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMS 602
Y H +VIHRD+K N+LL KI+DFG + V+ + + GT Y+
Sbjct: 122 SYCHSK---KVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLP 174
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
PE + K D++S GVL E + G+
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203
>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In
Phosphorylated P38a And In Solution
Length = 370
Score = 70.9 bits (172), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 108/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 25 KTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELR 83
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 84 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 131
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 132 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 183
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 184 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230
>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195
Length = 365
Score = 70.5 bits (171), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 20 KTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 78
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 79 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 126
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 127 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR---- 178
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 179 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI8|C Chain C, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI7|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structure Of The Cdk6-P16ink4a Tumor Suppressor
Complex
pdb|1BLX|A Chain A, P19ink4dCDK6 COMPLEX
pdb|1G3N|A Chain A, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
pdb|1G3N|E Chain E, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
Length = 326
Score = 70.5 bits (171), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 56/215 (26%), Positives = 105/215 (48%), Gaps = 20/215 (9%)
Query: 425 IAAAANNFSTTNKLGEGGFGPVYKGKLADE--QEVAIKRLSRSSGQ-----GIVEFKNEV 477
+ A + ++GEG +G V+K + + VA+KR+ +G+ + +
Sbjct: 6 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 478 RLIAKLQHTNLVRLLG-CSLHGEER----LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRF 532
R + +H N+VRL C++ +R LV+E + ++ L +L V +
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKD 124
Query: 533 IIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTK 592
++ + + +GL +LH + RV+HRDLK NIL+ K++DFG+ARI+ + +
Sbjct: 125 MMFQ-LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-- 178
Query: 593 RIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEI 627
+V T Y +PE + + D++S G + E+
Sbjct: 179 -VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212
>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
pdb|2V5Q|B Chain B, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
Length = 315
Score = 70.5 bits (171), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 438 LGEGGFGPVYKGKLADEQEVAIKRLSRSS----GQGIVEFKNEVRLIAKLQHTNLVRLLG 493
LG+GGF ++ AD +EV ++ S + E+ + L H ++V G
Sbjct: 29 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 494 CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRV 553
+ +V E +SL + RK + E R+ + + I G YLH R RV
Sbjct: 89 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARYYLRQ-IVLGCQYLH---RNRV 142
Query: 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI 613
IHRDLK N+ L++ + KI DFG+A E + T + GT Y++PE S
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 200
Query: 614 KTDVFSFGVLVLEIVSGQ 631
+ DV+S G ++ ++ G+
Sbjct: 201 EVDVWSIGCIMYTLLVGK 218
>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant
Length = 334
Score = 70.5 bits (171), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 432 FSTTNKLGEGGFGPVYKGK-----LADEQEVAIKRLSRSSGQGIV--EFKNEVRLIAKLQ 484
+ T +LG G F V K + L + KR ++SS +G+ + + EV ++ ++Q
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
H N++ L + + +L+ E + L FL K L E+ ++ I G+ Y
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPK----ISDFGMARIFEVNESEANTKRIVGTYGY 600
LH L++ H DLK NI+L D+ PK I DFG+A + N I GT +
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPAF 183
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
++PE + ++ D++S GV+ ++SG
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213
>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|C Chain C, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 263
Score = 70.5 bits (171), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 61/196 (31%), Positives = 102/196 (52%), Gaps = 19/196 (9%)
Query: 438 LGEGGFGPVYKGKLADEQEVAIKRLSR-SSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
+G+G FG V G + VA+K + ++ Q F E ++ +L+H+NLV+LLG +
Sbjct: 14 IGKGEFGDVMLGDYRGNK-VAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 69
Query: 497 HGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
+ L +V E+M SL +L + GR +VL + + + + YL + +H
Sbjct: 70 EEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 125
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT--YGYMSPEYAMSGIVSI 613
RDL A N+L+ + K+SDFG+ + EA++ + G + +PE S
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFST 178
Query: 614 KTDVFSFGVLVLEIVS 629
K+DV+SFG+L+ EI S
Sbjct: 179 KSDVWSFGILLWEIYS 194
>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase
Length = 362
Score = 70.5 bits (171), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 17 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 75
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 76 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 123
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 124 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 175
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 176 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P-
Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl-
Pyridin-3-Yl)naphthalen-1-Yl]urea
pdb|3CTQ|A Chain A, Structure Of Map Kinase P38 In Complex With A
1-O-Tolyl-1,2, 3-Triazole-4-Carboxamide
Length = 348
Score = 70.5 bits (171), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 108/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 11 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELR 69
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ K
Sbjct: 70 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCAK 117
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 118 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 169
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 170 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine
pdb|4AA5|A Chain A, P38alpha Map Kinase Bound To Cmpd 33
Length = 365
Score = 70.5 bits (171), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 20 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 78
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 79 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 126
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 127 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR---- 178
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 179 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|3HEC|A Chain A, P38 In Complex With Imatinib
pdb|3HEG|A Chain A, P38 In Complex With Sorafenib
Length = 348
Score = 70.5 bits (171), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 11 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 69
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 70 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 117
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 118 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 169
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 170 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
Length = 349
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 12 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 70
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 71 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 118
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 119 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 170
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 171 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217
>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48
pdb|3GCU|B Chain B, Human P38 Map Kinase In Complex With Rl48
pdb|3HV4|A Chain A, Human P38 Map Kinase In Complex With Rl51
pdb|3HV4|B Chain B, Human P38 Map Kinase In Complex With Rl51
pdb|3HV5|A Chain A, Human P38 Map Kinase In Complex With Rl24
pdb|3HV5|B Chain B, Human P38 Map Kinase In Complex With Rl24
pdb|3HV6|A Chain A, Human P38 Map Kinase In Complex With Rl39
pdb|3HV7|A Chain A, Human P38 Map Kinase In Complex With Rl38
pdb|3HUC|A Chain A, Human P38 Map Kinase In Complex With Rl40
pdb|3LFA|A Chain A, Human P38 Map Kinase In Complex With Dasatinib
pdb|3QUE|A Chain A, Human P38 Map Kinase In Complex With Skepinone-L
pdb|3QUD|A Chain A, Human P38 Map Kinase In Complex With
2-Amino-Phenylamino-Benzophenone
pdb|3UVP|A Chain A, Human P38 Map Kinase In Complex With A Benzamide
Substituted Benzosuberone
pdb|3UVQ|A Chain A, Human P38 Map Kinase In Complex With A Dibenzosuberone
Derivative
pdb|4EH2|A Chain A, Human P38 Map Kinase In Complex With Np-F1 And Rl87
pdb|4EH3|A Chain A, Human P38 Map Kinase In Complex With Np-F2 And Rl87
pdb|4EH4|A Chain A, Human P38 Map Kinase In Complex With Np-F3 And Rl87
pdb|4EH5|A Chain A, Human P38 Map Kinase In Complex With Np-F4 And Rl87
pdb|4EH6|A Chain A, Human P38 Map Kinase In Complex With Np-F5 And Rl87
pdb|4EH7|A Chain A, Human P38 Map Kinase In Complex With Np-F6 And Rl87
pdb|4EH8|A Chain A, Human P38 Map Kinase In Complex With Np-F7 And Rl87
pdb|4EH9|A Chain A, Human P38 Map Kinase In Complex With Np-F11 And Rl87
pdb|4EHV|A Chain A, Human P38 Map Kinase In Complex With Np-F10 And Rl87
pdb|3UVR|A Chain A, Human P38 Map Kinase In Complex With Km064
pdb|4DLI|A Chain A, Human P38 Map Kinase In Complex With Rl87
pdb|4DLJ|A Chain A, Human P38 Map Kinase In Complex With Rl163
Length = 360
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 15 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 73
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 74 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 122 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 174 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A
Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE
COMPLEX IN Solution
Length = 359
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 20 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 78
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 79 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 126
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 127 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 178
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 179 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant
Length = 360
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 15 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 73
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 74 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 122 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 174 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea
pdb|2BAK|A Chain A, P38alpha Map Kinase Bound To Mpaq
pdb|4A9Y|A Chain A, P38alpha Map Kinase Bound To Cmpd 8
pdb|4AA0|A Chain A, P38alpha Map Kinase Bound To Cmpd 2
pdb|4AA4|A Chain A, P38alpha Map Kinase Bound To Cmpd 22
pdb|4AAC|A Chain A, P38alpha Map Kinase Bound To Cmpd 29
Length = 365
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 20 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 78
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 79 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 126
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 127 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 178
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 179 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|3MW1|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|2YIS|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase.
pdb|2YIW|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase
Length = 359
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 14 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 72
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 73 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 120
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 121 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 172
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 173 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219
>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant
Length = 360
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 15 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 73
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 74 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 122 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 174 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
pdb|3IPH|A Chain A, Crystal Structure Of P38 In Complex With A Biphenylamide
Inhibitor
Length = 360
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 15 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 73
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 74 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQK 121
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 122 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR---- 173
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 174 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine
pdb|2YIX|A Chain A, Triazolopyridine Inhibitors Of P38
Length = 351
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 12 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 70
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 71 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 118
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 119 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 170
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 171 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217
>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In
Complex With 4-[3-Methylsulfanylanilino]-6,7-
Dimethoxyquinazoline
pdb|1KV1|A Chain A, P38 Map Kinase In Complex With Inhibitor 1
pdb|1KV2|A Chain A, Human P38 Map Kinase In Complex With Birb 796
pdb|1WBO|A Chain A, Fragment Based P38 Inhibitors
pdb|1W7H|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W82|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W83|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W84|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1ZZ2|A Chain A, Two Classes Of P38alpha Map Kinase Inhibitors Having A
Common Diphenylether Core But Exhibiting Divergent
Binding Modes
pdb|1WBN|A Chain A, Fragment Based P38 Inhibitors
pdb|1WBS|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBT|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-based Lead Generation.
pdb|1WBV|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBW|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1ZYJ|A Chain A, Human P38 Map Kinase In Complex With Inhibitor 1a
pdb|2ZAZ|A Chain A, Crystal Structure Of P38 In Complex With 4-Anilino
Quinoline Inhibitor
pdb|2ZB0|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|2ZB1|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|3HL7|A Chain A, Crystal Structure Of Human P38alpha Complexed With Sd-0006
pdb|3HLL|A Chain A, Crystal Structure Of Human P38alpha Complexed With
Ph-797804
pdb|3HP2|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyridinone Compound
pdb|3HP5|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyrimidopyridazinone Compound
pdb|3KF7|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Triazolopyrimidine Compound
pdb|3MGY|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3ROC|A Chain A, Crystal Structure Of Human P38 Alpha Complexed With A
Pyrimidinone Compound
pdb|3RIN|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|4E5B|A Chain A, Structure Of P38a Map Kinase Without Bog
pdb|4E6A|A Chain A, P38a-Pia23 Complex
pdb|4E6C|A Chain A, P38a-perifosine Complex
pdb|4E8A|A Chain A, The Crystal Structure Of P38a Map Kinase In Complex With
Pia24
Length = 360
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 15 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 73
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 74 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 122 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 174 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant
Length = 360
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 15 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 73
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 74 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 122 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 174 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map
Kinase
Length = 360
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 15 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 73
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 74 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 122 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 174 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1-
Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3-
Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide
Length = 380
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 68/249 (27%), Positives = 115/249 (46%), Gaps = 45/249 (18%)
Query: 402 GKRKSPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIK 460
G S E+ EL +TI + + +G G +G V VA+K
Sbjct: 18 GSHMSQERPTFYRQELN----KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK 73
Query: 461 RLSRSSGQGIVEFKN---EVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF- 516
+LSR Q I+ K E+RL+ ++H N++ LL F P +SL+ F
Sbjct: 74 KLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDV------------FTPARSLEEFN 120
Query: 517 -------LFNSGRKNVLNWEK------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNI 563
L + N++ +K +F+I + I +GL Y+H +IHRDLK SN+
Sbjct: 121 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNL 176
Query: 564 LLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGV 622
+++ KI DFG+AR ++ V T Y +PE ++ + +T D++S G
Sbjct: 177 AVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 231
Query: 623 LVLEIVSGQ 631
++ E+++G+
Sbjct: 232 IMAELLTGR 240
>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995
pdb|1BL7|A Chain A, The Complex Structure Of The Map Kinase P38SB220025
pdb|2EWA|A Chain A, Dual Binding Mode Of Pyridinylimidazole To Map Kinase P38
pdb|1A9U|A Chain A, The Complex Structure Of The Map Kinase P38SB203580
pdb|3HA8|A Chain A, The Complex Structure Of The Map Kinase P38COMPOUND 14B
Length = 379
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 68/249 (27%), Positives = 115/249 (46%), Gaps = 45/249 (18%)
Query: 402 GKRKSPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIK 460
G S E+ EL +TI + + +G G +G V VA+K
Sbjct: 17 GSHMSQERPTFYRQELN----KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK 72
Query: 461 RLSRSSGQGIVEFKN---EVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF- 516
+LSR Q I+ K E+RL+ ++H N++ LL F P +SL+ F
Sbjct: 73 KLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDV------------FTPARSLEEFN 119
Query: 517 -------LFNSGRKNVLNWEK------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNI 563
L + N++ +K +F+I + I +GL Y+H +IHRDLK SN+
Sbjct: 120 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNL 175
Query: 564 LLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGV 622
+++ KI DFG+AR ++ V T Y +PE ++ + +T D++S G
Sbjct: 176 AVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 230
Query: 623 LVLEIVSGQ 631
++ E+++G+
Sbjct: 231 IMAELLTGR 239
>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral
Cyclin
pdb|1XO2|B Chain B, Crystal Structure Of A Human Cyclin-Dependent Kinase 6
Complex With A Flavonol Inhibitor, Fisetin
pdb|2EUF|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclin In Complex With The
Inhibitor Pd0332991
pdb|2F2C|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclinwith The Inhibitor
Aminopurvalanol
Length = 308
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 56/215 (26%), Positives = 105/215 (48%), Gaps = 20/215 (9%)
Query: 425 IAAAANNFSTTNKLGEGGFGPVYKGKLADE--QEVAIKRLSRSSGQ-----GIVEFKNEV 477
+ A + ++GEG +G V+K + + VA+KR+ +G+ + +
Sbjct: 6 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 478 RLIAKLQHTNLVRLLG-CSLHGEER----LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRF 532
R + +H N+VRL C++ +R LV+E + ++ L +L V +
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKD 124
Query: 533 IIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTK 592
++ + + +GL +LH + RV+HRDLK NIL+ K++DFG+ARI+ + +
Sbjct: 125 MMFQ-LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-- 178
Query: 593 RIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEI 627
+V T Y +PE + + D++S G + E+
Sbjct: 179 -VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212
>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376
pdb|3NNV|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp437
pdb|3NNW|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp802
Length = 354
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 15 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 73
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 74 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 122 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 174 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955
Length = 350
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 13 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 71
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 72 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 119
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 120 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 171
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 172 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218
>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121
Length = 362
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 17 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 75
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 76 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 123
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 124 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 175
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 176 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase
Length = 367
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 22 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 80
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 81 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 128
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 129 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 180
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 181 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex
pdb|2QD9|A Chain A, P38 Alpha Map Kinase Inhibitor Based On Heterobicyclic
Scaffolds
pdb|2RG5|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11b
pdb|2RG6|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11j
pdb|3C5U|A Chain A, P38 Alpha Map Kinase Complexed With A Benzothiazole Based
Inhibitor
pdb|3BV2|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 30
pdb|3BV3|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 2
pdb|3BX5|A Chain A, P38 Alpha Map Kinase Complexed With Bms-640994
pdb|3L8X|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Pyrimidine
Based Inhibitor
pdb|3NWW|A Chain A, P38 Alpha Kinase Complexed With A
2-Aminothiazol-5-Yl-Pyrimidine Based Inhibitor
pdb|3MVL|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVL|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVM|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3MVM|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3OCG|A Chain A, P38 Alpha Kinase Complexed With A 5-Amino-Pyrazole Based
Inhibitor
pdb|3S4Q|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Triazine Based
Inhibitor
Length = 366
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 21 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 79
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 80 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 127
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 128 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 179
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 180 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex
With Dp802
Length = 354
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 15 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 73
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 74 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 122 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 174 -HTDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With
Bound Inhibitor Fragment
Length = 293
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 432 FSTTNKLGEGGFGPVYKGK-----LADEQEVAIKRLSRSSGQGIV--EFKNEVRLIAKLQ 484
+ T +LG G F V K + L + KR ++SS +G+ + + EV ++ ++Q
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
H N++ L + + +L+ E + L FL K L E+ ++ I G+ Y
Sbjct: 72 HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 128
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPK----ISDFGMARIFEVNESEANTKRIVGTYGY 600
LH L++ H DLK NI+L D+ PK I DFG+A + K I GT +
Sbjct: 129 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEF 182
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
++PE + ++ D++S GV+ ++SG
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSG 212
>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A
Dihydroquinazolinone Inhibitor
pdb|1OUK|A Chain A, The Structure Of P38 Alpha In Complex With A
Pyridinylimidazole Inhibitor
pdb|1OUY|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydropyrido- Pyrimidine Inhibitor
pdb|1R39|A Chain A, The Structure Of P38alpha
pdb|1YQJ|A Chain A, Crystal Structure Of P38 Alpha In Complex With A Selective
Pyridazine Inhibitor
pdb|2OKR|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2OKR|D Chain D, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|B Chain B, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|1WFC|A Chain A, Structure Of Apo, Unphosphorylated, P38 Mitogen Activated
Protein Kinase P38 (P38 Map Kinase) The Mammalian
Homologue Of The Yeast Hog1 Protein
pdb|3DS6|A Chain A, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|B Chain B, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|C Chain C, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|D Chain D, P38 Complex With A Phthalazine Inhibitor
pdb|3FC1|X Chain X, Crystal Structure Of P38 Kinase Bound To
Pyrimido-Pyridazinone Inhibitor
pdb|3GFE|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor
pdb|3ITZ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridazine Inhibitor
pdb|3LHJ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor.
pdb|3ZYA|A Chain A, Human P38 Map Kinase In Complex With 2-Amino-Phenylamino-
Dibenzosuberone
pdb|3U8W|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Triazolopyridazinone Inhibitor
Length = 366
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 21 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 79
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 80 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 127
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 128 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 179
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 180 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715
pdb|3ZSH|A Chain A, X-Ray Structure Of P38alpha Bound To Scio-469
pdb|3ZSI|A Chain A, X-Ray Structure Of P38alpha Bound To Vx-745
pdb|3ZS5|A Chain A, Structural Basis For Kinase Selectivity Of Three Clinical
P38alpha Inhibitors
Length = 362
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 17 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 75
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 76 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 123
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 124 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 175
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 176 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain With
Amppnp
pdb|3DGK|A Chain A, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain
Length = 295
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 432 FSTTNKLGEGGFGPVYKGK-----LADEQEVAIKRLSRSSGQGIV--EFKNEVRLIAKLQ 484
+ T +LG G F V K + L + KR ++SS +G+ + + EV ++ ++Q
Sbjct: 13 YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
H N++ L + + +L+ E + L FL K L E+ ++ I G+ Y
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPK----ISDFGMARIFEVNESEANTKRIVGTYGY 600
LH L++ H DLK NI+L D+ PK I DFG+A + K I GT +
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEF 183
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
++PE + ++ D++S GV+ ++SG
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213
>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In
Complex With Inhibitor Staurosporine
Length = 278
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 61/196 (31%), Positives = 102/196 (52%), Gaps = 19/196 (9%)
Query: 438 LGEGGFGPVYKGKLADEQEVAIKRLSR-SSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
+G+G FG V G + VA+K + ++ Q F E ++ +L+H+NLV+LLG +
Sbjct: 29 IGKGEFGDVMLGDYRGNK-VAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 84
Query: 497 HGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
+ L +V E+M SL +L + GR +VL + + + + YL + +H
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 140
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT--YGYMSPEYAMSGIVSI 613
RDL A N+L+ + K+SDFG+ + EA++ + G + +PE S
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFST 193
Query: 614 KTDVFSFGVLVLEIVS 629
K+DV+SFG+L+ EI S
Sbjct: 194 KSDVWSFGILLWEIYS 209
>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
Length = 360
Score = 70.1 bits (170), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 15 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 73
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 74 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQK 121
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 122 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 174 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole
Inhibitor
Length = 372
Score = 70.1 bits (170), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 27 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 85
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 86 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 133
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 134 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 185
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 186 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232
>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor
Length = 383
Score = 70.1 bits (170), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 38 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 96
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 97 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 144
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 145 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 196
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 197 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243
>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195
pdb|3FKL|A Chain A, P38 Kinase Crystal Structure In Complex With Ro9552
pdb|3FKN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro7125
pdb|3FL4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro5634
pdb|3FLQ|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((S)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin
pdb|3FLS|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((R)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin-7-One
pdb|3FLW|A Chain A, P38 Kinase Crystal Structure In Complex With Pamapimod
pdb|3FLY|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-Isopropylamino-8-Methyl-8h-Pyrido[2,
3- D]pyrimidin-7-One
pdb|3FLZ|A Chain A, P38 Kinase Crystal Structure In Complex With
8-Methyl-6-Phenoxy-2-
(Tetrahydro-Pyran-4-Ylamino)-8h-Pyrido[2,
3-D]pyrimidin-7-One
pdb|3FMH|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((R)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FMJ|A Chain A, P38 Kinase Crystal Structure In Complex With
4-(5-Methyl-3-Phenyl- Isoxazol-4-Yl)-Pyrimidin-2-Ylamine
pdb|3FMK|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((S)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FML|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6224
pdb|3FMM|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6226
pdb|3FMN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro2530
pdb|3FSF|A Chain A, P38 Kinase Crystal Structure In Complex With 3-(2,6-
Dichloro-Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-
Phenylamino]-
1-Methyl-3,4-Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3FSK|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6257
Length = 372
Score = 70.1 bits (170), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 27 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 85
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 86 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 133
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 134 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 185
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 186 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232
>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With
Nms-P937
pdb|4A4L|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
5-(2-Amino-Pyrimidin-4-Yl)-1h-Pyrrole Inhibitor
pdb|4A4O|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
2-
(2-Amino-Pyrimidin-4-Yl)-1,5,6,
7-Tetrahydro-Pyrrolopyridin- 4-One Inhibitor
Length = 311
Score = 70.1 bits (170), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 438 LGEGGFGPVYKGKLADEQEVAIKRLSRSS----GQGIVEFKNEVRLIAKLQHTNLVRLLG 493
LG+GGF ++ AD +EV ++ S + E+ + L H ++V G
Sbjct: 25 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 494 CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRV 553
+ +V E +SL + RK + E R+ + + I G YLH R RV
Sbjct: 85 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARYYLRQ-IVLGCQYLH---RNRV 138
Query: 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI 613
IHRDLK N+ L++ + KI DFG+A E + T + GT Y++PE S
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 614 KTDVFSFGVLVLEIVSGQ 631
+ DV+S G ++ ++ G+
Sbjct: 197 EVDVWSIGCIMYTLLVGK 214
>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A
Pyrrole-2- Carboxamide Inhibitor
Length = 371
Score = 70.1 bits (170), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 26 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 84
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 85 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 132
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 133 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 184
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 185 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231
>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based
Inhibitor
Length = 383
Score = 70.1 bits (170), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 38 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 96
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 97 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 144
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 145 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 196
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 197 -HTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243
>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 311
Score = 70.1 bits (170), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 438 LGEGGFGPVYKGKLADEQEVAIKRLSRSS----GQGIVEFKNEVRLIAKLQHTNLVRLLG 493
LG+GGF ++ AD +EV ++ S + E+ + L H ++V G
Sbjct: 25 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 494 CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRV 553
+ +V E +SL + RK + E R+ + + I G YLH R RV
Sbjct: 85 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARYYLRQ-IVLGCQYLH---RNRV 138
Query: 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI 613
IHRDLK N+ L++ + KI DFG+A E + T + GT Y++PE S
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 614 KTDVFSFGVLVLEIVSGQ 631
+ DV+S G ++ ++ G+
Sbjct: 197 EVDVWSIGCIMYTLLVGK 214
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
Length = 295
Score = 70.1 bits (170), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
LG+G +G VY G+ L+++ +AIK + + E+ L L+H N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 497 HGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHR 556
+ E +P SL L + N + + I +GL YLH +++HR
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 146
Query: 557 DLKASNILLDDKMNP-KISDFGMA-RIFEVNESEANTKRIVGTYGYMSPEYAMSGI--VS 612
D+K N+L++ KISDFG + R+ +N T+ GT YM+PE G
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPC---TETFTGTLQYMAPEIIDKGPRGYG 203
Query: 613 IKTDVFSFGVLVLEIVSGQ 631
D++S G ++E+ +G+
Sbjct: 204 KAADIWSLGCTIIEMATGK 222
>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|3NUX|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|4AUA|A Chain A, Liganded X-ray Crystal Structure Of Cyclin Dependent
Kinase 6 (cdk6)
pdb|4EZ5|A Chain A, Cdk6 (monomeric) In Complex With Inhibitor
Length = 307
Score = 70.1 bits (170), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 56/215 (26%), Positives = 105/215 (48%), Gaps = 20/215 (9%)
Query: 425 IAAAANNFSTTNKLGEGGFGPVYKGKLADE--QEVAIKRLSRSSGQ-----GIVEFKNEV 477
+ A + ++GEG +G V+K + + VA+KR+ +G+ + +
Sbjct: 6 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 478 RLIAKLQHTNLVRLLG-CSLHGEER----LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRF 532
R + +H N+VRL C++ +R LV+E + ++ L +L V +
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKD 124
Query: 533 IIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTK 592
++ + + +GL +LH + RV+HRDLK NIL+ K++DFG+ARI+ + +
Sbjct: 125 MMFQ-LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-- 178
Query: 593 RIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEI 627
+V T Y +PE + + D++S G + E+
Sbjct: 179 -VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212
>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase
In Complex With Amppnp And Mg2+
Length = 295
Score = 70.1 bits (170), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 432 FSTTNKLGEGGFGPVYKGK-----LADEQEVAIKRLSRSSGQGIV--EFKNEVRLIAKLQ 484
+ T +LG G F V K + L + KR ++SS +G+ + + EV ++ ++Q
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
H N++ L + + +L+ E + L FL K L E+ ++ I G+ Y
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPK----ISDFGMARIFEVNESEANTKRIVGTYGY 600
LH L++ H DLK NI+L D+ PK I DFG+A + K I GT +
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEF 183
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
++PE + ++ D++S GV+ ++SG
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213
>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
pdb|3E93|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
Length = 371
Score = 70.1 bits (170), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 26 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 84
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 85 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 132
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 133 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR---- 184
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 185 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231
>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mn.
pdb|1JKL|A Chain A, 1.6a X-Ray Structure Of Binary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue
pdb|1JKS|A Chain A, 1.5a X-Ray Structure Of Apo Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|A Chain A, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|B Chain B, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKK|A Chain A, 2.4a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mg.
pdb|3F5G|A Chain A, Crystal Structure Of Death Associated Protein Kinase In
Complex With Adp And Mg2+
pdb|3EH9|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Adp
pdb|3EHA|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Amppnp
Length = 294
Score = 69.7 bits (169), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 432 FSTTNKLGEGGFGPVYKGK-----LADEQEVAIKRLSRSSGQGIV--EFKNEVRLIAKLQ 484
+ T +LG G F V K + L + KR ++SS +G+ + + EV ++ ++Q
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
H N++ L + + +L+ E + L FL K L E+ ++ I G+ Y
Sbjct: 72 HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 128
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPK----ISDFGMARIFEVNESEANTKRIVGTYGY 600
LH L++ H DLK NI+L D+ PK I DFG+A + K I GT +
Sbjct: 129 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEF 182
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
++PE + ++ D++S GV+ ++SG
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSG 212
>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer
Length = 319
Score = 69.7 bits (169), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 67/280 (23%), Positives = 124/280 (44%), Gaps = 33/280 (11%)
Query: 438 LGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLH 497
+G+G FG VY G+ E + + + R + + FK EV + +H N+V +G +
Sbjct: 41 IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 498 GEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRD 557
++ ++L + ++ K VL+ K I + I +G+ YLH ++H+D
Sbjct: 101 PPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155
Query: 558 LKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY-----------MSPEYA 606
LK+ N+ D+ I+DFG+ I V ++ ++ G+ +SP+
Sbjct: 156 LKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214
Query: 607 MSGI-VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665
+ S +DVF+ G + E+ H R P + WQ+ G G++ P+
Sbjct: 215 EDKLPFSKHSDVFALGTIWYEL------HAREWPFKTQPAEAIIWQM---GTGMK---PN 262
Query: 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
L Q E+ + L C + +RPT +++ ML+
Sbjct: 263 LSQIGMGKEISDIL---LFCWAFEQEERPTFTKLMDMLEK 299
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 69.7 bits (169), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
LG+G +G VY G+ L+++ +AIK + + E+ L L+H N+V+ LG
Sbjct: 16 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 497 HGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHR 556
+ E +P SL L + N + + I +GL YLH +++HR
Sbjct: 76 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 132
Query: 557 DLKASNILLDDKMNP-KISDFGMA-RIFEVNESEANTKRIVGTYGYMSPEYAMSGI--VS 612
D+K N+L++ KISDFG + R+ +N T+ GT YM+PE G
Sbjct: 133 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPC---TETFTGTLQYMAPEIIDKGPRGYG 189
Query: 613 IKTDVFSFGVLVLEIVSGQ 631
D++S G ++E+ +G+
Sbjct: 190 KAADIWSLGCTIIEMATGK 208
>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydroquinolinone
pdb|1R3C|A Chain A, The Structure Of P38alpha C162s Mutant
pdb|2I0H|A Chain A, The Structure Of P38alpha In Complex With An
Arylpyridazinone
pdb|3GC7|A Chain A, The Structure Of P38alpha In Complex With A
Dihydroquinazolinone
pdb|3NEW|A Chain A, P38-Alpha Complexed With Compound 10
Length = 366
Score = 69.7 bits (169), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 21 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 79
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 80 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 127
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 128 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR---- 179
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 180 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk
Docking Peptide
Length = 362
Score = 69.7 bits (169), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 17 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 75
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 76 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 123
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 124 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR---- 175
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 176 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp
pdb|3GU5|A Chain A, Crystal Structure Of Dapkq23v-Amppnp-Mg2+
pdb|3GU6|A Chain A, Crystal Structure Of Dapkq23v-Adp
pdb|3GU7|A Chain A, Crystal Structure Of Dapkq23v-Adp-Mg2+
Length = 295
Score = 69.3 bits (168), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 432 FSTTNKLGEGGFGPVYKGK-----LADEQEVAIKRLSRSSGQGIV--EFKNEVRLIAKLQ 484
+ T +LG G F V K + L + KR ++SS +G+ + + EV ++ ++Q
Sbjct: 13 YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
H N++ L + + +L+ E + L FL K L E+ ++ I G+ Y
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPK----ISDFGMARIFEVNESEANTKRIVGTYGY 600
LH L++ H DLK NI+L D+ PK I DFG+A + K I GT +
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEF 183
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
++PE + ++ D++S GV+ ++SG
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213
>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex
Length = 334
Score = 69.3 bits (168), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 432 FSTTNKLGEGGFGPVYKGK-----LADEQEVAIKRLSRSSGQGIV--EFKNEVRLIAKLQ 484
+ T +LG G F V K + L + KR ++SS +G+ + + EV ++ ++Q
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
H N++ L + + +L+ E + L FL K L E+ ++ I G+ Y
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPK----ISDFGMARIFEVNESEANTKRIVGTYGY 600
LH L++ H DLK NI+L D+ PK I DFG+A + N I GT +
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEF 183
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
++PE + ++ D++S GV+ ++SG
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213
>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta
(I4122)
Length = 677
Score = 69.3 bits (168), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 432 FSTTNKLGEGGFGPVYKGKLADE-QEVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLV 489
+ +LG GGFG V + D ++VAIK+ + S + + E++++ KL H N+V
Sbjct: 17 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG--------ISQG 541
G ++L + +P ++++ RK + +E + EG IS
Sbjct: 77 SAREVP-DGLQKLAPND-LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 134
Query: 542 LLYLHKYSRLRVIHRDLKASNILLD---DKMNPKISDFGMARIFEVNESEANTKRIVGTY 598
L YLH+ R+IHRDLK NI+L ++ KI D G A+ E+++ E T+ VGT
Sbjct: 135 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTE-FVGTL 188
Query: 599 GYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y++PE ++ D +SFG L E ++G
Sbjct: 189 QYLAPELLEQKKYTVTVDYWSFGTLAFECITG 220
>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
pdb|1ZMW|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
Length = 327
Score = 69.3 bits (168), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADE----QEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQ 484
N+ +G+G F V KLA +EVA+K + ++ + + + EVR++ L
Sbjct: 15 NYRLLKTIGKGNFAKV---KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLN 71
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
H N+V+L + LV E+ + +L GR +F I + Y
Sbjct: 72 HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQY 128
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV-NESEANTKRIVGTYGYMSP 603
H+ ++HRDLKA N+LLD MN KI+DFG + F N+ +A G Y +P
Sbjct: 129 CHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA----FCGAPPYAAP 181
Query: 604 E-YAMSGIVSIKTDVFSFGVLVLEIVSG 630
E + + DV+S GV++ +VSG
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSG 209
>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312
pdb|2XZS|B Chain B, Death Associated Protein Kinase 1 Residues 1-312
Length = 312
Score = 69.3 bits (168), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 432 FSTTNKLGEGGFGPVYKGK-----LADEQEVAIKRLSRSSGQGIV--EFKNEVRLIAKLQ 484
+ T +LG G F V K + L + KR ++SS +G+ + + EV ++ ++Q
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
H N++ L + + +L+ E + L FL K L E+ ++ I G+ Y
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPK----ISDFGMARIFEVNESEANTKRIVGTYGY 600
LH L++ H DLK NI+L D+ PK I DFG+A + K I GT +
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEF 183
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
++PE + ++ D++S GV+ ++SG
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213
>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|B Chain B, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|C Chain C, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|D Chain D, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|E Chain E, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|F Chain F, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|G Chain G, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|H Chain H, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
Length = 676
Score = 69.3 bits (168), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 432 FSTTNKLGEGGFGPVYKGKLADE-QEVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLV 489
+ +LG GGFG V + D ++VAIK+ + S + + E++++ KL H N+V
Sbjct: 16 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG--------ISQG 541
G ++L + +P ++++ RK + +E + EG IS
Sbjct: 76 SAREVP-DGLQKLAPND-LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 542 LLYLHKYSRLRVIHRDLKASNILLD---DKMNPKISDFGMARIFEVNESEANTKRIVGTY 598
L YLH+ R+IHRDLK NI+L ++ KI D G A+ E+++ E T+ VGT
Sbjct: 134 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTE-FVGTL 187
Query: 599 GYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y++PE ++ D +SFG L E ++G
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219
>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-A
pdb|2FSM|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-B
Length = 367
Score = 69.3 bits (168), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 108/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 22 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 80
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 81 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 128
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 129 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 180
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
+ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 181 -HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In
Complex With A Ruthenium Octasporine Ligand (Osv)
pdb|2Y4P|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|3ZXT|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
Length = 285
Score = 69.3 bits (168), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 432 FSTTNKLGEGGFGPVYKGK-----LADEQEVAIKRLSRSSGQGIV--EFKNEVRLIAKLQ 484
+ T +LG G F V K + L + KR ++SS +G+ + + EV ++ ++Q
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
H N++ L + + +L+ E + L FL K L E+ ++ I G+ Y
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPK----ISDFGMARIFEVNESEANTKRIVGTYGY 600
LH L++ H DLK NI+L D+ PK I DFG+A + K I GT +
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEF 183
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
++PE + ++ D++S GV+ ++SG
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213
>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l)
Activating Mutant
Length = 367
Score = 69.3 bits (168), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 108/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 22 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 80
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 81 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 128
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 129 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 180
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
+ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 181 -HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304
Length = 326
Score = 69.3 bits (168), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 432 FSTTNKLGEGGFGPVYKGK-----LADEQEVAIKRLSRSSGQGIV--EFKNEVRLIAKLQ 484
+ T +LG G F V K + L + KR ++SS +G+ + + EV ++ ++Q
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
H N++ L + + +L+ E + L FL K L E+ ++ I G+ Y
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPK----ISDFGMARIFEVNESEANTKRIVGTYGY 600
LH L++ H DLK NI+L D+ PK I DFG+A + K I GT +
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEF 183
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
++PE + ++ D++S GV+ ++SG
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213
>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp
Length = 298
Score = 69.3 bits (168), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 62/209 (29%), Positives = 104/209 (49%), Gaps = 15/209 (7%)
Query: 438 LGEGGFGPVYKGKLADEQE----VAIKRLSR-SSGQGIVEFKNEVRLIAKLQHTNLVRLL 492
+G+G FG VY G+ D+ + AIK LSR + Q + F E L+ L H N++ L+
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 493 GCSL--HGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
G L G +L+ +M + L F+ + R + F + +++G+ YL +
Sbjct: 89 GIMLPPEGLPHVLL-PYMCHGDLLQFIRSPQRNPTVKDLISFGL--QVARGMEYL---AE 142
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE--SEANTKRIVGTYGYMSPEYAMS 608
+ +HRDL A N +LD+ K++DFG+AR E S + + + E +
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT 202
Query: 609 GIVSIKTDVFSFGVLVLEIVSGQKNHTRH 637
+ K+DV+SFGVL+ E+++ RH
Sbjct: 203 YRFTTKSDVWSFGVLLWELLTRGAPPYRH 231
>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a)
Activating Mutant
Length = 367
Score = 69.3 bits (168), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 108/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 22 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 80
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 81 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 128
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 129 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 180
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
+ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 181 -HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine
pdb|3GUB|A Chain A, Crystal Structure Of Dapkl93g Complexed With N6-(2-
Phenylethyl)adenosine
Length = 295
Score = 69.3 bits (168), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 432 FSTTNKLGEGGFGPVYKGK-----LADEQEVAIKRLSRSSGQGIV--EFKNEVRLIAKLQ 484
+ T +LG G F V K + L + KR ++SS +G+ + + EV ++ ++Q
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
H N++ L + + +L+ E + L FL K L E+ ++ I G+ Y
Sbjct: 73 HPNVITLHEVYENKTDVILIGELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPK----ISDFGMARIFEVNESEANTKRIVGTYGY 600
LH L++ H DLK NI+L D+ PK I DFG+A + K I GT +
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEF 183
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
++PE + ++ D++S GV+ ++SG
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213
>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk
Length = 476
Score = 68.9 bits (167), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 56/201 (27%), Positives = 103/201 (51%), Gaps = 16/201 (7%)
Query: 436 NKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRL 491
+ LG G FG V GK +VA+K L+R S + + + E++ + +H ++++L
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 492 LGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRL 551
+ +V E++ L ++ +GR L+ ++ + + I G+ Y H++
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGR---LDEKESRRLFQQILSGVDYCHRHM-- 136
Query: 552 RVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG-- 609
V+HRDLK N+LLD MN KI+DFG++ + E + G+ Y +PE +SG
Sbjct: 137 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRXSCGSPNYAAPE-VISGRL 191
Query: 610 IVSIKTDVFSFGVLVLEIVSG 630
+ D++S GV++ ++ G
Sbjct: 192 YAGPEVDIWSSGVILYALLCG 212
>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277
Length = 277
Score = 68.9 bits (167), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 432 FSTTNKLGEGGFGPVYKGK-----LADEQEVAIKRLSRSSGQGIV--EFKNEVRLIAKLQ 484
+ T +LG G F V K + L + KR ++SS +G+ + + EV ++ ++Q
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
H N++ L + + +L+ E + L FL K L E+ ++ I G+ Y
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPK----ISDFGMARIFEVNESEANTKRIVGTYGY 600
LH L++ H DLK NI+L D+ PK I DFG+A + K I GT +
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEF 183
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
++PE + ++ D++S GV+ ++SG
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213
>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVX|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVY|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
Length = 278
Score = 68.9 bits (167), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 432 FSTTNKLGEGGFGPVYKGK-----LADEQEVAIKRLSRSSGQGIV--EFKNEVRLIAKLQ 484
+ T +LG G F V K + L + KR ++SS +G+ + + EV ++ ++Q
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
H N++ L + + +L+ E + L FL K L E+ ++ I G+ Y
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPK----ISDFGMARIFEVNESEANTKRIVGTYGY 600
LH L++ H DLK NI+L D+ PK I DFG+A + K I GT +
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEF 183
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
++PE + ++ D++S GV+ ++SG
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213
>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
pdb|2R0I|B Chain B, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
Length = 327
Score = 68.9 bits (167), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADE----QEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQ 484
N+ +G+G F V KLA +EVA+K + ++ + + + EVR++ L
Sbjct: 15 NYRLLKTIGKGNFAKV---KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLN 71
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
H N+V+L + LV E+ + +L GR +F I + Y
Sbjct: 72 HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQY 128
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
H+ ++HRDLKA N+LLD MN KI+DFG + F G+ Y +PE
Sbjct: 129 CHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDTFCGSPPYAAPE 182
Query: 605 -YAMSGIVSIKTDVFSFGVLVLEIVSG 630
+ + DV+S GV++ +VSG
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSG 209
>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like
Kinase 1
pdb|2OWB|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like
Kinase 1
pdb|3FC2|A Chain A, Plk1 In Complex With Bi6727
Length = 335
Score = 68.9 bits (167), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 438 LGEGGFGPVYKGKLADEQEVAIKRLSRSS----GQGIVEFKNEVRLIAKLQHTNLVRLLG 493
LG+GGF ++ AD +EV ++ S + E+ + L H ++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 494 CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRV 553
+ +V E +SL + RK + E R+ + + I G YLH R RV
Sbjct: 109 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARYYLRQ-IVLGCQYLH---RNRV 162
Query: 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI 613
IHRDLK N+ L++ + KI DFG+A E + K + GT Y++PE S
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSF 220
Query: 614 KTDVFSFGVLVLEIVSGQ 631
+ DV+S G ++ ++ G+
Sbjct: 221 EVDVWSIGCIMYTLLVGK 238
>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A
Benzolactam-Derived Inhibitor
Length = 333
Score = 68.9 bits (167), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 438 LGEGGFGPVYKGKLADEQEVAIKRLSRSS----GQGIVEFKNEVRLIAKLQHTNLVRLLG 493
LG+GGF ++ AD +EV ++ S + E+ + L H ++V G
Sbjct: 47 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 494 CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRV 553
+ +V E +SL + RK + E R+ + + I G YLH R RV
Sbjct: 107 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARYYLRQ-IVLGCQYLH---RNRV 160
Query: 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI 613
IHRDLK N+ L++ + KI DFG+A E + K + GT Y++PE S
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSF 218
Query: 614 KTDVFSFGVLVLEIVSGQ 631
+ DV+S G ++ ++ G+
Sbjct: 219 EVDVWSIGCIMYTLLVGK 236
>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8U|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 68.9 bits (167), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 62/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 15 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 73
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 74 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI D+G+AR
Sbjct: 122 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLAR---- 173
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 174 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
pdb|1ZMU|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
Length = 327
Score = 68.9 bits (167), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADE----QEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQ 484
N+ +G+G F V KLA +EVA+K + ++ + + + EVR++ L
Sbjct: 15 NYRLLKTIGKGNFAKV---KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLN 71
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
H N+V+L + LV E+ + +L GR +F I + Y
Sbjct: 72 HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQY 128
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
H+ ++HRDLKA N+LLD MN KI+DFG + F G+ Y +PE
Sbjct: 129 CHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDTFCGSPPYAAPE 182
Query: 605 -YAMSGIVSIKTDVFSFGVLVLEIVSG 630
+ + DV+S GV++ +VSG
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSG 209
>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302
Length = 302
Score = 68.9 bits (167), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 432 FSTTNKLGEGGFGPVYKGK-----LADEQEVAIKRLSRSSGQGIV--EFKNEVRLIAKLQ 484
+ T +LG G F V K + L + KR ++SS +G+ + + EV ++ ++Q
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
H N++ L + + +L+ E + L FL K L E+ ++ I G+ Y
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPK----ISDFGMARIFEVNESEANTKRIVGTYGY 600
LH L++ H DLK NI+L D+ PK I DFG+A + K I GT +
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEF 183
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
++PE + ++ D++S GV+ ++SG
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213
>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536
Length = 294
Score = 68.6 bits (166), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 438 LGEGGFGPVYKGKLADEQEVAIKRLSRSS----GQGIVEFKNEVRLIAKLQHTNLVRLLG 493
LG+GGF ++ AD +EV ++ S + E+ + L H ++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 494 CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRV 553
+ +V E +SL + RK + E R+ + + I G YLH R RV
Sbjct: 83 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARYYLRQ-IVLGCQYLH---RNRV 136
Query: 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI 613
IHRDLK N+ L++ + KI DFG+A +V K + GT Y++PE S
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 194
Query: 614 KTDVFSFGVLVLEIVSGQ 631
+ DV+S G ++ ++ G+
Sbjct: 195 EVDVWSIGCIMYTLLVGK 212
>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|B Chain B, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|C Chain C, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|D Chain D, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
Length = 341
Score = 68.6 bits (166), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 17/219 (7%)
Query: 424 TIAAAANNFSTTNKLGEGGFGPVYKGKL----ADEQEVAIKRLS---RSSGQGIVEFKNE 476
T + KLG+G FG V +G+ VA+K L S + + +F E
Sbjct: 6 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 65
Query: 477 VRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE 536
V + L H NL+RL G L ++ V E P SL L +L R+ +
Sbjct: 66 VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV-- 122
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE--ANTKRI 594
+++G+ YL R IHRDL A N+LL + KI DFG+ R N+ R
Sbjct: 123 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 179
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQK 632
V + + +PE + S +D + FGV + E+ + GQ+
Sbjct: 180 V-PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 217
>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine
Length = 353
Score = 68.6 bits (166), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 13/207 (6%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEV-AIKRLSRS---SGQGIVEFKNEVRLIAKLQH 485
+NF LG+G FG V ++ + ++ A+K L + + E R+++ ++
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 486 TNLVRLLGCSLHGEERLL-VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
+ L C +RL V EF+ L F + S R + RF E IS L++
Sbjct: 83 HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD--EARARFYAAEIIS-ALMF 139
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
LH +I+RDLK N+LLD + + K++DFGM + E + T GT Y++PE
Sbjct: 140 LHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPE 194
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ D ++ GVL+ E++ G
Sbjct: 195 ILQEMLYGPAVDWWAMGVLLYEMLCGH 221
>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499
pdb|3FKO|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3668
pdb|3FLN|C Chain C, P38 Kinase Crystal Structure In Complex With R1487
Length = 372
Score = 68.6 bits (166), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 62/228 (27%), Positives = 109/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LS+ Q I+ K E+R
Sbjct: 27 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPF-QSIIHAKRTYRELR 85
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 86 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 133
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 134 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 185
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 186 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232
>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment
pdb|3H4J|A Chain A, Crystal Structure Of Pombe Ampk Kdaid Fragment
Length = 336
Score = 68.6 bits (166), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 56/203 (27%), Positives = 106/203 (52%), Gaps = 23/203 (11%)
Query: 438 LGEGGFGPVYKGKLAD----EQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVR 490
LGEG FG V KLA +Q+VA+K +SR + + E+ + L+H ++++
Sbjct: 17 LGEGSFGKV---KLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
L + ++V E+ + D+ + ++ + +RF + I + Y H++
Sbjct: 74 LYDVITTPTDIVMVIEYAGGELFDYIV--EKKRMTEDEGRRFF--QQIICAIEYCHRH-- 127
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN-TKRIVGTYGYMSPEYAMSG 609
+++HRDLK N+LLDD +N KI+DFG++ I ++ N K G+ Y +PE
Sbjct: 128 -KIVHRDLKPENLLLDDNLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAPEVINGK 182
Query: 610 IVS-IKTDVFSFGVLVLEIVSGQ 631
+ + + DV+S G+++ ++ G+
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGR 205
>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor
pdb|4EWH|A Chain A, Co-Crystal Structure Of Ack1 With Inhibitor
Length = 275
Score = 68.6 bits (166), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 17/219 (7%)
Query: 424 TIAAAANNFSTTNKLGEGGFGPVYKGKL----ADEQEVAIKRLS---RSSGQGIVEFKNE 476
T + KLG+G FG V +G+ VA+K L S + + +F E
Sbjct: 2 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 477 VRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE 536
V + L H NL+RL G L ++ V E P SL L +L R+ +
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV-- 118
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA--NTKRI 594
+++G+ YL R IHRDL A N+LL + KI DFG+ R N+ R
Sbjct: 119 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRK 175
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQK 632
V + + +PE + S +D + FGV + E+ + GQ+
Sbjct: 176 V-PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213
>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
pdb|3GC9|B Chain B, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
Length = 370
Score = 68.6 bits (166), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 60/229 (26%), Positives = 107/229 (46%), Gaps = 43/229 (18%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPV---YKGKLADEQEVAIKRLSRSSGQGIVEFKN---E 476
+T+ +G G +G V Y +L Q+VA+K+LSR Q ++ + E
Sbjct: 21 KTVWEVPQRLQGLRPVGSGAYGSVCSAYDARL--RQKVAVKKLSRPF-QSLIHARRTYRE 77
Query: 477 VRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF-------------LFNSGRK 523
+RL+ L+H N++ LL F P S++ F L N +
Sbjct: 78 LRLLKHLKHENVIGLLDV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKS 125
Query: 524 NVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583
L+ E ++ + +GL Y+H +IHRDLK SN+ +++ +I DFG+AR
Sbjct: 126 QALSDEHVQFLVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR--- 179
Query: 584 VNESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
+++ V T Y +PE ++ + +T D++S G ++ E++ G+
Sbjct: 180 --QADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226
>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
pdb|1H4L|B Chain B, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
Length = 292
Score = 68.6 bits (166), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 105/208 (50%), Gaps = 14/208 (6%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLS-RSSGQGIVEFK-NEVRLIAKLQHT 486
+ K+GEG +G V+K K + E VA+KR+ +G+ E+ L+ +L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 487 NLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
N+VRL LH +++L LV+EF +F +G L+ E + + +GL +
Sbjct: 62 NIVRLHDV-LHSDKKLTLVFEFCDQDLKKYFDSCNGD---LDPEIVKSFLFQLLKGLGFC 117
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
H + V+HRDLK N+L++ K++DFG+AR F + + + V T Y P+
Sbjct: 118 HSRN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE--VVTLWYRPPDV 172
Query: 606 AM-SGIVSIKTDVFSFGVLVLEIVSGQK 632
+ + S D++S G + E+ + +
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAAR 200
>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|B Chain B, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|C Chain C, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|D Chain D, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|E Chain E, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|F Chain F, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
Length = 327
Score = 68.6 bits (166), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADE----QEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQ 484
N+ +G+G F V KLA +EVA++ + ++ + + + EVR++ L
Sbjct: 15 NYRLLKTIGKGNFAKV---KLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLN 71
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
H N+V+L + LV E+ + +L GR +F I + Y
Sbjct: 72 HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQY 128
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
H+ ++HRDLKA N+LLD MN KI+DFG + F G+ Y +PE
Sbjct: 129 CHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDEFCGSPPYAAPE 182
Query: 605 -YAMSGIVSIKTDVFSFGVLVLEIVSG 630
+ + DV+S GV++ +VSG
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSG 209
>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYD|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp.
pdb|1ZYD|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp
Length = 303
Score = 68.6 bits (166), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 66/229 (28%), Positives = 109/229 (47%), Gaps = 37/229 (16%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTN 487
A++F LG+G FG V K + A D + AIK++ R + + + +EV L+A L H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQY 63
Query: 488 LVRLLGCSLHGEERLLV---------------YEFMPNKSLDFFLFNSGRKNVLNWEKRF 532
+VR L E R V E+ N++L + L +S N ++ +
Sbjct: 64 VVRYYAAWL--ERRNFVKPMTAVKKKSTLFIQMEYCENRTL-YDLIHSENLNQ-QRDEYW 119
Query: 533 IIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-------IFEVN 585
+ I + L Y+H +IHRDLK NI +D+ N KI DFG+A+ I +++
Sbjct: 120 RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 586 E-----SEANTKRIVGTYGYMSPEYAM-SGIVSIKTDVFSFGVLVLEIV 628
S N +GT Y++ E +G + K D++S G++ E++
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225
>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In
Complex With Ca2+ And Amppnp
Length = 494
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 16/205 (7%)
Query: 432 FSTTNKLGEGGFGPVY--KGKLAD-EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ KLG G +G V + K+ E+ + I R + S + EV ++ L H N+
Sbjct: 39 YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
++L LV E L + + + N ++ +II+ + G+ YLHK+
Sbjct: 99 MKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA---VIIKQVLSGVTYLHKH 155
Query: 549 SRLRVIHRDLKASNILLDDKMNP---KISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
+ ++HRDLK N+LL+ K KI DFG++ +F E++ K +GT Y++PE
Sbjct: 156 N---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKMKERLGTAYYIAPE- 208
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVSG 630
+ K DV+S GV++ +++G
Sbjct: 209 VLRKKYDEKCDVWSIGVILFILLAG 233
>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U46|B Chain B, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U4D|A Chain A, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U4D|B Chain B, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U54|B Chain B, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 17/219 (7%)
Query: 424 TIAAAANNFSTTNKLGEGGFGPVYKGKL----ADEQEVAIKRLS---RSSGQGIVEFKNE 476
T + KLG+G FG V +G+ VA+K L S + + +F E
Sbjct: 12 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 71
Query: 477 VRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE 536
V + L H NL+RL G L ++ V E P SL L +L R+ +
Sbjct: 72 VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV-- 128
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE--ANTKRI 594
+++G+ YL R IHRDL A N+LL + KI DFG+ R N+ R
Sbjct: 129 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQK 632
V + + +PE + S +D + FGV + E+ + GQ+
Sbjct: 186 V-PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 17/219 (7%)
Query: 424 TIAAAANNFSTTNKLGEGGFGPVYKGKL----ADEQEVAIKRLS---RSSGQGIVEFKNE 476
T + KLG+G FG V +G+ VA+K L S + + +F E
Sbjct: 12 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 71
Query: 477 VRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE 536
V + L H NL+RL G L ++ V E P SL L +L R+ +
Sbjct: 72 VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV-- 128
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA--NTKRI 594
+++G+ YL R IHRDL A N+LL + KI DFG+ R N+ R
Sbjct: 129 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRK 185
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQK 632
V + + +PE + S +D + FGV + E+ + GQ+
Sbjct: 186 V-PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95
pdb|3EQP|A Chain A, Crystal Structure Of Ack1 With Compound T95
pdb|3EQR|A Chain A, Crystal Structure Of Ack1 With Compound T74
pdb|3EQR|B Chain B, Crystal Structure Of Ack1 With Compound T74
Length = 276
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 17/219 (7%)
Query: 424 TIAAAANNFSTTNKLGEGGFGPVYKGKL----ADEQEVAIKRLS---RSSGQGIVEFKNE 476
T + KLG+G FG V +G+ VA+K L S + + +F E
Sbjct: 2 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 477 VRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE 536
V + L H NL+RL G L ++ V E P SL L +L R+ +
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV-- 118
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE--ANTKRI 594
+++G+ YL R IHRDL A N+LL + KI DFG+ R N+ R
Sbjct: 119 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQK 632
V + + +PE + S +D + FGV + E+ + GQ+
Sbjct: 176 V-PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213
>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In
Complex With P38 Map Kinase
Length = 360
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 62/228 (27%), Positives = 108/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 15 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELR 73
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 74 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DF +AR
Sbjct: 122 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLAR---- 173
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 174 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY4|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY5|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp.
pdb|1ZY5|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp
Length = 303
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 29/225 (12%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTN 487
A++F LG+G FG V K + A D + AIK++ R + + + +EV L+A L H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQY 63
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFF---------LFNSGRKNVLNWEKR--FIIIE 536
+VR L + + KS F L++ LN ++ + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-------IFEVNE--- 586
I + L Y+H +IHRDLK NI +D+ N KI DFG+A+ I +++
Sbjct: 124 QILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 587 --SEANTKRIVGTYGYMSPEYA-MSGIVSIKTDVFSFGVLVLEIV 628
S N +GT Y++ E +G + K D++S G++ E++
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225
>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The
Murine Receptor Tyrosine Kinase Tyro3 (Sky)
Length = 323
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 61/232 (26%), Positives = 107/232 (46%), Gaps = 19/232 (8%)
Query: 413 ISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQ----EVAIKRLSRS--S 466
IS ELK + + F+ LG+G FG V + +L E +VA+K L +
Sbjct: 7 ISDELK-EKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA 65
Query: 467 GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEER------LLVYEFMPNKSLDFFLFNS 520
I EF E + + H ++ +L+G SL + +++ FM + L FL S
Sbjct: 66 SSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS 125
Query: 521 G-RKNVLNWEKRFII--IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFG 577
+N N + ++ + I+ G+ YL S IHRDL A N +L + M ++DFG
Sbjct: 126 RIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFG 182
Query: 578 MARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
++R + +++ E + ++ +DV++FGV + EI++
Sbjct: 183 LSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YA9|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YAA|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAA|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAB|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
pdb|2YAB|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
Length = 361
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 65/221 (29%), Positives = 105/221 (47%), Gaps = 23/221 (10%)
Query: 418 KIFDFQTIAA--AANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIV--EF 473
K+ DF I + F+ K E G Y K KR SR+S +G+ E
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIK------KRQSRASRRGVCREEI 62
Query: 474 KNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI 533
+ EV ++ ++ H N++ L + + +L+ E + L FL +K L+ E+
Sbjct: 63 EREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATS 119
Query: 534 IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP----KISDFGMARIFEVNESEA 589
I+ I G+ YLH ++ H DLK NI+L DK P K+ DFG+A E+ E
Sbjct: 120 FIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EI-EDGV 173
Query: 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
K I GT +++PE + ++ D++S GV+ ++SG
Sbjct: 174 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor
Cis-3-[8-amino-1-(4-
Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
Length = 273
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 17/219 (7%)
Query: 424 TIAAAANNFSTTNKLGEGGFGPVYKGKL----ADEQEVAIKRLS---RSSGQGIVEFKNE 476
T + KLG+G FG V +G+ VA+K L S + + +F E
Sbjct: 2 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 477 VRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE 536
V + L H NL+RL G L ++ V E P SL L +L R+ +
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV-- 118
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE--ANTKRI 594
+++G+ YL R IHRDL A N+LL + KI DFG+ R N+ R
Sbjct: 119 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQK 632
V + + +PE + S +D + FGV + E+ + GQ+
Sbjct: 176 V-PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213
>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
pdb|1ZMV|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
Length = 327
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADE----QEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQ 484
N+ +G+G F V KLA +EVA++ + ++ + + + EVR++ L
Sbjct: 15 NYRLLKTIGKGNFAKV---KLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLN 71
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
H N+V+L + LV E+ + +L GR +F I + Y
Sbjct: 72 HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQY 128
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
H+ ++HRDLKA N+LLD MN KI+DFG + F G+ Y +PE
Sbjct: 129 CHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDTFCGSPPYAAPE 182
Query: 605 -YAMSGIVSIKTDVFSFGVLVLEIVSG 630
+ + DV+S GV++ +VSG
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSG 209
>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain
pdb|4HZR|B Chain B, Crystal Structure Of Ack1 Kinase Domain
Length = 277
Score = 67.8 bits (164), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 17/219 (7%)
Query: 424 TIAAAANNFSTTNKLGEGGFGPVYKGKL----ADEQEVAIKRLS---RSSGQGIVEFKNE 476
T + KLG+G FG V +G+ VA+K L S + + +F E
Sbjct: 6 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 65
Query: 477 VRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE 536
V + L H NL+RL G L ++ V E P SL L +L R+ +
Sbjct: 66 VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV-- 122
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE--ANTKRI 594
+++G+ YL R IHRDL A N+LL + KI DFG+ R N+ R
Sbjct: 123 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 179
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQK 632
V + + +PE + S +D + FGV + E+ + GQ+
Sbjct: 180 V-PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 217
>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4APC|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4B9D|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor.
pdb|4B9D|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor
Length = 350
Score = 67.8 bits (164), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 54/197 (27%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 436 NKLGEGGFGPVYKGK-LADEQEVAIKRL--SRSSGQGIVEFKNEVRLIAKLQHTNLVRLL 492
K+GEG FG K D ++ IK + SR S + E + EV ++A ++H N+V+
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
+V ++ D F + +K VL E + I++ Q L L +
Sbjct: 90 ESFEENGSLYIVMDYCEGG--DLFKRINAQKGVLFQEDQ--ILDWFVQICLALKHVHDRK 145
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVS 612
++HRD+K+ NI L ++ DFG+AR+ +N + + +GT Y+SPE + +
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGTPYYLSPEICENKPYN 203
Query: 613 IKTDVFSFGVLVLEIVS 629
K+D+++ G ++ E+ +
Sbjct: 204 NKSDIWALGCVLYELCT 220
>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 11 (p38 Beta) In Complex With Nilotinib
Length = 348
Score = 67.8 bits (164), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 60/229 (26%), Positives = 107/229 (46%), Gaps = 43/229 (18%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPV---YKGKLADEQEVAIKRLSRSSGQGIVEFKN---E 476
+T+ +G G +G V Y +L Q+VA+K+LSR Q ++ + E
Sbjct: 13 KTVWEVPQRLQGLRPVGSGAYGSVCSAYDARL--RQKVAVKKLSRPF-QSLIHARRTYRE 69
Query: 477 VRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF-------------LFNSGRK 523
+RL+ L+H N++ LL F P S++ F L N +
Sbjct: 70 LRLLKHLKHENVIGLLDV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKC 117
Query: 524 NVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583
L+ E ++ + +GL Y+H +IHRDLK SN+ +++ +I DFG+AR
Sbjct: 118 QALSDEHVQFLVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR--- 171
Query: 584 VNESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
+++ V T Y +PE ++ + +T D++S G ++ E++ G+
Sbjct: 172 --QADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218
>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From
Toxoplasma Gondii, 541.m00134, Kinase Domain
Length = 287
Score = 67.8 bits (164), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 63/219 (28%), Positives = 104/219 (47%), Gaps = 37/219 (16%)
Query: 429 ANNFSTTNKLGEGGFGPVY--KGKL--ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ 484
++ + KLG G +G V K KL A+ IK+ S ++ +EV ++ +L
Sbjct: 20 SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE----KRF------II 534
H N+++L YEF +K + + R L E ++F +I
Sbjct: 80 HPNIMKL-------------YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVI 126
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP---KISDFGMARIFEVNESEANT 591
++ + G YLHK++ ++HRDLK N+LL+ K KI DFG++ FEV
Sbjct: 127 MKQVLSGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG---GKM 180
Query: 592 KRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
K +GT Y++PE + K DV+S GV++ ++ G
Sbjct: 181 KERLGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 218
>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3,
Tgme49_105860
Length = 467
Score = 67.8 bits (164), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 63/219 (28%), Positives = 104/219 (47%), Gaps = 37/219 (16%)
Query: 429 ANNFSTTNKLGEGGFGPVY--KGKL--ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ 484
++ + KLG G +G V K KL A+ IK+ S ++ +EV ++ +L
Sbjct: 3 SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE----KRF------II 534
H N+++L YEF +K + + R L E ++F +I
Sbjct: 63 HPNIMKL-------------YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVI 109
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP---KISDFGMARIFEVNESEANT 591
++ + G YLHK++ ++HRDLK N+LL+ K KI DFG++ FEV
Sbjct: 110 MKQVLSGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG---GKM 163
Query: 592 KRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
K +GT Y++PE + K DV+S GV++ ++ G
Sbjct: 164 KERLGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 201
>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|B Chain B, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|C Chain C, Crystal Structure Of The Human Cdkl1 Kinase Domain
Length = 311
Score = 67.8 bits (164), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 12/205 (5%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVE--FKNEVRLIAKLQHT 486
+ K+GEG +G V+K + D Q VAIK+ S +++ E+R++ +L+H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLH 546
NLV LL LV+E+ + L + ++ V + I + + Q + + H
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDHTVL--HELDRYQRGVPEHLVKSITWQTL-QAVNFCH 119
Query: 547 KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYA 606
K++ IHRD+K NIL+ K+ DFG AR+ + + V T Y SPE
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE--VATRWYRSPELL 174
Query: 607 MSGI-VSIKTDVFSFGVLVLEIVSG 630
+ DV++ G + E++SG
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSG 199
>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580
pdb|3GCQ|A Chain A, Human P38 Map Kinase In Complex With Rl45
pdb|3GCS|A Chain A, Human P38 Map Kinase In Complex With Sorafenib
pdb|3GCV|A Chain A, Human P38 Map Kinase In Complex With Rl62
pdb|3HV3|A Chain A, Human P38 Map Kinase In Complex With Rl49
pdb|3IW5|A Chain A, Human P38 Map Kinase In Complex With An Indole Derivative
pdb|3IW6|A Chain A, Human P38 Map Kinase In Complex With A Benzylpiperazin-
Pyrrol
pdb|3IW7|A Chain A, Human P38 Map Kinase In Complex With An Imidazo-Pyridine
pdb|3IW8|A Chain A, Structure Of Inactive Human P38 Map Kinase In Complex With
A Thiazole-Urea
pdb|3HUB|A Chain A, Human P38 Map Kinase In Complex With Scios-469
pdb|3L8S|A Chain A, Human P38 Map Kinase In Complex With Cp-547632
pdb|3LFB|A Chain A, Human P38 Map Kinase In Complex With Rl98
pdb|3LFC|A Chain A, Human P38 Map Kinase In Complex With Rl99
pdb|3LFD|A Chain A, Human P38 Map Kinase In Complex With Rl113
pdb|3LFE|A Chain A, Human P38 Map Kinase In Complex With Rl116
pdb|3LFF|A Chain A, Human P38 Map Kinase In Complex With Rl166
pdb|3PG3|A Chain A, Human P38 Map Kinase In Complex With Rl182
Length = 360
Score = 67.8 bits (164), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 62/228 (27%), Positives = 108/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 15 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 73
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 74 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKSQK 121
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+ R
Sbjct: 122 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCR---- 173
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 174 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420
Length = 504
Score = 67.8 bits (164), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 27/211 (12%)
Query: 437 KLGEGGFGPVYKGKLAD-EQEVAIKRLSRS---------SGQGIVEFK----NEVRLIAK 482
KLG G +G V K + E AIK + +S + I +F NE+ L+
Sbjct: 43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 483 LQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
L H N+++L + LV EF L + N + + + I++ I G+
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAAN---IMKQILSGI 159
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDK---MNPKISDFGMARIFEVNESEANTKRIVGTYG 599
YLHK++ ++HRD+K NILL++K +N KI DFG++ F + + +GT
Sbjct: 160 CYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFF---SKDYKLRDRLGTAY 213
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y++PE + + K DV+S GV++ ++ G
Sbjct: 214 YIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243
>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
pdb|3GC8|B Chain B, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
Length = 370
Score = 67.4 bits (163), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 60/229 (26%), Positives = 107/229 (46%), Gaps = 43/229 (18%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPV---YKGKLADEQEVAIKRLSRSSGQGIVEFKN---E 476
+T+ +G G +G V Y +L Q+VA+K+LSR Q ++ + E
Sbjct: 21 KTVWEVPQRLQGLRPVGSGAYGSVCSAYDARL--RQKVAVKKLSRPF-QSLIHARRTYRE 77
Query: 477 VRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF-------------LFNSGRK 523
+RL+ L+H N++ LL F P S++ F L N +
Sbjct: 78 LRLLKHLKHENVIGLLDV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKC 125
Query: 524 NVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583
L+ E ++ + +GL Y+H +IHRDLK SN+ +++ +I DFG+AR
Sbjct: 126 QALSDEHVQFLVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR--- 179
Query: 584 VNESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
+++ V T Y +PE ++ + +T D++S G ++ E++ G+
Sbjct: 180 --QADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226
>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine
Kinase
pdb|3FZP|A Chain A, Crystal Structure Of Pyk2 Complexed With Atpgs
pdb|3FZR|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-431396
pdb|3FZS|A Chain A, Crystal Structure Of Pyk2 Complexed With Birb796
pdb|3FZT|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-4618433
pdb|3H3C|A Chain A, Crystal Structure Of Pyk2 In Complex With Sulfoximine-
Substituted Trifluoromethylpyrimidine Analog
pdb|3ET7|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-2318841
Length = 277
Score = 67.4 bits (163), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 74/274 (27%), Positives = 117/274 (42%), Gaps = 29/274 (10%)
Query: 438 LGEGGFGPVYKGKLADEQ----EVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLVRLL 492
LGEG FG VY+G + + VA+K + E F +E ++ L H ++V+L+
Sbjct: 16 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
G + E ++ E P L +L KN L + I + + YL +
Sbjct: 76 GI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLES---IN 129
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEVNE-SEANTKRIVGTYGYMSPEYAMSGIV 611
+HRD+ NIL+ K+ DFG++R E + +A+ R+ +MSPE
Sbjct: 130 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRF 187
Query: 612 SIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCS 671
+ +DV+ F V + EI+S K ++ ++IG KG L P L P
Sbjct: 188 TTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIGVL------EKGDRLPKPDLCPPVL 239
Query: 672 ANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
+ RC DRP E+VC L +
Sbjct: 240 YTLMTRCWDY-------DPSDRPRFTELVCSLSD 266
>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a
pdb|4H1M|A Chain A, Crystal Structure Of Pyk2 With The Indole 10c
Length = 293
Score = 67.4 bits (163), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 74/274 (27%), Positives = 117/274 (42%), Gaps = 29/274 (10%)
Query: 438 LGEGGFGPVYKGKLADEQ----EVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLVRLL 492
LGEG FG VY+G + + VA+K + E F +E ++ L H ++V+L+
Sbjct: 32 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
G + E ++ E P L +L KN L + I + + YL +
Sbjct: 92 GI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLES---IN 145
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEVNE-SEANTKRIVGTYGYMSPEYAMSGIV 611
+HRD+ NIL+ K+ DFG++R E + +A+ R+ +MSPE
Sbjct: 146 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRF 203
Query: 612 SIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCS 671
+ +DV+ F V + EI+S K ++ ++IG KG L P L P
Sbjct: 204 TTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIGVL------EKGDRLPKPDLCPPVL 255
Query: 672 ANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
+ RC DRP E+VC L +
Sbjct: 256 YTLMTRCWDY-------DPSDRPRFTELVCSLSD 282
>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N-
Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2
Length = 325
Score = 67.4 bits (163), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 64/213 (30%), Positives = 108/213 (50%), Gaps = 20/213 (9%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLAD----EQEVAIKRLSRSS--GQGIVEFKNEVRLI 480
A + F LG+G FG V+ K Q A+K L +++ + V K E ++
Sbjct: 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDIL 80
Query: 481 AKLQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEK--RFIIIEG 537
++ H +V+L + E +L L+ +F+ L F K V+ E+ +F + E
Sbjct: 81 VEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAE- 134
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT 597
++ L +LH L +I+RDLK NILLD++ + K++DFG+++ E + E GT
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGT 189
Query: 598 YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
YM+PE + D +SFGVL+ E+++G
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222
>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|E Chain E, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|C Chain C, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|B Chain B, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|F Chain F, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|D Chain D, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|H Chain H, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|G Chain G, Human Death-Associated Kinase Drp-1, Mutant S308d D40
Length = 321
Score = 67.4 bits (163), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 65/221 (29%), Positives = 105/221 (47%), Gaps = 23/221 (10%)
Query: 418 KIFDFQTIAA--AANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIV--EF 473
K+ DF I + F+ K E G Y K KR SR+S +G+ E
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIK------KRQSRASRRGVSREEI 62
Query: 474 KNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI 533
+ EV ++ ++ H N++ L + + +L+ E + L FL +K L+ E+
Sbjct: 63 EREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATS 119
Query: 534 IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP----KISDFGMARIFEVNESEA 589
I+ I G+ YLH ++ H DLK NI+L DK P K+ DFG+A E+ E
Sbjct: 120 FIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EI-EDGV 173
Query: 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
K I GT +++PE + ++ D++S GV+ ++SG
Sbjct: 174 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine
Kinase 2 Beta (ptk2b)
Length = 281
Score = 67.4 bits (163), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 74/274 (27%), Positives = 117/274 (42%), Gaps = 29/274 (10%)
Query: 438 LGEGGFGPVYKGKLADEQ----EVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLVRLL 492
LGEG FG VY+G + + VA+K + E F +E ++ L H ++V+L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
G + E ++ E P L +L KN L + I + + YL +
Sbjct: 80 GI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLES---IN 133
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEVNE-SEANTKRIVGTYGYMSPEYAMSGIV 611
+HRD+ NIL+ K+ DFG++R E + +A+ R+ +MSPE
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRF 191
Query: 612 SIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCS 671
+ +DV+ F V + EI+S K ++ ++IG KG L P L P
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIGVL------EKGDRLPKPDLCPPVL 243
Query: 672 ANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
+ RC DRP E+VC L +
Sbjct: 244 YTLMTRCWDY-------DPSDRPRFTELVCSLSD 270
>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|B Chain B, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|C Chain C, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|D Chain D, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|E Chain E, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|F Chain F, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|G Chain G, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|H Chain H, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
Length = 288
Score = 67.0 bits (162), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 65/221 (29%), Positives = 105/221 (47%), Gaps = 23/221 (10%)
Query: 418 KIFDFQTIAA--AANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIV--EF 473
K+ DF I + F+ K E G Y K KR SR+S +G+ E
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIK------KRQSRASRRGVSREEI 62
Query: 474 KNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI 533
+ EV ++ ++ H N++ L + + +L+ E + L FL +K L+ E+
Sbjct: 63 EREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATS 119
Query: 534 IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP----KISDFGMARIFEVNESEA 589
I+ I G+ YLH ++ H DLK NI+L DK P K+ DFG+A E+ E
Sbjct: 120 FIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EI-EDGV 173
Query: 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
K I GT +++PE + ++ D++S GV+ ++SG
Sbjct: 174 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|B Chain B, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|C Chain C, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|D Chain D, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2CKE|A Chain A, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|B Chain B, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|C Chain C, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|D Chain D, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
Length = 321
Score = 67.0 bits (162), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 65/221 (29%), Positives = 105/221 (47%), Gaps = 23/221 (10%)
Query: 418 KIFDFQTIAA--AANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIV--EF 473
K+ DF I + F+ K E G Y K KR SR+S +G+ E
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIK------KRQSRASRRGVSREEI 62
Query: 474 KNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI 533
+ EV ++ ++ H N++ L + + +L+ E + L FL +K L+ E+
Sbjct: 63 EREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATS 119
Query: 534 IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP----KISDFGMARIFEVNESEA 589
I+ I G+ YLH ++ H DLK NI+L DK P K+ DFG+A E+ E
Sbjct: 120 FIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EI-EDGV 173
Query: 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
K I GT +++PE + ++ D++S GV+ ++SG
Sbjct: 174 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
pdb|3MPA|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 67.0 bits (162), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 62/228 (27%), Positives = 108/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 15 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 73
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 74 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI FG+AR
Sbjct: 122 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLAR---- 173
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 174 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3KK9|A Chain A, Camkii Substrate Complex B
Length = 282
Score = 67.0 bits (162), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 15/208 (7%)
Query: 429 ANNFSTTNKLGEGGFGPVYK---GKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQH 485
++N+ +LG+G F V + E I + S + + + E R+ KLQH
Sbjct: 4 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
N+VRL LV++ + L + + + I+ I + + Y
Sbjct: 64 PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAYC 120
Query: 546 HKYSRLRVIHRDLKASNILLDDKMN---PKISDFGMARIFEVNESEANTKRIVGTYGYMS 602
H ++HR+LK N+LL K K++DFG+A EVN+SEA GT GY+S
Sbjct: 121 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-WHGFAGTPGYLS 174
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
PE S D+++ GV++ ++ G
Sbjct: 175 PEVLKKDPYSKPVDIWACGVILYILLVG 202
>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer
Length = 395
Score = 67.0 bits (162), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 56/206 (27%), Positives = 104/206 (50%), Gaps = 15/206 (7%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIV--EFKNEVRLIAKLQHTN 487
++F ++LG G G V+K V ++L + + + E++++ +
Sbjct: 68 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGR--KNVLNWEKRFIIIEGISQGLLYL 545
+V G E + E M SLD L +GR + +L +I +GL YL
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI-----KGLTYL 182
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
+ + +++HRD+K SNIL++ + K+ DFG++ ++ +S AN+ VGT YMSPE
Sbjct: 183 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYMSPER 236
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVSGQ 631
S+++D++S G+ ++E+ G+
Sbjct: 237 LQGTHYSVQSDIWSMGLSLVEMAVGR 262
>pdb|3KK8|A Chain A, Camkii Substrate Complex A
Length = 284
Score = 67.0 bits (162), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 15/208 (7%)
Query: 429 ANNFSTTNKLGEGGFGPVYK---GKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQH 485
++N+ +LG+G F V + E I + S + + + E R+ KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
N+VRL LV++ + L + + + I+ I + + Y
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 546 HKYSRLRVIHRDLKASNILLDDKMN---PKISDFGMARIFEVNESEANTKRIVGTYGYMS 602
H ++HR+LK N+LL K K++DFG+A EVN+SEA GT GY+S
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-WHGFAGTPGYLS 175
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
PE S D+++ GV++ ++ G
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVG 203
>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|D Chain D, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|E Chain E, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|F Chain F, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|G Chain G, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|H Chain H, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
Length = 321
Score = 67.0 bits (162), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 65/221 (29%), Positives = 105/221 (47%), Gaps = 23/221 (10%)
Query: 418 KIFDFQTIAA--AANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIV--EF 473
K+ DF I + F+ K E G Y K KR SR+S +G+ E
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIK------KRQSRASRRGVSREEI 62
Query: 474 KNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI 533
+ EV ++ ++ H N++ L + + +L+ E + L FL +K L+ E+
Sbjct: 63 EREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATS 119
Query: 534 IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP----KISDFGMARIFEVNESEA 589
I+ I G+ YLH ++ H DLK NI+L DK P K+ DFG+A E+ E
Sbjct: 120 FIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EI-EDGV 173
Query: 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
K I GT +++PE + ++ D++S GV+ ++SG
Sbjct: 174 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8T|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg-Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 67.0 bits (162), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 62/228 (27%), Positives = 108/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 15 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 73
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 74 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI D G+AR
Sbjct: 122 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLAR---- 173
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 174 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
Length = 321
Score = 67.0 bits (162), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 65/221 (29%), Positives = 105/221 (47%), Gaps = 23/221 (10%)
Query: 418 KIFDFQTIAA--AANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIV--EF 473
K+ DF I + F+ K E G Y K KR SR+S +G+ E
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIK------KRQSRASRRGVSREEI 62
Query: 474 KNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI 533
+ EV ++ ++ H N++ L + + +L+ E + L FL +K L+ E+
Sbjct: 63 EREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATS 119
Query: 534 IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP----KISDFGMARIFEVNESEA 589
I+ I G+ YLH ++ H DLK NI+L DK P K+ DFG+A E+ E
Sbjct: 120 FIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EI-EDGV 173
Query: 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
K I GT +++PE + ++ D++S GV+ ++SG
Sbjct: 174 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3DY7|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3E8N|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) Complexed With A Potent Inhibitor
Rdea119 And Mgatp
pdb|3V01|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions.
pdb|3V04|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions
Length = 341
Score = 66.6 bits (161), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 56/206 (27%), Positives = 104/206 (50%), Gaps = 15/206 (7%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIV--EFKNEVRLIAKLQHTN 487
++F ++LG G G V+K V ++L + + + E++++ +
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGR--KNVLNWEKRFIIIEGISQGLLYL 545
+V G E + E M SLD L +GR + +L +I +GL YL
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI-----KGLTYL 120
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
+ + +++HRD+K SNIL++ + K+ DFG++ ++ +S AN+ VGT YMSPE
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYMSPER 174
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVSGQ 631
S+++D++S G+ ++E+ G+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200
>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3EQB|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
Length = 333
Score = 66.6 bits (161), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 56/206 (27%), Positives = 104/206 (50%), Gaps = 15/206 (7%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIV--EFKNEVRLIAKLQHTN 487
++F ++LG G G V+K V ++L + + + E++++ +
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGR--KNVLNWEKRFIIIEGISQGLLYL 545
+V G E + E M SLD L +GR + +L +I +GL YL
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI-----KGLTYL 120
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
+ + +++HRD+K SNIL++ + K+ DFG++ ++ +S AN+ VGT YMSPE
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYMSPER 174
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVSGQ 631
S+++D++S G+ ++E+ G+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200
>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4987655 And Mgamp-Pnp
pdb|3OS3|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4858061 And Mgatp
Length = 307
Score = 66.6 bits (161), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 56/206 (27%), Positives = 104/206 (50%), Gaps = 15/206 (7%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIV--EFKNEVRLIAKLQHTN 487
++F ++LG G G V+K V ++L + + + E++++ +
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGR--KNVLNWEKRFIIIEGISQGLLYL 545
+V G E + E M SLD L +GR + +L +I +GL YL
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI-----KGLTYL 120
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
+ + +++HRD+K SNIL++ + K+ DFG++ ++ +S AN+ VGT YMSPE
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYMSPER 174
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVSGQ 631
S+++D++S G+ ++E+ G+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200
>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBJ|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
Length = 360
Score = 66.6 bits (161), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 62/228 (27%), Positives = 108/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 15 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 73
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 74 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI D G+AR
Sbjct: 122 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLAR---- 173
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 174 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex
pdb|3KL8|C Chain C, Camkiintide Inhibitor Complex
pdb|3KL8|E Chain E, Camkiintide Inhibitor Complex
pdb|3KL8|G Chain G, Camkiintide Inhibitor Complex
pdb|3KL8|I Chain I, Camkiintide Inhibitor Complex
Length = 269
Score = 66.6 bits (161), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 15/208 (7%)
Query: 429 ANNFSTTNKLGEGGFGPVYK---GKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQH 485
++N+ +LG+G F V + E I + S + + + E R+ KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
N+VRL LV++ + L + + + I+ I + + Y
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 546 HKYSRLRVIHRDLKASNILLDDKMN---PKISDFGMARIFEVNESEANTKRIVGTYGYMS 602
H ++HR+LK N+LL K K++DFG+A EVN+SEA GT GY+S
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-WHGFAGTPGYLS 175
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
PE S D+++ GV++ ++ G
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVG 203
>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin
pdb|4GUE|A Chain A, Structure Of N-terminal Kinase Domain Of Rsk2 With
Flavonoid Glycoside Quercitrin
Length = 305
Score = 66.6 bits (161), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 64/213 (30%), Positives = 108/213 (50%), Gaps = 20/213 (9%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLAD----EQEVAIKRLSRSS--GQGIVEFKNEVRLI 480
A + F LG+G FG V+ K Q A+K L +++ + V K E ++
Sbjct: 22 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDIL 81
Query: 481 AKLQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEK--RFIIIEG 537
++ H +V+L + E +L L+ +F+ L F K V+ E+ +F + E
Sbjct: 82 VEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAE- 135
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT 597
++ L +LH L +I+RDLK NILLD++ + K++DFG+++ E + E GT
Sbjct: 136 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGT 190
Query: 598 YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
YM+PE + D +SFGVL+ E+++G
Sbjct: 191 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223
>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex
With Flavonoid Glycoside Sl0101
Length = 304
Score = 66.6 bits (161), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 64/213 (30%), Positives = 108/213 (50%), Gaps = 20/213 (9%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLAD----EQEVAIKRLSRSS--GQGIVEFKNEVRLI 480
A + F LG+G FG V+ K Q A+K L +++ + V K E ++
Sbjct: 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDIL 80
Query: 481 AKLQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEK--RFIIIEG 537
++ H +V+L + E +L L+ +F+ L F K V+ E+ +F + E
Sbjct: 81 VEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAE- 134
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT 597
++ L +LH L +I+RDLK NILLD++ + K++DFG+++ E + E GT
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGT 189
Query: 598 YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
YM+PE + D +SFGVL+ E+++G
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222
>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human
5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant
(T172d)
pdb|3AQV|A Chain A, Human Amp-Activated Protein Kinase Alpha 2 Subunit Kinase
Domain (T172d) Complexed With Compound C
Length = 276
Score = 66.6 bits (161), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 22/209 (10%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQ----EVAIKRLSRS---SGQGIVEFKNEVRLIAKL 483
++ + LG G FG V K+ + Q +VA+K L+R S + + K E++ +
Sbjct: 12 HYVLGDTLGVGTFGKV---KIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF 68
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLL 543
+H ++++L + +V E++ L ++ GR + + F + I +
Sbjct: 69 RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF---QQILSAVD 125
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
Y H++ V+HRDLK N+LLD MN KI+DFG++ + E ++ G+ Y +P
Sbjct: 126 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS---CGSPNYAAP 179
Query: 604 EYAMSG--IVSIKTDVFSFGVLVLEIVSG 630
E +SG + D++S GV++ ++ G
Sbjct: 180 E-VISGRLYAGPEVDIWSCGVILYALLCG 207
>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp
pdb|3PP1|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgatp
Length = 328
Score = 66.2 bits (160), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 56/206 (27%), Positives = 104/206 (50%), Gaps = 15/206 (7%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIV--EFKNEVRLIAKLQHTN 487
++F ++LG G G V+K V ++L + + + E++++ +
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGR--KNVLNWEKRFIIIEGISQGLLYL 545
+V G E + E M SLD L +GR + +L +I +GL YL
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI-----KGLTYL 120
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
+ + +++HRD+K SNIL++ + K+ DFG++ ++ +S AN+ VGT YMSPE
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYMSPER 174
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVSGQ 631
S+++D++S G+ ++E+ G+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200
>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound
Length = 322
Score = 66.2 bits (160), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 56/206 (27%), Positives = 104/206 (50%), Gaps = 15/206 (7%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIV--EFKNEVRLIAKLQHTN 487
++F ++LG G G V+K V ++L + + + E++++ +
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGR--KNVLNWEKRFIIIEGISQGLLYL 545
+V G E + E M SLD L +GR + +L +I +GL YL
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI-----KGLTYL 120
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
+ + +++HRD+K SNIL++ + K+ DFG++ ++ +S AN+ VGT YMSPE
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYMSPER 174
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVSGQ 631
S+++D++S G+ ++E+ G+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200
>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBG|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
pdb|3OC1|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 66.2 bits (160), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 62/228 (27%), Positives = 108/228 (47%), Gaps = 41/228 (17%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN---EVR 478
+TI + + +G G +G V VA+K+LSR Q I+ K E+R
Sbjct: 15 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 73
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK 530
L+ ++H N++ LL F P +SL+ F L + N++ +K
Sbjct: 74 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 531 ------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+F+I + I +GL Y+H +IHRDLK SN+ +++ KI D G+AR
Sbjct: 122 LTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLAR---- 173
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 174 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
pdb|1Y8G|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
Length = 327
Score = 66.2 bits (160), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADE----QEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQ 484
N+ +G+G F V KLA +EVA+K + ++ + + + EVR+ L
Sbjct: 15 NYRLLKTIGKGNFAKV---KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLN 71
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
H N+V+L + LV E+ + +L GR +F I + Y
Sbjct: 72 HPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKF---RQIVSAVQY 128
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV-NESEANTKRIVGTYGYMSP 603
H+ ++HRDLKA N+LLD N KI+DFG + F N+ +A G Y +P
Sbjct: 129 CHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA----FCGAPPYAAP 181
Query: 604 E-YAMSGIVSIKTDVFSFGVLVLEIVSG 630
E + + DV+S GV++ +VSG
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSG 209
>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution.
pdb|2JED|B Chain B, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution
Length = 352
Score = 66.2 bits (160), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 425 IAAAANNFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSSGQGIVEFKNEVRLIAKL 483
I +F LG+G FG V+ + Q AIK L + +++ E ++ K
Sbjct: 13 IKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--LMDDDVECTMVEKR 70
Query: 484 ------QHTNLVRLLGCSLHGEERLL-VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE 536
+H L + C+ +E L V E++ L +++ + + +
Sbjct: 71 VLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAA 126
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
I GL +LH +++RDLK NILLD + KI+DFGM + E +A T G
Sbjct: 127 EIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNEFCG 181
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
T Y++PE + + D +SFGVL+ E++ GQ
Sbjct: 182 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216
>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
pdb|2BDW|B Chain B, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
Length = 362
Score = 65.9 bits (159), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 15/208 (7%)
Query: 429 ANNFSTTNKLGEGGFGPVYK---GKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQH 485
++N+ +LG+G F V + E I + S + + + E R+ KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
N+VRL LV++ + L + + + I+ I + + Y
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAYC 144
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNP---KISDFGMARIFEVNESEANTKRIVGTYGYMS 602
H ++HR+LK N+LL K K++DFG+A EVN+SEA GT GY+S
Sbjct: 145 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-WHGFAGTPGYLS 198
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
PE S D+++ GV++ ++ G
Sbjct: 199 PEVLKKDPYSKPVDIWACGVILYILLVG 226
>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated
Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2
Chain)
Length = 276
Score = 65.9 bits (159), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 56/209 (26%), Positives = 103/209 (49%), Gaps = 22/209 (10%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQ----EVAIKRLSRS---SGQGIVEFKNEVRLIAKL 483
++ + LG G FG V K+ + Q +VA+K L+R S + + K E++ +
Sbjct: 12 HYVLGDTLGVGTFGKV---KIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF 68
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLL 543
+H ++++L + +V E++ L ++ GR + + F + I +
Sbjct: 69 RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF---QQILSAVD 125
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
Y H++ V+HRDLK N+LLD MN KI+DFG++ + E + G+ Y +P
Sbjct: 126 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAP 179
Query: 604 EYAMSG--IVSIKTDVFSFGVLVLEIVSG 630
E +SG + D++S GV++ ++ G
Sbjct: 180 E-VISGRLYAGPEVDIWSCGVILYALLCG 207
>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W9Z|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 65.9 bits (159), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQ-GI-VEFKNEVRLIAKLQ 484
A + + ++G G +G VYK + VA+K + +G+ G+ + EV L+ +L+
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 485 ---HTNLVRLLG-CSLHGEER----LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE 536
H N+VRL+ C+ +R LV+E + ++ L +L + L E ++
Sbjct: 62 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+GL +LH ++HRDLK NIL+ K++DFG+ARI+ + A +V
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAP---VVV 173
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEI 627
T Y +PE + + D++S G + E+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204
>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNG|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNL|A Chain A, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|1UNL|B Chain B, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|3O0G|A Chain A, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
pdb|3O0G|B Chain B, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
Length = 292
Score = 65.9 bits (159), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 105/208 (50%), Gaps = 14/208 (6%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLS-RSSGQGIVEFK-NEVRLIAKLQHT 486
+ K+GEG +G V+K K + E VA+KR+ +G+ E+ L+ +L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 487 NLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
N+VRL LH +++L LV+EF +F +G L+ E + + +GL +
Sbjct: 62 NIVRLHDV-LHSDKKLTLVFEFCDQDLKKYFDSCNGD---LDPEIVKSFLFQLLKGLGFC 117
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
H + V+HRDLK N+L++ K+++FG+AR F + + + V T Y P+
Sbjct: 118 HSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE--VVTLWYRPPDV 172
Query: 606 AM-SGIVSIKTDVFSFGVLVLEIVSGQK 632
+ + S D++S G + E+ + +
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGR 200
>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|B Chain B, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|C Chain C, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|D Chain D, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|E Chain E, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|F Chain F, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
Length = 285
Score = 65.9 bits (159), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 19/208 (9%)
Query: 432 FSTTNKLGEGGFGPVYKGKLADEQ----EVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHT 486
F KLG G FG V+ L +E+ E IK +++ Q +E + E+ ++ L H
Sbjct: 24 FIFKRKLGSGAFGDVH---LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 487 NLVRLLGCSLHGEERLLVYEFMPN-KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
N++++ +V E + L+ + R L+ +++ + L Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 546 HKYSRLRVIHRDLKASNILLDDK--MNP-KISDFGMARIFEVNESEANTKRIVGTYGYMS 602
H V+H+DLK NIL D +P KI DFG+A +F+ +E N GT YM+
Sbjct: 141 HSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA---AGTALYMA 194
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
PE V+ K D++S GV++ +++G
Sbjct: 195 PE-VFKRDVTFKCDIWSAGVVMYFLLTG 221
>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With
Compound 1, Atp-Gs And Mg2p
pdb|3EQD|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Atp-Gs
And Mg2p
pdb|3EQF|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With K252a
And Mg2p
pdb|3EQG|A Chain A, X-ray Structure Of The Human Mitogen-activated Protein
Kinase Kinase 1 (mek1) In A Ternary Complex With Pd, Adp
And Mg2p
pdb|3EQH|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With U0126,
Adp And Mg2p
pdb|3EQI|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Adp And
Mg2p
Length = 360
Score = 65.9 bits (159), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 56/206 (27%), Positives = 104/206 (50%), Gaps = 15/206 (7%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIV--EFKNEVRLIAKLQHTN 487
++F ++LG G G V+K V ++L + + + E++++ +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGR--KNVLNWEKRFIIIEGISQGLLYL 545
+V G E + E M SLD L +GR + +L +I +GL YL
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI-----KGLTYL 147
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
+ + +++HRD+K SNIL++ + K+ DFG++ ++ +S AN+ VGT YMSPE
Sbjct: 148 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYMSPER 201
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVSGQ 631
S+++D++S G+ ++E+ G+
Sbjct: 202 LQGTHYSVQSDIWSMGLSLVEMAVGR 227
>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|E Chain E, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|F Chain F, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
Length = 303
Score = 65.5 bits (158), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 65/229 (28%), Positives = 107/229 (46%), Gaps = 37/229 (16%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTN 487
A++F LG+G FG V K + A D + AIK++ R + + + +EV L+A L H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLASLNHQY 63
Query: 488 LVRLLGCSLHGEERLLV---------------YEFMPNKSLDFFLFNSGRKNVLNWEKRF 532
+VR L E R V E+ N++L + L +S N ++ +
Sbjct: 64 VVRYYAAWL--ERRNFVKPXTAVKKKSTLFIQXEYCENRTL-YDLIHSENLNQ-QRDEYW 119
Query: 533 IIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-------IFEVN 585
+ I + L Y+H +IHR+LK NI +D+ N KI DFG+A+ I +++
Sbjct: 120 RLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 586 E-----SEANTKRIVGTYGYMSPEYA-MSGIVSIKTDVFSFGVLVLEIV 628
S N +GT Y++ E +G + K D +S G++ E +
Sbjct: 177 SQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225
>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
pdb|3G0F|B Chain B, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
Length = 336
Score = 65.5 bits (158), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 70/300 (23%), Positives = 129/300 (43%), Gaps = 40/300 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKG------KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAK 482
N S LG G FG V + K VA+K L S+ E +E+++++
Sbjct: 46 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 483 L-QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG---- 537
L H N+V LLG G L++ E+ L FL + + I+ +
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 538 -----------ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586
+++G+ +L + IHRDL A NILL KI DFG+AR + +
Sbjct: 166 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDS 222
Query: 587 SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
+ +M+PE + + + ++DV+S+G+ + E+ S + +P P++
Sbjct: 223 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG---SSPYPGMPVDSK 279
Query: 647 GYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706
Y +++ + G ++ P P ++M+ C + RPT ++V +++ +
Sbjct: 280 FY--KMIKE--GFRMLSPE-HAPAEMYDIMKT------CWDADPLKRPTFKQIVQLIEKQ 328
>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib
Length = 336
Score = 65.5 bits (158), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 70/300 (23%), Positives = 129/300 (43%), Gaps = 40/300 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKG------KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAK 482
N S LG G FG V + K VA+K L S+ E +E+++++
Sbjct: 46 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 483 L-QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG---- 537
L H N+V LLG G L++ E+ L FL + + I+ +
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 538 -----------ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586
+++G+ +L + IHRDL A NILL KI DFG+AR + +
Sbjct: 166 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 222
Query: 587 SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
+ +M+PE + + + ++DV+S+G+ + E+ S + +P P++
Sbjct: 223 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG---SSPYPGMPVDSK 279
Query: 647 GYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706
Y +++ + G ++ P P ++M+ C + RPT ++V +++ +
Sbjct: 280 FY--KMIKE--GFRMLSPE-HAPAEMYDIMKT------CWDADPLKRPTFKQIVQLIEKQ 328
>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C-kit Tyrosine Kinase
Length = 313
Score = 65.5 bits (158), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 70/300 (23%), Positives = 129/300 (43%), Gaps = 40/300 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKG------KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAK 482
N S LG G FG V + K VA+K L S+ E +E+++++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 483 L-QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG---- 537
L H N+V LLG G L++ E+ L FL + + I+ +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 538 -----------ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586
+++G+ +L + IHRDL A NILL KI DFG+AR + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 587 SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
+ +M+PE + + + ++DV+S+G+ + E+ S + +P P++
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG---SSPYPGMPVDSK 256
Query: 647 GYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706
Y +++ + G ++ P P ++M+ C + RPT ++V +++ +
Sbjct: 257 FY--KMIKE--GFRMLSPE-HAPAEMYDIMKT------CWDADPLKRPTFKQIVQLIEKQ 305
>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
pdb|3SLS|B Chain B, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
Length = 304
Score = 65.5 bits (158), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 61/212 (28%), Positives = 106/212 (50%), Gaps = 27/212 (12%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVR--LIAKLQHTN 487
++F ++LG G G V+K V ++L +E K +R +I +LQ +
Sbjct: 25 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRELQVLH 78
Query: 488 ------LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGR--KNVLNWEKRFIIIEGIS 539
+V G E + E M SLD L +GR + +L +I
Sbjct: 79 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI----- 133
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+GL YL + + +++HRD+K SNIL++ + K+ DFG++ ++ +S AN+ VGT
Sbjct: 134 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRS 187
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
YMSPE S+++D++S G+ ++E+ G+
Sbjct: 188 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219
>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|B Chain B, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|C Chain C, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
Length = 360
Score = 65.1 bits (157), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLAD----EQEVAIKRLSRS---SGQGIVEFKNEVRLIAK 482
+F+ LG+G FG V LAD E+ AIK L + + E R++A
Sbjct: 19 TDFNFLMVLGKGSFGKVM---LADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLAL 75
Query: 483 LQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQG 541
L + L +RL V E++ L + + G+ + IS G
Sbjct: 76 LDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK---FKEPQAVFYAAEISIG 132
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
L +LHK +I+RDLK N++LD + + KI+DFGM + E T+ GT Y+
Sbjct: 133 LFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMMDGVTTREFCGTPDYI 187
Query: 602 SPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+PE D +++GVL+ E+++GQ
Sbjct: 188 APEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 217
>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C- Kit Tyrosine Kinase
Length = 331
Score = 65.1 bits (157), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 70/300 (23%), Positives = 129/300 (43%), Gaps = 40/300 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKG------KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAK 482
N S LG G FG V + K VA+K L S+ E +E+++++
Sbjct: 41 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 100
Query: 483 L-QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG---- 537
L H N+V LLG G L++ E+ L FL + + I+ +
Sbjct: 101 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 160
Query: 538 -----------ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586
+++G+ +L + IHRDL A NILL KI DFG+AR + +
Sbjct: 161 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 217
Query: 587 SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
+ +M+PE + + + ++DV+S+G+ + E+ S + +P P++
Sbjct: 218 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG---SSPYPGMPVDSK 274
Query: 647 GYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706
Y +++ + G ++ P P ++M+ C + RPT ++V +++ +
Sbjct: 275 FY--KMIKE--GFRMLSPE-HAPAEMYDIMKT------CWDADPLKRPTFKQIVQLIEKQ 323
>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|B Chain B, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|C Chain C, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|D Chain D, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
Length = 319
Score = 65.1 bits (157), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADE----QEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQ 484
N+ +G+G F V KLA +EVA+K + ++ + + + EVR++ L
Sbjct: 8 NYRLLKTIGKGNFAKV---KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLN 64
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
H N+V+L + LV E+ + +L G +F I + Y
Sbjct: 65 HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKF---RQIVSAVQY 121
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
H+ ++HRDLKA N+LLD MN KI+DFG + F G+ Y +PE
Sbjct: 122 CHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDTFCGSPPYAAPE 175
Query: 605 -YAMSGIVSIKTDVFSFGVLVLEIVSG 630
+ + DV+S GV++ +VSG
Sbjct: 176 LFQGKKYDGPEVDVWSLGVILYTLVSG 202
>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With
Staurosporine At 2a Resolution
Length = 345
Score = 65.1 bits (157), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 23/217 (10%)
Query: 425 IAAAANNFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSSGQGIVEFKNEVR----- 478
I +F LG+G FG V+ + Q AIK L + +V ++V
Sbjct: 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKD----VVLMDDDVECTMVE 67
Query: 479 ---LIAKLQHTNLVRLLGCSLHGEERLL-VYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
L +H L + C+ +E L V E++ L +++ + + +
Sbjct: 68 KRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFY 123
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
I GL +LH +++RDLK NILLD + KI+DFGM + E +A T
Sbjct: 124 AAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNXF 178
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
GT Y++PE + + D +SFGVL+ E++ GQ
Sbjct: 179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex
pdb|1PKG|B Chain B, Structure Of A C-kit Kinase Product Complex
Length = 329
Score = 65.1 bits (157), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 70/300 (23%), Positives = 129/300 (43%), Gaps = 40/300 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKG------KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAK 482
N S LG G FG V + K VA+K L S+ E +E+++++
Sbjct: 39 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 98
Query: 483 L-QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG---- 537
L H N+V LLG G L++ E+ L FL + + I+ +
Sbjct: 99 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 158
Query: 538 -----------ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586
+++G+ +L + IHRDL A NILL KI DFG+AR + +
Sbjct: 159 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 215
Query: 587 SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
+ +M+PE + + + ++DV+S+G+ + E+ S + +P P++
Sbjct: 216 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG---SSPYPGMPVDSK 272
Query: 647 GYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706
Y +++ + G ++ P P ++M+ C + RPT ++V +++ +
Sbjct: 273 FY--KMIKE--GFRMLSPE-HAPAEMYDIMKT------CWDADPLKRPTFKQIVQLIEKQ 321
>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia
pdb|3GC0|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia In
Complex With Amp
Length = 329
Score = 64.7 bits (156), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 18/212 (8%)
Query: 426 AAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFK--NEVRLIAK 482
A + + + KLGEG +G VYK + VAIKR+ + V EV L+ +
Sbjct: 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKE 89
Query: 483 LQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
LQH N++ L H L++E+ N + N + + +I G++
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVN--- 146
Query: 543 LYLHKYSRLRVIHRDLKASNILL---DDKMNP--KISDFGMARIFEVNESEANTKRIVGT 597
+ H SR R +HRDLK N+LL D P KI DFG+AR F + + + I T
Sbjct: 147 -FCH--SR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII--T 200
Query: 598 YGYMSPEYAM-SGIVSIKTDVFSFGVLVLEIV 628
Y PE + S S D++S + E++
Sbjct: 201 LWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232
>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|C Chain C, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|D Chain D, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome
Length = 324
Score = 64.7 bits (156), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 55/223 (24%), Positives = 102/223 (45%), Gaps = 26/223 (11%)
Query: 430 NNFSTTNKLGEGGFGPVY--------KGKLADEQEVAIKRL-SRSSGQGIVEFKNEVRLI 480
+ + LGEG FG V K K + VA+K L ++ + + + +E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 481 AKL-QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFL-------------FNSGRKNVL 526
+ +H N++ LLG ++ E+ +L +L N + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 527 NWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586
++ +++G+ YL + + IHRDL A N+L+ + KI+DFG+AR +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 587 SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
NT +M+PE + + ++DV+SFGVL+ EI +
Sbjct: 212 YYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf
Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp
Analog And Substrate Peptide
Length = 334
Score = 64.7 bits (156), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 56/225 (24%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 430 NNFSTTNKLGEGGFGPVY--------KGKLADEQEVAIKRLSR-SSGQGIVEFKNEVRLI 480
+ + LGEG FG V K K + VA+K L ++ + + + +E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 481 AKL-QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFL-------------FNSGRKNVL 526
+ +H N++ LLG ++ E+ +L +L N + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 527 NWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586
++ +++G+ YL + + IHRDL A N+L+ + KI+DFG+AR ++N
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINN 209
Query: 587 SEANTKRIVGT--YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ K G +M+PE + + ++DV+SFGVL+ EI +
Sbjct: 210 IDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains
Trapped In Trans-Phosphorylation Reaction
Length = 334
Score = 64.7 bits (156), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 56/225 (24%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 430 NNFSTTNKLGEGGFGPVY--------KGKLADEQEVAIKRLSR-SSGQGIVEFKNEVRLI 480
+ + LGEG FG V K K + VA+K L ++ + + + +E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 481 AKL-QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFL-------------FNSGRKNVL 526
+ +H N++ LLG ++ E+ +L +L N + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 527 NWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586
++ +++G+ YL + + IHRDL A N+L+ + KI+DFG+AR ++N
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINN 209
Query: 587 SEANTKRIVGT--YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ K G +M+PE + + ++DV+SFGVL+ EI +
Sbjct: 210 IDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
pdb|1YRP|B Chain B, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
Length = 278
Score = 64.7 bits (156), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 22/213 (10%)
Query: 430 NNFSTTNKLGEGGFGPVYK------GKLADEQEVAIKRLSRSSGQGIV--EFKNEVRLIA 481
+++ +LG G F V K GK + + +RLS SS +G+ E + EV ++
Sbjct: 12 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLS-SSRRGVSREEIEREVNILR 70
Query: 482 KLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQG 541
+++H N++ L + + +L+ E + L FL K L ++ ++ I G
Sbjct: 71 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDG 127
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKM--NPKIS--DFGMARIFEVNESEANTKRIVGT 597
+ YLH R+ H DLK NI+L DK NP+I DFG+A E K I GT
Sbjct: 128 VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGT 181
Query: 598 YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
+++PE + ++ D++S GV+ ++SG
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
pdb|3UTO|B Chain B, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
Length = 573
Score = 64.7 bits (156), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 430 NNFSTTNKLGEGGFGPVYK-GKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+++ +LG G FG V++ + A A K + + E++ ++ L+H L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
V L E +++YEFM L F + N ++ ++ + + +GL ++H+
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGEL--FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 549 SRLRVIHRDLKASNILLDDKMNP--KISDFGMARIFEVNESEANTKRIVGTYGYMSPEYA 606
+ +H DLK NI+ K + K+ DFG+ + +S K GT + +PE A
Sbjct: 275 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVA 328
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSG 630
V TD++S GVL ++SG
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLSG 352
>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With A Beta-Carboline Ligand
pdb|3BQR|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With An Imidazo-Pyridazine Ligand
Length = 283
Score = 64.7 bits (156), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 22/217 (10%)
Query: 426 AAAANNFSTTNKLGEGGFGPVYK------GKLADEQEVAIKRLSRSSGQGIV--EFKNEV 477
+ +++ +LG G F V K GK + + +RLS SS +G+ E + EV
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLS-SSRRGVSREEIEREV 59
Query: 478 RLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG 537
++ +++H N++ L + + +L+ E + L FL K L ++ ++
Sbjct: 60 NILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQ 116
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKM--NPKIS--DFGMARIFEVNESEANTKR 593
I G+ YLH R+ H DLK NI+L DK NP+I DFG+A E K
Sbjct: 117 ILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKN 170
Query: 594 IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
I GT +++PE + ++ D++S GV+ ++SG
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 64.3 bits (155), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 103/211 (48%), Gaps = 19/211 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQ-GI-VEFKNEVRLIAKLQ 484
A + + ++G G +G VYK + VA+K + +G+ G+ + EV L+ +L+
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 485 ---HTNLVRLLG-CSLHGEER----LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE 536
H N+VRL+ C+ +R LV+E + ++ L +L + L E ++
Sbjct: 62 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+GL +LH ++HRDLK NIL+ K++DFG+ARI+ + +V
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALDPVVV 173
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEI 627
T Y +PE + + D++S G + E+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204
>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome.
pdb|2PWL|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 64.3 bits (155), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 56/225 (24%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 430 NNFSTTNKLGEGGFGPVY--------KGKLADEQEVAIKRLSR-SSGQGIVEFKNEVRLI 480
+ + LGEG FG V K K + VA+K L ++ + + + +E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 481 AKL-QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFL-------------FNSGRKNVL 526
+ +H N++ LLG ++ E+ +L +L N + +
Sbjct: 95 KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 527 NWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586
++ +++G+ YL + + IHRDL A N+L+ + KI+DFG+AR ++N
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINN 209
Query: 587 SEANTKRIVGT--YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ K G +M+PE + + ++DV+SFGVL+ EI +
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
pdb|2PZP|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 64.3 bits (155), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 56/225 (24%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 430 NNFSTTNKLGEGGFGPVY--------KGKLADEQEVAIKRL-SRSSGQGIVEFKNEVRLI 480
+ + LGEG FG V K K + VA+K L ++ + + + +E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 481 AKL-QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFL-------------FNSGRKNVL 526
+ +H N++ LLG ++ E+ +L +L N + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 527 NWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586
++ +++G+ YL + + IHRDL A N+L+ + KI+DFG+AR ++N
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINN 209
Query: 587 SEANTKRIVGT--YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ K G +M+PE + + ++DV+SFGVL+ EI +
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated
Protein Kinase And Immunoglobulin Domains
Length = 491
Score = 63.9 bits (154), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 430 NNFSTTNKLGEGGFGPVYK-GKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+++ +LG G FG V++ + A A K + + E++ ++ L+H L
Sbjct: 51 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
V L E +++YEFM L F + N ++ ++ + + +GL ++H+
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGEL--FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 168
Query: 549 SRLRVIHRDLKASNILLDDKMNP--KISDFGMARIFEVNESEANTKRIVGTYGYMSPEYA 606
+ +H DLK NI+ K + K+ DFG+ + +S K GT + +PE A
Sbjct: 169 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVA 222
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSG 630
V TD++S GVL ++SG
Sbjct: 223 EGKPVGYYTDMWSVGVLSYILLSG 246
>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase
Catalytic Subunit From Saccharomyces Cerevisiae
Length = 318
Score = 63.9 bits (154), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 15/207 (7%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGI--VEFKNEVRLIAKL- 483
+ +F LG G FG V+ + + + A+K L + + VE N+ RL+ +
Sbjct: 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLL 543
H ++R+ G ++ ++ +++ L L S R N +F E + L
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR--FPNPVAKFYAAE-VCLALE 120
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
YLH +I+RDLK NILLD + KI+DFG A+ T + GT Y++P
Sbjct: 121 YLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYXLCGTPDYIAP 172
Query: 604 EYAMSGIVSIKTDVFSFGVLVLEIVSG 630
E + + D +SFG+L+ E+++G
Sbjct: 173 EVVSTKPYNKSIDWWSFGILIYEMLAG 199
>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN3|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN9|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4ANB|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs
Length = 301
Score = 63.9 bits (154), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 55/206 (26%), Positives = 102/206 (49%), Gaps = 15/206 (7%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIV--EFKNEVRLIAKLQHTN 487
++F ++LG G G V+K V ++L + + + E++++ +
Sbjct: 9 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGR--KNVLNWEKRFIIIEGISQGLLYL 545
+V G E + E M SLD L +GR + +L +I +GL YL
Sbjct: 69 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI-----KGLTYL 123
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
+ + +++HRD+K SNIL++ + K+ DFG++ ++ + AN VGT YMSPE
Sbjct: 124 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDEMAN--EFVGTRSYMSPER 177
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVSGQ 631
S+++D++S G+ ++E+ G+
Sbjct: 178 LQGTHYSVQSDIWSMGLSLVEMAVGR 203
>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 63.9 bits (154), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 438 LGEGGFGPVY--------KGKLADEQEVAIKRL-SRSSGQGIVEFKNEVRLIAKL-QHTN 487
LGEG FG V K K +VA+K L S ++ + + + +E+ ++ + +H N
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFL-----------FNSGR--KNVLNWEKRFII 534
++ LLG ++ E+ +L +L FN + L+ +
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+++G+ YL + + IHRDL A N+L+ + KI+DFG+AR + T
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+PE I + ++DV+SFGVL+ EI +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZ5|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 63.5 bits (153), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 56/225 (24%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 430 NNFSTTNKLGEGGFGPVY--------KGKLADEQEVAIKRLSR-SSGQGIVEFKNEVRLI 480
+ + LGEG FG V K K + VA+K L ++ + + + +E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 481 AKL-QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFL-------------FNSGRKNVL 526
+ +H N++ LLG ++ E+ +L +L N + +
Sbjct: 95 KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 527 NWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586
++ +++G+ YL + + IHRDL A N+L+ + KI+DFG+AR ++N
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINN 209
Query: 587 SEANTKRIVGT--YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ K G +M+PE + + ++DV+SFGVL+ EI +
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6
pdb|3UDB|B Chain B, Crystal Structure Of Snrk2.6
pdb|3UDB|C Chain C, Crystal Structure Of Snrk2.6
pdb|3UDB|D Chain D, Crystal Structure Of Snrk2.6
pdb|3UDB|E Chain E, Crystal Structure Of Snrk2.6
pdb|3UDB|F Chain F, Crystal Structure Of Snrk2.6
Length = 317
Score = 63.5 bits (153), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 70/227 (30%), Positives = 107/227 (47%), Gaps = 20/227 (8%)
Query: 425 IAAAANNFSTTNKLGEGGFG--PVYKGKLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIA 481
I ++ + +G G FG + + K A+E VA+K + R G+ I E K E+
Sbjct: 14 IMHDSDRYELVKDIGAGNFGVARLMRDKQANEL-VAVKYIER--GEKIDENVKREIINHR 70
Query: 482 KLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQG 541
L+H N+VR L +V E+ L + N+GR + E RF + IS G
Sbjct: 71 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS--EDEARFFFQQLIS-G 127
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNP--KISDFGMARIFEVNESEANTKRIVGTYG 599
+ Y H ++V HRDLK N LLD P KI+DFG ++ ++ + K VGT
Sbjct: 128 VSYAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLH---SQPKSAVGTPA 181
Query: 600 YMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQKNHTRHHPDRPLNL 645
Y++PE + K DV+S GV + ++ G + P+ P N
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGA--YPFEDPEEPKNF 226
>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase
Length = 353
Score = 63.5 bits (153), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 38/219 (17%)
Query: 430 NNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLSRSSGQGIVEFK--NEVRLIAKLQH 485
+ + +G G +G V K + E+ VAIK+LSR I + E+ L+ +QH
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEK-VAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSL----DFFL----FNSGRKNVLNW----EKRFI 533
N++ LL F P SL DF+L + + ++ EK
Sbjct: 83 ENVIGLLDV------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY 130
Query: 534 IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR 593
++ + +GL Y+H V+HRDLK N+ +++ KI DFG+AR ++A
Sbjct: 131 LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTG 182
Query: 594 IVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
V T Y +PE +S + +T D++S G ++ E+++G+
Sbjct: 183 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
pdb|2PSQ|B Chain B, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
Length = 370
Score = 63.2 bits (152), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 56/225 (24%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 430 NNFSTTNKLGEGGFGPVY--------KGKLADEQEVAIKRLSR-SSGQGIVEFKNEVRLI 480
+ + LGEG FG V K K + VA+K L ++ + + + +E+ ++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 481 AKL-QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFL-------------FNSGRKNVL 526
+ +H N++ LLG ++ E+ +L +L N + +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 527 NWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586
++ +++G+ YL + + IHRDL A N+L+ + KI+DFG+AR ++N
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINN 255
Query: 587 SEANTKRIVGT--YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ K G +M+PE + + ++DV+SFGVL+ EI +
Sbjct: 256 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 63.2 bits (152), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 103/211 (48%), Gaps = 19/211 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQ-GI-VEFKNEVRLIAKLQ 484
A + + ++G G +G VYK + VA+K + +G+ G+ + EV L+ +L+
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 485 ---HTNLVRLLG-CSLHGEER----LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE 536
H N+VRL+ C+ +R LV+E + ++ L +L + L E ++
Sbjct: 62 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+GL +LH ++HRDLK NIL+ K++DFG+ARI+ + +V
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALFPVVV 173
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEI 627
T Y +PE + + D++S G + E+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204
>pdb|4EXU|A Chain A, Mapk13, Inactive Form
pdb|4EYJ|A Chain A, Mapk13 Complex With Inhibitor
pdb|4EYM|A Chain A, Mapk13 Complex With Inhibitor
Length = 371
Score = 63.2 bits (152), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 38/219 (17%)
Query: 430 NNFSTTNKLGEGGFGPVYKG--KLADEQEVAIKRLSRSSGQGIVEFK--NEVRLIAKLQH 485
+ + +G G +G V K + E+ VAIK+LSR I + E+ L+ +QH
Sbjct: 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEK-VAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 100
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSL----DFFL----FNSGRKNVLNWE----KRFI 533
N++ LL F P SL DF+L + + ++ E K
Sbjct: 101 ENVIGLLDV------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQY 148
Query: 534 IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR 593
++ + +GL Y+H V+HRDLK N+ +++ KI DFG+AR ++A
Sbjct: 149 LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTG 200
Query: 594 IVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
V T Y +PE +S + +T D++S G ++ E+++G+
Sbjct: 201 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239
>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|C Chain C, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|D Chain D, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|E Chain E, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|F Chain F, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
Length = 384
Score = 63.2 bits (152), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 16/210 (7%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEV-AIKRLSRSSGQGIVEFKN---EVRLIAKLQH 485
++F +G+G FG V + D +++ A+K +++ E +N E++++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
LV L E+ +V + + L + L ++NV E+ + I + ++ L
Sbjct: 75 PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL----QQNVHFKEETVKLF--ICELVMAL 128
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
R+IHRD+K NILLD+ + I+DF +A + E + GT YM+PE
Sbjct: 129 DYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML---PRETQITTMAGTKPYMAPEM 185
Query: 606 AMS---GIVSIKTDVFSFGVLVLEIVSGQK 632
S S D +S GV E++ G++
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain
pdb|1OEC|A Chain A, Fgfr2 Kinase Domain
Length = 316
Score = 63.2 bits (152), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 56/225 (24%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 430 NNFSTTNKLGEGGFGPVY--------KGKLADEQEVAIKRLSR-SSGQGIVEFKNEVRLI 480
+ + LGEG FG V K K + VA+K L ++ + + + +E+ ++
Sbjct: 27 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 481 AKL-QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFL-------------FNSGRKNVL 526
+ +H N++ LLG ++ E+ +L +L N + +
Sbjct: 87 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 527 NWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586
++ +++G+ YL + + IHRDL A N+L+ + KI+DFG+AR ++N
Sbjct: 147 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINN 201
Query: 587 SEANTKRIVGT--YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ K G +M+PE + + ++DV+SFGVL+ EI +
Sbjct: 202 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246
>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
pdb|3RI1|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
Length = 313
Score = 63.2 bits (152), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 56/225 (24%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 430 NNFSTTNKLGEGGFGPVY--------KGKLADEQEVAIKRLSR-SSGQGIVEFKNEVRLI 480
+ + LGEG FG V K K + VA+K L ++ + + + +E+ ++
Sbjct: 24 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 481 AKL-QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFL-------------FNSGRKNVL 526
+ +H N++ LLG ++ E+ +L +L N + +
Sbjct: 84 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 527 NWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586
++ +++G+ YL + + IHRDL A N+L+ + KI+DFG+AR ++N
Sbjct: 144 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINN 198
Query: 587 SEANTKRIVGT--YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ K G +M+PE + + ++DV+SFGVL+ EI +
Sbjct: 199 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243
>pdb|3B2T|A Chain A, Structure Of Phosphotransferase
pdb|3B2T|B Chain B, Structure Of Phosphotransferase
Length = 311
Score = 63.2 bits (152), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 56/225 (24%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 430 NNFSTTNKLGEGGFGPVY--------KGKLADEQEVAIKRLSR-SSGQGIVEFKNEVRLI 480
+ + LGEG FG V K K + VA+K L ++ + + + +E+ ++
Sbjct: 22 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 481 AKL-QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFL-------------FNSGRKNVL 526
+ +H N++ LLG ++ E+ +L +L N + +
Sbjct: 82 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 527 NWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586
++ +++G+ YL + + IHRDL A N+L+ + KI+DFG+AR ++N
Sbjct: 142 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLAR--DINN 196
Query: 587 SEANTKRIVGT--YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ K G +M+PE + + ++DV+SFGVL+ EI +
Sbjct: 197 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241
>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
pdb|2J90|B Chain B, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
Length = 304
Score = 63.2 bits (152), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 21/209 (10%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIV--EFKNEVRLIAKLQH 485
+ F+ K + G G Y K KR SS +G+ E + EV ++ +++H
Sbjct: 35 GSGQFAIVRKCRQKGTGKEYAAKFIK------KRRLXSSRRGVSREEIEREVNILREIRH 88
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
N++ L + + +L+ E + L FL K L ++ ++ I G+ YL
Sbjct: 89 PNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGVHYL 145
Query: 546 HKYSRLRVIHRDLKASNILLDDKM--NPKIS--DFGMARIFEVNESEANTKRIVGTYGYM 601
H R+ H DLK NI+L DK NP+I DFG+A E K I GT ++
Sbjct: 146 HSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFV 199
Query: 602 SPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
+PE + ++ D++S GV+ ++SG
Sbjct: 200 APEIVNYEPLGLEADMWSIGVITYILLSG 228
>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium
Dependent Protein Kinase Cgd7_1840 In Presence Of
Indirubin E804
Length = 277
Score = 62.8 bits (151), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 20/206 (9%)
Query: 432 FSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVE----FKNEVRLIAKLQHTN 487
++ N +G G +G V K+A ++ I+R ++ + VE FK E+ ++ L H N
Sbjct: 11 YTLENTIGRGSWGEV---KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
++RL + LV E L K V I++ + + Y HK
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGEL---FERVVHKRVFRESDAARIMKDVLSAVAYCHK 124
Query: 548 YSRLRVIHRDLKASNILL--DDKMNP-KISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
L V HRDLK N L D +P K+ DFG+A F+ + TK VGT Y+SP+
Sbjct: 125 ---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTK--VGTPYYVSPQ 178
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVSG 630
+ G+ + D +S GV++ ++ G
Sbjct: 179 -VLEGLYGPECDEWSAGVMMYVLLCG 203
>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZR|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 62.8 bits (151), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 55/225 (24%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 430 NNFSTTNKLGEGGFGPVY--------KGKLADEQEVAIKRLSR-SSGQGIVEFKNEVRLI 480
+ + LGEG FG V K K + VA+K L ++ + + + +E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 481 AKL-QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFL-------------FNSGRKNVL 526
+ +H N++ LLG ++ E+ +L +L N + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 527 NWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586
++ +++G+ YL + + IHRDL A N+L+ + +I+DFG+AR ++N
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLAR--DINN 209
Query: 587 SEANTKRIVGT--YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ K G +M+PE + + ++DV+SFGVL+ EI +
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino(
Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6-
Difluoro-Phenyl)-Amide)
Length = 349
Score = 62.8 bits (151), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKNEVRLIAKLQH 485
A ++ F ++LG G VY+ K Q+ A+K L ++ + IV + E+ ++ +L H
Sbjct: 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIV--RTEIGVLLRLSH 107
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
N+++L E LV E + L + G + + ++ I + + YL
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAAD---AVKQILEAVAYL 164
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNP---KISDFGMARIFEVNESEANTKRIVGTYGYMS 602
H+ ++HRDLK N+L KI+DFG+++I E + K + GT GY +
Sbjct: 165 HENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE---HQVLMKTVCGTPGYCA 218
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
PE + D++S G++ ++ G
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCG 246
>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|B Chain B, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|D Chain D, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
Length = 294
Score = 62.8 bits (151), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 20/206 (9%)
Query: 432 FSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVE----FKNEVRLIAKLQHTN 487
++ N +G G +G V K+A ++ I+R ++ + VE FK E+ ++ L H N
Sbjct: 28 YTLENTIGRGSWGEV---KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 84
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
++RL + LV E L K V I++ + + Y HK
Sbjct: 85 IIRLYETFEDNTDIYLVMELCTGGEL---FERVVHKRVFRESDAARIMKDVLSAVAYCHK 141
Query: 548 YSRLRVIHRDLKASNILL--DDKMNP-KISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
L V HRDLK N L D +P K+ DFG+A F+ + TK VGT Y+SP+
Sbjct: 142 ---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTK--VGTPYYVSPQ 195
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVSG 630
+ G+ + D +S GV++ ++ G
Sbjct: 196 -VLEGLYGPECDEWSAGVMMYVLLCG 220
>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And
Drb
pdb|4EC9|A Chain A, Crystal Structure Of Full-Length Cdk9 In Complex With
Cyclin T
Length = 373
Score = 62.8 bits (151), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 55/190 (28%), Positives = 98/190 (51%), Gaps = 21/190 (11%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLADE-QEVAIKR-LSRSSGQGI-VEFKNEVRLIAKLQH 485
+ + K+G+G FG V+K + Q+VA+K+ L + +G + E++++ L+H
Sbjct: 17 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 486 TNLVRLLG-CSLHGEER-------LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG 537
N+V L+ C LV++F + L L N K L+ KR +++
Sbjct: 77 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQM 133
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTK---RI 594
+ GL Y+H R +++HRD+KA+N+L+ K++DFG+AR F + ++ + R+
Sbjct: 134 LLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 190
Query: 595 VGTYGYMSPE 604
V T Y PE
Sbjct: 191 V-TLWYRPPE 199
>pdb|3ZGW|A Chain A, Crystal Structure Of Maternal Embryonic Leucine Zipper
Kinase (melk) In Complex With Amp-pnp
Length = 347
Score = 62.8 bits (151), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 51/205 (24%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 432 FSTTNKLGEGGFGPVYKGKLADE----QEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHT 486
+ +G GGF V KLA + VAIK + +++ G + K E+ + L+H
Sbjct: 12 YELHETIGTGGFAKV---KLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEALKNLRHQ 68
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLH 546
++ +L + +V E+ P L ++ + R L+ E+ ++ I + Y+H
Sbjct: 69 HICQLYHVLETANKIFMVLEYCPGGELFDYIISQDR---LSEEETRVVFRQIVSAVAYVH 125
Query: 547 KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYA 606
HRDLK N+L D+ K+ DFG+ + N+ + + + G+ Y +PE
Sbjct: 126 SQG---YAHRDLKPENLLFDEYHKLKLIDFGLCAKPKGNK-DYHLQTCCGSLAYAAPELI 181
Query: 607 M-SGIVSIKTDVFSFGVLVLEIVSG 630
+ + DV+S G+L+ ++ G
Sbjct: 182 QGKSYLGSEADVWSMGILLYVLMCG 206
>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed
With A Specific Inhibitor Of Human P38 Map Kinase
Length = 380
Score = 62.4 bits (150), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 55/225 (24%), Positives = 103/225 (45%), Gaps = 49/225 (21%)
Query: 432 FSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFK-NEVRLIAKLQHTNLV 489
++ + +GEG +G V ++ VAIK++S Q + E++++ + +H N++
Sbjct: 45 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 490 ---------------------RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNW 528
L+G L+ +LL + + N + +FL+
Sbjct: 105 GINDIIRAPTIEQMKDVYLVTHLMGADLY---KLLKTQHLSNDHICYFLYQ--------- 152
Query: 529 EKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588
I +GL Y+H + V+HRDLK SN+LL+ + KI DFG+AR+ + +
Sbjct: 153 ---------ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDH 200
Query: 589 AN-TKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
V T Y +PE ++ K+ D++S G ++ E++S +
Sbjct: 201 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245
>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 62.4 bits (150), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 55/190 (28%), Positives = 98/190 (51%), Gaps = 21/190 (11%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLADE-QEVAIKR-LSRSSGQGI-VEFKNEVRLIAKLQH 485
+ + K+G+G FG V+K + Q+VA+K+ L + +G + E++++ L+H
Sbjct: 17 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 486 TNLVRLLG-CSLHGEER-------LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG 537
N+V L+ C LV++F + L L N K L+ KR +++
Sbjct: 77 ENVVNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQM 133
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTK---RI 594
+ GL Y+H R +++HRD+KA+N+L+ K++DFG+AR F + ++ + R+
Sbjct: 134 LLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 190
Query: 595 VGTYGYMSPE 604
V T Y PE
Sbjct: 191 V-TLWYRPPE 199
>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb
pdb|3MIA|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Atp-Bound
Human P-Tefb
Length = 351
Score = 62.4 bits (150), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 55/190 (28%), Positives = 98/190 (51%), Gaps = 21/190 (11%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLADE-QEVAIKR-LSRSSGQGI-VEFKNEVRLIAKLQH 485
+ + K+G+G FG V+K + Q+VA+K+ L + +G + E++++ L+H
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75
Query: 486 TNLVRLLG-CSLHGEER-------LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG 537
N+V L+ C LV++F + L L N K L+ KR +++
Sbjct: 76 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQM 132
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTK---RI 594
+ GL Y+H R +++HRD+KA+N+L+ K++DFG+AR F + ++ + R+
Sbjct: 133 LLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 189
Query: 595 VGTYGYMSPE 604
V T Y PE
Sbjct: 190 V-TLWYRPPE 198
>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1
pdb|3BLQ|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
ATP
pdb|3BLR|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
Flavopiridol
pdb|3MY1|A Chain A, Structure Of Cdk9CYCLINT1 IN COMPLEX WITH DRB
pdb|3LQ5|A Chain A, Structure Of Cdk9CYCLINT IN COMPLEX WITH S-Cr8
pdb|3TN8|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNH|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNI|A Chain A, Structure Of Cdk9CYCLIN T F241L
pdb|4BCH|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCI|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCJ|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 62.4 bits (150), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 55/190 (28%), Positives = 98/190 (51%), Gaps = 21/190 (11%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLADE-QEVAIKR-LSRSSGQGI-VEFKNEVRLIAKLQH 485
+ + K+G+G FG V+K + Q+VA+K+ L + +G + E++++ L+H
Sbjct: 17 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 486 TNLVRLLG-CSLHGEER-------LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG 537
N+V L+ C LV++F + L L N K L+ KR +++
Sbjct: 77 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQM 133
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTK---RI 594
+ GL Y+H R +++HRD+KA+N+L+ K++DFG+AR F + ++ + R+
Sbjct: 134 LLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 190
Query: 595 VGTYGYMSPE 604
V T Y PE
Sbjct: 191 V-TLWYRPPE 199
>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase
(ttk)
pdb|3GFW|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase
(Ttk) In Complex With A Pyrolo-Pyridin Ligand
Length = 313
Score = 62.4 bits (150), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 49/190 (25%), Positives = 92/190 (48%), Gaps = 18/190 (9%)
Query: 422 FQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIK--RLSRSSGQGIVEFKNEVRL 479
FQ+++ +S ++G GG V++ +Q AIK L + Q + ++NE+
Sbjct: 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 480 IAKLQ-HTN-LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI---I 534
+ KLQ H++ ++RL + + +Y M ++D + +K++ WE++ +
Sbjct: 80 LNKLQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNM 136
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+E + H + ++H DLK +N L+ D M K+ DFG+A + + +
Sbjct: 137 LEAV-------HTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQ 188
Query: 595 VGTYGYMSPE 604
VGT YM PE
Sbjct: 189 VGTVNYMPPE 198
>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
pdb|3C4F|B Chain B, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
Length = 302
Score = 62.4 bits (150), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 438 LGEGGFGPVY--------KGKLADEQEVAIKRL-SRSSGQGIVEFKNEVRLIAKL-QHTN 487
LGEG FG V K K +VA+K L S ++ + + + +E+ ++ + +H N
Sbjct: 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFL-----------FNSGR--KNVLNWEKRFII 534
++ LLG ++ E+ +L +L +N + L+ +
Sbjct: 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+++G+ YL + + IHRDL A N+L+ + KI+DFG+AR + T
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+PE I + ++DV+SFGVL+ EI +
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232
>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1
Length = 361
Score = 62.0 bits (149), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 69/227 (30%), Positives = 106/227 (46%), Gaps = 20/227 (8%)
Query: 425 IAAAANNFSTTNKLGEGGFG--PVYKGKLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIA 481
I ++ + +G G FG + + K ++E VA+K + R G+ I E K E+
Sbjct: 13 IMHDSDRYELVKDIGSGNFGVARLMRDKQSNEL-VAVKYIER--GEKIDENVKREIINHR 69
Query: 482 KLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQG 541
L+H N+VR L +V E+ L + N+GR + E RF + IS G
Sbjct: 70 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS--EDEARFFFQQLIS-G 126
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNP--KISDFGMARIFEVNESEANTKRIVGTYG 599
+ Y H ++V HRDLK N LLD P KI DFG ++ ++ + K VGT
Sbjct: 127 VSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPA 180
Query: 600 YMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQKNHTRHHPDRPLNL 645
Y++PE + K DV+S GV + ++ G + P+ P N
Sbjct: 181 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGA--YPFEDPEEPKNF 225
>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
pdb|3RHX|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
Length = 306
Score = 62.0 bits (149), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 438 LGEGGFGPVY--------KGKLADEQEVAIKRL-SRSSGQGIVEFKNEVRLIAKL-QHTN 487
LGEG FG V K K +VA+K L S ++ + + + +E+ ++ + +H N
Sbjct: 25 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFL-----------FNSGR--KNVLNWEKRFII 534
++ LLG ++ E+ +L +L +N + L+ +
Sbjct: 85 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+++G+ YL + + IHRDL A N+L+ + KI+DFG+AR + T
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+PE I + ++DV+SFGVL+ EI +
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236
>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|B Chain B, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|C Chain C, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 62.0 bits (149), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 438 LGEGGFGPVY--------KGKLADEQEVAIKRL-SRSSGQGIVEFKNEVRLIAKL-QHTN 487
LGEG FG V K K +VA+K L S ++ + + + +E+ ++ + +H N
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFL-----------FNSGR--KNVLNWEKRFII 534
++ LLG ++ E+ +L +L +N + L+ +
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+++G+ YL + + IHRDL A N+L+ + KI+DFG+AR + T
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+PE I + ++DV+SFGVL+ EI +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|B Chain B, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|C Chain C, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|D Chain D, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
Length = 317
Score = 62.0 bits (149), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 438 LGEGGFGPVY--------KGKLADEQEVAIKRL-SRSSGQGIVEFKNEVRLIAKL-QHTN 487
LGEG FG V K K +VA+K L S ++ + + + +E+ ++ + +H N
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFL-----------FNSGR--KNVLNWEKRFII 534
++ LLG ++ E+ +L +L +N + L+ +
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+++G+ YL + + IHRDL A N+L+ + KI+DFG+AR + T
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+PE I + ++DV+SFGVL+ EI +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3JS2|B Chain B, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3KY2|A Chain A, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
pdb|3KY2|B Chain B, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
Length = 317
Score = 62.0 bits (149), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 438 LGEGGFGPVY--------KGKLADEQEVAIKRL-SRSSGQGIVEFKNEVRLIAKL-QHTN 487
LGEG FG V K K +VA+K L S ++ + + + +E+ ++ + +H N
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFL-----------FNSGR--KNVLNWEKRFII 534
++ LLG ++ E+ +L +L +N + L+ +
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+++G+ YL + + IHRDL A N+L+ + KI+DFG+AR + T
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+PE I + ++DV+SFGVL+ EI +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGK|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1AGW|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|1AGW|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|2FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
pdb|2FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
Length = 310
Score = 62.0 bits (149), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 438 LGEGGFGPVY--------KGKLADEQEVAIKRL-SRSSGQGIVEFKNEVRLIAKL-QHTN 487
LGEG FG V K K +VA+K L S ++ + + + +E+ ++ + +H N
Sbjct: 29 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFL-----------FNSGR--KNVLNWEKRFII 534
++ LLG ++ E+ +L +L +N + L+ +
Sbjct: 89 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+++G+ YL + + IHRDL A N+L+ + KI+DFG+AR + T
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+PE I + ++DV+SFGVL+ EI +
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240
>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F63|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F64|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F64|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F65|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
pdb|4F65|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
Length = 309
Score = 62.0 bits (149), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 438 LGEGGFGPVY--------KGKLADEQEVAIKRL-SRSSGQGIVEFKNEVRLIAKL-QHTN 487
LGEG FG V K K +VA+K L S ++ + + + +E+ ++ + +H N
Sbjct: 28 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFL-----------FNSGR--KNVLNWEKRFII 534
++ LLG ++ E+ +L +L +N + L+ +
Sbjct: 88 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+++G+ YL + + IHRDL A N+L+ + KI+DFG+AR + T
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+PE I + ++DV+SFGVL+ EI +
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239
>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1
Length = 327
Score = 62.0 bits (149), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 432 FSTTNKLGEGGFGPVYK---------GKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAK 482
F LG+GG+G V++ GK+ +V K + + + K E ++ +
Sbjct: 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIF-AMKVLKKAMIVRNAKDTAHTKAERNILEE 77
Query: 483 LQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
++H +V L+ G + L+ E++ L R+ + + + IS L
Sbjct: 78 VKHPFIVDLIYAFQTGGKLYLILEYLSGGEL---FMQLEREGIFMEDTACFYLAEISMAL 134
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMS 602
+LH+ +I+RDLK NI+L+ + + K++DFG+ + E T GT YM+
Sbjct: 135 GHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHXFCGTIEYMA 189
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
PE M + D +S G L+ ++++G
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTG 217
>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
pdb|3TT0|B Chain B, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
Length = 382
Score = 62.0 bits (149), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 438 LGEGGFGPVY--------KGKLADEQEVAIKRL-SRSSGQGIVEFKNEVRLIAKL-QHTN 487
LGEG FG V K K +VA+K L S ++ + + + +E+ ++ + +H N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFL-----------FNSGR--KNVLNWEKRFII 534
++ LLG ++ E+ +L +L +N + L+ +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+++G+ YL + + IHRDL A N+L+ + KI+DFG+AR + T
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+PE I + ++DV+SFGVL+ EI +
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
pdb|2Q0B|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 55/225 (24%), Positives = 104/225 (46%), Gaps = 30/225 (13%)
Query: 430 NNFSTTNKLGEGGFGPVY--------KGKLADEQEVAIKRLSR-SSGQGIVEFKNEVRLI 480
+ + LGEG FG V K K + VA+K L ++ + + + +E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 481 AKL-QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFL-------------FNSGRKNVL 526
+ +H N++ LLG ++ + +L +L N + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 527 NWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586
++ +++G+ YL + + IHRDL A N+L+ + KI+DFG+AR ++N
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINN 209
Query: 587 SEANTKRIVGT--YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ K G +M+PE + + ++DV+SFGVL+ EI +
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A60|B Chain B, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A61|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form Ii)
Length = 327
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 432 FSTTNKLGEGGFGPVYK---------GKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAK 482
F LG+GG+G V++ GK+ +V K + + + K E ++ +
Sbjct: 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIF-AMKVLKKAMIVRNAKDTAHTKAERNILEE 77
Query: 483 LQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
++H +V L+ G + L+ E++ L R+ + + + IS L
Sbjct: 78 VKHPFIVDLIYAFQTGGKLYLILEYLSGGEL---FMQLEREGIFMEDTACFYLAEISMAL 134
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMS 602
+LH+ +I+RDLK NI+L+ + + K++DFG+ + E T GT YM+
Sbjct: 135 GHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMA 189
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
PE M + D +S G L+ ++++G
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTG 217
>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase
(Ttk) In Complex With A Pyrimido-Diazepin Ligand
Length = 313
Score = 61.6 bits (148), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 49/190 (25%), Positives = 91/190 (47%), Gaps = 18/190 (9%)
Query: 422 FQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIK--RLSRSSGQGIVEFKNEVRL 479
FQ+++ +S ++G GG V++ +Q AIK L + Q + ++NE+
Sbjct: 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 480 IAKLQ-HTN-LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI---I 534
+ KLQ H++ ++RL + + +Y M ++D + +K++ WE++ +
Sbjct: 80 LNKLQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNM 136
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+E + H + ++H DLK +N L+ D M K+ DFG+A + +
Sbjct: 137 LEAV-------HTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVKDSQ 188
Query: 595 VGTYGYMSPE 604
VGT YM PE
Sbjct: 189 VGTVNYMPPE 198
>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase
pdb|2GNH|A Chain A, Pka Five Fold Mutant Model Of Rho-Kinase With H1152p
pdb|2GNI|A Chain A, Pka Fivefold Mutant Model Of Rho-Kinase With Inhibitor
Fasudil (Ha1077)
Length = 350
Score = 61.2 bits (147), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 427 AAANNFSTTNKLGEGGFGPV-----------YKGKLADEQEVA-IKRLSRSSGQGIVEFK 474
A + F +G G FG V Y K+ D+Q+V +K++ +
Sbjct: 38 AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-------- 89
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
NE R++ + LV+L +V E+MP + L GR + + RF
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPH--ARFYA 147
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ I YLH L +I+RDLK N+L+D + K++DFG A+ + T +
Sbjct: 148 AQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXL 198
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis
Length = 394
Score = 61.2 bits (147), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 61/242 (25%), Positives = 108/242 (44%), Gaps = 20/242 (8%)
Query: 399 PTYGKRKSPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVA 458
P G + +P D + ++ D +T ++ +G G FG V++ KL + EVA
Sbjct: 9 PLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVA 68
Query: 459 IKRLSRSSGQGIVEFKN-EVRLIAKLQHTNLVRLLGCSLHGEERL------LVYEFMPNK 511
IK++ + FKN E++++ ++H N+V L ++ LV E++P
Sbjct: 69 IKKVLQDK-----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET 123
Query: 512 SLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP 571
+ K + + + + + L Y+H + + HRD+K N+LLD
Sbjct: 124 VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGV 180
Query: 572 -KISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGI-VSIKTDVFSFGVLVLEIVS 629
K+ DFG A+I E N I Y Y +PE + D++S G ++ E++
Sbjct: 181 LKLIDFGSAKILIA--GEPNVSXICSRY-YRAPELIFGATNYTTNIDIWSTGCVMAELMQ 237
Query: 630 GQ 631
GQ
Sbjct: 238 GQ 239
>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With
Y- 27632
Length = 350
Score = 61.2 bits (147), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 427 AAANNFSTTNKLGEGGFGPV-----------YKGKLADEQEVA-IKRLSRSSGQGIVEFK 474
A + F +G G FG V Y K+ D+Q+V +K++ +
Sbjct: 38 AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-------- 89
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
NE R++ + LV+L +V E+MP + L GR + + RF
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPH--ARFYA 147
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ I YLH L +I+RDLK N+L+D + K++DFG A+ + T +
Sbjct: 148 AQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXL 198
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma
pdb|1CM8|B Chain B, Phosphorylated Map Kinase P38-Gamma
Length = 367
Score = 61.2 bits (147), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 55/214 (25%), Positives = 104/214 (48%), Gaps = 43/214 (20%)
Query: 438 LGEGGFGPV---YKGKLADEQEVAIKRLSRSSGQGIVEFK--NEVRLIAKLQHTNLVRLL 492
+G G +G V G+ +VAIK+L R + + E+RL+ ++H N++ LL
Sbjct: 33 VGSGAYGAVCSAVDGRTG--AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 493 GCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNWEK------RFIIIEGI 538
F P+++LD F + ++ EK +F++ + +
Sbjct: 91 DV------------FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML 138
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTY 598
+GL Y+H +IHRDLK N+ +++ KI DFG+AR ++++ V T
Sbjct: 139 -KGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMXGXVVTR 189
Query: 599 GYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6
pdb|3UC4|B Chain B, The Crystal Structure Of Snf1-Related Kinase 2.6
Length = 362
Score = 61.2 bits (147), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 68/227 (29%), Positives = 105/227 (46%), Gaps = 20/227 (8%)
Query: 425 IAAAANNFSTTNKLGEGGFG--PVYKGKLADEQEVAIKRLSRSSGQGIV-EFKNEVRLIA 481
I ++ + +G G FG + + K ++E VA+K + R G+ I K E+
Sbjct: 14 IMHDSDRYELVKDIGSGNFGVARLMRDKQSNEL-VAVKYIER--GEKIAANVKREIINHR 70
Query: 482 KLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQG 541
L+H N+VR L +V E+ L + N+GR + E RF + IS G
Sbjct: 71 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS--EDEARFFFQQLIS-G 127
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNP--KISDFGMARIFEVNESEANTKRIVGTYG 599
+ Y H ++V HRDLK N LLD P KI DFG ++ ++ + K VGT
Sbjct: 128 VSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPA 181
Query: 600 YMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQKNHTRHHPDRPLNL 645
Y++PE + K DV+S GV + ++ G + P+ P N
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGA--YPFEDPEEPKNF 226
>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
pdb|2PY3|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 61.2 bits (147), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 55/225 (24%), Positives = 104/225 (46%), Gaps = 30/225 (13%)
Query: 430 NNFSTTNKLGEGGFGPVY--------KGKLADEQEVAIKRLSR-SSGQGIVEFKNEVRLI 480
+ + LGEG FG V K K + VA+K L ++ + + + +E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 481 AKL-QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFL-------------FNSGRKNVL 526
+ +H N++ LLG ++ + +L +L N + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 527 NWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586
++ +++G+ YL + + IHRDL A N+L+ + KI+DFG+AR ++N
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINN 209
Query: 587 SEANTKRIVGT--YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ K G +M+PE + + ++DV+SFGVL+ EI +
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 437 KLGEGGFGPVYKG--KLADEQEVAIKRLSRSSGQGIV---EFKNEVRLIAKLQHTNLVRL 491
+LG G FG V KG ++ + ++ ++ E E ++ +L + +VR+
Sbjct: 18 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 492 LGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI-IIEGISQGLLYLHKYSR 550
+G E +LV E L+ +L ++N +K I ++ +S G+ YL + +
Sbjct: 78 IGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEESN- 131
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG-----YMSPEY 605
+HRDL A N+LL + KISDFG+++ +E+ + T+G + +PE
Sbjct: 132 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQ----THGKWPVKWYAPEC 185
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVS-GQK 632
S K+DV+SFGVL+ E S GQK
Sbjct: 186 INYYKFSSKSDVWSFGVLMWEAFSYGQK 213
>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 635
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 437 KLGEGGFGPVYKG--KLADEQEVAIKRLSRSSGQGIV---EFKNEVRLIAKLQHTNLVRL 491
+LG G FG V KG ++ + ++ ++ E E ++ +L + +VR+
Sbjct: 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 435
Query: 492 LGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI-IIEGISQGLLYLHKYSR 550
+G E +LV E L+ +L ++N +K I ++ +S G+ YL + +
Sbjct: 436 IGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEESN- 489
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG-----YMSPEY 605
+HRDL A N+LL + KISDFG+++ +E+ + T+G + +PE
Sbjct: 490 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPEC 543
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVS-GQK 632
S K+DV+SFGVL+ E S GQK
Sbjct: 544 INYYKFSSKSDVWSFGVLMWEAFSYGQK 571
>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3
pdb|3G33|C Chain C, Crystal Structure Of Cdk4CYCLIN D3
Length = 308
Score = 60.8 bits (146), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 428 AANNFSTTNKLGEGGFGPVYK------GKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIA 481
A + + ++G G +G VYK G + V + G + EV L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 482 KLQ---HTNLVRLLG-CSLHGEER----LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI 533
+L+ H N+VRL+ C+ +R LV+E + ++ L +L + L E
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 534 IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR 593
++ +GL +LH ++HRDLK NIL+ K++DFG+ARI+ +
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALTP 178
Query: 594 IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEI 627
+V T Y +PE + + D++S G + E+
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212
>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 636
Score = 60.8 bits (146), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 437 KLGEGGFGPVYKG--KLADEQEVAIKRLSRSSGQGIV---EFKNEVRLIAKLQHTNLVRL 491
+LG G FG V KG ++ + ++ ++ E E ++ +L + +VR+
Sbjct: 377 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 436
Query: 492 LGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI-IIEGISQGLLYLHKYSR 550
+G E +LV E L+ +L ++N +K I ++ +S G+ YL + +
Sbjct: 437 IGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEESN- 490
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG-----YMSPEY 605
+HRDL A N+LL + KISDFG+++ +E+ + T+G + +PE
Sbjct: 491 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPEC 544
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVS-GQK 632
S K+DV+SFGVL+ E S GQK
Sbjct: 545 INYYKFSSKSDVWSFGVLMWEAFSYGQK 572
>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3
Length = 361
Score = 60.5 bits (145), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 425 IAAAANNFSTTNKLGEGGFG--PVYKGKLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIA 481
I ++ + +G G FG + + KL E VA+K + R G I E + E+
Sbjct: 15 IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKEL-VAVKYIER--GAAIDENVQREIINHR 71
Query: 482 KLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQG 541
L+H N+VR L ++ E+ L + N+GR + E RF + +S G
Sbjct: 72 SLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFS--EDEARFFFQQLLS-G 128
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNP--KISDFGMARIFEVNESEANTKRIVGTYG 599
+ Y H +++ HRDLK N LLD P KI DFG ++ ++ + K VGT
Sbjct: 129 VSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPA 182
Query: 600 YMSPEYAMSGIVSIK-TDVFSFGVLVLEIVSG 630
Y++PE + K DV+S GV + ++ G
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214
>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2-
Phenylaminopyrimidines As Potent Inhibitors Of Spleen
Tyrosine Kinase (Syk)
Length = 291
Score = 60.5 bits (145), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 437 KLGEGGFGPVYKG--KLADEQEVAIKRLSRSSGQGIV---EFKNEVRLIAKLQHTNLVRL 491
+LG G FG V KG ++ + ++ ++ E E ++ +L + +VR+
Sbjct: 32 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 91
Query: 492 LGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI-IIEGISQGLLYLHKYSR 550
+G E +LV E L+ +L ++N +K I ++ +S G+ YL + +
Sbjct: 92 IGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEESN- 145
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG-----YMSPEY 605
+HRDL A N+LL + KISDFG+++ +E+ + T+G + +PE
Sbjct: 146 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPEC 199
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVS-GQK 632
S K+DV+SFGVL+ E S GQK
Sbjct: 200 INYYKFSSKSDVWSFGVLMWEAFSYGQK 227
>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2-
Phenylcyclopropyl)urea
Length = 293
Score = 60.5 bits (145), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 437 KLGEGGFGPVYKG--KLADEQEVAIKRLSRSSGQGIV---EFKNEVRLIAKLQHTNLVRL 491
+LG G FG V KG ++ + ++ ++ E E ++ +L + +VR+
Sbjct: 34 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 492 LGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI-IIEGISQGLLYLHKYSR 550
+G E +LV E L+ +L ++N +K I ++ +S G+ YL + +
Sbjct: 94 IGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEESN- 147
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG-----YMSPEY 605
+HRDL A N+LL + KISDFG+++ +E+ + T+G + +PE
Sbjct: 148 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPEC 201
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVS-GQK 632
S K+DV+SFGVL+ E S GQK
Sbjct: 202 INYYKFSSKSDVWSFGVLMWEAFSYGQK 229
>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Pyrazolylbenzimidazole Inhibitor 416
pdb|3VF9|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Thienopyrazolylindole Inhibitor 027
pdb|3TUC|A Chain A, Crystal Structure Of Syk Kinase Domain With
1-Benzyl-N-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-2-Oxo-1,
2-Dihydropyridine-3- Carboxamide
pdb|3TUD|A Chain A, Crystal Structure Of Syk Kinase Domain With
N-(4-Methyl-3-(8-Methyl-7-
Oxo-2-(Phenylamino)-7,8-Dihydropyrido[2,
3-D]pyrimidin-6-Yl)phenyl)-3- (Trifluoromethyl)benzamide
Length = 299
Score = 60.5 bits (145), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 437 KLGEGGFGPVYKG--KLADEQEVAIKRLSRSSGQGIV---EFKNEVRLIAKLQHTNLVRL 491
+LG G FG V KG ++ + ++ ++ E E ++ +L + +VR+
Sbjct: 34 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 492 LGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI-IIEGISQGLLYLHKYSR 550
+G E +LV E L+ +L ++N +K I ++ +S G+ YL + +
Sbjct: 94 IGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEESN- 147
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG-----YMSPEY 605
+HRDL A N+LL + KISDFG+++ +E+ + T+G + +PE
Sbjct: 148 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPEC 201
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVS-GQK 632
S K+DV+SFGVL+ E S GQK
Sbjct: 202 INYYKFSSKSDVWSFGVLMWEAFSYGQK 229
>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836
Length = 273
Score = 60.5 bits (145), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 437 KLGEGGFGPVYKG--KLADEQEVAIKRLSRSSGQGIV---EFKNEVRLIAKLQHTNLVRL 491
+LG G FG V KG ++ + ++ ++ E E ++ +L + +VR+
Sbjct: 12 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 71
Query: 492 LGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI-IIEGISQGLLYLHKYSR 550
+G E +LV E L+ +L ++N +K I ++ +S G+ YL + +
Sbjct: 72 IGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEESN- 125
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG-----YMSPEY 605
+HRDL A N+LL + KISDFG+++ +E+ + T+G + +PE
Sbjct: 126 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPEC 179
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVS-GQK 632
S K+DV+SFGVL+ E S GQK
Sbjct: 180 INYYKFSSKSDVWSFGVLMWEAFSYGQK 207
>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 60.5 bits (145), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 437 KLGEGGFGPVYKG--KLADEQEVAIKRLSRSSGQGIV---EFKNEVRLIAKLQHTNLVRL 491
+LG G FG V KG ++ + ++ ++ E E ++ +L + +VR+
Sbjct: 18 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 492 LGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI-IIEGISQGLLYLHKYSR 550
+G E +LV E L+ +L ++N +K I ++ +S G+ YL + +
Sbjct: 78 IGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEESN- 131
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG-----YMSPEY 605
+HRDL A N+LL + KISDFG+++ +E+ + T+G + +PE
Sbjct: 132 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPEC 185
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVS-GQK 632
S K+DV+SFGVL+ E S GQK
Sbjct: 186 INYYKFSSKSDVWSFGVLMWEAFSYGQK 213
>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57
Length = 360
Score = 60.5 bits (145), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 49/204 (24%), Positives = 100/204 (49%), Gaps = 7/204 (3%)
Query: 432 FSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFK-NEVRLIAKLQHTNLV 489
++ + +GEG +G V ++ VAIK++S Q + E++++ + +H N++
Sbjct: 25 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+ + ++ ++ L+ + L+ + + I +GL Y+H +
Sbjct: 85 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN-TKRIVGTYGYMSPEYAMS 608
V+HRDLK SN+LL+ + KI DFG+AR+ + + V T Y +PE ++
Sbjct: 145 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 609 GIVSIKT-DVFSFGVLVLEIVSGQ 631
K+ D++S G ++ E++S +
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNR 225
>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue
pdb|2PMN|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp-Site
Inhibitor
pdb|2PMO|X Chain X, Crystal Structure Of Pfpk7 In Complex With Hymenialdisine
Length = 348
Score = 60.5 bits (145), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 46/162 (28%), Positives = 79/162 (48%), Gaps = 21/162 (12%)
Query: 472 EFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSL-----DFFLFNSGRKNVL 526
+FKNE+++I +++ + G + +E ++YE+M N S+ FF+ + +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 527 NWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586
+ II+ + Y+H + + HRD+K SNIL+D K+SDFG E
Sbjct: 149 PIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFG--------E 198
Query: 587 SEANTKRIV----GTYGYMSPEY--AMSGIVSIKTDVFSFGV 622
SE + + GTY +M PE+ S K D++S G+
Sbjct: 199 SEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGI 240
>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A Sulfonamidopyrazine Piperidine Inhibitor
pdb|4DFN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
An Adamantylpyrazine Inhibitor
Length = 274
Score = 60.5 bits (145), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 437 KLGEGGFGPVYKG--KLADEQEVAIKRLSRSSGQGIV---EFKNEVRLIAKLQHTNLVRL 491
+LG G FG V KG ++ + ++ ++ E E ++ +L + +VR+
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 492 LGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI-IIEGISQGLLYLHKYSR 550
+G E +LV E L+ +L ++N +K I ++ +S G+ YL + +
Sbjct: 74 IGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEESN- 127
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG-----YMSPEY 605
+HRDL A N+LL + KISDFG+++ +E+ + T+G + +PE
Sbjct: 128 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPEC 181
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVS-GQK 632
S K+DV+SFGVL+ E S GQK
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQK 209
>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4FMQ|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 60.1 bits (144), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 49/204 (24%), Positives = 100/204 (49%), Gaps = 7/204 (3%)
Query: 432 FSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFK-NEVRLIAKLQHTNLV 489
++ + +GEG +G V ++ VAIK++S Q + E++++ + +H N++
Sbjct: 27 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 86
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+ + ++ ++ L+ + L+ + + I +GL Y+H +
Sbjct: 87 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 146
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN-TKRIVGTYGYMSPEYAMS 608
V+HRDLK SN+LL+ + KI DFG+AR+ + + V T Y +PE ++
Sbjct: 147 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 609 GIVSIKT-DVFSFGVLVLEIVSGQ 631
K+ D++S G ++ E++S +
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNR 227
>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A
Natural Jnk1 Inhibitor
Length = 379
Score = 60.1 bits (144), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 65/214 (30%), Positives = 97/214 (45%), Gaps = 33/214 (15%)
Query: 432 FSTTNKLGEGGFGPV---YKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ +G G G V Y L E+ VAIK+LSR F+N+ AK + L
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYREL 74
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNV----LNWEKRFIIIE 536
V L+ C H L+ F P KSL+ F L ++ V L+ E+ ++
Sbjct: 75 V-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLY 133
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+ G+ +LH +IHRDLK SNI++ KI DFG+AR S T +V
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPEVVT 188
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y Y +PE + D++S G ++ E++ G
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain
pdb|1XBB|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Gleevec
pdb|1XBC|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Staurosporin
pdb|3FQE|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
Ym193306
pdb|3FQH|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQH|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQS|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
R406
pdb|4FL1|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
pdb|4FYN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
3-(8-{4-
[ethyl-(2-hydroxy-ethyl)-amino]-phenylamino}-imidazo[1,
2-a]pyrazin-5- Yl)-phenol
pdb|4FYO|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
N-{(s)-1-
[7-(3,4-dimethoxy-phenylamino)-thiazolo[5,
4-d]pyrimidin-5-yl]- Pyrrolidin-3-yl}-terephthalamic
Acid
pdb|4FZ6|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
[6-((s)-2-
Methyl-pyrrolidin-1-yl)-pyridin-2-yl]-(6-phenyl-
imidazo[1,2- B]pyridazin-8-yl)-amine
Length = 291
Score = 60.1 bits (144), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 437 KLGEGGFGPVYKG--KLADEQEVAIKRLSRSSGQGIV---EFKNEVRLIAKLQHTNLVRL 491
+LG G FG V KG ++ + ++ ++ E E ++ +L + +VR+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 492 LGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI-IIEGISQGLLYLHKYSR 550
+G E +LV E L+ +L ++N +K I ++ +S G+ YL + +
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEESN- 137
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG-----YMSPEY 605
+HRDL A N+LL + KISDFG+++ +E+ + T+G + +PE
Sbjct: 138 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPEC 191
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVS-GQK 632
S K+DV+SFGVL+ E S GQK
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQK 219
>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With
N,n-dimethyl-4-(4-
Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide
pdb|2OJI|A Chain A, Crystal Structure Of Erk2 In Complex With
N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2OJJ|A Chain A, Crystal Structure Of Erk2 In Complex With (S)-N-(1-(3-
Chloro-4-Fluorophenyl)-2-Hydroxyethyl)-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|3I5Z|A Chain A, Crystal Structure Of Erk2 Bound To
(S)-N-(2-Hydroxy-1-Phenylethyl)-4-
(5-Methyl-2-(Phenylamino)pyrimidin-4-Yl)-1h-Pyrrole-2-
Carboxamide
pdb|3I60|A Chain A, Crystal Structure Of Erk2 Bound To
(s)-4-(2-(2-chlorophenylamino)-5-
Methylpyrimidin-4-yl)-n-(2-hydroxy-1-phenylethyl)-1h-
pyrrole-2- Carboxamide
Length = 380
Score = 60.1 bits (144), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 49/204 (24%), Positives = 100/204 (49%), Gaps = 7/204 (3%)
Query: 432 FSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFK-NEVRLIAKLQHTNLV 489
++ + +GEG +G V ++ VAIK++S Q + E++++ + +H N++
Sbjct: 45 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+ + ++ ++ L+ + L+ + + I +GL Y+H +
Sbjct: 105 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 164
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN-TKRIVGTYGYMSPEYAMS 608
V+HRDLK SN+LL+ + KI DFG+AR+ + + V T Y +PE ++
Sbjct: 165 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 221
Query: 609 GIVSIKT-DVFSFGVLVLEIVSGQ 631
K+ D++S G ++ E++S +
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLSNR 245
>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2
pdb|4AE9|B Chain B, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2
Length = 343
Score = 60.1 bits (144), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 427 AAANNFSTTNKLGEGGFGPV-----------YKGKLADEQEVA-IKRLSRSSGQGIVEFK 474
A + F LG G FG V Y K+ D+Q+V +K++ +
Sbjct: 31 AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL-------- 82
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
NE R++ + LV+L +V E++P + L GR RF
Sbjct: 83 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FXEPHARFYA 140
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ I YLH L +I+RDLK N+L+D + +++DFG A+ + T +
Sbjct: 141 AQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXL 191
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 192 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227
>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75
pdb|4FV1|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek4
pdb|4FV2|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek5
pdb|4FV3|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek6
pdb|4FV4|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek7
pdb|4FV5|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek9
pdb|4FV8|A Chain A, Crystal Structure Of The Erk2 Complexed With E63
pdb|4FV9|A Chain A, Crystal Structure Of The Erk2 Complexed With E71
pdb|4G6N|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 60.1 bits (144), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 49/204 (24%), Positives = 100/204 (49%), Gaps = 7/204 (3%)
Query: 432 FSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFK-NEVRLIAKLQHTNLV 489
++ + +GEG +G V ++ VAIK++S Q + E++++ + +H N++
Sbjct: 25 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+ + ++ ++ L+ + L+ + + I +GL Y+H +
Sbjct: 85 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN-TKRIVGTYGYMSPEYAMS 608
V+HRDLK SN+LL+ + KI DFG+AR+ + + V T Y +PE ++
Sbjct: 145 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 609 GIVSIKT-DVFSFGVLVLEIVSGQ 631
K+ D++S G ++ E++S +
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNR 225
>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A
Pyrazolopyridazine Derivative
pdb|3W55|A Chain A, The Structure Of Erk2 In Complex With Fr148083
Length = 368
Score = 60.1 bits (144), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 49/204 (24%), Positives = 100/204 (49%), Gaps = 7/204 (3%)
Query: 432 FSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFK-NEVRLIAKLQHTNLV 489
++ + +GEG +G V ++ VAIK++S Q + E++++ + +H N++
Sbjct: 33 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 92
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+ + ++ ++ L+ + L+ + + I +GL Y+H +
Sbjct: 93 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 152
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN-TKRIVGTYGYMSPEYAMS 608
V+HRDLK SN+LL+ + KI DFG+AR+ + + V T Y +PE ++
Sbjct: 153 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 209
Query: 609 GIVSIKT-DVFSFGVLVLEIVSGQ 631
K+ D++S G ++ E++S +
Sbjct: 210 SKGYTKSIDIWSVGCILAEMLSNR 233
>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule
Inhibitor
Length = 368
Score = 60.1 bits (144), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 49/204 (24%), Positives = 100/204 (49%), Gaps = 7/204 (3%)
Query: 432 FSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFK-NEVRLIAKLQHTNLV 489
++ + +GEG +G V ++ VAIK++S Q + E++++ + +H N++
Sbjct: 25 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+ + ++ ++ L+ + L+ + + I +GL Y+H +
Sbjct: 85 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN-TKRIVGTYGYMSPEYAMS 608
V+HRDLK SN+LL+ + KI DFG+AR+ + + V T Y +PE ++
Sbjct: 145 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 609 GIVSIKT-DVFSFGVLVLEIVSGQ 631
K+ D++S G ++ E++S +
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNR 225
>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
pdb|2ZOQ|B Chain B, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
Length = 382
Score = 60.1 bits (144), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 49/204 (24%), Positives = 97/204 (47%), Gaps = 7/204 (3%)
Query: 432 FSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFK-NEVRLIAKLQHTNLV 489
++ +GEG +G V + VAIK++S Q + E++++ + +H N++
Sbjct: 45 YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+ + ++ ++ L+ + L+ + + I +GL Y+H +
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSAN 164
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN-TKRIVGTYGYMSPEYAMS 608
V+HRDLK SN+L++ + KI DFG+ARI + V T Y +PE ++
Sbjct: 165 ---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLN 221
Query: 609 GIVSIKT-DVFSFGVLVLEIVSGQ 631
K+ D++S G ++ E++S +
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLSNR 245
>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1
pdb|3FPQ|B Chain B, Crystal Structure Of The Kinase Domain Of Wnk1
Length = 290
Score = 60.1 bits (144), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 33/211 (15%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAI-------KRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
++G G F VYKG L E V + ++L++S Q FK E + LQH N+V
Sbjct: 33 EIGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEXLKGLQHPNIV 88
Query: 490 RLLG---CSLHGEERL-LVYEFMPNKSLDFFL--FNSGRKNVL-NWEKRFIIIEGISQGL 542
R ++ G++ + LV E + +L +L F + VL +W ++ I +GL
Sbjct: 89 RFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQ------ILKGL 142
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNP-KISDFGMARIFEVNESEANTKRIVGTYGYM 601
+LH + +IHRDLK NI + KI D G+A + + ++A ++GT +
Sbjct: 143 QFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFX 197
Query: 602 SPE-YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+PE Y S+ DV++FG LE + +
Sbjct: 198 APEXYEEKYDESV--DVYAFGXCXLEXATSE 226
>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
A- 443654
Length = 351
Score = 59.7 bits (143), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 427 AAANNFSTTNKLGEGGFGPV-----------YKGKLADEQEVA-IKRLSRSSGQGIVEFK 474
A + F LG G FG V Y K+ D+Q+V +K++ +
Sbjct: 39 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-------- 90
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
NE R++ + LV+L +V E++P + L GR RF
Sbjct: 91 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FXEPHARFYA 148
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ I YLH L +I+RDLK N+L+D + +++DFG A+ + T +
Sbjct: 149 AQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXL 199
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map
Kinase Jnk1
Length = 370
Score = 59.7 bits (143), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 65/214 (30%), Positives = 97/214 (45%), Gaps = 33/214 (15%)
Query: 432 FSTTNKLGEGGFGPV---YKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ +G G G V Y L E+ VAIK+LSR F+N+ AK + L
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYREL 74
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNV----LNWEKRFIIIE 536
V L+ C H L+ F P KSL+ F L ++ V L+ E+ ++
Sbjct: 75 V-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLY 133
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+ G+ +LH +IHRDLK SNI++ KI DFG+AR S T +V
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVT 188
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y Y +PE + D++S G ++ E++ G
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 59.7 bits (143), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 65/214 (30%), Positives = 97/214 (45%), Gaps = 33/214 (15%)
Query: 432 FSTTNKLGEGGFGPV---YKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ +G G G V Y L E+ VAIK+LSR F+N+ AK + L
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYREL 74
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNV----LNWEKRFIIIE 536
V L+ C H L+ F P KSL+ F L ++ V L+ E+ ++
Sbjct: 75 V-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLY 133
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+ G+ +LH +IHRDLK SNI++ KI DFG+AR S T +V
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVT 188
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y Y +PE + D++S G ++ E++ G
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 59.7 bits (143), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFK------NEVRL 479
A + F LG G FG V K + A+K L + Q +V+ K NE R+
Sbjct: 38 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKEIEHTLNEKRI 94
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
+ + LV+L +V E+ P + L GR + + RF + I
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH--ARFYAAQ-IV 151
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
YLH L +I+RDLK N+++D + K++DFG+A+ + T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAK-----RVKGRTWXLCGTPE 203
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077)
pdb|1XH4|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|3BWJ|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Lead Compound Arc-1034
pdb|3KKV|A Chain A, Structure Of Pka With A Protein Kinase B-Selective
Inhibitor
Length = 350
Score = 59.7 bits (143), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 427 AAANNFSTTNKLGEGGFGPV-----------YKGKLADEQEVA-IKRLSRSSGQGIVEFK 474
A + F LG G FG V Y K+ D+Q+V +K++ +
Sbjct: 38 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-------- 89
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
NE R++ + LV+L +V E++P + L GR RF
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FXEPHARFYA 147
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ I YLH L +I+RDLK N+L+D + +++DFG A+ + T +
Sbjct: 148 AQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXL 198
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 59.7 bits (143), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 427 AAANNFSTTNKLGEGGFGPV-----------YKGKLADEQEVA-IKRLSRSSGQGIVEFK 474
A + F LG G FG V Y K+ D+Q+V +K++ +
Sbjct: 38 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-------- 89
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
NE R++ + LV+L +V E++P + L GR RF
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FXEPHARFYA 147
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ I YLH L +I+RDLK N+L+D + +++DFG A+ + T +
Sbjct: 148 AQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXL 198
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle
Protein Titin
pdb|1TKI|B Chain B, Autoinhibited Serine Kinase Domain Of The Giant Muscle
Protein Titin
Length = 321
Score = 59.7 bits (143), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 49/195 (25%), Positives = 92/195 (47%), Gaps = 10/195 (5%)
Query: 438 LGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLH 497
LG G FG V++ ++ + + + G V K E+ ++ +H N++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 498 GEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRD 557
EE ++++EF+ LD F + LN + + + + L +LH ++ + H D
Sbjct: 73 MEELVMIFEFISG--LDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFD 127
Query: 558 LKASNILLDDKMNP--KISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKT 615
++ NI+ + + KI +FG AR + + N + + Y +PE +VS T
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 616 DVFSFGVLVLEIVSG 630
D++S G LV ++SG
Sbjct: 185 DMWSLGTLVYVLLSG 199
>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
pdb|3ZUV|C Chain C, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
Length = 364
Score = 59.7 bits (143), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 49/204 (24%), Positives = 100/204 (49%), Gaps = 7/204 (3%)
Query: 432 FSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFK-NEVRLIAKLQHTNLV 489
++ + +GEG +G V ++ VAIK++S Q + E++++ + +H N++
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+ + ++ ++ L+ + L+ + + I +GL Y+H +
Sbjct: 89 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN-TKRIVGTYGYMSPEYAMS 608
V+HRDLK SN+LL+ + KI DFG+AR+ + + V T Y +PE ++
Sbjct: 149 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN 205
Query: 609 GIVSIKT-DVFSFGVLVLEIVSGQ 631
K+ D++S G ++ E++S +
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229
>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2
Length = 365
Score = 59.7 bits (143), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 49/204 (24%), Positives = 100/204 (49%), Gaps = 7/204 (3%)
Query: 432 FSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFK-NEVRLIAKLQHTNLV 489
++ + +GEG +G V ++ VAIK++S Q + E++++ + +H N++
Sbjct: 30 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+ + ++ ++ L+ + L+ + + I +GL Y+H +
Sbjct: 90 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 149
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN-TKRIVGTYGYMSPEYAMS 608
V+HRDLK SN+LL+ + KI DFG+AR+ + + V T Y +PE ++
Sbjct: 150 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN 206
Query: 609 GIVSIKT-DVFSFGVLVLEIVSGQ 631
K+ D++S G ++ E++S +
Sbjct: 207 SKGYTKSIDIWSVGCILAEMLSNR 230
>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Map Kinase Erk2
Length = 365
Score = 59.7 bits (143), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 49/204 (24%), Positives = 100/204 (49%), Gaps = 7/204 (3%)
Query: 432 FSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFK-NEVRLIAKLQHTNLV 489
++ + +GEG +G V ++ VAIK++S Q + E++++ + +H N++
Sbjct: 30 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+ + ++ ++ L+ + L+ + + I +GL Y+H +
Sbjct: 90 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 149
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN-TKRIVGTYGYMSPEYAMS 608
V+HRDLK SN+LL+ + KI DFG+AR+ + + V T Y +PE ++
Sbjct: 150 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 206
Query: 609 GIVSIKT-DVFSFGVLVLEIVSGQ 631
K+ D++S G ++ E++S +
Sbjct: 207 SKGYTKSIDIWSVGCILAEMLSNR 230
>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In
Complex With
(4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin
2-Yl]amino}phenyl)acetic Acid
Length = 366
Score = 59.7 bits (143), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 49/204 (24%), Positives = 100/204 (49%), Gaps = 7/204 (3%)
Query: 432 FSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFK-NEVRLIAKLQHTNLV 489
++ + +GEG +G V ++ VAIK++S Q + E++++ + +H N++
Sbjct: 31 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 90
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+ + ++ ++ L+ + L+ + + I +GL Y+H +
Sbjct: 91 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 150
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN-TKRIVGTYGYMSPEYAMS 608
V+HRDLK SN+LL+ + KI DFG+AR+ + + V T Y +PE ++
Sbjct: 151 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 207
Query: 609 GIVSIKT-DVFSFGVLVLEIVSGQ 631
K+ D++S G ++ E++S +
Sbjct: 208 SKGYTKSIDIWSVGCILAEMLSNR 231
>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
pdb|3C9W|B Chain B, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
Length = 357
Score = 59.7 bits (143), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 49/204 (24%), Positives = 100/204 (49%), Gaps = 7/204 (3%)
Query: 432 FSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFK-NEVRLIAKLQHTNLV 489
++ + +GEG +G V ++ VAIK++S Q + E++++ + +H N++
Sbjct: 22 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 81
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+ + ++ ++ L+ + L+ + + I +GL Y+H +
Sbjct: 82 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 141
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN-TKRIVGTYGYMSPEYAMS 608
V+HRDLK SN+LL+ + KI DFG+AR+ + + V T Y +PE ++
Sbjct: 142 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 198
Query: 609 GIVSIKT-DVFSFGVLVLEIVSGQ 631
K+ D++S G ++ E++S +
Sbjct: 199 SKGYTKSIDIWSVGCILAEMLSNR 222
>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|2FYS|A Chain A, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|1ERK|A Chain A, Structure Of Signal-Regulated Kinase
pdb|3ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2SB220025
pdb|4ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2OLOMOUCINE
pdb|3QYI|A Chain A, Map Kinase Erk2 Complexed With
1,1-Dioxo-2,3-Dihydrothiophen-3-Yl Benzenesulfonate
Length = 364
Score = 59.7 bits (143), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 49/204 (24%), Positives = 100/204 (49%), Gaps = 7/204 (3%)
Query: 432 FSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFK-NEVRLIAKLQHTNLV 489
++ + +GEG +G V ++ VAIK++S Q + E++++ + +H N++
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+ + ++ ++ L+ + L+ + + I +GL Y+H +
Sbjct: 89 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN-TKRIVGTYGYMSPEYAMS 608
V+HRDLK SN+LL+ + KI DFG+AR+ + + V T Y +PE ++
Sbjct: 149 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 609 GIVSIKT-DVFSFGVLVLEIVSGQ 631
K+ D++S G ++ E++S +
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229
>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native
pdb|3MFS|A Chain A, Cask-4m Cam Kinase Domain, Amppnp
pdb|3MFT|A Chain A, Cask-4m Cam Kinase Domain, Mn2+
pdb|3MFU|A Chain A, Cask-4m Cam Kinase Domain, Amppnp-Mn2+
Length = 351
Score = 59.7 bits (143), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 438 LGEGGFGPVYK------GKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRL 491
+G+G F V + G+ + V + + + S G + K E + L+H ++V L
Sbjct: 32 IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 492 LGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEK-RFIIIEGISQGLLYLHKYSR 550
L +V+EFM L F + + E + I + L Y H +
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN- 150
Query: 551 LRVIHRDLKASNILLDDKMNP---KISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
+IHRD+K N+LL K N K+ DFG+A ++ ES VGT +M+PE
Sbjct: 151 --IIHRDVKPENVLLASKENSAPVKLGDFGVA--IQLGESGLVAGGRVGTPHFMAPEVVK 206
Query: 608 SGIVSIKTDVFSFGVLVLEIVSG 630
DV+ GV++ ++SG
Sbjct: 207 REPYGKPVDVWGCGVILFILLSG 229
>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94
pdb|4G6O|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 59.7 bits (143), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 49/204 (24%), Positives = 100/204 (49%), Gaps = 7/204 (3%)
Query: 432 FSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFK-NEVRLIAKLQHTNLV 489
++ + +GEG +G V ++ VAIK++S Q + E++++ + +H N++
Sbjct: 25 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+ + ++ ++ L+ + L+ + + I +GL Y+H +
Sbjct: 85 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN-TKRIVGTYGYMSPEYAMS 608
V+HRDLK SN+LL+ + KI DFG+AR+ + + V T Y +PE ++
Sbjct: 145 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 609 GIVSIKT-DVFSFGVLVLEIVSGQ 631
K+ D++S G ++ E++S +
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNR 225
>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein
Kinase A (Pka)
pdb|1SZM|B Chain B, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein
Kinase A (Pka)
Length = 350
Score = 59.7 bits (143), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 31/216 (14%)
Query: 427 AAANNFSTTNKLGEGGFGPV-----------YKGKLADEQEVA-IKRLSRSSGQGIVEFK 474
A + F LG G FG V Y K+ D+Q+V +K++ +
Sbjct: 38 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-------- 89
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
NE R++ + LV+L +V E+ P + L GR RF
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR--FXEPHARFYA 147
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ I YLH L +I+RDLK N+++D + K++DFG A+ + T +
Sbjct: 148 AQ-IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXL 198
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX
Length = 358
Score = 59.7 bits (143), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 49/204 (24%), Positives = 100/204 (49%), Gaps = 7/204 (3%)
Query: 432 FSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFK-NEVRLIAKLQHTNLV 489
++ + +GEG +G V ++ VAIK++S Q + E++++ + +H N++
Sbjct: 23 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+ + ++ ++ L+ + L+ + + I +GL Y+H +
Sbjct: 83 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 142
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN-TKRIVGTYGYMSPEYAMS 608
V+HRDLK SN+LL+ + KI DFG+AR+ + + V T Y +PE ++
Sbjct: 143 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 199
Query: 609 GIVSIKT-DVFSFGVLVLEIVSGQ 631
K+ D++S G ++ E++S +
Sbjct: 200 SKGYTKSIDIWSVGCILAEMLSNR 223
>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632
pdb|2GNL|A Chain A, Pka Threefold Mutant Model Of Rho-Kinase With Inhibitor H-
1152p
Length = 350
Score = 59.7 bits (143), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 427 AAANNFSTTNKLGEGGFGPV-----------YKGKLADEQEVA-IKRLSRSSGQGIVEFK 474
A + F +G G FG V Y K+ D+Q+V +K++ +
Sbjct: 38 AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-------- 89
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
NE R++ + LV+L +V E++P + L GR + + RF
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYA 147
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ I YLH L +I+RDLK N+L+D + K++DFG A+ + T +
Sbjct: 148 AQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXL 198
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e)
Length = 358
Score = 59.7 bits (143), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 49/204 (24%), Positives = 100/204 (49%), Gaps = 7/204 (3%)
Query: 432 FSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFK-NEVRLIAKLQHTNLV 489
++ + +GEG +G V ++ VAIK++S Q + E++++ + +H N++
Sbjct: 23 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+ + ++ ++ L+ + L+ + + I +GL Y+H +
Sbjct: 83 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 142
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN-TKRIVGTYGYMSPEYAMS 608
V+HRDLK SN+LL+ + KI DFG+AR+ + + V T Y +PE ++
Sbjct: 143 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 199
Query: 609 GIVSIKT-DVFSFGVLVLEIVSGQ 631
K+ D++S G ++ E++S +
Sbjct: 200 SKGYTKSIDIWSVGCILAEMLSNR 223
>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|3QYZ|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|4GT3|A Chain A, Atp-Bound Form Of The Erk2 Kinase
pdb|4GVA|A Chain A, Adp-Bound Form Of The Erk2 Kinase
Length = 364
Score = 59.3 bits (142), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 49/204 (24%), Positives = 100/204 (49%), Gaps = 7/204 (3%)
Query: 432 FSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFK-NEVRLIAKLQHTNLV 489
++ + +GEG +G V ++ VAIK++S Q + E++++ + +H N++
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+ + ++ ++ L+ + L+ + + I +GL Y+H +
Sbjct: 89 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN-TKRIVGTYGYMSPEYAMS 608
V+HRDLK SN+LL+ + KI DFG+AR+ + + V T Y +PE ++
Sbjct: 149 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 609 GIVSIKT-DVFSFGVLVLEIVSGQ 631
K+ D++S G ++ E++S +
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229
>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex
With Gold
pdb|3ZUU|B Chain B, The Structure Of Ost1 (D160a, S175d) Kinase In Complex
With Gold
Length = 362
Score = 59.3 bits (142), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 68/227 (29%), Positives = 105/227 (46%), Gaps = 20/227 (8%)
Query: 425 IAAAANNFSTTNKLGEGGFG--PVYKGKLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIA 481
I ++ + +G G FG + + K ++E VA+K + R G+ I E K E+
Sbjct: 14 IMHDSDRYELVKDIGSGNFGVARLMRDKQSNEL-VAVKYIER--GEKIDENVKREIINHR 70
Query: 482 KLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQG 541
L+H N+VR L +V E+ L + N+GR + E RF + IS G
Sbjct: 71 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS--EDEARFFFQQLIS-G 127
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNP--KISDFGMARIFEVNESEANTKRIVGTYG 599
+ Y H ++V HRDLK N LLD P KI FG ++ ++ +T VGT
Sbjct: 128 VSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDT---VGTPA 181
Query: 600 YMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQKNHTRHHPDRPLNL 645
Y++PE + K DV+S GV + ++ G + P+ P N
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGA--YPFEDPEEPKNF 226
>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
pdb|1S9I|B Chain B, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
Length = 354
Score = 59.3 bits (142), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 52/204 (25%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIV--EFKNEVRLIAKLQHTN 487
++F ++LG G G V K + + ++L + + + E++++ +
Sbjct: 16 DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
+V G E + E M SLD L + R + E + + +GL YL +
Sbjct: 76 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR---IPEEILGKVSIAVLRGLAYLRE 132
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
+ +++HRD+K SNIL++ + K+ DFG++ ++ +S AN+ VGT YM+PE
Sbjct: 133 --KHQIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYMAPERLQ 186
Query: 608 SGIVSIKTDVFSFGVLVLEIVSGQ 631
S+++D++S G+ ++E+ G+
Sbjct: 187 GTHYSVQSDIWSMGLSLVELAVGR 210
>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
pdb|4AE6|B Chain B, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
Length = 343
Score = 59.3 bits (142), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 427 AAANNFSTTNKLGEGGFGPV-----------YKGKLADEQEVA-IKRLSRSSGQGIVEFK 474
A + F LG G FG V Y K+ D+Q+V +K++ +
Sbjct: 31 AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL-------- 82
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
NE R++ + LV+L +V E++P + L GR + + RF
Sbjct: 83 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYA 140
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ I YLH L +I+RDLK N+L+D + +++DFG A+ + T +
Sbjct: 141 AQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXL 191
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 192 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227
>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|B Chain B, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|C Chain C, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|D Chain D, Structure Of Human Phosphorylase Kinase, Gamma 2
Length = 365
Score = 59.3 bits (142), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 47/183 (25%), Positives = 90/183 (49%), Gaps = 17/183 (9%)
Query: 456 EVAIKRLSRSSGQGIVEF-KNEVRLIAKLQ-HTNLVRLLGCSLHGEERLLVYEFMPNKSL 513
EV +RLS + + E + E ++ ++ H +++ L+ LV++ M L
Sbjct: 128 EVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL 187
Query: 514 DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKI 573
+L K L+ ++ I+ + + + +LH + ++HRDLK NILLDD M ++
Sbjct: 188 FDYL---TEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL 241
Query: 574 SDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI------KTDVFSFGVLVLEI 627
SDFG + E E + + GT GY++PE + + D+++ GV++ +
Sbjct: 242 SDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTL 298
Query: 628 VSG 630
++G
Sbjct: 299 LAG 301
>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
pdb|1UKI|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
Length = 369
Score = 59.3 bits (142), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 65/214 (30%), Positives = 97/214 (45%), Gaps = 33/214 (15%)
Query: 432 FSTTNKLGEGGFGPV---YKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ +G G G V Y L E+ VAIK+LSR F+N+ AK + L
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYREL 74
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNV----LNWEKRFIIIE 536
V L+ C H L+ F P KSL+ F L ++ V L+ E+ ++
Sbjct: 75 V-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLY 133
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+ G+ +LH +IHRDLK SNI++ KI DFG+AR S T +V
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVT 188
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y Y +PE + D++S G ++ E++ G
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 371
Score = 59.3 bits (142), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 65/214 (30%), Positives = 97/214 (45%), Gaps = 33/214 (15%)
Query: 432 FSTTNKLGEGGFGPV---YKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ +G G G V Y L E+ VAIK+LSR F+N+ AK + L
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYREL 75
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNV----LNWEKRFIIIE 536
V L+ C H L+ F P KSL+ F L ++ V L+ E+ ++
Sbjct: 76 V-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLY 134
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+ G+ +LH +IHRDLK SNI++ KI DFG+AR S T +V
Sbjct: 135 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVT 189
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y Y +PE + D++S G ++ E++ G
Sbjct: 190 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222
>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1
Reveals A Novel Autoinhibitory Conformation For A Dual
Kinase Protein
Length = 355
Score = 59.3 bits (142), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 62/237 (26%), Positives = 109/237 (45%), Gaps = 30/237 (12%)
Query: 412 SISHELKIFDFQTIA--AAANNFSTTNKLGEGGFGPVY---------KGKLADEQEVAIK 460
++ HEL+ + A NF LG G +G V+ GKL A+K
Sbjct: 34 TVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKL-----YAMK 88
Query: 461 RLSRSS----GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDF 515
L +++ + + E +++ ++ + + L + E +L L+ +++ L
Sbjct: 89 VLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL-- 146
Query: 516 FLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISD 575
F S R+ E + + E I L +LHK L +I+RD+K NILLD + ++D
Sbjct: 147 FTHLSQRERFTEHEVQIYVGE-IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTD 202
Query: 576 FGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIV--SIKTDVFSFGVLVLEIVSG 630
FG+++ F +E+E GT YM+P+ G D +S GVL+ E+++G
Sbjct: 203 FGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258
>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors
pdb|2UZU|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
pdb|2UZV|A Chain A, Pka Structures Of Indazole-pyridine Series Of Akt
Inhibitors
pdb|2UZW|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
Length = 336
Score = 59.3 bits (142), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 31/216 (14%)
Query: 427 AAANNFSTTNKLGEGGFGPV-----------YKGKLADEQEVA-IKRLSRSSGQGIVEFK 474
A + F LG G FG V Y K+ D+Q+V +K++ +
Sbjct: 24 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-------- 75
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
NE R++ + LV+L +V E++P + L GR + RF
Sbjct: 76 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARFYA 133
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ I YLH L +I+RDLK N+L+D + +++DFG A+ + T +
Sbjct: 134 AQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTL 184
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 185 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 220
>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol
pdb|4FUY|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek2
pdb|4FV0|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek3
Length = 360
Score = 59.3 bits (142), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 49/204 (24%), Positives = 100/204 (49%), Gaps = 7/204 (3%)
Query: 432 FSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFK-NEVRLIAKLQHTNLV 489
++ + +GEG +G V ++ VAIK++S Q + E++++ + +H N++
Sbjct: 25 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+ + ++ ++ L+ + L+ + + I +GL Y+H +
Sbjct: 85 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN-TKRIVGTYGYMSPEYAMS 608
V+HRDLK SN+LL+ + KI DFG+AR+ + + V T Y +PE ++
Sbjct: 145 ---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 609 GIVSIKT-DVFSFGVLVLEIVSGQ 631
K+ D++S G ++ E++S +
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNR 225
>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate
Peptide And Inhibitor
pdb|3CQW|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate
Peptide And Inhibitor
pdb|3MV5|A Chain A, Crystal Structure Of Akt-1-Inhibitor Complexes
pdb|3MVH|A Chain A, Crystal Structure Of Akt-1-Inhibitor Complexes
Length = 342
Score = 59.3 bits (142), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 29/215 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
N F LG+G FG V + +K + + K EV ++AK + + +
Sbjct: 10 NEFEYLKLLGKGTFGKV----------ILVKEKATGRYYAMKILKKEV-IVAKDEVAHTL 58
Query: 490 ---RLLGCSLHGEERLLVYEFMPNKSLDFFL---------FNSGRKNVLNWEK-RFIIIE 536
R+L S H L Y F + L F + F+ R+ V + ++ RF E
Sbjct: 59 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 118
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+S L YLH S V++RDLK N++LD + KI+DFG+ + E + A K G
Sbjct: 119 IVS-ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCG 173
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
T Y++PE D + GV++ E++ G+
Sbjct: 174 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208
>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
pdb|3OZ6|B Chain B, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
Length = 388
Score = 59.3 bits (142), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 61/227 (26%), Positives = 107/227 (47%), Gaps = 36/227 (15%)
Query: 432 FSTTNKLGEGGFGPVYKGKLADEQEV-AIKRLS---RSSGQGIVEFKNEVRLIAKLQ-HT 486
+ KLG+G +G V+K EV A+K++ ++S F+ E+ ++ +L H
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHE 69
Query: 487 NLVRLLGCSLHGEER--LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
N+V LL +R LV+++M L R N+L + ++ + + + Y
Sbjct: 70 NIVNLLNVLRADNDRDVYLVFDYMETD-----LHAVIRANILEPVHKQYVVYQLIKVIKY 124
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF------------EVNESEAN-- 590
LH ++HRD+K SNILL+ + + K++DFG++R F +NE+ N
Sbjct: 125 LHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 591 -----TKRIVGTYGYMSPEYAMSGIVSIK-TDVFSFGVLVLEIVSGQ 631
V T Y +PE + K D++S G ++ EI+ G+
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
pdb|1CDK|B Chain B, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
Length = 350
Score = 59.3 bits (142), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVEFK------NEVRL 479
A + F LG G FG V K + A+K L + Q +V+ K NE R+
Sbjct: 38 AHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
+ + LV+L +V E++P + L GR + + RF + I
Sbjct: 95 LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQ-IV 151
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
YLH L +I+RDLK N+L+D + +++DFG A+ + T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPE 203
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-670
pdb|3L9L|A Chain A, Crystal Structure Of Pka With Compound 36
pdb|3L9L|B Chain B, Crystal Structure Of Pka With Compound 36
pdb|3OOG|A Chain A, Human Camp-Dependent Protein Kinase In Complex With A
Small Fragment
pdb|3OVV|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OWP|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OXT|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3P0M|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3POO|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
Length = 351
Score = 59.3 bits (142), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 427 AAANNFSTTNKLGEGGFGPV-----------YKGKLADEQEVA-IKRLSRSSGQGIVEFK 474
A + F LG G FG V Y K+ D+Q+V +K++ +
Sbjct: 39 AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL-------- 90
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
NE R++ + LV+L +V E++P + L GR + + RF
Sbjct: 91 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYA 148
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ I YLH L +I+RDLK N+L+D + +++DFG A+ + T +
Sbjct: 149 AQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXL 199
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3AGL|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3VQH|A Chain A, Bromine Sad Partially Resolves Multiple Binding Modes For
Pka Inhibitor H-89
Length = 351
Score = 59.3 bits (142), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 427 AAANNFSTTNKLGEGGFGPV-----------YKGKLADEQEVA-IKRLSRSSGQGIVEFK 474
A + F LG G FG V Y K+ D+Q+V +K++ +
Sbjct: 39 AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL-------- 90
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
NE R++ + LV+L +V E++P + L GR + + RF
Sbjct: 91 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYA 148
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ I YLH L +I+RDLK N+L+D + +++DFG A+ + T +
Sbjct: 149 AQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXL 199
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor
pdb|3OCB|B Chain B, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor
pdb|3OW4|A Chain A, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|3OW4|B Chain B, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|3QKK|A Chain A, Spirochromane Akt Inhibitors
pdb|3QKL|A Chain A, Spirochromane Akt Inhibitors
pdb|3QKM|A Chain A, Spirocyclic Sulfonamides As Akt Inhibitors
pdb|4EKK|A Chain A, Akt1 With Amp-Pnp
pdb|4EKK|B Chain B, Akt1 With Amp-Pnp
pdb|4EKL|A Chain A, Akt1 With Gdc0068
Length = 341
Score = 59.3 bits (142), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 29/215 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
N F LG+G FG V + +K + + K EV ++AK + + +
Sbjct: 9 NEFEYLKLLGKGTFGKV----------ILVKEKATGRYYAMKILKKEV-IVAKDEVAHTL 57
Query: 490 ---RLLGCSLHGEERLLVYEFMPNKSLDFFL---------FNSGRKNVLNWEK-RFIIIE 536
R+L S H L Y F + L F + F+ R+ V + ++ RF E
Sbjct: 58 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 117
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+S L YLH S V++RDLK N++LD + KI+DFG+ + E + A K G
Sbjct: 118 IVS-ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCG 172
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
T Y++PE D + GV++ E++ G+
Sbjct: 173 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207
>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|D Chain D, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 59.3 bits (142), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 49/204 (24%), Positives = 99/204 (48%), Gaps = 7/204 (3%)
Query: 432 FSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFK-NEVRLIAKLQHTNLV 489
++ + +GEG +G V ++ VAIK++S Q + E++++ +H N++
Sbjct: 27 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+ + ++ ++ L+ + L+ + + I +GL Y+H +
Sbjct: 87 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 146
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN-TKRIVGTYGYMSPEYAMS 608
V+HRDLK SN+LL+ + KI DFG+AR+ + + V T Y +PE ++
Sbjct: 147 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 609 GIVSIKT-DVFSFGVLVLEIVSGQ 631
K+ D++S G ++ E++S +
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNR 227
>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex
With N-(4-
(5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h-
Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide
Length = 446
Score = 59.3 bits (142), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 29/215 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
N F LG+G FG V + +K + + K EV ++AK + + +
Sbjct: 148 NEFEYLKLLGKGTFGKV----------ILVKEKATGRYYAMKILKKEV-IVAKDEVAHTL 196
Query: 490 ---RLLGCSLHGEERLLVYEFMPNKSLDFFL---------FNSGRKNVLNWEK-RFIIIE 536
R+L S H L Y F + L F + F+ R+ V + ++ RF E
Sbjct: 197 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 256
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+S L YLH S V++RDLK N++LD + KI+DFG+ + E + A K G
Sbjct: 257 IVS-ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCG 311
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
T Y++PE D + GV++ E++ G+
Sbjct: 312 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric
Inhibitor
Length = 446
Score = 59.3 bits (142), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 29/215 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
N F LG+G FG V + +K + + K EV ++AK + + +
Sbjct: 151 NEFEYLKLLGKGTFGKV----------ILVKEKATGRYYAMKILKKEV-IVAKDEVAHTL 199
Query: 490 ---RLLGCSLHGEERLLVYEFMPNKSLDFFL---------FNSGRKNVLNWEK-RFIIIE 536
R+L S H L Y F + L F + F+ R+ V + ++ RF E
Sbjct: 200 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 259
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+S L YLH S V++RDLK N++LD + KI+DFG+ + E + A K G
Sbjct: 260 IVS-ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCG 314
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
T Y++PE D + GV++ E++ G+
Sbjct: 315 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349
>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl)amide
pdb|2C1B|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
(4r,2s)-5'-(4-(4-Chlorobenzyloxy)pyrrolidin-2-
Ylmethanesulfonyl)isoquinoline
pdb|2VO7|A Chain A, Structure Of Pka Complexed With 4-(4-Chlorobenzyl)-1-(7h-
Pyrrolo(2,3-D)pyrimidin-4-Yl)piperidin-4-Ylamine
pdb|3AG9|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
pdb|3AG9|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
Length = 351
Score = 59.3 bits (142), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 427 AAANNFSTTNKLGEGGFGPV-----------YKGKLADEQEVA-IKRLSRSSGQGIVEFK 474
A + F LG G FG V Y K+ D+Q+V +K++ +
Sbjct: 39 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-------- 90
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
NE R++ + LV+L +V E++P + L GR + + RF
Sbjct: 91 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYA 148
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ I YLH L +I+RDLK N+L+D + +++DFG A+ + T +
Sbjct: 149 AQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXL 199
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol
Length = 351
Score = 59.3 bits (142), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 427 AAANNFSTTNKLGEGGFGPV-----------YKGKLADEQEVA-IKRLSRSSGQGIVEFK 474
A + F LG G FG V Y K+ D+Q+V +K++ +
Sbjct: 39 AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL-------- 90
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
NE R++ + LV+L +V E++P + L GR + + RF
Sbjct: 91 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYA 148
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ I YLH L +I+RDLK N+L+D + +++DFG A+ + T +
Sbjct: 149 AQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXL 199
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In
Complex With Staurosporine
pdb|1Q8T|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase
(Pka) In Complex With Rho-Kinase Inhibitor Y-27632
pdb|1Q8U|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor H-1152p
pdb|1SVE|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 1
pdb|1SVG|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 4
pdb|1VEB|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 5
pdb|3E8C|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|C Chain C, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|D Chain D, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|F Chain F, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8E|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|I Chain I, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|L Chain L, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|P Chain P, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
Length = 350
Score = 59.3 bits (142), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 427 AAANNFSTTNKLGEGGFGPV-----------YKGKLADEQEVA-IKRLSRSSGQGIVEFK 474
A + F LG G FG V Y K+ D+Q+V +K++ +
Sbjct: 38 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-------- 89
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
NE R++ + LV+L +V E++P + L GR + + RF
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYA 147
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ I YLH L +I+RDLK N+L+D + +++DFG A+ + T +
Sbjct: 148 AQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXL 198
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 8
pdb|1XH5|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH6|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH8|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|2GFC|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 59.3 bits (142), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 427 AAANNFSTTNKLGEGGFGPV-----------YKGKLADEQEVA-IKRLSRSSGQGIVEFK 474
A + F LG G FG V Y K+ D+Q+V +K++ +
Sbjct: 38 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-------- 89
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
NE R++ + LV+L +V E++P + L GR + + RF
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYA 147
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ I YLH L +I+RDLK N+L+D + +++DFG A+ + T +
Sbjct: 148 AQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXL 198
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
pdb|3DNE|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 59.3 bits (142), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 427 AAANNFSTTNKLGEGGFGPV-----------YKGKLADEQEVA-IKRLSRSSGQGIVEFK 474
A + F LG G FG V Y K+ D+Q+V +K++ +
Sbjct: 38 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-------- 89
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
NE R++ + LV+L +V E++P + L GR + + RF
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYA 147
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ I YLH L +I+RDLK N+L+D + +++DFG A+ + T +
Sbjct: 148 AQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXL 198
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of
Camp-Dependent Protein Kinase And An Inhibitor Peptide
Displays An Open Conformation
Length = 350
Score = 59.3 bits (142), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVEFK------NEVRL 479
A + F LG G FG V K + A+K L + Q +V+ K NE R+
Sbjct: 38 AHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
+ + LV+L +V E++P + L GR + + RF + I
Sbjct: 95 LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQ-IV 151
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
YLH L +I+RDLK N+L+D + +++DFG A+ + T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPE 203
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 18
pdb|3L9M|B Chain B, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 18
pdb|3L9N|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 27
Length = 351
Score = 59.3 bits (142), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 31/216 (14%)
Query: 427 AAANNFSTTNKLGEGGFGPV-----------YKGKLADEQEVA-IKRLSRSSGQGIVEFK 474
A + F LG G FG V Y K+ D+Q+V +K++ +
Sbjct: 39 AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL-------- 90
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
NE R++ + LV+L +V E+ P + L GR + + RF
Sbjct: 91 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH--ARFYA 148
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ I YLH L +I+RDLK N+++D + K++DFG A+ + T +
Sbjct: 149 AQ-IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXL 199
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit
Of Camp- Dependent Protein Kinase Reveal Open And Closed
Conformations
Length = 350
Score = 59.3 bits (142), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVEFK------NEVRL 479
A + F LG G FG V K + A+K L + Q +V+ K NE R+
Sbjct: 38 AHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
+ + LV+L +V E++P + L GR + + RF + I
Sbjct: 95 LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQ-IV 151
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
YLH L +I+RDLK N+L+D + +++DFG A+ + T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPE 203
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase
pdb|3ZUT|B Chain B, The Structure Of Ost1 (D160a) Kinase
Length = 362
Score = 59.3 bits (142), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 68/227 (29%), Positives = 105/227 (46%), Gaps = 20/227 (8%)
Query: 425 IAAAANNFSTTNKLGEGGFG--PVYKGKLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIA 481
I ++ + +G G FG + + K ++E VA+K + R G+ I E K E+
Sbjct: 14 IMHDSDRYELVKDIGSGNFGVARLMRDKQSNEL-VAVKYIER--GEKIDENVKREIINHR 70
Query: 482 KLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQG 541
L+H N+VR L +V E+ L + N+GR + E RF + IS G
Sbjct: 71 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS--EDEARFFFQQLIS-G 127
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNP--KISDFGMARIFEVNESEANTKRIVGTYG 599
+ Y H ++V HRDLK N LLD P KI FG ++ ++ + K VGT
Sbjct: 128 VSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLH---SQPKSTVGTPA 181
Query: 600 YMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQKNHTRHHPDRPLNL 645
Y++PE + K DV+S GV + ++ G + P+ P N
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGA--YPFEDPEEPKNF 226
>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 59.3 bits (142), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 65/214 (30%), Positives = 97/214 (45%), Gaps = 33/214 (15%)
Query: 432 FSTTNKLGEGGFGPV---YKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ +G G G V Y L E+ VAIK+LSR F+N+ AK + L
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYREL 74
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNV----LNWEKRFIIIE 536
V L+ C H L+ F P KSL+ F L ++ V L+ E+ ++
Sbjct: 75 V-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLY 133
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+ G+ +LH +IHRDLK SNI++ KI DFG+AR S T +V
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVT 188
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y Y +PE + D++S G ++ E++ G
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2
Length = 364
Score = 59.3 bits (142), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 49/204 (24%), Positives = 100/204 (49%), Gaps = 7/204 (3%)
Query: 432 FSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFK-NEVRLIAKLQHTNLV 489
++ + +GEG +G V ++ VAIK++S Q + E++++ + +H N++
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+ + ++ ++ L+ + L+ + + I +GL Y+H +
Sbjct: 89 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN-TKRIVGTYGYMSPEYAMS 608
V+HRDLK SN+LL+ + KI DFG+AR+ + + V T Y +PE ++
Sbjct: 149 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 609 GIVSIKT-DVFSFGVLVLEIVSGQ 631
K+ D++S G ++ E++S +
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229
>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb
Length = 350
Score = 58.9 bits (141), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 31/216 (14%)
Query: 427 AAANNFSTTNKLGEGGFGPV-----------YKGKLADEQEVA-IKRLSRSSGQGIVEFK 474
A + F LG G FG V Y K+ D+Q+V +K++ +
Sbjct: 38 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-------- 89
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
NE R++ + LV+L +V E+ P + L GR + + RF
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH--ARFYA 147
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ I YLH L +I+RDLK N+++D + K++DFG A+ + T +
Sbjct: 148 AQ-IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXL 198
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Back Pocket Binder
Length = 368
Score = 58.9 bits (141), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 37/107 (34%), Positives = 56/107 (52%), Gaps = 3/107 (2%)
Query: 523 KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582
K+ L E +++G+ +L + + IHRDL A NILL +K KI DFG+AR
Sbjct: 194 KDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 250
Query: 583 EVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ +M+PE + +I++DV+SFGVL+ EI S
Sbjct: 251 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297
>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363
Length = 340
Score = 58.9 bits (141), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 29/215 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
N F LG+G FG V + +K + + K EV ++AK + + +
Sbjct: 8 NEFEYLKLLGKGTFGKV----------ILVKEKATGRYYAMKILKKEV-IVAKDEVAHTL 56
Query: 490 ---RLLGCSLHGEERLLVYEFMPNKSLDFFL---------FNSGRKNVLNWEK-RFIIIE 536
R+L S H L Y F + L F + F+ R+ V + ++ RF E
Sbjct: 57 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 116
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+S L YLH S V++RDLK N++LD + KI+DFG+ + E + A K G
Sbjct: 117 IVS-ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCG 171
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
T Y++PE D + GV++ E++ G+
Sbjct: 172 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206
>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|B Chain B, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|E Chain E, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
Length = 371
Score = 58.9 bits (141), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 31/216 (14%)
Query: 427 AAANNFSTTNKLGEGGFGPV-----------YKGKLADEQEVA-IKRLSRSSGQGIVEFK 474
A + F LG G FG V Y K+ D+Q+V +K++ +
Sbjct: 59 AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL-------- 110
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
NE R++ + LV+L +V E++P + L GR + RF
Sbjct: 111 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARFYA 168
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ I YLH L +I+RDLK N+L+D + +++DFG A+ + T +
Sbjct: 169 AQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXL 219
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 220 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255
>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2
Length = 364
Score = 58.9 bits (141), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 49/204 (24%), Positives = 100/204 (49%), Gaps = 7/204 (3%)
Query: 432 FSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFK-NEVRLIAKLQHTNLV 489
++ + +GEG +G V ++ VAIK++S Q + E++++ + +H N++
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENII 88
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+ + ++ ++ L+ + L+ + + I +GL Y+H +
Sbjct: 89 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN-TKRIVGTYGYMSPEYAMS 608
V+HRDLK SN+LL+ + KI DFG+AR+ + + V T Y +PE ++
Sbjct: 149 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 609 GIVSIKT-DVFSFGVLVLEIVSGQ 631
K+ D++S G ++ E++S +
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229
>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A
Novel Pyrrolopyrimidine Inhibitor
Length = 359
Score = 58.9 bits (141), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 37/107 (34%), Positives = 56/107 (52%), Gaps = 3/107 (2%)
Query: 523 KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582
K+ L E +++G+ +L + + IHRDL A NILL +K KI DFG+AR
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 243
Query: 583 EVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ +M+PE + +I++DV+SFGVL+ EI S
Sbjct: 244 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
pdb|1Y6B|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
Length = 366
Score = 58.9 bits (141), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 37/107 (34%), Positives = 56/107 (52%), Gaps = 3/107 (2%)
Query: 523 KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582
K+ L E +++G+ +L + + IHRDL A NILL +K KI DFG+AR
Sbjct: 192 KDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 248
Query: 583 EVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ +M+PE + +I++DV+SFGVL+ EI S
Sbjct: 249 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295
>pdb|2F7E|E Chain E, Pka Complexed With
(S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6-
Yl-Pyridin-3-Yloxymethyl-Etylamine
pdb|2F7X|E Chain E, Protein Kinase A Bound To
(s)-2-(1h-indol-3-yl)-1-[5-((e)-2-
Pyridin-4-yl-vinyl)-pyridin-3-yloxymethyl]-ethylamine
pdb|2F7Z|E Chain E, Protein Kinase A Bound To
(R)-1-(1h-Indol-3-Ylmethyl)-2-(2-
Pyridin-4-Yl-[1,7]naphtyridin-5-Yloxy)-Ehylamine
pdb|2OH0|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
pdb|2OJF|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
Length = 351
Score = 58.9 bits (141), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFK------NEVRL 479
A + F LG G FG V K + A+K L + Q +V+ K NE R+
Sbjct: 39 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 95
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
+ + LV+L +V E++P + L GR + + RF + I
Sbjct: 96 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQ-IV 152
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
YLH L +I+RDLK N+L+D + +++DFG A+ + T + GT
Sbjct: 153 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPE 204
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With
Compound A
Length = 356
Score = 58.9 bits (141), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 37/107 (34%), Positives = 56/107 (52%), Gaps = 3/107 (2%)
Query: 523 KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582
K+ L E +++G+ +L + + IHRDL A NILL +K KI DFG+AR
Sbjct: 185 KDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 241
Query: 583 EVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ +M+PE + +I++DV+SFGVL+ EI S
Sbjct: 242 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288
>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain
pdb|2F2U|B Chain B, Crystal Structure Of The Rho-Kinase Kinase Domain
pdb|2H9V|A Chain A, Structural Basis For Induced-Fit Binding Of Rho-Kinase To
The Inhibitor Y27632
Length = 402
Score = 58.9 bits (141), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 65/238 (27%), Positives = 106/238 (44%), Gaps = 19/238 (7%)
Query: 404 RKSPEKDQSISHELKIFD-FQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEV-AIKR 461
RK+ D ++ KI + + A ++ +G G FG V + Q+V A+K
Sbjct: 48 RKNKNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKL 107
Query: 462 LSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLF 518
LS+ + F E R I ++ V L C+ ++ L +V E+MP L +
Sbjct: 108 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS 167
Query: 519 NSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGM 578
N W K + ++ +L L + +IHRD+K N+LLD + K++DFG
Sbjct: 168 NYDVPE--KWAKFYT-----AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGT 220
Query: 579 A-RIFEVNESEANTKRIVGTYGYMSPEYAMS----GIVSIKTDVFSFGVLVLEIVSGQ 631
++ E +T VGT Y+SPE S G + D +S GV + E++ G
Sbjct: 221 CMKMDETGMVHCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGD 276
>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase,
Kinase: An Active Protein Kinase Complexed With
Nucleotide, Substrate-Analogue And Product
Length = 298
Score = 58.9 bits (141), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 46/163 (28%), Positives = 81/163 (49%), Gaps = 16/163 (9%)
Query: 475 NEVRLIAKLQ-HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI 533
EV ++ K+ H N+++L LV++ M L +L K L+ ++
Sbjct: 72 KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRK 128
Query: 534 IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR 593
I+ + + + LHK L ++HRDLK NILLDD MN K++DFG + + E +
Sbjct: 129 IMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLRE 182
Query: 594 IVGTYGYMSPEYAMSGI------VSIKTDVFSFGVLVLEIVSG 630
+ GT Y++PE + + D++S GV++ +++G
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide
Substrate Complex: Kinase Substrate Recognition
Length = 277
Score = 58.9 bits (141), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 46/163 (28%), Positives = 81/163 (49%), Gaps = 16/163 (9%)
Query: 475 NEVRLIAKLQ-HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI 533
EV ++ K+ H N+++L LV++ M L +L K L+ ++
Sbjct: 59 KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRK 115
Query: 534 IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR 593
I+ + + + LHK L ++HRDLK NILLDD MN K++DFG + + E +
Sbjct: 116 IMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLRE 169
Query: 594 IVGTYGYMSPEYAMSGI------VSIKTDVFSFGVLVLEIVSG 630
+ GT Y++PE + + D++S GV++ +++G
Sbjct: 170 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212
>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
pdb|2WTK|F Chain F, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
Length = 305
Score = 58.9 bits (141), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 32/223 (14%)
Query: 426 AAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKR--------LSRSSGQGIVEFKNEV 477
A + + LGEG +G V K + E +R R G K E+
Sbjct: 1 AKLIGKYLMGDLLGEGSYGKV---KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEI 57
Query: 478 RLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNW--EKRFIII 535
+L+ +L+H N+++L+ L+ EE+ +Y M ++ + G + +L+ EKRF +
Sbjct: 58 QLLRRLRHKNVIQLVDV-LYNEEKQKMYMVM-----EYCV--CGMQEMLDSVPEKRFPVC 109
Query: 536 EG------ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589
+ + GL YLH ++H+D+K N+LL KIS G+A ++
Sbjct: 110 QAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADD 166
Query: 590 NTKRIVGTYGYMSPEYA--MSGIVSIKTDVFSFGVLVLEIVSG 630
+ G+ + PE A + K D++S GV + I +G
Sbjct: 167 TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209
>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine
Mutation At Position 52
Length = 364
Score = 58.9 bits (141), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 48/204 (23%), Positives = 100/204 (49%), Gaps = 7/204 (3%)
Query: 432 FSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFK-NEVRLIAKLQHTNLV 489
++ + +GEG +G V ++ VAI+++S Q + E++++ + +H N++
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+ + ++ ++ L+ + L+ + + I +GL Y+H +
Sbjct: 89 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN-TKRIVGTYGYMSPEYAMS 608
V+HRDLK SN+LL+ + KI DFG+AR+ + + V T Y +PE ++
Sbjct: 149 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 609 GIVSIKT-DVFSFGVLVLEIVSGQ 631
K+ D++S G ++ E++S +
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229
>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With Atp
pdb|3HMO|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With The Inhibitor Staurosporine
pdb|3HMP|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With A Quinazolin Ligand Compound 4
Length = 342
Score = 58.5 bits (140), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 47/186 (25%), Positives = 92/186 (49%), Gaps = 12/186 (6%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIK--RLSRSSGQGIVEFKNEVRLI 480
+ I+ +S ++G GG V++ +Q AIK L + Q + ++NE+ +
Sbjct: 49 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108
Query: 481 AKLQ-HTN-LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGI 538
KLQ H++ ++RL + + +Y M ++D + +K++ WE++ + +
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYW-KNM 164
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTY 598
+ + +H++ ++H DLK +N L+ D M K+ DFG+A + + + VGT
Sbjct: 165 LEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTV 220
Query: 599 GYMSPE 604
YM PE
Sbjct: 221 NYMPPE 226
>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 58.5 bits (140), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 49/204 (24%), Positives = 99/204 (48%), Gaps = 7/204 (3%)
Query: 432 FSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFK-NEVRLIAKLQHTNLV 489
++ + +GEG +G V ++ VAIK++S Q + E++++ +H N++
Sbjct: 27 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+ + ++ ++ L+ + L+ + + I +GL Y+H +
Sbjct: 87 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 146
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN-TKRIVGTYGYMSPEYAMS 608
V+HRDLK SN+LL+ + KI DFG+AR+ + + V T Y +PE ++
Sbjct: 147 ---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 609 GIVSIKT-DVFSFGVLVLEIVSGQ 631
K+ D++S G ++ E++S +
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNR 227
>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map
Kinase Jnk1
Length = 370
Score = 58.5 bits (140), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 33/214 (15%)
Query: 432 FSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSR--SSGQGIVEFKNEVRLIAKLQHTNL 488
+ +G G G V A E+ VAIK+LSR + E+ L+ + H N+
Sbjct: 26 YQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNV----LNWEKRFIIIE 536
+ LL F P KSL+ F L ++ V L+ E+ ++
Sbjct: 86 IGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLY 133
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+ G+ +LH +IHRDLK SNI++ KI DFG+AR S T +V
Sbjct: 134 QMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVT 188
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y Y +PE + D++S GV++ E++ G
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221
>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With
N-(4-chlorophenyl)-2-
((pyridin-4-ylmethyl)amino)benzamide
Length = 360
Score = 58.5 bits (140), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 36/92 (39%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT 597
+++G+ +L S + IHRDL A NILL + KI DFG+AR N
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 598 YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+PE I S K+DV+S+GVL+ EI S
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296
>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|C Chain C, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|D Chain D, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
Length = 295
Score = 58.5 bits (140), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 14/207 (6%)
Query: 430 NNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLS--RSSGQGIVEFKNEVRLIAKLQHT 486
+ + +G+G F V + KL E A K ++ + S + + + E R+ L+H+
Sbjct: 4 DEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHS 63
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLH 546
N+VRL LV++ + L F R+ + I + I + +L+ H
Sbjct: 64 NIVRLHDSISEEGFHYLVFDLVTGGEL--FEDIVAREYYSEADASHCI-QQILEAVLHCH 120
Query: 547 KYSRLRVIHRDLKASNILLDDKMN---PKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
+ + V+HRDLK N+LL K K++DFG+A EV + GT GY+SP
Sbjct: 121 Q---MGVVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLSP 175
Query: 604 EYAMSGIVSIKTDVFSFGVLVLEIVSG 630
E D+++ GV++ ++ G
Sbjct: 176 EVLRKEAYGKPVDIWACGVILYILLVG 202
>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715
Length = 317
Score = 58.5 bits (140), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 48/189 (25%), Positives = 90/189 (47%), Gaps = 18/189 (9%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIK--RLSRSSGQGIVEFKNEVRLI 480
+ I+ +S ++G GG V++ +Q AIK L + Q + ++NE+ +
Sbjct: 5 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 64
Query: 481 AKLQ-HTN-LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI---II 535
KLQ H++ ++RL + + +Y M ++D + +K++ WE++ ++
Sbjct: 65 NKLQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNML 121
Query: 536 EGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIV 595
E + H + ++H DLK +N L+ D M K+ DFG+A + + + V
Sbjct: 122 EAV-------HTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQV 173
Query: 596 GTYGYMSPE 604
GT YM PE
Sbjct: 174 GTVNYMPPE 182
>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2-
Yl)amino]benzamide
Length = 320
Score = 58.5 bits (140), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 48/189 (25%), Positives = 90/189 (47%), Gaps = 18/189 (9%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIK--RLSRSSGQGIVEFKNEVRLI 480
+ I+ +S ++G GG V++ +Q AIK L + Q + ++NE+ +
Sbjct: 1 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 60
Query: 481 AKLQ-HTN-LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI---II 535
KLQ H++ ++RL + + +Y M ++D + +K++ WE++ ++
Sbjct: 61 NKLQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNML 117
Query: 536 EGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIV 595
E + H + ++H DLK +N L+ D M K+ DFG+A + + + V
Sbjct: 118 EAV-------HTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQV 169
Query: 596 GTYGYMSPE 604
GT YM PE
Sbjct: 170 GTVNYMPPE 178
>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC
Length = 405
Score = 58.5 bits (140), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 64/239 (26%), Positives = 114/239 (47%), Gaps = 30/239 (12%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGI-VEFKNEVRLIAKLQHTNLVRLLGCS 495
K+G G +G VYK K D ++ L + G GI + E+ L+ +L+H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 496 L-HGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY-----LHKY 548
L H + ++ L++++ + F+ K +K + G+ + LLY +H
Sbjct: 88 LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 549 SRLRVIHRDLKASNILL----DDKMNPKISDFGMARIFEVN-ESEANTKRIVGTYGYMSP 603
V+HRDLK +NIL+ ++ KI+D G AR+F + A+ +V T+ Y +P
Sbjct: 145 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204
Query: 604 EYAMSGIVSIKT-DVFSFGVLVLEIVSGQK-NHTR----------HHP--DRPLNLIGY 648
E + K D+++ G + E+++ + H R HH DR N++G+
Sbjct: 205 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 263
>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered
N- Terminal Helix
pdb|1XHA|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 58.5 bits (140), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFK------NEVRL 479
A + F LG G FG V K + A+K L + Q +V+ K NE R+
Sbjct: 38 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKEIEHTLNEKRI 94
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
+ + LV+L +V E+ P + L GR + + RF + I
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH--ARFYAAQ-IV 151
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
YLH L +I+RDLK N+++D + +++DFG+A+ + T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAK-----RVKGRTWXLCGTPE 203
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By
Mutational Studies
Length = 298
Score = 58.5 bits (140), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 46/163 (28%), Positives = 81/163 (49%), Gaps = 16/163 (9%)
Query: 475 NEVRLIAKLQ-HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI 533
EV ++ K+ H N+++L LV++ M L +L K L+ ++
Sbjct: 72 KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRK 128
Query: 534 IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR 593
I+ + + + LHK L ++HRDLK NILLDD MN K++DFG + + E +
Sbjct: 129 IMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLRS 182
Query: 594 IVGTYGYMSPEYAMSGI------VSIKTDVFSFGVLVLEIVSG 630
+ GT Y++PE + + D++S GV++ +++G
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796
pdb|3NPC|B Chain B, Crystal Structure Of Jnk2 Complexed With Birb796
Length = 364
Score = 58.5 bits (140), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 58/186 (31%), Positives = 88/186 (47%), Gaps = 28/186 (15%)
Query: 457 VAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF 516
VA+K+LSR F+N+ AK + LV LL C H L+ F P K+L+ F
Sbjct: 52 VAVKKLSRP-------FQNQTH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQKTLEEF 101
Query: 517 --------LFNSGRKNV----LNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNIL 564
L ++ V L+ E+ ++ + G+ +LH +IHRDLK SNI+
Sbjct: 102 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIV 158
Query: 565 LDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLV 624
+ KI DFG+AR N T +V Y Y +PE + + D++S G ++
Sbjct: 159 VKSDCTLKILDFGLARTACTN--FMMTPYVVTRY-YRAPEVILGMGYAANVDIWSVGCIM 215
Query: 625 LEIVSG 630
E+V G
Sbjct: 216 GELVKG 221
>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|B Chain B, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|D Chain D, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|E Chain E, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
Length = 371
Score = 58.5 bits (140), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 67/259 (25%), Positives = 115/259 (44%), Gaps = 33/259 (12%)
Query: 390 KAKDNVSLLPTYGKRKSPEKDQS----------ISHELKIFDFQTIAAAANNFSTTN-KL 438
+A SL T+ R S ++ S ++ +LK D++ +++T +L
Sbjct: 44 QAHSLTSLAKTWAARGSRSREPSPKTEDNEGVLLTEKLKPVDYEYREEV--HWATHQLRL 101
Query: 439 GEGGFGPVYKGKLADEQ---EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCS 495
G G FG V++ + D+Q + A+K++ V E+ A L +V L G
Sbjct: 102 GRGSFGEVHR--MEDKQTGFQCAVKKVRLE-----VFRAEELMACAGLTSPRIVPLYGAV 154
Query: 496 LHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
G + E + SL + G L ++ + +GL YLH SR R++H
Sbjct: 155 REGPWVNIFMELLEGGSLGQLVKEQG---CLPEDRALYYLGQALEGLEYLH--SR-RILH 208
Query: 556 RDLKASNILLD-DKMNPKISDFGMARIFE---VNESEANTKRIVGTYGYMSPEYAMSGIV 611
D+KA N+LL D + + DFG A + + +S I GT +M+PE +
Sbjct: 209 GDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSC 268
Query: 612 SIKTDVFSFGVLVLEIVSG 630
K DV+S ++L +++G
Sbjct: 269 DAKVDVWSSCCMMLHMLNG 287
>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
pdb|3MDY|C Chain C, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
Length = 337
Score = 58.5 bits (140), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 63/270 (23%), Positives = 115/270 (42%), Gaps = 27/270 (10%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
A ++G+G +G V+ GK E+ VA+K + + E+ ++H N+
Sbjct: 36 AKQIQMVKQIGKGRYGEVWMGKWRGEK-VAVKVFFTTEEASWFR-ETEIYQTVLMRHENI 93
Query: 489 VRLLGCSLHGE----ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
+ + + G + L+ ++ N SL +L + L+ + + GL +
Sbjct: 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCH 149
Query: 545 LHK-----YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF--EVNESEANTKRIVGT 597
LH + + HRDLK+ NIL+ I+D G+A F + NE + VGT
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209
Query: 598 YGYMSPEYAMSGI------VSIKTDVFSFGVLVLEI----VSGQKNHTRHHPDRPLNLIG 647
YM PE + I D++SFG+++ E+ VSG P L
Sbjct: 210 KRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269
Query: 648 YAWQLLSDGKGLELIDPSLEQPCSANEVMR 677
+++ + + ++ + PS S++E +R
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLR 299
>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 58.5 bits (140), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 37/216 (17%)
Query: 432 FSTTNKLGEGGFGPV---YKGKLADEQEVAIKRLSR--SSGQGIVEFKNEVRLIAKLQHT 486
+ +G G G V Y L E+ VAIK+LSR + E+ L+ + H
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNV----LNWEKRFII 534
N++ LL F P KSL+ F L ++ V L+ E+ +
Sbjct: 84 NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ + G+ +LH +IHRDLK SNI++ KI DFG+AR S T +
Sbjct: 132 LYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYV 186
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
V Y Y +PE + D++S GV++ E++ G
Sbjct: 187 VTRY-YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221
>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat
Length = 332
Score = 58.5 bits (140), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 26/217 (11%)
Query: 419 IFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIV-EFKNE 476
I+DF+ + LG G F V + Q+ VAIK +++ + +G +NE
Sbjct: 19 IYDFRDV------------LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENE 66
Query: 477 VRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE 536
+ ++ K++H N+V L G L+ + + L + G + + +I
Sbjct: 67 IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIF 123
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNIL---LDDKMNPKISDFGMARIFEVNESEANTKR 593
+ + YLH L ++HRDLK N+L LD+ ISDFG++++ + +
Sbjct: 124 QVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLST 177
Query: 594 IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT GY++PE S D +S GV+ ++ G
Sbjct: 178 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214
>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain
Length = 343
Score = 58.2 bits (139), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 67/306 (21%), Positives = 140/306 (45%), Gaps = 41/306 (13%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIK--RLSRSSGQGIVEFKNEVRLI 480
+ I+ +S ++G GG V++ +Q AIK L + Q + ++NE+ +
Sbjct: 2 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 61
Query: 481 AKLQ-HTN-LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGI 538
KLQ H++ ++RL + + +Y M ++D + +K++ WE++ + +
Sbjct: 62 NKLQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYW-KNM 117
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTY 598
+ + +H++ ++H DLK +N L+ D M K+ DFG+A + + + VGT
Sbjct: 118 LEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTV 173
Query: 599 GYMSPEYAMSGIVSIK------------TDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
YM PE A+ + S + +DV+S G ++ + G+ + +N I
Sbjct: 174 NYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-----QQIINQI 227
Query: 647 GYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC--MLQ 704
++ +E P + + +V++C C++ R ++PE++ +Q
Sbjct: 228 SKLHAIIDPNHEIEF--PDIPEK-DLQDVLKC------CLKRDPKQRISIPELLAHPYVQ 278
Query: 705 NETMPL 710
+T P+
Sbjct: 279 IQTHPV 284
>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-293 In Complex With Atp
Length = 293
Score = 58.2 bits (139), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 14/204 (6%)
Query: 432 FSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIV-EFKNEVRLIAKLQHTNLV 489
+ + LG G F V + Q+ VAIK +++ + +G +NE+ ++ K++H N+V
Sbjct: 20 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
L G L+ + + L + G + + +I + + YLH
Sbjct: 80 ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLHD-- 134
Query: 550 RLRVIHRDLKASNIL---LDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYA 606
L ++HRDLK N+L LD+ ISDFG++++ + + GT GY++PE
Sbjct: 135 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVL 190
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSG 630
S D +S GV+ ++ G
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCG 214
>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
pdb|2VZ6|B Chain B, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
Length = 313
Score = 58.2 bits (139), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 432 FSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLS--RSSGQGIVEFKNEVRLIAKLQHTNL 488
+ +LG+G F V + K+ QE A K ++ + S + + + E R+ L+H N+
Sbjct: 24 YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNI 83
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
VRL L+++ + L F R+ + I + I + +L+ H+
Sbjct: 84 VRLHDSISEEGHHYLIFDLVTGGEL--FEDIVAREYYSEADASHCI-QQILEAVLHCHQ- 139
Query: 549 SRLRVIHRDLKASNILLDDKMN---PKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
+ V+HRDLK N+LL K+ K++DFG+A EV + GT GY+SPE
Sbjct: 140 --MGVVHRDLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPGYLSPEV 195
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVSG 630
D+++ GV++ ++ G
Sbjct: 196 LRKDPYGKPVDLWACGVILYILLVG 220
>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDR|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With The Inhibitor
A- 443654
pdb|2UW9|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|2X39|A Chain A, Structure Of
4-Amino-N-(4-Chlorobenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidine-4-Carboxamide Bound To Pkb
pdb|2XH5|A Chain A, Structure Of 4-(4-Tert-Butylbenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidin-4-Amine Bound To Pkb
Length = 342
Score = 58.2 bits (139), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 30/230 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
N+F LG+G FG V + ++ + + + EV +IAK + + V
Sbjct: 10 NDFDYLKLLGKGTFGKV----------ILVREKATGRYYAMKILRKEV-IIAKDEVAHTV 58
Query: 490 ---RLLGCSLHGEERLLVYEFMPNKSLDFFL---------FNSGRKNVLNWEK-RFIIIE 536
R+L + H L Y F + L F + F+ R+ V E+ RF E
Sbjct: 59 TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 118
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+S L YLH V++RD+K N++LD + KI+DFG+ + E A K G
Sbjct: 119 IVS-ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCG 172
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
T Y++PE D + GV++ E++ G+ +R LI
Sbjct: 173 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 222
>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B
(pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3
Peptide
Length = 337
Score = 58.2 bits (139), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 30/230 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
N+F LG+G FG V + ++ + + + EV +IAK + + V
Sbjct: 5 NDFDYLKLLGKGTFGKV----------ILVREKATGRYYAMKILRKEV-IIAKDEVAHTV 53
Query: 490 ---RLLGCSLHGEERLLVYEFMPNKSLDFFL---------FNSGRKNVLNWEK-RFIIIE 536
R+L + H L Y F + L F + F+ R+ V E+ RF E
Sbjct: 54 TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+S L YLH V++RD+K N++LD + KI+DFG+ + E A K G
Sbjct: 114 IVS-ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCG 167
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
T Y++PE D + GV++ E++ G+ +R LI
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
pdb|4FG8|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
Length = 315
Score = 58.2 bits (139), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 26/217 (11%)
Query: 419 IFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIV-EFKNE 476
I+DF+ + LG G F V + Q+ VAIK +++ + +G +NE
Sbjct: 19 IYDFRDV------------LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 477 VRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE 536
+ ++ K++H N+V L G L+ + + L + G + + +I
Sbjct: 67 IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIF 123
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNIL---LDDKMNPKISDFGMARIFEVNESEANTKR 593
+ + YLH L ++HRDLK N+L LD+ ISDFG++++ + +
Sbjct: 124 QVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLST 177
Query: 594 IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT GY++PE S D +S GV+ ++ G
Sbjct: 178 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214
>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2
pdb|3E7O|B Chain B, Crystal Structure Of Jnk2
Length = 360
Score = 58.2 bits (139), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 58/186 (31%), Positives = 87/186 (46%), Gaps = 28/186 (15%)
Query: 457 VAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF 516
VA+K+LSR F+N+ AK + LV LL C H L+ F P K+L+ F
Sbjct: 50 VAVKKLSRP-------FQNQTH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQKTLEEF 99
Query: 517 --------LFNSGRKNV----LNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNIL 564
L ++ V L+ E+ ++ + G+ +LH +IHRDLK SNI+
Sbjct: 100 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIV 156
Query: 565 LDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLV 624
+ KI DFG+AR N T +V Y Y +PE + D++S G ++
Sbjct: 157 VKSDCTLKILDFGLARTASTN--FMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIM 213
Query: 625 LEIVSG 630
E+V G
Sbjct: 214 GELVKG 219
>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h-
Purin-6-yl)-benzyl)-amine
pdb|2UVZ|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
C-Phenyl-C-(4-( 9h-Purin-6-Yl)-Phenyl)-Methylamine
pdb|2UW0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 6-(4-(4-(4-
Chloro-Phenyl)-Piperidin-4-Yl)-Phenyl)-9h-Purine
pdb|2UW3|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 5-Methyl-4-
Phenyl-1h-Pyrazole
pdb|2UW5|A Chain A, Structure Of Pka-Pkb Chimera Complexed With (R)-2-(4-
Chloro-Phenyl)-2-(4-1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW6|A Chain A, Structure Of Pka-Pkb Chimera Complexed With (S)-2-(4-
Chloro-Phenyl)-2-(4-1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW8|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 2-(4-Chloro-
Phenyl)-2-Phenyl-Ethylamine
pdb|2VNW|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
(1-(9h-Purin-6- Yl)piperidin-4-Yl)methanamine
pdb|2VNY|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
(1-(9h-Purin-6- Yl)piperidin-4-Yl)amine
pdb|2VO3|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4-
Chlorophenyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine
pdb|2VO6|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 4-(4-
Chlorobenzyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Ylamine
Length = 351
Score = 58.2 bits (139), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 31/216 (14%)
Query: 427 AAANNFSTTNKLGEGGFGPV-----------YKGKLADEQEVA-IKRLSRSSGQGIVEFK 474
A + F LG G FG V Y K+ D+Q+V +K++ +
Sbjct: 39 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-------- 90
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
NE R++ + L +L +V E+ P + L GR RF
Sbjct: 91 NEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR--FXEPHARFYA 148
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ I YLH L +I+RDLK N+++D + K++DFG A+ + T +
Sbjct: 149 AQ-IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXL 199
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FG9|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FGB|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I Apo Form
Length = 320
Score = 58.2 bits (139), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 26/217 (11%)
Query: 419 IFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIV-EFKNE 476
I+DF+ + LG G F V + Q+ VAIK +++ + +G +NE
Sbjct: 19 IYDFRDV------------LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 477 VRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE 536
+ ++ K++H N+V L G L+ + + L + G + + +I
Sbjct: 67 IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIF 123
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNIL---LDDKMNPKISDFGMARIFEVNESEANTKR 593
+ + YLH L ++HRDLK N+L LD+ ISDFG++++ + +
Sbjct: 124 QVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLST 177
Query: 594 IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT GY++PE S D +S GV+ ++ G
Sbjct: 178 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214
>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The
Kinase Domain Of Focal Adhesion Kinase With A
Phosphorylated Activation Loop
Length = 276
Score = 58.2 bits (139), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 53/196 (27%), Positives = 88/196 (44%), Gaps = 12/196 (6%)
Query: 438 LGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLVRLL 492
+GEG FG V++G + VAIK + + E F E + + H ++V+L+
Sbjct: 18 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
G + ++ E L FL RK L+ + +S L YL R
Sbjct: 78 GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVS 612
+HRD+ A N+L+ K+ DFG++R E + +K + +M+PE +
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKL-PIKWMAPESINFRRFT 190
Query: 613 IKTDVFSFGVLVLEIV 628
+DV+ FGV + EI+
Sbjct: 191 SASDVWMFGVCMWEIL 206
>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3)
Length = 350
Score = 57.8 bits (138), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 60/239 (25%), Positives = 105/239 (43%), Gaps = 25/239 (10%)
Query: 403 KRKSPEKDQS----ISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQ--- 455
+R PE + + ++ +LK D++ + + +LG G FG V++ + D+Q
Sbjct: 42 QRLGPETEDNEGVLLTEKLKPVDYE-YREEVHWMTHQPRLGRGSFGEVHR--MKDKQTGF 98
Query: 456 EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDF 515
+ A+K++ V E+ A L +V L G G + E + SL
Sbjct: 99 QCAVKKVRLE-----VFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 153
Query: 516 FLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD-DKMNPKIS 574
+ G L ++ + +GL YLH R++H D+KA N+LL D +
Sbjct: 154 LIKQMG---CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALC 207
Query: 575 DFGMARIFE---VNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
DFG A + + +S I GT +M+PE M K D++S ++L +++G
Sbjct: 208 DFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266
>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With
Inhibitor Jnj- 7706621
pdb|3AMB|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With
Inhibitor Vx- 680
Length = 351
Score = 57.8 bits (138), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 427 AAANNFSTTNKLGEGGFGPV-----------YKGKLADEQEVA-IKRLSRSSGQGIVEFK 474
A + F LG G FG V Y K+ D+Q+V +K++ +
Sbjct: 39 AHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL-------- 90
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
NE R+ + LV+L +V E+ P + L GR + + RF
Sbjct: 91 NEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPH--ARFYA 148
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ I YLH L +I+RDLK N+L+D + K++DFG A+ + T +
Sbjct: 149 AQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXL 199
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp
pdb|1Q62|A Chain A, Pka Double Mutant Model Of Pkb
Length = 350
Score = 57.8 bits (138), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 31/216 (14%)
Query: 427 AAANNFSTTNKLGEGGFGPV-----------YKGKLADEQEVA-IKRLSRSSGQGIVEFK 474
A + F LG G FG V Y K+ D+Q+V +K++ +
Sbjct: 38 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-------- 89
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
NE R++ + LV+L +V E+ P + L GR + + RF
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH--ARFYA 147
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ I YLH L +I+RDLK N+++D + +++DFG A+ + T +
Sbjct: 148 AQ-IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAK-----RVKGRTWXL 198
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
pdb|2JAM|B Chain B, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
Length = 304
Score = 57.8 bits (138), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 53/198 (26%), Positives = 91/198 (45%), Gaps = 16/198 (8%)
Query: 438 LGEGGFGPVY--KGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCS 495
LG G F V+ K +L + A+K + +S +NE+ ++ K++H N+V L
Sbjct: 17 LGSGAFSEVFLVKQRLTGKL-FALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 496 LHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
LV + + L + G V + ++I+ + + YLH+ ++H
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHENG---IVH 129
Query: 556 RDLKASNIL-LDDKMNPKI--SDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVS 612
RDLK N+L L + N KI +DFG++++ E GT GY++PE S
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAPEVLAQKPYS 185
Query: 613 IKTDVFSFGVLVLEIVSG 630
D +S GV+ ++ G
Sbjct: 186 KAVDCWSIGVITYILLCG 203
>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
pdb|4EBV|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
Length = 304
Score = 57.8 bits (138), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 53/196 (27%), Positives = 88/196 (44%), Gaps = 12/196 (6%)
Query: 438 LGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLVRLL 492
+GEG FG V++G + VAIK + + E F E + + H ++V+L+
Sbjct: 46 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
G + ++ E L FL RK L+ + +S L YL R
Sbjct: 106 GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 159
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVS 612
+HRD+ A N+L+ K+ DFG++R E + +K + +M+PE +
Sbjct: 160 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI-KWMAPESINFRRFT 218
Query: 613 IKTDVFSFGVLVLEIV 628
+DV+ FGV + EI+
Sbjct: 219 SASDVWMFGVCMWEIL 234
>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid-
Regulated Kinase 1 In Complex With Amp-Pnp
pdb|3HDM|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 1
pdb|3HDN|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 2
Length = 373
Score = 57.8 bits (138), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 19/212 (8%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAK--- 482
A ++F +G+G FG V + A+E A+K L + + I++ K E ++++
Sbjct: 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQK---KAILKKKEEKHIMSERNV 91
Query: 483 ----LQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGI 538
++H LV L ++ V +++ L + L + L RF E I
Sbjct: 92 LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYAAE-I 148
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTY 598
+ L YLH L +++RDLK NILLD + + ++DFG+ + E E + T GT
Sbjct: 149 ASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTP 203
Query: 599 GYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y++PE D + G ++ E++ G
Sbjct: 204 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235
>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|B Chain B, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|C Chain C, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALO|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Ternary Complex With Amp-Pnp And P38 Peptide
pdb|3VUT|A Chain A, Crystal Structures Of Non-Phosphorylated Map2k4
pdb|3VUT|B Chain B, Crystal Structures Of Non-Phosphorylated Map2k4
Length = 327
Score = 57.8 bits (138), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 63/231 (27%), Positives = 106/231 (45%), Gaps = 23/231 (9%)
Query: 414 SHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVE 472
S +LKI Q A + ++G G +G V K Q +A+KR+ + V+
Sbjct: 6 SGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-----RSTVD 60
Query: 473 FKNEVRLIAKLQHTN-------LVRLLGCSLHGEERLLVYEFMPNKSLDFFLF-NSGRKN 524
K + +L+ L +V+ G + + E M F+ + S +
Sbjct: 61 EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDD 120
Query: 525 VLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
V+ E I + L +L + L++IHRD+K SNILLD N K+ DFG++ ++
Sbjct: 121 VIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISG--QL 176
Query: 585 NESEANTKRIVGTYGYMSPEY----AMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+S A T R G YM+PE A +++DV+S G+ + E+ +G+
Sbjct: 177 VDSIAKT-RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
pdb|2R9S|B Chain B, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
Length = 356
Score = 57.4 bits (137), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 33/212 (15%)
Query: 432 FSTTNKLGEGGFGPV---YKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ +G G G V Y L ++ VAIK+LSR F+N+ AK + L
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYREL 67
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNV----LNWEKRFIIIE 536
V L+ C H L+ F P K+L+ F L ++ V L+ E+ ++
Sbjct: 68 V-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLY 126
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+ G+ +LH +IHRDLK SNI++ KI DFG+AR S T +V
Sbjct: 127 QMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYVVT 181
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIV 628
Y Y +PE + D++S G ++ E+V
Sbjct: 182 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 212
>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d
With Gsk3 Peptide And Amp-Pnp
Length = 336
Score = 57.4 bits (137), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 30/230 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
N+F LG+G FG V + ++ + + + EV +IAK + + V
Sbjct: 5 NDFDYLKLLGKGTFGKV----------ILVREKATGRYYAMKILRKEV-IIAKDEVAHTV 53
Query: 490 ---RLLGCSLHGEERLLVYEFMPNKSLDFFL---------FNSGRKNVLNWEK-RFIIIE 536
R+L + H L Y F + L F + F+ R+ V E+ RF E
Sbjct: 54 TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+S L YLH V++RD+K N++LD + KI+DFG+ + E A K G
Sbjct: 114 IVS-ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCG 167
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
T Y++PE D + GV++ E++ G+ +R LI
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1
Catalytic Domain Apo Form
Length = 390
Score = 57.4 bits (137), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 48/189 (25%), Positives = 90/189 (47%), Gaps = 18/189 (9%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIK--RLSRSSGQGIVEFKNEVRLI 480
+ I+ +S ++G GG V++ +Q AIK L + Q + ++NE+ +
Sbjct: 49 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108
Query: 481 AKLQ-HTN-LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI---II 535
KLQ H++ ++RL + + +Y M ++D + +K++ WE++ ++
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNML 165
Query: 536 EGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIV 595
E + H + ++H DLK +N L+ D M K+ DFG+A + + + V
Sbjct: 166 EAV-------HTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQV 217
Query: 596 GTYGYMSPE 604
GT YM PE
Sbjct: 218 GTVNYMPPE 226
>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And
Kinase Domains Of Focal Adhesion Kinase.
pdb|2JKQ|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 57.4 bits (137), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 53/196 (27%), Positives = 88/196 (44%), Gaps = 12/196 (6%)
Query: 438 LGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLVRLL 492
+GEG FG V++G + VAIK + + E F E + + H ++V+L+
Sbjct: 18 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
G + ++ E L FL RK L+ + +S L YL R
Sbjct: 78 GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVS 612
+HRD+ A N+L+ K+ DFG++R E + +K + +M+PE +
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI-KWMAPESINFRRFT 190
Query: 613 IKTDVFSFGVLVLEIV 628
+DV+ FGV + EI+
Sbjct: 191 SASDVWMFGVCMWEIL 206
>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak)
pdb|4I4F|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With An Allosteric Binding Pyrazolobenzothiazine
Compound
Length = 281
Score = 57.4 bits (137), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 53/196 (27%), Positives = 88/196 (44%), Gaps = 12/196 (6%)
Query: 438 LGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLVRLL 492
+GEG FG V++G + VAIK + + E F E + + H ++V+L+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
G + ++ E L FL RK L+ + +S L YL R
Sbjct: 83 GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 136
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVS 612
+HRD+ A N+L+ K+ DFG++R E + +K + +M+PE +
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFT 195
Query: 613 IKTDVFSFGVLVLEIV 628
+DV+ FGV + EI+
Sbjct: 196 SASDVWMFGVCMWEIL 211
>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E87|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3D0E|A Chain A, Crystal Structure Of Human Akt2 In Complex With Gsk690693
pdb|3D0E|B Chain B, Crystal Structure Of Human Akt2 In Complex With Gsk690693
Length = 335
Score = 57.4 bits (137), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 30/230 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
N+F LG+G FG V + ++ + + + EV +IAK + + V
Sbjct: 5 NDFDYLKLLGKGTFGKV----------ILVREKATGRYYAMKILRKEV-IIAKDEVAHTV 53
Query: 490 ---RLLGCSLHGEERLLVYEFMPNKSLDFFL---------FNSGRKNVLNWEK-RFIIIE 536
R+L + H L Y F + L F + F+ R+ V E+ RF E
Sbjct: 54 TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+S L YLH V++RD+K N++LD + KI+DFG+ + E A K G
Sbjct: 114 IVS-ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCG 167
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
T Y++PE D + GV++ E++ G+ +R LI
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562
Length = 364
Score = 57.4 bits (137), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 33/212 (15%)
Query: 432 FSTTNKLGEGGFGPV---YKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ +G G G V Y L ++ VAIK+LSR F+N+ AK + L
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYREL 74
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNV----LNWEKRFIIIE 536
V L+ C H L+ F P K+L+ F L ++ V L+ E+ ++
Sbjct: 75 V-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLY 133
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+ G+ +LH +IHRDLK SNI++ KI DFG+AR S T +V
Sbjct: 134 QMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYVVT 188
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIV 628
Y Y +PE + D++S G ++ E+V
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 219
>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDV|A Chain A, Structure Of Pka-Pkb Chimera Complexed With A-443654
pdb|2UVX|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 7-Azaindole
pdb|2UW4|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
2-(4-(5-Methyl- 1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW7|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|4AXA|A Chain A, Structure Of Pka-pkb Chimera Complexed With
(1s)-2-amino-1-(
4-chlorophenyl)-1-(4-(1h-pyrazol-4-yl)phenyl)ethan-1-ol
Length = 351
Score = 57.4 bits (137), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 21/211 (9%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFK------NEVRL 479
A + F LG G FG V K + A+K L + Q +V+ K NE R+
Sbjct: 39 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 95
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
+ + L +L +V E+ P + L GR + + RF + I
Sbjct: 96 LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH--ARFYAAQ-IV 152
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
YLH L +I+RDLK N+++D + K++DFG A+ + T + GT
Sbjct: 153 LTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPE 204
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4-
Chlorophenyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine
Length = 351
Score = 57.4 bits (137), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 427 AAANNFSTTNKLGEGGFGPV-----------YKGKLADEQEVA-IKRLSRSSGQGIVEFK 474
A + F LG G FG V Y K+ D+Q+V +K++ +
Sbjct: 39 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-------- 90
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
NE R++ + L +L +V E+ P + L GR + + RF
Sbjct: 91 NEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH--ARFYA 148
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ I YLH L +I+RDLK N+++D + K++DFG A+ + T +
Sbjct: 149 AQ-IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXL 199
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
pdb|1MRY|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
Length = 339
Score = 57.4 bits (137), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 30/230 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
N+F LG+G FG V + ++ + + + EV +IAK + + V
Sbjct: 8 NDFDYLKLLGKGTFGKV----------ILVREKATGRYYAMKILRKEV-IIAKDEVAHTV 56
Query: 490 ---RLLGCSLHGEERLLVYEFMPNKSLDFFL---------FNSGRKNVLNWEK-RFIIIE 536
R+L + H L Y F + L F + F+ R+ V E+ RF E
Sbjct: 57 TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 116
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+S L YLH V++RD+K N++LD + KI+DFG+ + E A K G
Sbjct: 117 IVS-ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCG 170
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
T Y++PE D + GV++ E++ G+ +R LI
Sbjct: 171 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 220
>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B
Akt By Hydrophobic Motif Phosphorylation
pdb|1GZO|A Chain A, Structure Of Protein Kinase B Unphosphorylated
Length = 315
Score = 57.4 bits (137), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 30/230 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
N+F LG+G FG V + ++ + + + EV +IAK + + V
Sbjct: 5 NDFDYLKLLGKGTFGKV----------ILVREKATGRYYAMKILRKEV-IIAKDEVAHTV 53
Query: 490 ---RLLGCSLHGEERLLVYEFMPNKSLDFFL---------FNSGRKNVLNWEK-RFIIIE 536
R+L + H L Y F + L F + F+ R+ V E+ RF E
Sbjct: 54 TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+S L YLH V++RD+K N++LD + KI+DFG+ + E A K G
Sbjct: 114 IVS-ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCG 167
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
T Y++PE D + GV++ E++ G+ +R LI
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g
pdb|2HW7|A Chain A, Crystal Structure Of Mnk2-D228g In Complex With
Staurosporine
Length = 316
Score = 57.4 bits (137), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 21/208 (10%)
Query: 438 LGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ-HTNLVRLLGCS 495
LGEG V L QE A+K + + G EV ++ + Q H N++ L+
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 496 LHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
+ LV+E M S+ L + ++ N + ++++ ++ L +LH + H
Sbjct: 81 EEEDRFYLVFEKMRGGSI---LSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAH 134
Query: 556 RDLKASNILLD--DKMNP-KISDFGMARIFEVNE--SEANTKRIV---GTYGYMSPEY-- 605
RDLK NIL + ++++P KI DFG+ ++N S +T ++ G+ YM+PE
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 606 AMSGIVSI---KTDVFSFGVLVLEIVSG 630
A S SI + D++S GV++ ++SG
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSG 222
>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
pdb|3PXK|B Chain B, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
Length = 282
Score = 57.4 bits (137), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 53/196 (27%), Positives = 88/196 (44%), Gaps = 12/196 (6%)
Query: 438 LGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLVRLL 492
+GEG FG V++G + VAIK + + E F E + + H ++V+L+
Sbjct: 21 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
G + ++ E L FL RK L+ + +S L YL R
Sbjct: 81 GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 134
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVS 612
+HRD+ A N+L+ K+ DFG++R E + +K + +M+PE +
Sbjct: 135 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFT 193
Query: 613 IKTDVFSFGVLVLEIV 628
+DV+ FGV + EI+
Sbjct: 194 SASDVWMFGVCMWEIL 209
>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2ETM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2IJM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
pdb|2IJM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
Length = 281
Score = 57.4 bits (137), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 53/196 (27%), Positives = 88/196 (44%), Gaps = 12/196 (6%)
Query: 438 LGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLVRLL 492
+GEG FG V++G + VAIK + + E F E + + H ++V+L+
Sbjct: 20 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
G + ++ E L FL RK L+ + +S L YL R
Sbjct: 80 GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 133
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVS 612
+HRD+ A N+L+ K+ DFG++R E + +K + +M+PE +
Sbjct: 134 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI-KWMAPESINFRRFT 192
Query: 613 IKTDVFSFGVLVLEIV 628
+DV+ FGV + EI+
Sbjct: 193 SASDVWMFGVCMWEIL 208
>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain
Length = 335
Score = 57.4 bits (137), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 30/230 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
N+F LG+G FG V + ++ + + + EV +IAK + + V
Sbjct: 5 NDFDYLKLLGKGTFGKV----------ILVREKATGRYYAMKILRKEV-IIAKDEVAHTV 53
Query: 490 ---RLLGCSLHGEERLLVYEFMPNKSLDFFL---------FNSGRKNVLNWEK-RFIIIE 536
R+L + H L Y F + L F + F+ R+ V E+ RF E
Sbjct: 54 TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+S L YLH V++RD+K N++LD + KI+DFG+ + E A K G
Sbjct: 114 IVS-ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCG 167
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
T Y++PE D + GV++ E++ G+ +R LI
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 57.4 bits (137), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 53/196 (27%), Positives = 88/196 (44%), Gaps = 12/196 (6%)
Query: 438 LGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLVRLL 492
+GEG FG V++G + VAIK + + E F E + + H ++V+L+
Sbjct: 18 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
G + ++ E L FL RK L+ + +S L YL R
Sbjct: 78 GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVS 612
+HRD+ A N+L+ K+ DFG++R E + +K + +M+PE +
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI-KWMAPESINFRRFT 190
Query: 613 IKTDVFSFGVLVLEIV 628
+DV+ FGV + EI+
Sbjct: 191 SASDVWMFGVCMWEIL 206
>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk
Inhibitor For The Prevention Of Ischemia-Reperfusion
Injury
pdb|3TTI|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-930, An Orally
Active Anti-Fibrotic Jnk Inhibitor
Length = 464
Score = 57.4 bits (137), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 69/240 (28%), Positives = 104/240 (43%), Gaps = 31/240 (12%)
Query: 401 YGKRKSPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIK 460
Y KS +Q S E+ F T+ N +G Y L ++ VAIK
Sbjct: 37 YNMSKSKVDNQFYSVEVGDSTF-TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIK 93
Query: 461 RLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF---- 516
+LSR F+N+ AK + LV L+ C H L+ F P K+L+ F
Sbjct: 94 KLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVY 143
Query: 517 ----LFNSGRKNV----LNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDK 568
L ++ V L+ E+ ++ + G+ +LH +IHRDLK SNI++
Sbjct: 144 LVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSD 200
Query: 569 MNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIV 628
KI DFG+AR S T +V Y Y +PE + D++S G ++ E+V
Sbjct: 201 CTLKILDFGLART--AGTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 257
>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A
Methanesulfonamide Diaminopyrimidine Inhibitor
Length = 276
Score = 57.4 bits (137), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 53/196 (27%), Positives = 88/196 (44%), Gaps = 12/196 (6%)
Query: 438 LGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLVRLL 492
+GEG FG V++G + VAIK + + E F E + + H ++V+L+
Sbjct: 15 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
G + ++ E L FL RK L+ + +S L YL R
Sbjct: 75 GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 128
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVS 612
+HRD+ A N+L+ K+ DFG++R E + +K + +M+PE +
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI-KWMAPESINFRRFT 187
Query: 613 IKTDVFSFGVLVLEIV 628
+DV+ FGV + EI+
Sbjct: 188 SASDVWMFGVCMWEIL 203
>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
pdb|2I6L|B Chain B, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
Length = 320
Score = 57.4 bits (137), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 59/222 (26%), Positives = 108/222 (48%), Gaps = 16/222 (7%)
Query: 438 LGEGGFGPVYKGKLAD-EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLL---- 492
LG GG G V+ D ++ VAIK++ + Q + E+++I +L H N+V++
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 493 --GCSLH---GEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
G L G L ++ + ++ L N + L E + + + +GL Y+H
Sbjct: 79 PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHS 138
Query: 548 YSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNES-EANTKRIVGTYGYMSPEY 605
+ V+HRDLK +N+ ++ + + KI DFG+ARI + + S + + + T Y SP
Sbjct: 139 AN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRL 195
Query: 606 AMSGIVSIKT-DVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
+S K D+++ G + E+++G+ H + LI
Sbjct: 196 LLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237
>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 386
Score = 57.4 bits (137), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 64/214 (29%), Positives = 96/214 (44%), Gaps = 33/214 (15%)
Query: 432 FSTTNKLGEGGFGPV---YKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ +G G G V Y L E+ VAIK+LSR F+N+ AK + L
Sbjct: 28 YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYREL 76
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNV----LNWEKRFIIIE 536
V L+ C H L+ F P KSL+ F L ++ V L+ E+ ++
Sbjct: 77 V-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLY 135
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+ G+ +LH +IHRDLK SNI++ KI DFG+AR S +V
Sbjct: 136 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMVPFVVT 190
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y Y +PE + D++S G ++ E++ G
Sbjct: 191 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223
>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And
Potent Inhibitors For Akt: Synthesis And Sar Studies
Length = 337
Score = 57.4 bits (137), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVEFK------NEVRL 479
A + F LG G FG V K + A+K L + Q +V+ K NE R+
Sbjct: 25 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 81
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
+ + LV+L +V E++ + L GR + + RF + I
Sbjct: 82 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQ-IV 138
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
YLH L +I+RDLK N+L+D++ +++DFG A+ + T + GT
Sbjct: 139 LTFEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAK-----RVKGRTWXLCGTPE 190
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 191 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221
>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit
Of Camp- Dependent Protein Kinase In Complex With Sp20
And Amp-Pnp
pdb|4DFZ|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit
Of Camp- Dependent Protein Kinase In Complex With Sp20
Length = 350
Score = 57.0 bits (136), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 21/211 (9%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVEFK------NEVRL 479
A + F LG G FG V K + A+K L + Q +V+ K NE R+
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
+ + LV+L +V E++ + L GR RF + I
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FXEPHARFYAAQ-IV 151
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
YLH L +I+RDLK N+L+D + +++DFG A+ + T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPE 203
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor
Length = 358
Score = 57.0 bits (136), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 33/212 (15%)
Query: 432 FSTTNKLGEGGFGPV---YKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ +G G G V Y L E+ VAIK+LSR F+N+ AK + L
Sbjct: 20 YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYREL 68
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNV----LNWEKRFIIIE 536
V L+ C H L+ F P KSL+ F L ++ V L+ E+ ++
Sbjct: 69 V-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLY 127
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+ G+ +LH +IHRDLK SNI++ KI DFG+AR S T +V
Sbjct: 128 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVT 182
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIV 628
Y Y +PE + D++S G ++ E+V
Sbjct: 183 RY-YRAPEVILGMGYKENVDLWSVGCIMGEMV 213
>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent
Protein Kinase Ii Gamma
Length = 336
Score = 57.0 bits (136), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 57/218 (26%), Positives = 100/218 (45%), Gaps = 17/218 (7%)
Query: 422 FQTIAAAA---NNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLS--RSSGQGIVEFKN 475
FQ +A +++ +LG+G F V + K QE A K ++ + S + + +
Sbjct: 20 FQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLER 79
Query: 476 EVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIII 535
E R+ L+H N+VRL LV++ + L F R+ + I
Sbjct: 80 EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGEL--FEDIVAREYYSEADASHCIH 137
Query: 536 EGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMN---PKISDFGMARIFEVNESEANTK 592
+ I + + ++H++ ++HRDLK N+LL K K++DFG+A EV +
Sbjct: 138 Q-ILESVNHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGEQQAWF 191
Query: 593 RIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT GY+SPE D+++ GV++ ++ G
Sbjct: 192 GFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229
>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of
Camp-Dependent Protein Kinase
Length = 345
Score = 57.0 bits (136), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 31/216 (14%)
Query: 427 AAANNFSTTNKLGEGGFGPV-----------YKGKLADEQEVA-IKRLSRSSGQGIVEFK 474
A + F LG G FG V Y K+ D+Q+V +K++ +
Sbjct: 33 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-------- 84
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
NE R++ + LV+L +V E++ + L GR RF
Sbjct: 85 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FXEPHARFYA 142
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ I YLH L +I+RDLK N+L+D + +++DFG A+ + T +
Sbjct: 143 AQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXL 193
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 194 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229
>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent
Protein Kinase With Unphosphorylated Turn Motif
Length = 371
Score = 57.0 bits (136), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 21/211 (9%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVEFK------NEVRL 479
A + F LG G FG V K + A+K L + Q +V+ K NE R+
Sbjct: 59 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 115
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
+ + LV+L +V E++ + L GR RF + I
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FXEPHARFYAAQ-IV 172
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
YLH L +I+RDLK N+L+D + +++DFG A+ + T + GT
Sbjct: 173 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPE 224
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 225 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255
>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine
Inhibitor
Length = 369
Score = 57.0 bits (136), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 69/238 (28%), Positives = 107/238 (44%), Gaps = 39/238 (16%)
Query: 412 SISHELKIFDFQTIAAAANNFSTTNK------LGEGGFGPV---YKGKLADEQEVAIKRL 462
S+S + +F ++ + F+ + +G G G V Y L E+ VAIK+L
Sbjct: 5 SMSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKL 62
Query: 463 SRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF------ 516
SR F+N+ AK + LV L+ C H L+ F P KSL+ F
Sbjct: 63 SRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 112
Query: 517 --LFNSGRKNV----LNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMN 570
L ++ V L+ E+ ++ + G+ +LH +IHRDLK SNI++
Sbjct: 113 MELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCT 169
Query: 571 PKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIV 628
KI DFG+AR S T +V Y Y +PE + D++S G ++ E+V
Sbjct: 170 LKILDFGLART--AGTSFMMTPYVVTRY-YRAPEVILGMGYKENVDLWSVGCIMGEMV 224
>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The
Catalytic Subunit Of Camp-Dependent Protein Kinase
pdb|3TNP|C Chain C, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
pdb|3TNP|F Chain F, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
pdb|3TNQ|B Chain B, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
Length = 350
Score = 57.0 bits (136), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 21/211 (9%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVEFK------NEVRL 479
A + F LG G FG V K + A+K L + Q +V+ K NE R+
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
+ + LV+L +V E++ + L GR RF + I
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FXEPHARFYAAQ-IV 151
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
YLH L +I+RDLK N+L+D + +++DFG A+ + T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPE 203
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory
Subunit Of Protein Kinase A That Represents The
Inhibited State
pdb|2CPK|E Chain E, Crystal Structure Of The Catalytic Subunit Of Cyclic
Adenosine Monophosphate-Dependent Protein Kinase
pdb|4DG0|E Chain E, Crystal Structure Of Myristoylated Wt Catalytic Subunit Of
Camp- Dependent Protein Kinase In Complex With Sp20 And
Amp-Pnp
pdb|4DG2|E Chain E, Crystal Structure Of Myristoylated Wt Catalytic Subunit Of
Camp- Dependent Protein Kinase In Complex With Sp20
pdb|4DH1|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With Low Mg2+, Atp And Ip20
pdb|4DH3|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Atp And Ip20
pdb|4DH5|A Chain A, Room Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Adp,
Phosphate, And Ip20
pdb|4DH7|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Amp-pnp And
Ip20'
pdb|4DH8|A Chain A, Room Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Amp-pnp And
Ip20
Length = 350
Score = 57.0 bits (136), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 21/211 (9%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVEFK------NEVRL 479
A + F LG G FG V K + A+K L + Q +V+ K NE R+
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
+ + LV+L +V E++ + L GR RF + I
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FXEPHARFYAAQ-IV 151
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
YLH L +I+RDLK N+L+D + +++DFG A+ + T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPE 203
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 2-(aminothiazoly)phenol (cmp2)
Length = 336
Score = 57.0 bits (136), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 59/239 (24%), Positives = 105/239 (43%), Gaps = 25/239 (10%)
Query: 403 KRKSPEKDQS----ISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQ--- 455
+R PE + + ++ +LK D++ + + ++G G FG V++ + D+Q
Sbjct: 28 QRLGPETEDNEGVLLTEKLKPVDYE-YREEVHWMTHQPRVGRGSFGEVHR--MKDKQTGF 84
Query: 456 EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDF 515
+ A+K++ V E+ A L +V L G G + E + SL
Sbjct: 85 QCAVKKVRLE-----VFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 139
Query: 516 FLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD-DKMNPKIS 574
+ G L ++ + +GL YLH R++H D+KA N+LL D +
Sbjct: 140 LIKQMG---CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALC 193
Query: 575 DFGMARIFE---VNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
DFG A + + +S I GT +M+PE M K D++S ++L +++G
Sbjct: 194 DFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252
>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2IWI|B Chain B, Crystal Structure Of The Human Pim2 In Complex With A
Ruthenium Organometallic Ligand Ru1
Length = 312
Score = 57.0 bits (136), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 22/212 (10%)
Query: 438 LGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN------EVRLIAKLQ----HT 486
LG+GGFG V+ G +L D +VAIK + R+ G + EV L+ K+ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLH 546
++RLL E +LV E P + D F + + + + R + ++ H
Sbjct: 99 GVIRLLDWFETQEGFMLVLE-RPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA---IQH 154
Query: 547 KYSRLRVIHRDLKASNILLDDKMN-PKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
+SR V+HRD+K NIL+D + K+ DFG + E T GT Y PE+
Sbjct: 155 CHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTD-FDGTRVYSPPEW 209
Query: 606 -AMSGIVSIKTDVFSFGVLVLEIVSGQKNHTR 636
+ ++ V+S G+L+ ++V G R
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCGDIPFER 241
>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With
Mgamp-Pnp
Length = 423
Score = 57.0 bits (136), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 69/240 (28%), Positives = 104/240 (43%), Gaps = 31/240 (12%)
Query: 401 YGKRKSPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIK 460
Y KS +Q S E+ F T+ N +G Y L ++ VAIK
Sbjct: 37 YNMSKSKVDNQFYSVEVGDSTF-TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIK 93
Query: 461 RLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF---- 516
+LSR F+N+ AK + LV L+ C H L+ F P K+L+ F
Sbjct: 94 KLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVY 143
Query: 517 ----LFNSGRKNV----LNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDK 568
L ++ V L+ E+ ++ + G+ +LH +IHRDLK SNI++
Sbjct: 144 LVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSD 200
Query: 569 MNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIV 628
KI DFG+AR S T +V Y Y +PE + D++S G ++ E+V
Sbjct: 201 CTLKILDFGLART--AGTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 257
>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From
Par-3
Length = 396
Score = 56.6 bits (135), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 49/164 (29%), Positives = 76/164 (46%), Gaps = 19/164 (11%)
Query: 485 HTNLVRLLGCSLHGEERLL-VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLL 543
H LV L C E RL V E++ L +F+ R+ L E IS L
Sbjct: 112 HPFLVGLHSC-FQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALN 167
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
YLH+ +I+RDLK N+LLD + + K++D+GM + E T GT Y++P
Sbjct: 168 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAP 222
Query: 604 EYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIG 647
E D ++ GVL+ E+++G+ P +++G
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMAGRS---------PFDIVG 257
>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8W|B Chain B, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|B Chain B, Crystal Structure Of Pkciota Kinase Domain
Length = 345
Score = 56.6 bits (135), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 47/148 (31%), Positives = 71/148 (47%), Gaps = 10/148 (6%)
Query: 485 HTNLVRLLGCSLHGEERLL-VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLL 543
H LV L C E RL V E++ L +F+ R+ L E IS L
Sbjct: 69 HPFLVGLHSC-FQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALN 124
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
YLH+ +I+RDLK N+LLD + + K++D+GM + E T GT Y++P
Sbjct: 125 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAP 179
Query: 604 EYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
E D ++ GVL+ E+++G+
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAGR 207
>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic
Subunit Of Camp-Dependent Protein Kinase Complexed With
A Peptide Inhibitor And Detergent
Length = 350
Score = 56.6 bits (135), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 21/211 (9%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVEFK------NEVRL 479
A + F LG G FG V K + A+K L + Q +V+ K NE R+
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
+ + LV+L +V E++ + L GR RF + I
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FAEPHARFYAAQ-IV 151
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
YLH L +I+RDLK N+L+D + +++DFG A+ + T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPE 203
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
pdb|2JC6|C Chain C, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
Length = 334
Score = 56.6 bits (135), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 432 FSTTNKLGEGGFGPVYKGKLADEQEV----AIKRLSRSSGQGI-VEFKNEVRLIAKLQHT 486
F LG G F V LA+E+ A+K + + + +G +NE+ ++ K++H
Sbjct: 24 FEFKETLGTGAFSEVV---LAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHE 80
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLH 546
N+V L LV + + L + G + +I + + YLH
Sbjct: 81 NIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKG---FYTEKDASTLIRQVLDAVYYLH 137
Query: 547 KYSRLRVIHRDLKASNILL---DDKMNPKISDFGMARIFEVNESEANTKRIV-GTYGYMS 602
R+ ++HRDLK N+L D++ ISDFG++++ E + + GT GY++
Sbjct: 138 ---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM----EGKGDVMSTACGTPGYVA 190
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
PE S D +S GV+ ++ G
Sbjct: 191 PEVLAQKPYSKAVDCWSIGVIAYILLCG 218
>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical
Protein Kinase C-Iota
Length = 364
Score = 56.6 bits (135), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 49/164 (29%), Positives = 76/164 (46%), Gaps = 19/164 (11%)
Query: 485 HTNLVRLLGCSLHGEERLL-VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLL 543
H LV L C E RL V E++ L +F+ R+ L E IS L
Sbjct: 80 HPFLVGLHSC-FQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALN 135
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
YLH+ +I+RDLK N+LLD + + K++D+GM + E T GT Y++P
Sbjct: 136 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAP 190
Query: 604 EYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIG 647
E D ++ GVL+ E+++G+ P +++G
Sbjct: 191 EILRGEDYGFSVDWWALGVLMFEMMAGRS---------PFDIVG 225
>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik)
pdb|4DN5|B Chain B, Crystal Structure Of Nf-kb-inducing Kinase (nik)
Length = 356
Score = 56.6 bits (135), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 66/259 (25%), Positives = 114/259 (44%), Gaps = 33/259 (12%)
Query: 390 KAKDNVSLLPTYGKRKSPEKDQS----------ISHELKIFDFQTIAAAANNFSTTN-KL 438
+A SL T+ R S ++ S ++ +LK D++ +++T +L
Sbjct: 25 QAHSLTSLAKTWAARGSRSREPSPKTEDNEGVLLTEKLKPVDYEYREEV--HWATHQLRL 82
Query: 439 GEGGFGPVYKGKLADEQ---EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCS 495
G G FG V++ + D+Q + A+K++ V E+ A L +V L G
Sbjct: 83 GRGSFGEVHR--MEDKQTGFQCAVKKVRLE-----VFRAEELMACAGLTSPRIVPLYGAV 135
Query: 496 LHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
G + E + SL + G L ++ + +GL YLH SR R++H
Sbjct: 136 REGPWVNIFMELLEGGSLGQLVKEQG---CLPEDRALYYLGQALEGLEYLH--SR-RILH 189
Query: 556 RDLKASNILLD-DKMNPKISDFGMARIFE---VNESEANTKRIVGTYGYMSPEYAMSGIV 611
D+KA N+LL D + + DFG A + + + I GT +M+PE +
Sbjct: 190 GDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSC 249
Query: 612 SIKTDVFSFGVLVLEIVSG 630
K DV+S ++L +++G
Sbjct: 250 DAKVDVWSSCCMMLHMLNG 268
>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|B Chain B, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|C Chain C, A Novel Small Molecule Apkc Inhibitor
Length = 349
Score = 56.6 bits (135), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 47/148 (31%), Positives = 71/148 (47%), Gaps = 10/148 (6%)
Query: 485 HTNLVRLLGCSLHGEERLL-VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLL 543
H LV L C E RL V E++ L +F+ R+ L E IS L
Sbjct: 65 HPFLVGLHSC-FQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALN 120
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
YLH+ +I+RDLK N+LLD + + K++D+GM + E T GT Y++P
Sbjct: 121 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAP 175
Query: 604 EYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
E D ++ GVL+ E+++G+
Sbjct: 176 EILRGEDYGFSVDWWALGVLMFEMMAGR 203
>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
pdb|2JKO|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 56.6 bits (135), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 53/196 (27%), Positives = 88/196 (44%), Gaps = 12/196 (6%)
Query: 438 LGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLVRLL 492
+GEG FG V++G + VAIK + + E F E + + H ++V+L+
Sbjct: 18 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
G + ++ E L FL RK L+ + +S L YL R
Sbjct: 78 GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVS 612
+HRD+ A N+L+ K+ DFG++R E + +K + +M+PE +
Sbjct: 132 FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPI-KWMAPESINFRRFT 190
Query: 613 IKTDVFSFGVLVLEIV 628
+DV+ FGV + EI+
Sbjct: 191 SASDVWMFGVCMWEIL 206
>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent
Protein Kinase
Length = 350
Score = 56.6 bits (135), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVEFK------NEVRL 479
A + F LG G FG V K + A+K L + Q +V+ K NE R+
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
+ + LV+L +V E++ + L GR + + RF + I
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQ-IV 151
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
YLH L +I+RDLK N+L+D + +++DFG A+ + T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPE 203
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein
Kinase C Beta Ii
Length = 674
Score = 56.6 bits (135), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 13/206 (6%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQEV-AIKRLSRS---SGQGIVEFKNEVRLIAKLQHT 486
+F+ LG+G FG V + E+ A+K L + + E R++A
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 401
Query: 487 NLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
+ L +RL V E++ L + + GR I+ GL +L
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGLFFL 458
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
+I+RDLK N++LD + + KI+DFGM + E TK GT Y++PE
Sbjct: 459 QSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPEI 513
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVSGQ 631
D ++FGVL+ E+++GQ
Sbjct: 514 IAYQPYGKSVDWWAFGVLLYEMLAGQ 539
>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And
Regulatory (Ri{alpha}) Subunits Of Pka
Length = 350
Score = 56.6 bits (135), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVEFK------NEVRL 479
A + F LG G FG V K + A+K L + Q +V+ K NE R+
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
+ + LV+L +V E++ + L GR + + RF + I
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQ-IV 151
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
YLH L +I+RDLK N+L+D + +++DFG A+ + T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLAGTPE 203
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map
Kinase Jnk1
Length = 370
Score = 56.6 bits (135), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 61/216 (28%), Positives = 94/216 (43%), Gaps = 37/216 (17%)
Query: 432 FSTTNKLGEGGFGPV---YKGKLADEQEVAIKRLSR--SSGQGIVEFKNEVRLIAKLQHT 486
+ +G G G V Y L E+ VAIK+LSR + E+ L+ + H
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNV----LNWEKRFII 534
N++ LL F P KSL+ F L ++ V L+ E+ +
Sbjct: 84 NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ + G+ +LH +IHRDLK SNI++ KI DFG+AR S T +
Sbjct: 132 LYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYV 186
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
V Y Y +PE + D++S G ++ E++ G
Sbjct: 187 VTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo
Form)
pdb|4FVQ|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain
(Mg-Atp-Bound Form)
Length = 289
Score = 56.6 bits (135), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 28/210 (13%)
Query: 438 LGEGGFGPVYKG---KLAD-----EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
LG+G F ++KG ++ D E EV +K L ++ F +++KL H +LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
G + G+E +LV EF+ SLD +L KN +N + + + ++ + +L + +
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAAMHFLEENT 133
Query: 550 RLRVIHRDLKASNILL---DDKM--NP---KISDFGMARIFEVNESEANTKRIVGTYGYM 601
+IH ++ A NILL +D+ NP K+SD G++ V + +RI ++
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS--ITVLPKDILQERI----PWV 184
Query: 602 SPEYAMSGI-VSIKTDVFSFGVLVLEIVSG 630
PE + +++ TD +SFG + EI SG
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSG 214
>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase
(nik)
pdb|4G3C|B Chain B, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase
(nik)
pdb|4G3E|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 6-alkynylindoline (cmp1)
pdb|4G3E|B Chain B, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 6-alkynylindoline (cmp1)
Length = 352
Score = 56.6 bits (135), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 60/239 (25%), Positives = 105/239 (43%), Gaps = 25/239 (10%)
Query: 403 KRKSPEKDQS----ISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQ--- 455
+R PE + + ++ +LK D++ + + ++G G FG V++ K D+Q
Sbjct: 44 QRLGPETEDNEGVLLTEKLKPVDYE-YREEVHWMTHQPRVGRGSFGEVHRMK--DKQTGF 100
Query: 456 EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDF 515
+ A+K++ V E+ A L +V L G G + E + SL
Sbjct: 101 QCAVKKVRLE-----VFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 155
Query: 516 FLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD-DKMNPKIS 574
+ G L ++ + +GL YLH R++H D+KA N+LL D +
Sbjct: 156 LIKQMG---CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALC 209
Query: 575 DFGMARIFE---VNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
DFG A + + +S I GT +M+PE M K D++S ++L +++G
Sbjct: 210 DFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268
>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 56.2 bits (134), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 61/216 (28%), Positives = 94/216 (43%), Gaps = 37/216 (17%)
Query: 432 FSTTNKLGEGGFGPV---YKGKLADEQEVAIKRLSR--SSGQGIVEFKNEVRLIAKLQHT 486
+ +G G G V Y L E+ VAIK+LSR + E+ L+ + H
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNV----LNWEKRFII 534
N++ LL F P KSL+ F L ++ V L+ E+ +
Sbjct: 84 NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ + G+ +LH +IHRDLK SNI++ KI DFG+AR S T +
Sbjct: 132 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYV 186
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
V Y Y +PE + D++S G ++ E++ G
Sbjct: 187 VTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant
Catalytic Subunit Of Camp-Dependent Protein Kinase
Complexed With The Peptide Inhibitor Pki(5-24) And
Adenosine
pdb|1JLU|E Chain E, Crystal Structure Of The Catalytic Subunit Of
Camp-dependent Protein Kinase Complexed With A
Phosphorylated Substrate Peptide And Detergent
pdb|1RE8|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 2
pdb|1REJ|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 1
pdb|1REK|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 8
pdb|2QVS|E Chain E, Crystal Structure Of Type Iia Holoenzyme Of Camp-Dependent
Protein Kinase
pdb|3FJQ|E Chain E, Crystal Structure Of Camp-Dependent Protein Kinase
Catalytic Subunit Alpha In Complex With Peptide
Inhibitor Pki Alpha (6-25)
pdb|3IDB|A Chain A, Crystal Structure Of (108-268)riib:c Holoenzyme Of Camp-
Dependent Protein Kinase
pdb|3IDC|A Chain A, Crystal Structure Of (102-265)riib:c Holoenzyme Of Camp-
Dependent Protein Kinase
pdb|3O7L|D Chain D, Crystal Structure Of Phospholamban (1-19):pka
C-Subunit:amp-Pnp:mg2+ Complex
pdb|3OW3|A Chain A, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|1ATP|E Chain E, 2.2 Angstrom Refined Crystal Structure Of The Catalytic
Subunit Of Camp-Dependent Protein Kinase Complexed With
Mnatp And A Peptide Inhibitor
pdb|4DIN|A Chain A, Novel Localization And Quaternary Structure Of The Pka Ri
Beta Holoenzyme
Length = 350
Score = 56.2 bits (134), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVEFK------NEVRL 479
A + F LG G FG V K + A+K L + Q +V+ K NE R+
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
+ + LV+L +V E++ + L GR + + RF + I
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQ-IV 151
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
YLH L +I+RDLK N+L+D + +++DFG A+ + T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPE 203
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit
Of Camp- Dependent Protein Kinase
Length = 350
Score = 56.2 bits (134), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVEFK------NEVRL 479
A + F LG G FG V K + A+K L + Q +V+ K NE R+
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
+ + LV+L +V E++ + L GR + + RF + I
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQ-IV 151
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
YLH L +I+RDLK N+L+D + +++DFG A+ + T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPE 203
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To
Hydroxyfasudil
Length = 351
Score = 56.2 bits (134), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVEFK------NEVRL 479
A + F LG G FG V K + A+K L + Q +V+ K NE R+
Sbjct: 39 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 95
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
+ + LV+L +V E++ + L GR + + RF + I
Sbjct: 96 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQ-IV 152
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
YLH L +I+RDLK N+L+D + +++DFG A+ + T + GT
Sbjct: 153 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPE 204
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of
Camp-Dependent Protein Kinase And Adenosine Further
Defines Conformational Flexibility
pdb|1BX6|A Chain A, Crystal Structure Of The Potent Natural Product Inhibitor
Balanol In Complex With The Catalytic Subunit Of Camp-
Dependent Protein Kinase
Length = 350
Score = 56.2 bits (134), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVEFK------NEVRL 479
A + F LG G FG V K + A+K L + Q +V+ K NE R+
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
+ + LV+L +V E++ + L GR + + RF + I
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQ-IV 151
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
YLH L +I+RDLK N+L+D + +++DFG A+ + T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPE 203
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp-
Dependent Protein Kinase Complexed With A Substrate
Peptide, Adp And Detergent
Length = 350
Score = 56.2 bits (134), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVEFK------NEVRL 479
A + F LG G FG V K + A+K L + Q +V+ K NE R+
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
+ + LV+L +V E++ + L GR + + RF + I
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQ-IV 151
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
YLH L +I+RDLK N+L+D + +++DFG A+ + T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPE 203
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide
pdb|4H39|A Chain A, Crystal Structure Of Jnk3 In Complex With Jip1 Peptide
pdb|4H3B|A Chain A, Crystal Structure Of Jnk3 In Complex With Sab Peptide
pdb|4H3B|C Chain C, Crystal Structure Of Jnk3 In Complex With Sab Peptide
Length = 356
Score = 56.2 bits (134), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 33/212 (15%)
Query: 432 FSTTNKLGEGGFGPV---YKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ +G G G V Y L ++ VAIK+LSR F+N+ AK + L
Sbjct: 20 YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYREL 68
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNV----LNWEKRFIIIE 536
V L+ C H L+ F P K+L+ F L ++ V L+ E+ ++
Sbjct: 69 V-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 127
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+ G+ +LH +IHRDLK SNI++ KI DFG+AR S T +V
Sbjct: 128 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVT 182
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIV 628
Y Y +PE + D++S G ++ E+V
Sbjct: 183 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 213
>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant
V617f (Mg- Atp-Bound Form)
Length = 289
Score = 56.2 bits (134), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 28/210 (13%)
Query: 438 LGEGGFGPVYKG---KLAD-----EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
LG+G F ++KG ++ D E EV +K L ++ F +++KL H +LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
G G+E +LV EF+ SLD +L KN +N + + + ++ + +L + +
Sbjct: 76 LNYGVCFCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAWAMHFLEENT 133
Query: 550 RLRVIHRDLKASNILL---DDKM--NP---KISDFGMARIFEVNESEANTKRIVGTYGYM 601
+IH ++ A NILL +D+ NP K+SD G++ V + +RI ++
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS--ITVLPKDILQERI----PWV 184
Query: 602 SPEYAMSGI-VSIKTDVFSFGVLVLEIVSG 630
PE + +++ TD +SFG + EI SG
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSG 214
>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3
Length = 356
Score = 56.2 bits (134), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 33/212 (15%)
Query: 432 FSTTNKLGEGGFGPV---YKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ +G G G V Y L ++ VAIK+LSR F+N+ AK + L
Sbjct: 20 YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYREL 68
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNV----LNWEKRFIIIE 536
V L+ C H L+ F P K+L+ F L ++ V L+ E+ ++
Sbjct: 69 V-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 127
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+ G+ +LH +IHRDLK SNI++ KI DFG+AR S T +V
Sbjct: 128 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVT 182
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIV 628
Y Y +PE + D++S G ++ E+V
Sbjct: 183 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 213
>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O17|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O2M|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
pdb|3O2M|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
Length = 370
Score = 55.8 bits (133), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 64/212 (30%), Positives = 95/212 (44%), Gaps = 33/212 (15%)
Query: 432 FSTTNKLGEGGFGPV---YKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ +G G G V Y L E+ VAIK+LSR F+N+ AK + L
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYREL 74
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNV----LNWEKRFIIIE 536
V L+ C H L+ F P KSL+ F L ++ V L+ E+ ++
Sbjct: 75 V-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLY 133
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+ G+ +LH +IHRDLK SNI++ KI DFG+AR S +V
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMEPEVVT 188
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIV 628
Y Y +PE + D++S G ++ E+V
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 219
>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious
Tri-Substituted Thiophene Based Jnk Inhibitor
Length = 363
Score = 55.8 bits (133), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 33/212 (15%)
Query: 432 FSTTNKLGEGGFGPV---YKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ +G G G V Y L ++ VAIK+LSR F+N+ AK + L
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYREL 74
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNV----LNWEKRFIIIE 536
V L+ C H L+ F P K+L+ F L ++ V L+ E+ ++
Sbjct: 75 V-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 133
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+ G+ +LH +IHRDLK SNI++ KI DFG+AR S T +V
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVT 188
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIV 628
Y Y +PE + D++S G ++ E+V
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 219
>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein
Kinase Catalytic Subunit
pdb|1J3H|B Chain B, Crystal Structure Of Apoenzyme Camp-Dependent Protein
Kinase Catalytic Subunit
Length = 350
Score = 55.8 bits (133), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVEFK------NEVRL 479
A + F LG G FG V K + A+K L + Q +V+ K NE R+
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
+ + LV+L +V E++ + L GR + + RF + I
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQ-IV 151
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
YLH L +I+RDLK N+L+D + +++DFG A+ + T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLXGTPE 203
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMQ|A Chain A, The Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMU|A Chain A, The Crystal Structure Of Jnk3 In Complex With A
Phenantroline Inhibitor
pdb|1PMV|A Chain A, The Structure Of Jnk3 In Complex With A
Dihydroanthrapyrazole Inhibitor
Length = 364
Score = 55.8 bits (133), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 33/212 (15%)
Query: 432 FSTTNKLGEGGFGPV---YKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ +G G G V Y L ++ VAIK+LSR F+N+ AK + L
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYREL 75
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNV----LNWEKRFIIIE 536
V L+ C H L+ F P K+L+ F L ++ V L+ E+ ++
Sbjct: 76 V-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 134
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+ G+ +LH +IHRDLK SNI++ KI DFG+AR S T +V
Sbjct: 135 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVT 189
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIV 628
Y Y +PE + D++S G ++ E+V
Sbjct: 190 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 220
>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3
Length = 355
Score = 55.8 bits (133), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 33/212 (15%)
Query: 432 FSTTNKLGEGGFGPV---YKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ +G G G V Y L ++ VAIK+LSR F+N+ AK + L
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYREL 67
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNV----LNWEKRFIIIE 536
V L+ C H L+ F P K+L+ F L ++ V L+ E+ ++
Sbjct: 68 V-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 126
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+ G+ +LH +IHRDLK SNI++ KI DFG+AR S T +V
Sbjct: 127 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVT 181
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIV 628
Y Y +PE + D++S G ++ E+V
Sbjct: 182 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 212
>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H89 Protein
Kinase Inhibitor N-[2-
(4-Bromocinnamylamino)ethyl]-5-Isoquinoline
pdb|1YDR|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H7 Protein
Kinase Inhibitor 1-(5-
Isoquinolinesulfonyl)-2-Methylpiperazine
pdb|1YDS|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H8 Protein
Kinase Inhibitor [n-(2-Methylamino)ethyl]-5-
Isoquinolinesulfonamide
Length = 350
Score = 55.8 bits (133), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 31/216 (14%)
Query: 427 AAANNFSTTNKLGEGGFGPV-----------YKGKLADEQEVA-IKRLSRSSGQGIVEFK 474
A + F LG G FG V Y K+ D+Q+V +K++ +
Sbjct: 38 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-------- 89
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
NE R++ + LV+L +V E++ + L GR + + RF
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYA 147
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ I YLH L +I+RDLK N+L+D + +++DFG A+ + T +
Sbjct: 148 AQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXL 198
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And
Thiazole Based Inhibitors Of Jnk For The Treatment Of
Neurodegenerative Diseases
pdb|3OY1|A Chain A, Highly Selective C-Jun N-Terminal Kinase (Jnk) 2 And 3
Inhibitors With In Vitro Cns-Like Pharmacokinetic
Properties
Length = 362
Score = 55.8 bits (133), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 33/212 (15%)
Query: 432 FSTTNKLGEGGFGPV---YKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ +G G G V Y L ++ VAIK+LSR F+N+ AK + L
Sbjct: 25 YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYREL 73
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNV----LNWEKRFIIIE 536
V L+ C H L+ F P K+L+ F L ++ V L+ E+ ++
Sbjct: 74 V-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 132
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+ G+ +LH +IHRDLK SNI++ KI DFG+AR S T +V
Sbjct: 133 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVT 187
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIV 628
Y Y +PE + D++S G ++ E+V
Sbjct: 188 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 218
>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-{3-Cyano-6-[3-(1-
Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2,
3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide
pdb|2O2U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Cyano-4,5,6,7-
Tetrahydro-1-Benzothien-2-Yl)-2-Fluorobenzamide
pdb|2ZDT|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|2ZDU|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|3DA6|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Methyl-
4-(3-(2-(Methylamino)pyrimidin-4-Yl)pyridin-2-Yloxy)
Naphthalen-1-Yl)-1h-Benzo[d]imidazol-2-Amine
pdb|2WAJ|A Chain A, Crystal Structure Of Human Jnk3 Complexed With A
1-Aryl-3,4- Dihydroisoquinoline Inhibitor
pdb|3V6R|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6R|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
Length = 364
Score = 55.8 bits (133), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 33/212 (15%)
Query: 432 FSTTNKLGEGGFGPV---YKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ +G G G V Y L ++ VAIK+LSR F+N+ AK + L
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYREL 74
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNV----LNWEKRFIIIE 536
V L+ C H L+ F P K+L+ F L ++ V L+ E+ ++
Sbjct: 75 V-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 133
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+ G+ +LH +IHRDLK SNI++ KI DFG+AR S T +V
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVT 188
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIV 628
Y Y +PE + D++S G ++ E+V
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 219
>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2P33|A Chain A, Synthesis And Sar Of Aminopyrimidines As Novel C-Jun N-
Terminal Kinase (Jnk) Inhibitors
pdb|3CGF|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3CGO|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3G90|X Chain X, Jnk-3 Bound To
(Z)-5-Fluoro-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)
Methyl)-3-(Hydroxyimino)indolin-2-One
pdb|3G9N|A Chain A, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Phenylindolin-2-One
pdb|3G9L|X Chain X, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Styrylindolin-2-One
Length = 365
Score = 55.8 bits (133), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 33/212 (15%)
Query: 432 FSTTNKLGEGGFGPV---YKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ +G G G V Y L ++ VAIK+LSR F+N+ AK + L
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYREL 75
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNV----LNWEKRFIIIE 536
V L+ C H L+ F P K+L+ F L ++ V L+ E+ ++
Sbjct: 76 V-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 134
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+ G+ +LH +IHRDLK SNI++ KI DFG+AR S T +V
Sbjct: 135 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVT 189
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIV 628
Y Y +PE + D++S G ++ E+V
Sbjct: 190 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 220
>pdb|3SOA|A Chain A, Full-Length Human Camkii
Length = 444
Score = 55.8 bits (133), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKG-KLADEQEVA-----IKRLSRSSGQGIVEFKNEVRLIAKL 483
+ +LG+G F V + K+ QE A K+LS Q + + E R+ L
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ---KLEREARICRLL 67
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLL 543
+H N+VRL L+++ + L F R+ + I + I + +L
Sbjct: 68 KHPNIVRLHDSISEEGHHYLIFDLVTGGEL--FEDIVAREYYSEADASHCI-QQILEAVL 124
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMN---PKISDFGMARIFEVNESEANTKRIVGTYGY 600
+ H+ + V+HR+LK N+LL K+ K++DFG+A EV + GT GY
Sbjct: 125 HCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPGY 179
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
+SPE D+++ GV++ ++ G
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVILYILLVG 209
>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a
Mutant In Complex With Sp600125 Inhibitor
Length = 390
Score = 55.8 bits (133), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 47/189 (24%), Positives = 89/189 (47%), Gaps = 18/189 (9%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIK--RLSRSSGQGIVEFKNEVRLI 480
+ I+ +S ++G GG V++ +Q AIK L + Q + ++NE+ +
Sbjct: 49 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108
Query: 481 AKLQ-HTN-LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI---II 535
KLQ H++ ++RL + + +Y M ++D + +K++ WE++ ++
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNML 165
Query: 536 EGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIV 595
E + H + ++H DLK +N L+ D M K+ DFG+A + + + V
Sbjct: 166 EAV-------HTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQV 217
Query: 596 GTYGYMSPE 604
G YM PE
Sbjct: 218 GAVNYMPPE 226
>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent
Protein Kinase With Unphosphorylated Activation Loop
pdb|4DFY|E Chain E, Crystal Structure Of R194a Mutant Of Camp-Dependent
Protein Kinase With Unphosphorylated Activation Loop
Length = 371
Score = 55.8 bits (133), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 21/211 (9%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVEFK------NEVRL 479
A + F LG G FG V K + A+K L + Q +V+ K NE R+
Sbjct: 59 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 115
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
+ + LV+L +V E++ + L GR + RF + I
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARFYAAQ-IV 172
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
YLH L +I+RDLK N+L+D + +++DFG A+ + T + GT
Sbjct: 173 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGATWTLCGTPE 224
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 225 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255
>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C
Beta Ii Complexed With A Bisindolylmaleimide Inhibitor
pdb|2I0E|B Chain B, Structure Of Catalytic Domain Of Human Protein Kinase C
Beta Ii Complexed With A Bisindolylmaleimide Inhibitor
Length = 353
Score = 55.8 bits (133), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 13/206 (6%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQEV-AIKRLSRS---SGQGIVEFKNEVRLIAKLQHT 486
+F+ LG+G FG V + E+ A+K L + + E R++A
Sbjct: 21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 487 NLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
+ L +RL V E++ L + + GR I+ GL +L
Sbjct: 81 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGLFFL 137
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
+I+RDLK N++LD + + KI+DFGM + E TK GT Y++PE
Sbjct: 138 QSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPEI 192
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVSGQ 631
D ++FGVL+ E+++GQ
Sbjct: 193 IAYQPYGKSVDWWAFGVLLYEMLAGQ 218
>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 55.5 bits (132), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 53/196 (27%), Positives = 88/196 (44%), Gaps = 12/196 (6%)
Query: 438 LGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLVRLL 492
+GEG FG V++G + VAIK + + E F E + + H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
G + ++ E L FL RK L+ + +S L YL R
Sbjct: 458 GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVS 612
+HRD+ A N+L+ K+ DFG++R E + +K + +M+PE +
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI-KWMAPESINFRRFT 570
Query: 613 IKTDVFSFGVLVLEIV 628
+DV+ FGV + EI+
Sbjct: 571 SASDVWMFGVCMWEIL 586
>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent
Protein Kinase Reveals Unexpected Apoenzyme Conformation
pdb|1SYK|B Chain B, Crystal Structure Of E230q Mutant Of Camp-Dependent
Protein Kinase Reveals Unexpected Apoenzyme Conformation
Length = 350
Score = 55.1 bits (131), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVEFK------NEVRL 479
A + F LG G FG V K + A+K L + Q +V+ K NE R+
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
+ + LV+L +V E++ + L GR + + RF + I
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQ-IV 151
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
YLH L +I+RDLK N+L+D + +++DFG A+ + T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPE 203
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y++PE +S + D ++ GVL+ ++ +G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234
>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors
pdb|2G01|B Chain B, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors
pdb|2GMX|A Chain A, Selective Aminopyridine-Based C-Jun N-Terminal Kinase
Inhibitors With Cellular Activity
pdb|2GMX|B Chain B, Selective Aminopyridine-Based C-Jun N-Terminal Kinase
Inhibitors With Cellular Activity
pdb|2H96|A Chain A, Discovery Of Potent, Highly Selective, And Orally
Bioavailable Pyridine Carboxamide C-Jun Nh2-Terminal
Kinase Inhibitors
pdb|2H96|B Chain B, Discovery Of Potent, Highly Selective, And Orally
Bioavailable Pyridine Carboxamide C-Jun Nh2-Terminal
Kinase Inhibitors
pdb|2NO3|A Chain A, Novel 4-Anilinopyrimidines As Potent Jnk1 Inhibitors
pdb|2NO3|B Chain B, Novel 4-Anilinopyrimidines As Potent Jnk1 Inhibitors
Length = 370
Score = 55.1 bits (131), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 64/212 (30%), Positives = 95/212 (44%), Gaps = 33/212 (15%)
Query: 432 FSTTNKLGEGGFGPV---YKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ +G G G V Y L E+ VAIK+LSR F+N+ AK + L
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYREL 74
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNV----LNWEKRFIIIE 536
V L+ C H L+ F P KSL+ F L ++ V L+ E+ ++
Sbjct: 75 V-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLY 133
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+ G+ +LH +IHRDLK SNI++ KI DFG+AR S +V
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMEPEVVT 188
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIV 628
Y Y +PE + D++S G ++ E+V
Sbjct: 189 RY-YRAPEVILGMGYKENVDLWSVGCIMGEMV 219
>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka
C-Subunit:amp-Pnp:mg2+ Complex
Length = 350
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVEFK------NEVRL 479
A + F LG G FG V K + A+K L + Q +V+ K NE R+
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
+ + LV+L +V E++ + L GR + + RF + I
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQ-IV 151
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
YLH L +I+RDLK N+++D + +++DFG A+ + T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPE 203
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y++PE +S + D ++ GVL+ E+ +G
Sbjct: 204 YLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234
>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains.
pdb|2J0K|B Chain B, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 53/196 (27%), Positives = 88/196 (44%), Gaps = 12/196 (6%)
Query: 438 LGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLVRLL 492
+GEG FG V++G + VAIK + + E F E + + H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
G + ++ E L FL RK L+ + +S L YL R
Sbjct: 458 GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVS 612
+HRD+ A N+L+ K+ DFG++R E + +K + +M+PE +
Sbjct: 512 FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPI-KWMAPESINFRRFT 570
Query: 613 IKTDVFSFGVLVLEIV 628
+DV+ FGV + EI+
Sbjct: 571 SASDVWMFGVCMWEIL 586
>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737
Length = 364
Score = 54.7 bits (130), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 37/214 (17%)
Query: 432 FSTTNKLGEGGFGPV---YKGKLADEQEVAIKRLSR--SSGQGIVEFKNEVRLIAKLQHT 486
+ +G G G V Y L ++ VAIK+LSR + E+ L+ + H
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNV----LNWEKRFII 534
N++ LL F P K+L+ F L ++ V L+ E+ +
Sbjct: 84 NIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYL 131
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ + G+ +LH +IHRDLK SNI++ KI DFG+AR S T +
Sbjct: 132 LYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYV 186
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIV 628
V Y Y +PE + D++S G ++ E+V
Sbjct: 187 VTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 219
>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With
Sb203580
Length = 362
Score = 54.7 bits (130), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 28/221 (12%)
Query: 425 IAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRL--SRSSGQGIVEFKN------- 475
+ A + ++ + G +G V G ++ VAIKR+ + S G+ + +
Sbjct: 17 LHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRV 76
Query: 476 --EVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI 533
E+RL+ H N++ L +H EE + ++ + L + V++ ++R +
Sbjct: 77 LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTE-----LMRTDLAQVIH-DQRIV 130
Query: 534 IIEGISQGLLY-----LHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588
I Q +Y LH V+HRDL NILL D + I DF +AR + ++
Sbjct: 131 ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR---EDTAD 187
Query: 589 ANTKRIVGTYGYMSPEYAMS--GIVSIKTDVFSFGVLVLEI 627
AN V Y +PE M G + D++S G ++ E+
Sbjct: 188 ANKTHYVTHRWYRAPELVMQFKGFTKL-VDMWSAGCVMAEM 227
>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In
A Putative Auto-Inhibition State
Length = 340
Score = 54.7 bits (130), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 60/224 (26%), Positives = 109/224 (48%), Gaps = 36/224 (16%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIA 481
Q A++ +LG G +G V K + + Q +A+KR+ + V + + RL+
Sbjct: 44 QNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-----RATVNSQEQKRLLM 98
Query: 482 KLQHTNLVRLLGC--------SLHGEERLLVYEFMPNKSLDFF---LFNSGR---KNVLN 527
L + +R + C +L E + + + + SLD F + + G+ +++L
Sbjct: 99 DLDIS--MRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILG 156
Query: 528 WEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587
I I + L +LH S+L VIHRD+K SN+L++ K+ DFG++ + +S
Sbjct: 157 K-----IAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGY--LVDS 207
Query: 588 EANTKRIVGTYGYMSPEYAMSGI----VSIKTDVFSFGVLVLEI 627
A T G YM+PE + S+K+D++S G+ ++E+
Sbjct: 208 VAKTID-AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 250
>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain
Length = 316
Score = 54.7 bits (130), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 438 LGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ-HTNLVRLLGCS 495
LGEG V L QE A+K + + G EV ++ + Q H N++ L+
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 496 LHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
+ LV+E M S+ L + ++ N + ++++ ++ L +LH + H
Sbjct: 81 EEEDRFYLVFEKMRGGSI---LSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAH 134
Query: 556 RDLKASNILLD--DKMNP-KISDFGMARIFEVNE--SEANTKRIV---GTYGYMSPEY-- 605
RDLK NIL + ++++P KI DF + ++N S +T ++ G+ YM+PE
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 606 AMSGIVSI---KTDVFSFGVLVLEIVSG 630
A S SI + D++S GV++ ++SG
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSG 222
>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv976
Length = 323
Score = 54.7 bits (130), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 78/315 (24%), Positives = 132/315 (41%), Gaps = 63/315 (20%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLADE----QEVAIKRLSRSS--------GQGIVEFK 474
A + + + LG G G V KLA E ++VAIK +S+ + +
Sbjct: 7 ALRDEYIMSKTLGSGACGEV---KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 63
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
E+ ++ KL H ++++ E+ +V E M L F G K + +
Sbjct: 64 TEIEILKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGEL--FDKVVGNKRLKEATCKLYF 120
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP---KISDFGMARIFEVNESEANT 591
+ + + YLH+ +IHRDLK N+LL + KI+DFG ++I E +
Sbjct: 121 YQML-LAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSL 172
Query: 592 KR-IVGTYGYMSPEYAMSGIVSIKT-------DVFSFGVLVLEIVSGQKNHTRHHPDRPL 643
R + GT Y++PE +VS+ T D +S GV++ +SG + H L
Sbjct: 173 MRTLCGTPTYLAPEV----LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 228
Query: 644 ---------NLIGYAWQLLSDG-----KGLELIDP--------SLEQPCSANEVMRCIHV 681
N I W +S+ K L ++DP +L P +E M+
Sbjct: 229 KDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQ 288
Query: 682 GLLCVQDQAMDRPTM 696
LL ++++ +P +
Sbjct: 289 DLLSEENESTAKPQV 303
>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC7|D Chain D, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC8|A Chain A, Crystal Structure Of The Apo Erk5 Kinase Domain
pdb|4IC8|B Chain B, Crystal Structure Of The Apo Erk5 Kinase Domain
Length = 442
Score = 54.7 bits (130), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 57/227 (25%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 417 LKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKN 475
LK F + + +G G +G V + Q+VAIK++ ++ + K
Sbjct: 42 LKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIP-NAFDVVTNAKR 100
Query: 476 ---EVRLIAKLQHTNLVRL---LGCSLHGEERLLVYEFMPNKSLDFF-LFNSGRKNVLNW 528
E++++ +H N++ + L ++ E VY + D + +S + L
Sbjct: 101 TLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEH 160
Query: 529 EKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588
+ F+ + +GL Y+H +VIHRDLK SN+L+++ KI DFGMAR + +E
Sbjct: 161 VRYFLY--QLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAE 215
Query: 589 AN--TKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQK 632
V T Y +PE +S + D++S G + E+++ ++
Sbjct: 216 HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262
>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
pdb|1KOB|B Chain B, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
Length = 387
Score = 54.7 bits (130), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 51/206 (24%), Positives = 93/206 (45%), Gaps = 19/206 (9%)
Query: 432 FSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+ +LG G FG V++ + A + K ++ KNE+ ++ +L H L+
Sbjct: 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFL----FNSGRKNVLNWEKRFIIIEGISQGLLYLH 546
L E +L+ EF+ L + + V+N+ ++ +GL ++H
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQ------ACEGLKHMH 166
Query: 547 KYSRLRVIHRDLKASNILLDDKM--NPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
++S ++H D+K NI+ + K + KI DFG+A +E K T + +PE
Sbjct: 167 EHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPE 220
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVSG 630
V TD+++ GVL ++SG
Sbjct: 221 IVDREPVGFYTDMWAIGVLGYVLLSG 246
>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs
Resolution)
Length = 362
Score = 54.3 bits (129), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 28/221 (12%)
Query: 425 IAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIV-----------EF 473
+ A + ++ + G +G V G ++ VAIKR+ + G
Sbjct: 17 LHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRV 76
Query: 474 KNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI 533
E+RL+ H N++ L +H EE + ++ + L + V++ ++R +
Sbjct: 77 LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTE-----LMRTDLAQVIH-DQRIV 130
Query: 534 IIEGISQGLLY-----LHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588
I Q +Y LH V+HRDL NILL D + I DF +AR + ++
Sbjct: 131 ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR---EDTAD 187
Query: 589 ANTKRIVGTYGYMSPEYAMS--GIVSIKTDVFSFGVLVLEI 627
AN V Y +PE M G + D++S G ++ E+
Sbjct: 188 ANKTHYVTHRWYRAPELVMQFKGFTKL-VDMWSAGCVMAEM 227
>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent
Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In
Complex With Sto-609
Length = 298
Score = 54.3 bits (129), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 53/172 (30%), Positives = 83/172 (48%), Gaps = 24/172 (13%)
Query: 470 IVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSG-------R 522
I + E+ ++ KL H N+V+L+ E L + F L N G
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLY--------MVFELVNQGPVMEVPTL 131
Query: 523 KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582
K + + RF + + +G+ YLH ++IHRD+K SN+L+ + + KI+DFG++
Sbjct: 132 KPLSEDQARFYF-QDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSN-- 185
Query: 583 EVNESEANTKRIVGTYGYMSPE--YAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
E S+A VGT +M+PE I S K DV++ GV + V GQ
Sbjct: 186 EFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit
Of Camp- Dependent Protein Kinase
Length = 350
Score = 53.9 bits (128), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 21/211 (9%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVEFK------NEVRL 479
A + F LG G FG V K + A+K L + Q +V+ K NE R+
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
+ + LV+L +V E++ + L GR + + RF + I
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQ-IV 151
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
YLH L +I+RDLK N+L+D + +++DFG A+ + T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPE 203
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y++P +S + D ++ GVL+ E+ +G
Sbjct: 204 YLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 7 Activated Mutant (S287d, T291d)
Length = 318
Score = 53.9 bits (128), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 35/101 (34%), Positives = 55/101 (54%), Gaps = 12/101 (11%)
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA-RIFEVNESEANTKRIV 595
I + L YL + + VIHRD+K SNILLD++ K+ DFG++ R+ + + R
Sbjct: 132 AIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD----DKAKDRSA 185
Query: 596 GTYGYMSPEY-----AMSGIVSIKTDVFSFGVLVLEIVSGQ 631
G YM+PE I+ DV+S G+ ++E+ +GQ
Sbjct: 186 GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
pdb|2BUJ|B Chain B, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
Length = 317
Score = 53.5 bits (127), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 60/228 (26%), Positives = 95/228 (41%), Gaps = 19/228 (8%)
Query: 420 FDFQTIAAAANNFSTTNKLGEGGFGPV-YKGKLADEQEVAIKRLSRSSGQGIVEFKNEVR 478
F + ++ KLGEGGF V L D A+KR+ Q E + E
Sbjct: 19 FQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREAD 78
Query: 479 LIAKLQHTNLVRLLGCSLH----GEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFI 533
+ H N++RL+ L E L+ F +L + + N L ++
Sbjct: 79 MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW 138
Query: 534 IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFG---MARIFEVNESEAN 590
++ GI +GL +H HRDLK +NILL D+ P + D G A I +A
Sbjct: 139 LLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQAL 195
Query: 591 TKRIVG----TYGYMSPEY---AMSGIVSIKTDVFSFGVLVLEIVSGQ 631
T + T Y +PE ++ +TDV+S G ++ ++ G+
Sbjct: 196 TLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774
Length = 355
Score = 53.5 bits (127), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 37/214 (17%)
Query: 432 FSTTNKLGEGGFGPV---YKGKLADEQEVAIKRLSR--SSGQGIVEFKNEVRLIAKLQHT 486
+ +G G G V Y L ++ VAIK+LSR + E+ L+ + H
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNV----LNWEKRFII 534
N++ LL F P K+L+ F L ++ V L+ E+ +
Sbjct: 84 NIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYL 131
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ + G+ +LH +IHRDLK SNI++ KI DFG+AR S T +
Sbjct: 132 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYV 186
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIV 628
V Y Y +PE + D++S G ++ E+V
Sbjct: 187 VTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 219
>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor
Length = 398
Score = 53.5 bits (127), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 57/227 (25%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 417 LKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKN 475
LK F + + +G G +G V + Q+VAIK++ ++ + K
Sbjct: 41 LKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIP-NAFDVVTNAKR 99
Query: 476 ---EVRLIAKLQHTNLVRL---LGCSLHGEERLLVYEFMPNKSLDFF-LFNSGRKNVLNW 528
E++++ +H N++ + L ++ E VY + D + +S + L
Sbjct: 100 TLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEH 159
Query: 529 EKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588
+ F+ + +GL Y+H +VIHRDLK SN+L+++ KI DFGMAR + +E
Sbjct: 160 VRYFLY--QLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAE 214
Query: 589 AN--TKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQK 632
V T Y +PE +S + D++S G + E+++ ++
Sbjct: 215 HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261
>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|C Chain C, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|D Chain D, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|E Chain E, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|F Chain F, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|G Chain G, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|H Chain H, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 443
Score = 53.5 bits (127), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 86/352 (24%), Positives = 146/352 (41%), Gaps = 75/352 (21%)
Query: 402 GKRKSPEKDQSISHEL---KIFDF-------QTI--AAAANNFSTTNKLGEGGFGPVYKG 449
GKR+ + I+ L K+F F Q++ A + + + LG G G V
Sbjct: 109 GKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEV--- 165
Query: 450 KLADE----QEVAIKRLSRSS--------GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLH 497
KLA E ++VAI+ +S+ + + E+ ++ KL H ++++
Sbjct: 166 KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKN-FFD 224
Query: 498 GEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRD 557
E+ +V E M L F G K + + + + + YLH+ +IHRD
Sbjct: 225 AEDYYIVLELMEGGEL--FDKVVGNKRLKEATCKLYFYQML-LAVQYLHENG---IIHRD 278
Query: 558 LKASNILLDDKMNP---KISDFGMARIFEVNESEANTKR-IVGTYGYMSPEYAMSGIVSI 613
LK N+LL + KI+DFG ++I E + R + GT Y++PE +VS+
Sbjct: 279 LKPENVLLSSQEEDCLIKITDFGHSKIL----GETSLMRTLCGTPTYLAPEV----LVSV 330
Query: 614 KT-------DVFSFGVLVLEIVSGQKNHTRHHPDRPL---------NLIGYAWQLLSDG- 656
T D +S GV++ +SG + H L N I W +S+
Sbjct: 331 GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKA 390
Query: 657 ----KGLELIDP--------SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTM 696
K L ++DP +L P +E M+ LL ++++ P +
Sbjct: 391 LDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQV 442
>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d)
Length = 290
Score = 53.1 bits (126), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 57/223 (25%), Positives = 110/223 (49%), Gaps = 36/223 (16%)
Query: 424 TIAAAANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAK 482
++ A++ +LG G +G V K + + Q +A+KR+ + V + + RL+
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-----RATVNSQEQKRLLMD 55
Query: 483 LQHTNLVRLLGC--------SLHGEERLLVYEFMPNKSLDFF---LFNSGR---KNVLNW 528
L + +R + C +L E + + + + SLD F + + G+ +++L
Sbjct: 56 LDIS--MRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGK 113
Query: 529 EKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588
I I + L +LH S+L VIHRD+K SN+L++ K+ DFG++ + V++
Sbjct: 114 -----IAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISG-YLVDDVA 165
Query: 589 ANTKRIVGTYGYMSPEYAMSGI----VSIKTDVFSFGVLVLEI 627
+ G YM+PE + S+K+D++S G+ ++E+
Sbjct: 166 KDID--AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206
>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With The Imidazo[1,2-B]pyridazine Inhibitor K00135
Length = 301
Score = 53.1 bits (126), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 52/219 (23%), Positives = 98/219 (44%), Gaps = 25/219 (11%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHT 486
A+ + +G+G +G V++G E VA+K S + + E+ L+H
Sbjct: 5 TVAHQITLLECVGKGRYGEVWRGSWQGEN-VAVKIFSSRDEKSWFR-ETELYNTVMLRHE 62
Query: 487 NLVRLLGCSL---HGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
N++ + + H +L L+ + SL +L + L+ I+ I+ GL
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGL 118
Query: 543 LYLH-----KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF--EVNESEANTKRIV 595
+LH + + HRDLK+ NIL+ I+D G+A + N+ + V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 596 GTYGYMSPEYAMSGIVSI-------KTDVFSFGVLVLEI 627
GT YM+PE + + + + D+++FG+++ E+
Sbjct: 179 GTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEV 216
>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin
Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin
Length = 330
Score = 53.1 bits (126), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 53/224 (23%), Positives = 98/224 (43%), Gaps = 25/224 (11%)
Query: 422 FQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIA 481
F A + +G+G +G V++G E VA+K S + + E+
Sbjct: 29 FLVQRTVARQITLLECVGKGRYGEVWRGSWQGEN-VAVKIFSSRDEKSWFR-ETELYNTV 86
Query: 482 KLQHTNLVRLLGCSL---HGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG 537
L+H N++ + + H +L L+ + SL +L + L+ I+
Sbjct: 87 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLS 142
Query: 538 ISQGLLYLH-----KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF--EVNESEAN 590
I+ GL +LH + + HRDLK+ NIL+ I+D G+A + N+ +
Sbjct: 143 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 202
Query: 591 TKRIVGTYGYMSPEYAMSGIVSI-------KTDVFSFGVLVLEI 627
VGT YM+PE + + + + D+++FG+++ E+
Sbjct: 203 NNPRVGTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEV 245
>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2-
Aminopyridine Inhibitor
pdb|3MTF|B Chain B, Crystal Structure Of The Acvr1 Kinase In Complex With A 2-
Aminopyridine Inhibitor
pdb|3OOM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With The Imidazo[1,2-B]pyridazine Inhibitor K00507
pdb|3Q4U|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|B Chain B, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|C Chain C, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|D Chain D, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
Length = 301
Score = 53.1 bits (126), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 52/219 (23%), Positives = 98/219 (44%), Gaps = 25/219 (11%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHT 486
A + + +G+G +G V++G E VA+K S + + E+ L+H
Sbjct: 5 TVARDITLLECVGKGRYGEVWRGSWQGEN-VAVKIFSSRDEKSWFR-ETELYNTVMLRHE 62
Query: 487 NLVRLLGCSL---HGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
N++ + + H +L L+ + SL +L + L+ I+ I+ GL
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGL 118
Query: 543 LYLH-----KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF--EVNESEANTKRIV 595
+LH + + HRDLK+ NIL+ I+D G+A + N+ + V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 596 GTYGYMSPEYAMSGIVSI-------KTDVFSFGVLVLEI 627
GT YM+PE + + + + D+++FG+++ E+
Sbjct: 179 GTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEV 216
>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX
Length = 361
Score = 52.8 bits (125), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 48/178 (26%), Positives = 77/178 (43%), Gaps = 9/178 (5%)
Query: 457 VAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF 516
V + + + S G + K E + L+H ++V LL +V+EFM L F
Sbjct: 59 VDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFE 118
Query: 517 LFNSGRKNVLNWEK-RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP---K 572
+ + E + I + L Y H + +IHRD+K +LL K N K
Sbjct: 119 IVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVK 175
Query: 573 ISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
+ FG+A ++ ES VGT +M+PE DV+ GV++ ++SG
Sbjct: 176 LGGFGVA--IQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231
>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form
pdb|3C0G|B Chain B, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form
pdb|3C0H|A Chain A, Cask Cam-Kinase Domain- Amppnp Complex, P1 Form
pdb|3C0H|B Chain B, Cask Cam-Kinase Domain- Amppnp Complex, P1 Form
pdb|3C0I|A Chain A, Cask Cam-Kinase Domain- 3'-Amp Complex, P212121 Form
Length = 351
Score = 52.8 bits (125), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 48/178 (26%), Positives = 77/178 (43%), Gaps = 9/178 (5%)
Query: 457 VAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF 516
V + + + S G + K E + L+H ++V LL +V+EFM L F
Sbjct: 57 VDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFE 116
Query: 517 LFNSGRKNVLNWEK-RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP---K 572
+ + E + I + L Y H + +IHRD+K +LL K N K
Sbjct: 117 IVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVK 173
Query: 573 ISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
+ FG+A ++ ES VGT +M+PE DV+ GV++ ++SG
Sbjct: 174 LGGFGVA--IQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1531
Length = 322
Score = 52.8 bits (125), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 71/272 (26%), Positives = 116/272 (42%), Gaps = 51/272 (18%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLADE----QEVAIKRLSRSS--------GQGIVEFK 474
A + + + LG G G V KLA E ++VAIK +S+ + +
Sbjct: 7 ALRDEYIMSKTLGSGACGEV---KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 63
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
E+ ++ KL H ++++ E+ +V E M L F G K + +
Sbjct: 64 TEIEILKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGEL--FDKVVGNKRLKEATCKLYF 120
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP---KISDFGMARIFEVNESEANT 591
+ + + YLH+ +IHRDLK N+LL + KI+DFG ++I E +
Sbjct: 121 YQML-LAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSL 172
Query: 592 KR-IVGTYGYMSPEYAMSGIVSIKT-------DVFSFGVLVLEIVSGQKNHTRHHPDRPL 643
R + GT Y++PE +VS+ T D +S GV++ +SG + H L
Sbjct: 173 MRTLCGTPTYLAPEV----LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 228
Query: 644 ---------NLIGYAWQLLSDGKGLELIDPSL 666
N I W +S+ K L+L+ L
Sbjct: 229 KDQITSGKYNFIPEVWAEVSE-KALDLVKKLL 259
>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In
Complex With Inhibitor Pv1533
Length = 322
Score = 52.8 bits (125), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 71/272 (26%), Positives = 116/272 (42%), Gaps = 51/272 (18%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLADE----QEVAIKRLSRSS--------GQGIVEFK 474
A + + + LG G G V KLA E ++VAIK +S+ + +
Sbjct: 6 ALRDEYIMSKTLGSGACGEV---KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 62
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
E+ ++ KL H ++++ E+ +V E M L F G K + +
Sbjct: 63 TEIEILKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGEL--FDKVVGNKRLKEATCKLYF 119
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP---KISDFGMARIFEVNESEANT 591
+ + + YLH+ +IHRDLK N+LL + KI+DFG ++I E +
Sbjct: 120 YQML-LAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSL 171
Query: 592 KR-IVGTYGYMSPEYAMSGIVSIKT-------DVFSFGVLVLEIVSGQKNHTRHHPDRPL 643
R + GT Y++PE +VS+ T D +S GV++ +SG + H L
Sbjct: 172 MRTLCGTPTYLAPEV----LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 227
Query: 644 ---------NLIGYAWQLLSDGKGLELIDPSL 666
N I W +S+ K L+L+ L
Sbjct: 228 KDQITSGKYNFIPEVWAEVSE-KALDLVKKLL 258
>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A
Specific Inhibitor
pdb|2W7X|A Chain A, Cellular Inhibition Of Checkpoint Kinase 2 And
Potentiation Of Cytotoxic Drugs By Novel Chk2 Inhibitor
Pv1019
pdb|2YIQ|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1322
pdb|2YIR|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1352
pdb|2YIT|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Pv1162, A Novel Inhibitor
pdb|2YCQ|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1115
pdb|2YCS|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Pv788
Length = 323
Score = 52.8 bits (125), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 71/272 (26%), Positives = 116/272 (42%), Gaps = 51/272 (18%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLADE----QEVAIKRLSRSS--------GQGIVEFK 474
A + + + LG G G V KLA E ++VAIK +S+ + +
Sbjct: 7 ALRDEYIMSKTLGSGACGEV---KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 63
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
E+ ++ KL H ++++ E+ +V E M L F G K + +
Sbjct: 64 TEIEILKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGEL--FDKVVGNKRLKEATCKLYF 120
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP---KISDFGMARIFEVNESEANT 591
+ + + YLH+ +IHRDLK N+LL + KI+DFG ++I E +
Sbjct: 121 YQML-LAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSL 172
Query: 592 KR-IVGTYGYMSPEYAMSGIVSIKT-------DVFSFGVLVLEIVSGQKNHTRHHPDRPL 643
R + GT Y++PE +VS+ T D +S GV++ +SG + H L
Sbjct: 173 MRTLCGTPTYLAPEV----LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 228
Query: 644 ---------NLIGYAWQLLSDGKGLELIDPSL 666
N I W +S+ K L+L+ L
Sbjct: 229 KDQITSGKYNFIPEVWAEVSE-KALDLVKKLL 259
>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of
Camp-Dependent Protein Kinase
Length = 350
Score = 52.8 bits (125), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 21/211 (9%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVEFK------NEVRL 479
A + F LG G FG V K + A+K L + Q +V+ K NE R+
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
+ + LV+L +V E++ + L GR + + RF + I
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQ-IV 151
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
YLH L +I+RDLK N+L+D + +++DFG A+ + T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPE 203
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
++PE +S + D ++ GVL+ E+ +G
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor,
Sr- 3451
Length = 353
Score = 52.8 bits (125), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 37/214 (17%)
Query: 432 FSTTNKLGEGGFGPV---YKGKLADEQEVAIKRLSR--SSGQGIVEFKNEVRLIAKLQHT 486
+ +G G G V Y L ++ VAIK+LSR + E+ L+ + H
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNV----LNWEKRFII 534
N++ LL F P K+L+ F L ++ V L+ E+ +
Sbjct: 84 NIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 131
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ + G+ +LH +IHRDLK SNI++ KI DFG+AR S T +
Sbjct: 132 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYV 186
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIV 628
V Y Y +PE + D++S G ++ E+V
Sbjct: 187 VTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 219
>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp
pdb|2CN8|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Debromohymenialdisine
pdb|2WTC|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTD|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTI|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XBJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XM8|A Chain A, Co-Crystal Structure Of A Small Molecule Inhibitor Bound
To The Kinase Domain Of Chk2
pdb|2XM9|A Chain A, Structure Of A Small Molecule Inhibitor With The Kinase
Domain Of Chk2
pdb|4A9R|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9S|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9T|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9U|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
Length = 329
Score = 52.8 bits (125), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 70/268 (26%), Positives = 115/268 (42%), Gaps = 51/268 (19%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGKLADE----QEVAIKRLSRSS--------GQGIVEFK 474
A + + + LG G G V KLA E ++VAIK +S+ + +
Sbjct: 13 ALRDEYIMSKTLGSGACGEV---KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 69
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
E+ ++ KL H ++++ E+ +V E M L F G K + +
Sbjct: 70 TEIEILKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGEL--FDKVVGNKRLKEATCKLYF 126
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP---KISDFGMARIFEVNESEANT 591
+ + + YLH+ +IHRDLK N+LL + KI+DFG ++I E +
Sbjct: 127 YQML-LAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSL 178
Query: 592 KR-IVGTYGYMSPEYAMSGIVSIKT-------DVFSFGVLVLEIVSGQKNHTRHHPDRPL 643
R + GT Y++PE +VS+ T D +S GV++ +SG + H L
Sbjct: 179 MRTLCGTPTYLAPEV----LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 234
Query: 644 ---------NLIGYAWQLLSDGKGLELI 662
N I W +S+ K L+L+
Sbjct: 235 KDQITSGKYNFIPEVWAEVSE-KALDLV 261
>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6U|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 419
Score = 52.8 bits (125), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 79/309 (25%), Positives = 131/309 (42%), Gaps = 63/309 (20%)
Query: 402 GKRKSPEKDQSISHEL---KIFDF-------QTI--AAAANNFSTTNKLGEGGFGPVYKG 449
GKR+ + I+ L K+F F Q++ A + + + LG G G V
Sbjct: 95 GKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEV--- 151
Query: 450 KLADE----QEVAIKRLSRSS--------GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLH 497
KLA E ++VAI+ +S+ + + E+ ++ KL H ++++
Sbjct: 152 KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKN-FFD 210
Query: 498 GEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRD 557
E+ +V E M L F G K + + + + + YLH+ +IHRD
Sbjct: 211 AEDYYIVLELMEGGEL--FDKVVGNKRLKEATCKLYFYQML-LAVQYLHENG---IIHRD 264
Query: 558 LKASNILLDDKMNP---KISDFGMARIFEVNESEANTKR-IVGTYGYMSPEYAMSGIVSI 613
LK N+LL + KI+DFG ++I E + R + GT Y++PE +VS+
Sbjct: 265 LKPENVLLSSQEEDCLIKITDFGHSKIL----GETSLMRTLCGTPTYLAPEV----LVSV 316
Query: 614 KT-------DVFSFGVLVLEIVSGQKNHTRHHPDRPL---------NLIGYAWQLLSDGK 657
T D +S GV++ +SG + H L N I W +S+ K
Sbjct: 317 GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE-K 375
Query: 658 GLELIDPSL 666
L+L+ L
Sbjct: 376 ALDLVKKLL 384
>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase
(gak)
pdb|3LL6|B Chain B, Crystal Structure Of The Human Cyclin G Associated Kinase
(gak)
Length = 337
Score = 52.8 bits (125), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 46/170 (27%), Positives = 77/170 (45%), Gaps = 12/170 (7%)
Query: 420 FDFQTIAAAANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVR 478
F QT+ L EGGF VY+ + + +E A+KRL + + EV
Sbjct: 18 FVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVC 77
Query: 479 LIAKLQ-HTNLVRLLGCSLHGEER--------LLVYEFMPNKSLDFFLFNSGRKNVLNWE 529
+ KL H N+V+ + G+E LL+ E + ++F L + L+ +
Sbjct: 78 FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEF-LKKMESRGPLSCD 136
Query: 530 KRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579
I + + ++H+ + +IHRDLK N+LL ++ K+ DFG A
Sbjct: 137 TVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185
>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7
pdb|2B9I|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Msg5
pdb|2B9J|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Far1
pdb|2F49|A Chain A, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2F49|B Chain B, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2FA2|A Chain A, Crystal Structure Of Fus3 Without A Peptide From Ste5
pdb|2FA2|B Chain B, Crystal Structure Of Fus3 Without A Peptide From Ste5
Length = 353
Score = 52.0 bits (123), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 55/234 (23%), Positives = 100/234 (42%), Gaps = 62/234 (26%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKN--EVRLIAKLQH 485
+++F + LGEG +G V E VAIK++ + + + E++++ +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKILKHFKH 68
Query: 486 TNLV---------------------RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKN 524
N++ L+ LH R++ + + + + +F++ + R
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQTDLH---RVISTQMLSDDHIQYFIYQTLR-- 123
Query: 525 VLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+ LH + VIHRDLK SN+L++ + K+ DFG+ARI +
Sbjct: 124 ----------------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI--I 162
Query: 585 NESEANTK----------RIVGTYGYMSPEYAM-SGIVSIKTDVFSFGVLVLEI 627
+ES A+ V T Y +PE + S S DV+S G ++ E+
Sbjct: 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase
pdb|2WNT|B Chain B, Crystal Structure Of The Human Ribosomal Protein S6 Kinase
Length = 330
Score = 52.0 bits (123), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 22/214 (10%)
Query: 452 ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLVYEFMPN 510
A E A+K + +S + E+ ++ + QH N++ L G+ LV E M
Sbjct: 50 ATNMEYAVKVIDKSKR----DPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRG 105
Query: 511 KSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNIL-LDDK 568
L D L R+ + + ++ I + + YLH V+HRDLK SNIL +D+
Sbjct: 106 GELLDKIL----RQKFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDES 158
Query: 569 MNP---KISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVL 625
NP +I DFG A+ T T +++PE D++S G+L+
Sbjct: 159 GNPECLRICDFGFAKQLRAENGLLMTP--CYTANFVAPEVLKRQGYDEGCDIWSLGILLY 216
Query: 626 EIVSGQ---KNHTRHHPDRPLNLIGYAWQLLSDG 656
+++G N P+ L IG LS G
Sbjct: 217 TMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGG 250
>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182
Length = 353
Score = 52.0 bits (123), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 55/234 (23%), Positives = 100/234 (42%), Gaps = 62/234 (26%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKN--EVRLIAKLQH 485
+++F + LGEG +G V E VAIK++ + + + E++++ +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKILKHFKH 68
Query: 486 TNLV---------------------RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKN 524
N++ L+ LH R++ + + + + +F++ + R
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQTDLH---RVISTQMLSDDHIQYFIYQTLR-- 123
Query: 525 VLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+ LH + VIHRDLK SN+L++ + K+ DFG+ARI +
Sbjct: 124 ----------------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI--I 162
Query: 585 NESEANTK----------RIVGTYGYMSPEYAM-SGIVSIKTDVFSFGVLVLEI 627
+ES A+ V T Y +PE + S S DV+S G ++ E+
Sbjct: 163 DESAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain
pdb|2HW6|B Chain B, Crystal Structure Of Mnk1 Catalytic Domain
Length = 307
Score = 52.0 bits (123), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 434 TTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ-HTNLVRL 491
T+ LGEG + V L + +E A+K + + +G EV + + Q + N++ L
Sbjct: 17 TSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILEL 76
Query: 492 LGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRL 551
+ LV+E + S+ L + ++ N + ++ ++ L +LH
Sbjct: 77 IEFFEDDTRFYLVFEKLQGGSI---LAHIQKQKHFNEREASRVVRDVAAALDFLHTKG-- 131
Query: 552 RVIHRDLKASNILLD--DKMNP-KISDFGMARIFEVNES-------EANTKRIVGTYGYM 601
+ HRDLK NIL + +K++P KI DF + ++N S E T G+ YM
Sbjct: 132 -IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTP--CGSAEYM 188
Query: 602 SPEYA-----MSGIVSIKTDVFSFGVLVLEIVSG 630
+PE + + D++S GV++ ++SG
Sbjct: 189 APEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222
>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain
Length = 332
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 35/103 (33%), Positives = 53/103 (51%), Gaps = 17/103 (16%)
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNIL--LDDKMNPKISDFGMARIFEVNESE------- 588
I++ + +LH ++HRDLK SNI +DD + K+ DFG+ + +E E
Sbjct: 173 IAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVV--KVGDFGLVTAMDQDEEEQTVLTPM 227
Query: 589 ---ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIV 628
A VGT YMSPE S K D+FS G+++ E++
Sbjct: 228 PAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270
Score = 37.0 bits (84), Expect = 0.045, Method: Compositional matrix adjust.
Identities = 23/68 (33%), Positives = 35/68 (51%), Gaps = 2/68 (2%)
Query: 431 NFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNL 488
+F +G GGFG V++ K D+ AIKR+ + + E EV+ +AKL+H +
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 489 VRLLGCSL 496
VR L
Sbjct: 67 VRYFNAWL 74
>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3
Length = 353
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 55/234 (23%), Positives = 100/234 (42%), Gaps = 62/234 (26%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKN--EVRLIAKLQH 485
+++F + LGEG +G V E VAIK++ + + + E++++ +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKILKHFKH 68
Query: 486 TNLV---------------------RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKN 524
N++ L+ LH R++ + + + + +F++ + R
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQTDLH---RVISTQMLSDDHIQYFIYQTLR-- 123
Query: 525 VLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+ LH + VIHRDLK SN+L++ + K+ DFG+ARI +
Sbjct: 124 ----------------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI--I 162
Query: 585 NESEANTK----------RIVGTYGYMSPEYAM-SGIVSIKTDVFSFGVLVLEI 627
+ES A+ V T Y +PE + S S DV+S G ++ E+
Sbjct: 163 DESAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain
pdb|3RNY|B Chain B, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain
Length = 346
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 22/214 (10%)
Query: 452 ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLVYEFMPN 510
A E A+K + +S + E+ ++ + QH N++ L G+ LV E M
Sbjct: 50 ATNMEYAVKVIDKSKR----DPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRG 105
Query: 511 -KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNIL-LDDK 568
+ LD L R+ + + ++ I + + YLH V+HRDLK SNIL +D+
Sbjct: 106 GELLDKIL----RQKFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDES 158
Query: 569 MNP---KISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVL 625
NP +I DFG A+ T T +++PE D++S G+L+
Sbjct: 159 GNPECLRICDFGFAKQLRAENGLLMTP--CYTANFVAPEVLKRQGYDEGCDIWSLGILLY 216
Query: 626 EIVSGQ---KNHTRHHPDRPLNLIGYAWQLLSDG 656
+++G N P+ L IG LS G
Sbjct: 217 TMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGG 250
>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
pdb|2VN9|B Chain B, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
Length = 301
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 430 NNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLS--RSSGQGIVEFKNEVRLIAKLQHT 486
+ + +LG+G F V + K+ QE A K ++ + S + + + E R+ L+H
Sbjct: 4 DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 63
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLH 546
N+VRL LV++ + L F R+ + I + I + + + H
Sbjct: 64 NIVRLHDSISEEGFHYLVFDLVTGGEL--FEDIVAREYYSEADASHCI-QQILESVNHCH 120
Query: 547 KYSRLRVIHRDLKASNILLDDKMN---PKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
++HRDLK N+LL K K++DFG+A EV + GT GY+SP
Sbjct: 121 LNG---IVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLSP 175
Query: 604 EYAMSGIVSIKTDVFSFGVLVLEIVSG 630
E D+++ GV++ ++ G
Sbjct: 176 EVLRKDPYGKPVDMWACGVILYILLVG 202
>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide
pdb|4F9A|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide
pdb|4F9A|C Chain C, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide
pdb|4F9B|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Pha767491
pdb|4F9B|C Chain C, Human Cdc7 Kinase In Complex With Dbf4 And Pha767491
pdb|4F9C|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Xl413
Length = 361
Score = 51.2 bits (121), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 56/253 (22%), Positives = 111/253 (43%), Gaps = 64/253 (25%)
Query: 422 FQTIAAAANNFSTTNKLGEGGFGPVYKG----KLADEQEVAIKRLSRSSGQGIVEFKNEV 477
++ + +N F +K+GEG F VY ++ E+++A+K L +S + +
Sbjct: 13 YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--------HPI 64
Query: 478 RLIAKLQ-------HTNLVRLLGCSLHGEERLLVYEFMPNKS----LDFFLFNSGRKNVL 526
R+ A+LQ N++ + C + ++ ++ ++S L+ F R+ +L
Sbjct: 65 RIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNSLSFQEVREYML 124
Query: 527 NWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP-KISDFGMAR----- 580
N K L +H++ ++HRD+K SN L + ++ + DFG+A+
Sbjct: 125 NLFK----------ALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171
Query: 581 ---IFEVNESEANTKRI------------------VGTYGYMSPEYAMSGI-VSIKTDVF 618
+ + +SEA +R GT G+ +PE + D++
Sbjct: 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMW 231
Query: 619 SFGVLVLEIVSGQ 631
S GV+ L ++SG+
Sbjct: 232 SAGVIFLSLLSGR 244
>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN-
Dependent Protein Kinase Ii Delta In Complex With
Calmodulin
Length = 327
Score = 51.2 bits (121), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 430 NNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLS--RSSGQGIVEFKNEVRLIAKLQHT 486
+ + +LG+G F V + K+ QE A K ++ + S + + + E R+ L+H
Sbjct: 4 DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 63
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLH 546
N+VRL LV++ + L F R+ + I + I + + + H
Sbjct: 64 NIVRLHDSISEEGFHYLVFDLVTGGEL--FEDIVAREYYSEADASHCI-QQILESVNHCH 120
Query: 547 KYSRLRVIHRDLKASNILLDDKMN---PKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
++HRDLK N+LL K K++DFG+A EV + GT GY+SP
Sbjct: 121 LNG---IVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLSP 175
Query: 604 EYAMSGIVSIKTDVFSFGVLVLEIVSG 630
E D+++ GV++ ++ G
Sbjct: 176 EVLRKDPYGKPVDMWACGVILYILLVG 202
>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution
pdb|1XR1|A Chain A, Crystal Structure Of Hpim-1 Kinase In Complex With Amp-Pnp
At 2.1 A Resolution
Length = 300
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 20/227 (8%)
Query: 415 HELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEF 473
H K+ + + + LG GGFG VY G +++D VAIK + + E
Sbjct: 8 HATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL 67
Query: 474 KN------EVRLIAKLQH--TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNV 525
N EV L+ K+ + ++RLL + +L+ E P D F F + R
Sbjct: 68 PNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GA 125
Query: 526 LNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEV 584
L E + + + + H V+HRD+K NIL+D ++ K+ DFG + +
Sbjct: 126 LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK- 181
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSG 630
+ GT Y PE+ ++ V+S G+L+ ++V G
Sbjct: 182 ---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225
>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From
Crystallographic Fragment Screen
Length = 301
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 20/227 (8%)
Query: 415 HELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEF 473
H K+ + + + LG GGFG VY G +++D VAIK + + E
Sbjct: 9 HATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL 68
Query: 474 KN------EVRLIAKLQH--TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNV 525
N EV L+ K+ + ++RLL + +L+ E P D F F + R
Sbjct: 69 PNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GA 126
Query: 526 LNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEV 584
L E + + + + H V+HRD+K NIL+D ++ K+ DFG + +
Sbjct: 127 LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK- 182
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSG 630
+ GT Y PE+ ++ V+S G+L+ ++V G
Sbjct: 183 ---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226
>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa
Length = 300
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 20/227 (8%)
Query: 415 HELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEF 473
H K+ + + + LG GGFG VY G +++D VAIK + + E
Sbjct: 8 HATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL 67
Query: 474 KN------EVRLIAKLQH--TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNV 525
N EV L+ K+ + ++RLL + +L+ E P D F F + R
Sbjct: 68 PNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GA 125
Query: 526 LNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEV 584
L E + + + + H V+HRD+K NIL+D ++ K+ DFG + +
Sbjct: 126 LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK- 181
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSG 630
+ GT Y PE+ ++ V+S G+L+ ++V G
Sbjct: 182 ---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225
>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|B Chain B, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|C Chain C, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|D Chain D, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3TV7|A Chain A, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|B Chain B, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|C Chain C, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|D Chain D, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TWJ|A Chain A, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|B Chain B, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|C Chain C, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|D Chain D, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
Length = 410
Score = 50.8 bits (120), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 17/237 (7%)
Query: 404 RKSPEKDQSIS-HELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEV-AIKR 461
RK+ D +S ++ I + + A ++ +G G FG V + ++V A+K
Sbjct: 42 RKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL 101
Query: 462 LSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLF 518
LS+ + F E R I ++ V L + + L +V E+MP L +
Sbjct: 102 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS 161
Query: 519 NSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGM 578
N +V RF E + L L + IHRD+K N+LLD + K++DFG
Sbjct: 162 NY---DVPEKWARFYTAEVV----LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT 214
Query: 579 ARIFEVNESEANTKRIVGTYGYMSPEYAMS----GIVSIKTDVFSFGVLVLEIVSGQ 631
E VGT Y+SPE S G + D +S GV + E++ G
Sbjct: 215 CMKMN-KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From
Crystallographic Fragment Screen
pdb|2XIZ|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-3 From
Crystallographic Fragment Screen
pdb|2XJ1|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inibitor
pdb|2XJ2|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inhibitor
Length = 301
Score = 50.8 bits (120), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 20/227 (8%)
Query: 415 HELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEF 473
H K+ + + + LG GGFG VY G +++D VAIK + + E
Sbjct: 9 HATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL 68
Query: 474 KN------EVRLIAKLQH--TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNV 525
N EV L+ K+ + ++RLL + +L+ E P D F F + R
Sbjct: 69 PNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GA 126
Query: 526 LNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEV 584
L E + + + + H V+HRD+K NIL+D ++ K+ DFG + +
Sbjct: 127 LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK- 182
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSG 630
+ GT Y PE+ ++ V+S G+L+ ++V G
Sbjct: 183 ---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226
>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From
Crystallographic Fragment Screen
Length = 301
Score = 50.8 bits (120), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 20/227 (8%)
Query: 415 HELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEF 473
H K+ + + + LG GGFG VY G +++D VAIK + + E
Sbjct: 9 HATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL 68
Query: 474 KN------EVRLIAKLQH--TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNV 525
N EV L+ K+ + ++RLL + +L+ E P D F F + R
Sbjct: 69 PNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GA 126
Query: 526 LNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEV 584
L E + + + + H V+HRD+K NIL+D ++ K+ DFG + +
Sbjct: 127 LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK- 182
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSG 630
+ GT Y PE+ ++ V+S G+L+ ++V G
Sbjct: 183 ---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226
>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil
pdb|2ESM|B Chain B, Crystal Structure Of Rock 1 Bound To Fasudil
pdb|2ETK|A Chain A, Crystal Structure Of Rock 1 Bound To Hydroxyfasudil
pdb|2ETK|B Chain B, Crystal Structure Of Rock 1 Bound To Hydroxyfasudil
pdb|2ETR|A Chain A, Crystal Structure Of Rock I Bound To Y-27632
pdb|2ETR|B Chain B, Crystal Structure Of Rock I Bound To Y-27632
pdb|3D9V|A Chain A, Crystal Structure Of Rock I Bound To H-1152p A Di-
Methylated Variant Of Fasudil
pdb|3D9V|B Chain B, Crystal Structure Of Rock I Bound To H-1152p A Di-
Methylated Variant Of Fasudil
pdb|3NCZ|A Chain A, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|B Chain B, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|C Chain C, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|D Chain D, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NDM|A Chain A, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|B Chain B, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|C Chain C, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|D Chain D, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
Length = 415
Score = 50.8 bits (120), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 17/237 (7%)
Query: 404 RKSPEKDQSIS-HELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEV-AIKR 461
RK+ D +S ++ I + + A ++ +G G FG V + ++V A+K
Sbjct: 47 RKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL 106
Query: 462 LSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLF 518
LS+ + F E R I ++ V L + + L +V E+MP L +
Sbjct: 107 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS 166
Query: 519 NSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGM 578
N +V RF E + L L + IHRD+K N+LLD + K++DFG
Sbjct: 167 NY---DVPEKWARFYTAEVV----LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT 219
Query: 579 ARIFEVNESEANTKRIVGTYGYMSPEYAMS----GIVSIKTDVFSFGVLVLEIVSGQ 631
E VGT Y+SPE S G + D +S GV + E++ G
Sbjct: 220 CMKMN-KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 275
>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe
Complex Structure
pdb|2V55|C Chain C, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe
Complex Structure
Length = 406
Score = 50.8 bits (120), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 17/237 (7%)
Query: 404 RKSPEKDQSIS-HELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEV-AIKR 461
RK+ D +S ++ I + + A ++ +G G FG V + ++V A+K
Sbjct: 47 RKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL 106
Query: 462 LSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLF 518
LS+ + F E R I ++ V L + + L +V E+MP L +
Sbjct: 107 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS 166
Query: 519 NSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGM 578
N +V RF E + L L + IHRD+K N+LLD + K++DFG
Sbjct: 167 NY---DVPEKWARFYTAEVV----LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT 219
Query: 579 ARIFEVNESEANTKRIVGTYGYMSPEYAMS----GIVSIKTDVFSFGVLVLEIVSGQ 631
E VGT Y+SPE S G + D +S GV + E++ G
Sbjct: 220 CMKMN-KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 275
>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of
P27kip1 Carboxy-Terminal Peptide
Length = 320
Score = 50.8 bits (120), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 20/227 (8%)
Query: 415 HELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEF 473
H K+ + + + LG GGFG VY G +++D VAIK + + E
Sbjct: 28 HATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL 87
Query: 474 KN------EVRLIAKLQH--TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNV 525
N EV L+ K+ + ++RLL + +L+ E P D F F + R
Sbjct: 88 PNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GA 145
Query: 526 LNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEV 584
L E + + + + H V+HRD+K NIL+D ++ K+ DFG + +
Sbjct: 146 LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK- 201
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSG 630
+ GT Y PE+ ++ V+S G+L+ ++V G
Sbjct: 202 ---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245
>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Naphtho-Difuran Ligand
Length = 313
Score = 50.4 bits (119), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 438 LGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN------EVRLIAKLQH--TNL 488
LG GGFG VY G +++D VAIK + + E N EV L+ K+ + +
Sbjct: 45 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
+RLL + +L+ E P D F F + R L E + + + + H
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNC 162
Query: 549 SRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
V+HRD+K NIL+D ++ K+ DFG + + + GT Y PE+
Sbjct: 163 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIR 215
Query: 608 SGIVSIKT-DVFSFGVLVLEIVSG 630
++ V+S G+L+ ++V G
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCG 239
>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With
Ly333531
Length = 312
Score = 50.4 bits (119), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 438 LGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN------EVRLIAKLQH--TNL 488
LG GGFG VY G +++D VAIK + + E N EV L+ K+ + +
Sbjct: 44 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
+RLL + +L+ E P D F F + R L E + + + + H
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNC 161
Query: 549 SRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
V+HRD+K NIL+D ++ K+ DFG + + + GT Y PE+
Sbjct: 162 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIR 214
Query: 608 SGIVSIKT-DVFSFGVLVLEIVSG 630
++ V+S G+L+ ++V G
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCG 238
>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Pyrrolo[2,3- A]carbazole Ligand
pdb|3QF9|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Furan- Thiazolidinedione Ligand
pdb|4GW8|A Chain A, Human Proto-Oncogene Serine Threonine Kinase (Pim1) In
Complex With A Consensus Peptide And Leucettine L41
Length = 313
Score = 50.4 bits (119), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 438 LGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN------EVRLIAKLQH--TNL 488
LG GGFG VY G +++D VAIK + + E N EV L+ K+ + +
Sbjct: 45 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
+RLL + +L+ E P D F F + R L E + + + + H
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNC 162
Query: 549 SRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
V+HRD+K NIL+D ++ K+ DFG + + + GT Y PE+
Sbjct: 163 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIR 215
Query: 608 SGIVSIKT-DVFSFGVLVLEIVSG 630
++ V+S G+L+ ++V G
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCG 239
>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its
Consensus Peptide Pimtide
pdb|2BZJ|A Chain A, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru3
pdb|2BZK|B Chain B, Crystal Structure Of The Human Pim1 In Complex With Amppnp
And Pimtide
pdb|2C3I|B Chain B, Crystal Structure Of Human Pim1 In Complex With
Imidazopyridazin I
pdb|2BZH|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2OI4|X Chain X, Crystal Structure Of Human Pim1 In Complex With
Fluorinated Ruthenium Pyridocarbazole
pdb|3BWF|A Chain A, Crystal Structure Of The Human Pim1 In Complex With An
Osmium Compound
Length = 313
Score = 50.4 bits (119), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 438 LGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN------EVRLIAKLQH--TNL 488
LG GGFG VY G +++D VAIK + + E N EV L+ K+ + +
Sbjct: 44 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
+RLL + +L+ E P D F F + R L E + + + + H
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNC 161
Query: 549 SRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
V+HRD+K NIL+D ++ K+ DFG + + + GT Y PE+
Sbjct: 162 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIR 214
Query: 608 SGIVSIKT-DVFSFGVLVLEIVSG 630
++ V+S G+L+ ++V G
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCG 238
>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And
The Jnk Inhibitor V
Length = 314
Score = 50.4 bits (119), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 438 LGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN------EVRLIAKLQH--TNL 488
LG GGFG VY G +++D VAIK + + E N EV L+ K+ + +
Sbjct: 45 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
+RLL + +L+ E P D F F + R L E + + + + H
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNC 162
Query: 549 SRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
V+HRD+K NIL+D ++ K+ DFG + + + GT Y PE+
Sbjct: 163 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIR 215
Query: 608 SGIVSIKT-DVFSFGVLVLEIVSG 630
++ V+S G+L+ ++V G
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCG 239
>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261
pdb|2BZI|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru2
Length = 313
Score = 50.4 bits (119), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 438 LGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN------EVRLIAKLQH--TNL 488
LG GGFG VY G +++D VAIK + + E N EV L+ K+ + +
Sbjct: 44 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
+RLL + +L+ E P D F F + R L E + + + + H
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNC 161
Query: 549 SRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
V+HRD+K NIL+D ++ K+ DFG + + + GT Y PE+
Sbjct: 162 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIR 214
Query: 608 SGIVSIKT-DVFSFGVLVLEIVSG 630
++ V+S G+L+ ++V G
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCG 238
>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small
Molecule Inhibitor
pdb|3UMX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indol-3-Yl)methylene]-7-(Azepan-1-Ylmethyl)-6-
Hydroxybenzofuran- 3(2h)-One
pdb|4ENX|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
Inhibitor (2e,5z)-2-
(2-Chlorophenylimino)-5-(4-Hydroxy-3-
Nitrobenzylidene)thiazolidin-4- One
pdb|4ENY|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
(2e,5z)-2-(2-
Chlorophenylimino)-5-(4-Hydroxy-3-
Methoxybenzylidene)thiazolidin-4- One
pdb|3UMW|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indazol-3-Yl)methylene]-6-Methoxy-7-(Piperazin-1-
Ylmethyl)benzofuran- 3(2h)-One
Length = 298
Score = 50.4 bits (119), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 438 LGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN------EVRLIAKLQH--TNL 488
LG GGFG VY G +++D VAIK + + E N EV L+ K+ + +
Sbjct: 17 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
+RLL + +L+ E P D F F + R L E + + + + H
Sbjct: 77 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNC 134
Query: 549 SRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
V+HRD+K NIL+D ++ K+ DFG + + + GT Y PE+
Sbjct: 135 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIR 187
Query: 608 SGIVSIKT-DVFSFGVLVLEIVSG 630
++ V+S G+L+ ++V G
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCG 211
>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand I
pdb|3CY2|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand Ii
Length = 314
Score = 50.4 bits (119), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 438 LGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN------EVRLIAKLQH--TNL 488
LG GGFG VY G +++D VAIK + + E N EV L+ K+ + +
Sbjct: 45 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
+RLL + +L+ E P D F F + R L E + + + + H
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNC 162
Query: 549 SRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
V+HRD+K NIL+D ++ K+ DFG + + + GT Y PE+
Sbjct: 163 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIR 215
Query: 608 SGIVSIKT-DVFSFGVLVLEIVSG 630
++ V+S G+L+ ++V G
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCG 239
>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain
Length = 313
Score = 50.4 bits (119), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 438 LGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN------EVRLIAKLQH--TNL 488
LG GGFG VY G +++D VAIK + + E N EV L+ K+ + +
Sbjct: 44 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
+RLL + +L+ E P D F F + R L E + + + + H
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNC 161
Query: 549 SRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
V+HRD+K NIL+D ++ K+ DFG + + + GT Y PE+
Sbjct: 162 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIR 214
Query: 608 SGIVSIKT-DVFSFGVLVLEIVSG 630
++ V+S G+L+ ++V G
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCG 238
>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JY0|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JYA|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
Length = 294
Score = 50.4 bits (119), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 438 LGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN------EVRLIAKLQH--TNL 488
LG GGFG VY G +++D VAIK + + E N EV L+ K+ + +
Sbjct: 17 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
+RLL + +L+ E P D F F + R L E + + + + H
Sbjct: 77 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNC 134
Query: 549 SRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
V+HRD+K NIL+D ++ K+ DFG + + + GT Y PE+
Sbjct: 135 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIR 187
Query: 608 SGIVSIKT-DVFSFGVLVLEIVSG 630
++ V+S G+L+ ++V G
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCG 211
>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With
4-(4-
Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One
pdb|3T9I|A Chain A, Pim1 Complexed With A Novel 3,6-Disubstituted Indole At
2.6 Ang Resolution
Length = 328
Score = 50.1 bits (118), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 438 LGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN------EVRLIAKLQH--TNL 488
LG GGFG VY G +++D VAIK + + E N EV L+ K+ + +
Sbjct: 59 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
+RLL + +L+ E P D F F + R L E + + + + H
Sbjct: 119 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNC 176
Query: 549 SRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
V+HRD+K NIL+D ++ K+ DFG + + + GT Y PE+
Sbjct: 177 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIR 229
Query: 608 SGIVSIKT-DVFSFGVLVLEIVSG 630
++ V+S G+L+ ++V G
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCG 253
>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target
Of Aberrant Somatic Hypermutations In Diffuse Large Cell
Lymphoma
pdb|1YXT|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amppnp
pdb|1YXU|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|B Chain B, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|C Chain C, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|D Chain D, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXV|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
3,4-Dihydroxy-1- Methylquinolin-2(1h)-One
pdb|1YXX|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
(3e)-3-[(4- Hydroxyphenyl)imino]-1h-Indol-2(3h)-One
pdb|2O3P|A Chain A, Crystal Structure Of Pim1 With Quercetin
pdb|2O63|A Chain A, Crystal Structure Of Pim1 With Myricetin
pdb|2O64|A Chain A, Crystal Structure Of Pim1 With Quercetagetin
pdb|2O65|A Chain A, Crystal Structure Of Pim1 With Pentahydroxyflavone
Length = 293
Score = 50.1 bits (118), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 438 LGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN------EVRLIAKLQH--TNL 488
LG GGFG VY G +++D VAIK + + E N EV L+ K+ + +
Sbjct: 16 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
+RLL + +L+ E P D F F + R L E + + + + H
Sbjct: 76 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNC 133
Query: 549 SRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
V+HRD+K NIL+D ++ K+ DFG + + + GT Y PE+
Sbjct: 134 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIR 186
Query: 608 SGIVSIKT-DVFSFGVLVLEIVSG 630
++ V+S G+L+ ++V G
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCG 210
>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine
pdb|1YI3|A Chain A, Crystal Structure Of Pim-1 Bound To Ly294002
pdb|1YI4|A Chain A, Structure Of Pim-1 Bound To Adenosine
Length = 273
Score = 50.1 bits (118), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 438 LGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN------EVRLIAKLQ--HTNL 488
LG GGFG VY G +++D VAIK + + E N EV L+ K+ + +
Sbjct: 12 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
+RLL + +L+ E P D F F + R L E + + + + H
Sbjct: 72 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNX 129
Query: 549 SRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
V+HRD+K NIL+D ++ K+ DFG + + + GT Y PE+
Sbjct: 130 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIR 182
Query: 608 SGIVSIKT-DVFSFGVLVLEIVSG 630
++ V+S G+L+ ++V G
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCG 206
>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R01|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R02|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R04|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3VBQ|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBT|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBV|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBW|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBX|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBY|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VC4|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
Length = 299
Score = 50.1 bits (118), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 438 LGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN------EVRLIAKLQH--TNL 488
LG GGFG VY G +++D VAIK + + E N EV L+ K+ + +
Sbjct: 17 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
+RLL + +L+ E P D F F + R L E + + + + H
Sbjct: 77 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNC 134
Query: 549 SRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
V+HRD+K NIL+D ++ K+ DFG + + + GT Y PE+
Sbjct: 135 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIR 187
Query: 608 SGIVSIKT-DVFSFGVLVLEIVSG 630
++ V+S G+L+ ++V G
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCG 211
>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors
Length = 273
Score = 50.1 bits (118), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 438 LGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN------EVRLIAKLQH--TNL 488
LG GGFG VY G +++D VAIK + + E N EV L+ K+ + +
Sbjct: 12 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
+RLL + +L+ E P D F F + R L E + + + + H
Sbjct: 72 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNC 129
Query: 549 SRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
V+HRD+K NIL+D ++ K+ DFG + + + GT Y PE+
Sbjct: 130 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIR 182
Query: 608 SGIVSIKT-DVFSFGVLVLEIVSG 630
++ V+S G+L+ ++V G
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCG 206
>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor
Length = 276
Score = 50.1 bits (118), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 438 LGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN------EVRLIAKLQH--TNL 488
LG GGFG VY G +++D VAIK + + E N EV L+ K+ + +
Sbjct: 15 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
+RLL + +L+ E P D F F + R L E + + + + H
Sbjct: 75 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNC 132
Query: 549 SRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
V+HRD+K NIL+D ++ K+ DFG + + + GT Y PE+
Sbjct: 133 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIR 185
Query: 608 SGIVSIKT-DVFSFGVLVLEIVSG 630
++ V+S G+L+ ++V G
Sbjct: 186 YHRYHGRSAAVWSLGILLYDMVCG 209
>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
pdb|4ALW|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
Length = 328
Score = 50.1 bits (118), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 438 LGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN------EVRLIAKLQH--TNL 488
LG GGFG VY G +++D VAIK + + E N EV L+ K+ + +
Sbjct: 59 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
+RLL + +L+ E P D F F + R L E + + + + H
Sbjct: 119 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNC 176
Query: 549 SRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
V+HRD+K NIL+D ++ K+ DFG + + + GT Y PE+
Sbjct: 177 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIR 229
Query: 608 SGIVSIKT-DVFSFGVLVLEIVSG 630
++ V+S G+L+ ++V G
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCG 253
>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|B Chain B, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|C Chain C, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|D Chain D, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
Length = 273
Score = 50.1 bits (118), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 438 LGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN------EVRLIAKLQ--HTNL 488
LG GGFG VY G +++D VAIK + + E N EV L+ K+ + +
Sbjct: 12 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
+RLL + +L+ E P D F F + R L E + + + + H
Sbjct: 72 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNC 129
Query: 549 SRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
V+HRD+K NIL+D ++ K+ DFG + + + GT Y PE+
Sbjct: 130 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIR 182
Query: 608 SGIVSIKT-DVFSFGVLVLEIVSG 630
++ V+S G+L+ ++V G
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCG 206
>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With
Inhibitor
pdb|3BGP|A Chain A, Human Pim-1 Complexed With A Benzoisoxazole Inhibitor Vx1
pdb|3BGQ|A Chain A, Human Pim-1 Kinase In Complex With An Triazolo Pyridazine
Inhibitor Vx2
pdb|3BGZ|A Chain A, Human Pim-1 Kinase In Complex With Diphenyl Indole
Inhibitor Vx3
Length = 333
Score = 50.1 bits (118), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 20/227 (8%)
Query: 415 HELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEF 473
H K+ + + + LG GGFG VY G +++D VAIK + + E
Sbjct: 41 HATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL 100
Query: 474 KN------EVRLIAKLQH--TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNV 525
N EV L+ K+ + ++RLL + +L+ E P D F F + R
Sbjct: 101 PNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GA 158
Query: 526 LNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEV 584
L E + + + + H V+HRD+K NIL+D ++ K+ DFG + +
Sbjct: 159 LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK- 214
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSG 630
+ GT Y PE+ ++ V+S G+L+ ++V G
Sbjct: 215 ---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 258
>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546
Length = 308
Score = 49.7 bits (117), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 20/212 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN------EVRLIAK 482
+ + LG GGFG VY G +++D VAIK + + E N EV L+ K
Sbjct: 31 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 90
Query: 483 LQH--TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ + ++RLL + +L+ E P D F F + R L E + +
Sbjct: 91 VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFWQVLE 148
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+ + H V+HRD+K NIL+D ++ K+ DFG + + + GT
Sbjct: 149 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRV 201
Query: 600 YMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSG 630
Y PE+ ++ V+S G+L+ ++V G
Sbjct: 202 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 233
>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|B Chain B, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|C Chain C, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|D Chain D, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
Length = 316
Score = 49.7 bits (117), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 56/218 (25%), Positives = 103/218 (47%), Gaps = 36/218 (16%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTN 487
A++ +LG G +G V K + + Q A+KR+ + V + + RL+ L +
Sbjct: 33 ADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRI-----RATVNSQEQKRLLXDLDISX 87
Query: 488 LVRLLGC--------SLHGEERLLVYEFMPNKSLDFF---LFNSGR---KNVLNWEKRFI 533
R + C +L E + + + + SLD F + + G+ +++L
Sbjct: 88 --RTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGK----- 140
Query: 534 IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR 593
I I + L +LH S+L VIHRD+K SN+L++ K DFG++ + V++ +
Sbjct: 141 IAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISG-YLVDDVAKDID- 196
Query: 594 IVGTYGYMSPEYAMSGI----VSIKTDVFSFGVLVLEI 627
G Y +PE + S+K+D++S G+ +E+
Sbjct: 197 -AGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIEL 233
>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B
(STK17B)
pdb|3LM5|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B
(STK17B) IN Complex With Quercetin
Length = 327
Score = 49.7 bits (117), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 430 NNFS--TTNKLGEGGFGPVYKG-KLADEQEVAIKRLS-RSSGQGI-VEFKNEVRLIAKLQ 484
NNF T+ +LG G F V + + QE A K L R GQ E +E+ ++ +
Sbjct: 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86
Query: 485 HT-NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLL 543
++ L + E +L+ E+ + F L +++ +I+ I +G+
Sbjct: 87 SCPRVINLHEVYENTSEIILILEYAAGGEI-FSLCLPELAEMVSENDVIRLIKQILEGVY 145
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKM---NPKISDFGMARIFEVNESEANTKRIVGTYGY 600
YLH+ + ++H DLK NILL + KI DFGM+R ++ + + I+GT Y
Sbjct: 146 YLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR--KIGHA-CELREIMGTPEY 199
Query: 601 MSPEYAMSGIVSIKTDVFSFGVL 623
++PE ++ TD+++ G++
Sbjct: 200 LAPEILNYDPITTATDMWNIGII 222
>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX
pdb|3ANQ|B Chain B, Human Dyrk1aINHIBITOR COMPLEX
pdb|3ANQ|C Chain C, Human Dyrk1aINHIBITOR COMPLEX
pdb|3ANQ|D Chain D, Human Dyrk1aINHIBITOR COMPLEX
pdb|3ANR|A Chain A, Human Dyrk1aHARMINE COMPLEX
pdb|3ANR|B Chain B, Human Dyrk1aHARMINE COMPLEX
pdb|3ANR|C Chain C, Human Dyrk1aHARMINE COMPLEX
pdb|3ANR|D Chain D, Human Dyrk1aHARMINE COMPLEX
Length = 368
Score = 49.3 bits (116), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTN-- 487
+ + + +G+G FG V K EQE ++ ++ + + + EVRL+ + +
Sbjct: 35 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 94
Query: 488 ----LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLL 543
+V L + LV+E + D + R LN ++F + + LL
Sbjct: 95 MKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKF--AQQMCTALL 152
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNP-----KISDFGMA-----RIFEVNESEANTKR 593
+L L +IH DLK NILL NP KI DFG + RI++ +S
Sbjct: 153 FL-ATPELSIIHCDLKPENILL---CNPKRSAIKIVDFGSSCQLGQRIYQXIQSRF---- 204
Query: 594 IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
Y SPE + + D++S G +++E+ +G+
Sbjct: 205 ------YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 236
>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine-
Phosphorylation-Regulated Kinase 1a
pdb|2VX3|B Chain B, Crystal Structure Of The Human Dual Specificity Tyrosine-
Phosphorylation-Regulated Kinase 1a
pdb|2VX3|C Chain C, Crystal Structure Of The Human Dual Specificity Tyrosine-
Phosphorylation-Regulated Kinase 1a
pdb|2VX3|D Chain D, Crystal Structure Of The Human Dual Specificity Tyrosine-
Phosphorylation-Regulated Kinase 1a
pdb|2WO6|A Chain A, Human Dual-Specificity Tyrosine-Phosphorylation-Regulated
Kinase 1a In Complex With A Consensus Substrate Peptide
pdb|2WO6|B Chain B, Human Dual-Specificity Tyrosine-Phosphorylation-Regulated
Kinase 1a In Complex With A Consensus Substrate Peptide
Length = 382
Score = 49.3 bits (116), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTN-- 487
+ + + +G+G FG V K EQE ++ ++ + + + EVRL+ + +
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113
Query: 488 ----LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLL 543
+V L + LV+E + D + R LN ++F + + LL
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKF--AQQMCTALL 171
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNP-----KISDFGMA-----RIFEVNESEANTKR 593
+L L +IH DLK NILL NP KI DFG + RI++ +S
Sbjct: 172 FL-ATPELSIIHCDLKPENILL---CNPKRSAIKIVDFGSSCQLGQRIYQXIQSRF---- 223
Query: 594 IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
Y SPE + + D++S G +++E+ +G+
Sbjct: 224 ------YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|B Chain B, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|C Chain C, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|D Chain D, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|E Chain E, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|F Chain F, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|G Chain G, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|H Chain H, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|I Chain I, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|J Chain J, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|K Chain K, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|L Chain L, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|M Chain M, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|N Chain N, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|O Chain O, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|P Chain P, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|Q Chain Q, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|R Chain R, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|S Chain S, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|T Chain T, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|U Chain U, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|V Chain V, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|W Chain W, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|X Chain X, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
Length = 305
Score = 49.3 bits (116), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 25/218 (11%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTN 487
A + +G+G +G V++G L + VA+K S Q + E+ L+H N
Sbjct: 6 VARQVALVECVGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFR-ETEIYNTVLLRHDN 63
Query: 488 LVRLLGCSLHGE----ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLL 543
++ + + + L+ + + SL FL ++ L + + GL
Sbjct: 64 ILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFL----QRQTLEPHLALRLAVSAACGLA 119
Query: 544 YLH-----KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE---ANTKRIV 595
+LH + + HRD K+ N+L+ + I+D G+A + N R V
Sbjct: 120 HLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPR-V 178
Query: 596 GTYGYMSPEYAMSGIV-----SIK-TDVFSFGVLVLEI 627
GT YM+PE I S K TD+++FG+++ EI
Sbjct: 179 GTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216
>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41
pdb|4AZE|B Chain B, Human Dyrk1a In Complex With Leucettine L41
pdb|4AZE|C Chain C, Human Dyrk1a In Complex With Leucettine L41
Length = 382
Score = 49.3 bits (116), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 53/215 (24%), Positives = 94/215 (43%), Gaps = 26/215 (12%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTN-- 487
+ + + +G+G FG V K EQE ++ ++ + + + EVRL+ + +
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113
Query: 488 ----LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLL 543
+V L + LV+E + D + R LN ++F + + LL
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKF--AQQMCTALL 171
Query: 544 YLHKYSRLRVIHRDLKASNILL--DDKMNPKISDFGMA-----RIFEVNESEANTKRIVG 596
+L L +IH DLK NILL + KI DFG + RI++ +S
Sbjct: 172 FL-ATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRIYQXIQSRF------- 223
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
Y SPE + + D++S G +++E+ +G+
Sbjct: 224 ---YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp
Site Inhibitor
Length = 301
Score = 48.9 bits (115), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 29/220 (13%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
A +G+G FG V++GK E EVA+K S + + E+ L+H N+
Sbjct: 3 ARTIVLQESIGKGRFGEVWRGKWRGE-EVAVKIFSSREERSWFR-EAEIYQTVMLRHENI 60
Query: 489 VRLLGCSLHGE----ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
+ + + LV ++ + SL F+ + + E + + GL +
Sbjct: 61 LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAH 116
Query: 545 LH-----KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI----- 594
LH + + HRDLK+ NIL+ I+D G+A ++S +T I
Sbjct: 117 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHR 173
Query: 595 VGTYGYMSPEYA-----MSGIVSIK-TDVFSFGVLVLEIV 628
VGT YM+PE M S K D+++ G++ EI
Sbjct: 174 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 213
>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|B Chain B, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|C Chain C, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|D Chain D, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
Length = 432
Score = 48.9 bits (115), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 53/210 (25%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKN-EVRLIAKL-QHTNL 488
+F + LG G G + + D ++VA+KR+ F + EV+L+ + +H N+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC----FSFADREVQLLRESDEHPNV 80
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
+R C+ + + + +L ++ + L E +++ + GL +LH
Sbjct: 81 IRYF-CTEKDRQFQYIAIELCAATLQEYVEQKDFAH-LGLEP-ITLLQQTTSGLAHLHS- 136
Query: 549 SRLRVIHRDLKASNILLD-----DKMNPKISDFGMARIFEV-NESEANTKRIVGTYGYMS 602
L ++HRDLK NIL+ K+ ISDFG+ + V S + + GT G+++
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 603 PEYAMSGIVSIKT---DVFSFGVLVLEIVS 629
PE T D+FS G + ++S
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224
>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation
Length = 293
Score = 48.9 bits (115), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 438 LGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKN------EVRLIAKLQH--TNL 488
LG GGFG VY G +++D VAIK + + E N EV L+ K+ + +
Sbjct: 16 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
+RLL + +L+ E M D F F + R L E + + + + H
Sbjct: 76 IRLLDWFERPDSFVLILERM-EPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNC 133
Query: 549 SRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
V+HRD+K NIL+D ++ K+ DFG + + + GT Y PE+
Sbjct: 134 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIR 186
Query: 608 SGIVSIKT-DVFSFGVLVLEIVSG 630
++ V+S G+L+ ++V G
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCG 210
>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90
Ribosomal S6 Kinase 2 (rsk2)
pdb|4D9U|A Chain A, Rsk2 C-Terminal Kinase Domain, (E)-Tert-Butyl
3-(4-Amino-7-(3-
Hydroxypropyl)-5-P-Tolyl-7h-Pyrrolo[2,
3-D]pyrimidin-6-Yl)-2- Cyanoacrylate
pdb|4D9T|A Chain A, Rsk2 C-Terminal Kinase Domain With Inhibitor (E)-Methyl
3-(4-Amino-7-
(3-Hydroxypropyl)-5-P-Tolyl-7h-Pyrrolo[2,
3-D]pyrimidin-6-Yl)-2- Cyanoacrylate
Length = 342
Score = 48.9 bits (115), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 50/183 (27%), Positives = 81/183 (44%), Gaps = 15/183 (8%)
Query: 452 ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNK 511
A E A+K + +S E + +R QH N++ L G+ +V E M
Sbjct: 45 ATNMEFAVKIIDKSKRDPTEEIEILLRY---GQHPNIITLKDVYDDGKYVYVVTELMKGG 101
Query: 512 SLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNIL-LDDKMN 570
L L R+ + + ++ I++ + YLH V+HRDLK SNIL +D+ N
Sbjct: 102 EL---LDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGN 155
Query: 571 P---KISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEI 627
P +I DFG A+ T T +++PE D++S GVL+ +
Sbjct: 156 PESIRICDFGFAKQLRAENGLLMTP--CYTANFVAPEVLERQGYDAACDIWSLGVLLYTM 213
Query: 628 VSG 630
++G
Sbjct: 214 LTG 216
>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|D Chain D, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|F Chain F, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|H Chain H, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1IAS|A Chain A, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|B Chain B, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|C Chain C, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|D Chain D, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|E Chain E, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|3FAA|A Chain A, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|B Chain B, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|C Chain C, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|D Chain D, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|E Chain E, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3KCF|A Chain A, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|B Chain B, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|C Chain C, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|D Chain D, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|E Chain E, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|2X7O|A Chain A, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|B Chain B, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|C Chain C, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|D Chain D, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|E Chain E, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
Length = 342
Score = 48.9 bits (115), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 29/220 (13%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
A +G+G FG V++GK E EVA+K S + + E+ L+H N+
Sbjct: 41 ARTIVLQESIGKGRFGEVWRGKWRGE-EVAVKIFSSREERSWFR-EAEIYQTVMLRHENI 98
Query: 489 VRLLGCSLHGE----ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
+ + + LV ++ + SL F+ + + E + + GL +
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAH 154
Query: 545 LH-----KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI----- 594
LH + + HRDLK+ NIL+ I+D G+A ++S +T I
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHR 211
Query: 595 VGTYGYMSPEYA-----MSGIVSIK-TDVFSFGVLVLEIV 628
VGT YM+PE M S K D+++ G++ EI
Sbjct: 212 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251
>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With
Inhibitor
Length = 326
Score = 48.9 bits (115), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 29/220 (13%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
A +G+G FG V++GK E EVA+K S + + E+ L+H N+
Sbjct: 28 ARTIVLQESIGKGRFGEVWRGKWRGE-EVAVKIFSSREERSWFR-EAEIYQTVMLRHENI 85
Query: 489 VRLLGCSLHGE----ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
+ + + LV ++ + SL F+ + + E + + GL +
Sbjct: 86 LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAH 141
Query: 545 LH-----KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI----- 594
LH + + HRDLK+ NIL+ I+D G+A ++S +T I
Sbjct: 142 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHR 198
Query: 595 VGTYGYMSPEYA-----MSGIVSIK-TDVFSFGVLVLEIV 628
VGT YM+PE M S K D+++ G++ EI
Sbjct: 199 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 238
>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3-
Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine
pdb|2WOU|A Chain A, Alk5 In Complex With
4-((4-((2,6-Dimethyl-3-Pyridyl)oxy)-2-
Pyridyl)amino)benzenesulfonamide
Length = 306
Score = 48.5 bits (114), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 29/220 (13%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
A +G+G FG V++GK E EVA+K S + + E+ L+H N+
Sbjct: 5 ARTIVLQESIGKGRFGEVWRGKWRGE-EVAVKIFSSREERSWFR-EAEIYQTVMLRHENI 62
Query: 489 VRLLGCSLHGE----ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
+ + + LV ++ + SL F+ + + E + + GL +
Sbjct: 63 LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAH 118
Query: 545 LH-----KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI----- 594
LH + + HRDLK+ NIL+ I+D G+A ++S +T I
Sbjct: 119 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHR 175
Query: 595 VGTYGYMSPEYA-----MSGIVSIK-TDVFSFGVLVLEIV 628
VGT YM+PE M S K D+++ G++ EI
Sbjct: 176 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 215
>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human
Tgf- Beta Type I Receptor
pdb|3GXL|A Chain A, Alk-5 Kinase Complex With Gw857175
pdb|3HMM|A Chain A, Structure Of Alk5 + Gw855857
Length = 303
Score = 48.5 bits (114), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 29/219 (13%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
A +G+G FG V++GK E EVA+K S + + E+ L+H N+
Sbjct: 2 ARTIVLQESIGKGRFGEVWRGKWRGE-EVAVKIFSSREERSWFR-EAEIYQTVMLRHENI 59
Query: 489 VRLLGCSLHGE----ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
+ + + LV ++ + SL F+ + + E + + GL +
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAH 115
Query: 545 LH-----KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI----- 594
LH + + HRDLK+ NIL+ I+D G+A ++S +T I
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHR 172
Query: 595 VGTYGYMSPEYA-----MSGIVSIK-TDVFSFGVLVLEI 627
VGT YM+PE M S K D+++ G++ EI
Sbjct: 173 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211
>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542
Length = 309
Score = 48.5 bits (114), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 29/220 (13%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
A +G+G FG V++GK E EVA+K S + + E+ L+H N+
Sbjct: 8 ARTIVLQESIGKGRFGEVWRGKWRGE-EVAVKIFSSREERSWFR-EAEIYQTVMLRHENI 65
Query: 489 VRLLGCSLHGE----ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
+ + + LV ++ + SL F+ + + E + + GL +
Sbjct: 66 LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAH 121
Query: 545 LH-----KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI----- 594
LH + + HRDLK+ NIL+ I+D G+A ++S +T I
Sbjct: 122 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHR 178
Query: 595 VGTYGYMSPEYA-----MSGIVSIK-TDVFSFGVLVLEIV 628
VGT YM+PE M S K D+++ G++ EI
Sbjct: 179 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 218
>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
In With Amp-Pnp
pdb|3KN5|B Chain B, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
In With Amp-Pnp
pdb|3KN6|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
pdb|3KN6|B Chain B, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
Length = 325
Score = 47.4 bits (111), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 16/210 (7%)
Query: 438 LGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
LGEG F K Q A+K +S+ + ++L H N+V+L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG--HPNIVKLHEVFH 76
Query: 497 HGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHR 556
LV E + L F +K+ E +I+ + +S + ++H V+HR
Sbjct: 77 DQLHTFLVMELLNGGEL--FERIKKKKHFSETEASYIMRKLVS-AVSHMHDVG---VVHR 130
Query: 557 DLKASNILL---DDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI 613
DLK N+L +D + KI DFG AR+ + T T Y +PE
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF--TLHYAAPELLNQNGYDE 188
Query: 614 KTDVFSFGVLVLEIVSGQKNHTRHHPDRPL 643
D++S GV++ ++SGQ H DR L
Sbjct: 189 SCDLWSLGVILYTMLSGQVPFQSH--DRSL 216
>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|B Chain B, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|C Chain C, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|D Chain D, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|E Chain E, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|F Chain F, Crystal Structure Of Human Pas Kinase Bound To Adp
Length = 335
Score = 46.6 bits (109), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 49/204 (24%), Positives = 89/204 (43%), Gaps = 23/204 (11%)
Query: 418 KIFDFQTIAAA----ANNFSTTNKLGEGGFGPVYKGKLADE-QEVAIKRLSRS------- 465
K + + +AA + +ST + LG G FG V+ ++ +EV +K + +
Sbjct: 8 KAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCW 67
Query: 466 -SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKN 524
+ + E+ ++++++H N++++L + LV E LD F F
Sbjct: 68 IEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVME-KHGSGLDLFAFIDRHPR 126
Query: 525 VLNWEKRFIIIEGISQGLLYLHKYSRLR-VIHRDLKASNILLDDKMNPKISDFGMARIFE 583
+ +I + +S Y RL+ +IHRD+K NI++ + K+ DFG A E
Sbjct: 127 LDEPLASYIFRQLVSA-----VGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181
Query: 584 VNESEANTKRIVGTYGYMSPEYAM 607
+ GT Y +PE M
Sbjct: 182 RGKL---FYTFCGTIEYCAPEVLM 202
>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major
pdb|3E3P|B Chain B, Glycogen Synthase Kinase From Leishmania Major
Length = 360
Score = 46.2 bits (108), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 29/219 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNE----VRLIAKLQ 484
+ F G+G FG V GK + VAIK++ + F+N ++ +A L
Sbjct: 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-----RFRNRELQIMQDLAVLH 77
Query: 485 HTNLVRLLGC--SLHGEERLLVY-----EFMPNKSLDFFLFNSGRKNVLNWE---KRFII 534
H N+V+L +L +R +Y E++P+ +L N R+ V K F+
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP-KISDFGMARIFEVNESEANTKR 593
S G L+L + V HRD+K N+L+++ K+ DFG A+ +++ SE N
Sbjct: 137 QLIRSIGCLHL---PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK--KLSPSEPNVAY 191
Query: 594 IVGTYGYMSPEYAMSGI-VSIKTDVFSFGVLVLEIVSGQ 631
I Y Y +PE + D++S G + E++ G+
Sbjct: 192 ICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.319 0.136 0.416
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 23,712,914
Number of Sequences: 62578
Number of extensions: 1046063
Number of successful extensions: 4687
Number of sequences better than 100.0: 1000
Number of HSP's better than 100.0 without gapping: 839
Number of HSP's successfully gapped in prelim test: 261
Number of HSP's that attempted gapping in prelim test: 2327
Number of HSP's gapped (non-prelim): 1150
length of query: 752
length of database: 14,973,337
effective HSP length: 106
effective length of query: 646
effective length of database: 8,340,069
effective search space: 5387684574
effective search space used: 5387684574
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.8 bits)
S2: 55 (25.8 bits)